*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 250 ALA A 4 ALA^? 37.50 N6 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -9.47 2.58 4.42 -9.97 2.04 3.08 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 250 ALA B 64 ALA.? 15.41 N1 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -22.22 17.81 20.01 -22.67 17.81 18.54 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 250 ALA C 4 ALA^? 13.75 C2 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -25.90 34.40 28.80 -25.82 35.52 27.80 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 250 ALA C 64 ALA.? 14.62 N1 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -21.29 34.81 25.43 -22.58 35.15 26.14 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 86 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 250 ALA D 64 ALA.? 26.15 N6 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -16.76 49.68 19.26 -17.00 50.74 18.25 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 7 hits 2wwt_o00 naa= 3 ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 A 39 ARG B 23 ARG.? 16.12 O1A ADP C1001 A 219 LYS B 114 LYS.? -3.14 O1A ADP C1001s A 376 GLY B 22 GLY.? 14.86 O1A ADP C1001 A 399 GLY B 73 GLY~? 6.44 O1A ADP C1001 coo -12.38 76.96 90.60 -12.31 75.41 87.97 -35.24 15.53 3.08 -37.20 16.95 1.17 coo -15.03 67.62 79.35 -16.01 71.68 83.38 -38.05 28.30 5.66 -42.50 28.99 10.13 coo -9.88 73.08 89.49 -9.40 72.65 89.00 -33.99 15.05 9.19 -33.34 14.99 8.60 coo -11.12 75.93 79.79 -10.82 76.54 80.30 -38.60 21.75 11.85 -37.95 21.79 12.31 13pk_c00 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c00 naa= 4 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 C 39 ARG B 23 ARG.? 16.12 O1A ADP C1001 C 219 LYS B 114 LYS.? -3.14 O1A ADP C1001s C 376 GLY B 22 GLY.? 14.86 O1A ADP C1001 C 399 GLY B 73 GLY~? 6.44 O1A ADP C1001 coo -3.47 26.80 67.67 -1.24 26.00 69.62 -35.24 15.53 3.08 -37.20 16.95 1.17 coo 5.22 26.79 80.32 0.48 26.84 77.06 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 1.35 28.76 68.50 2.09 28.66 68.61 -33.99 15.05 9.19 -33.34 14.99 8.60 coo 2.85 20.10 73.72 2.25 20.01 73.15 -38.60 21.75 11.85 -37.95 21.79 12.31 13pk_c02 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c02 naa= 4 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 D 39 ARG B 11 ARG~? 27.94 N6 ADP C1001 D 219 LYS B 19 LYS.? 15.59 N6 ADP C1001 D 376 GLY B 12 GLY~? 22.61 N6 ADP C1001 D 399 GLY B 93 GLY.? 16.72 N6 ADP C1001 coo 0.59 75.69 110.95 1.51 77.84 112.93 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 1.28 85.37 123.16 0.84 80.41 120.28 -31.10 21.58 3.18 -29.68 25.32 0.22 coo -1.06 80.88 111.45 -0.91 81.65 111.55 -17.91 15.52 4.82 -17.88 16.00 4.18 coo 7.52 81.86 116.81 7.49 81.18 116.34 -22.84 26.20 1.59 -22.97 25.70 2.25 13pk_c03 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c03 naa= 4 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 C 88 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 89 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 92 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 115 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 35.82 109.51 58.11 36.79 111.39 58.16 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 34.50 112.32 53.52 36.24 113.36 54.10 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 44.76 111.03 53.07 46.05 111.62 51.50 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 43.88 105.59 49.49 44.98 111.77 48.53 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 C 88 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 89 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 92 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 115 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 35.82 109.51 58.11 36.79 111.39 58.16 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 34.50 112.32 53.52 36.24 113.36 54.10 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 44.76 111.03 53.07 46.05 111.62 51.50 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 43.88 105.59 49.49 44.98 111.77 48.53 -21.36 39.39 22.00 -17.64 41.95 19.02 1a95_c00 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 2 hits 1a95_c00 naa= 4 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 A 88 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 89 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 92 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 115 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 28.94 110.40 17.72 27.05 109.42 17.78 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 27.21 110.68 22.97 26.09 108.99 22.41 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 28.82 100.59 20.87 28.57 98.90 22.12 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 34.37 100.82 23.64 28.36 99.87 25.42 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 A 88 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 89 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 92 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 115 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 28.94 110.40 17.72 27.05 109.42 17.78 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 27.21 110.68 22.97 26.09 108.99 22.41 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 28.82 100.59 20.87 28.57 98.90 22.12 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 34.37 100.82 23.64 28.36 99.87 25.42 -21.36 39.39 22.00 -17.64 41.95 19.02 1a95_c01 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 2 hits 1a95_c01 naa= 4 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 B 88 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 89 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 92 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 115 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 15.87 130.02 20.98 17.78 130.94 20.91 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 18.52 128.66 25.62 19.66 130.36 25.09 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 17.38 138.95 26.03 17.97 140.13 27.68 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 11.86 138.01 29.49 18.01 139.06 30.49 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 B 88 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 89 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 92 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 115 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 15.87 130.02 20.98 17.78 130.94 20.91 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 18.52 128.66 25.62 19.66 130.36 25.09 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 17.38 138.95 26.03 17.97 140.13 27.68 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 11.86 138.01 29.49 18.01 139.06 30.49 -21.36 39.39 22.00 -17.64 41.95 19.02 1a95_c02 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 2 hits 1a95_c02 naa= 4 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 D 88 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 89 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 92 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 115 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 16.10 122.43 61.36 15.17 120.52 61.32 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 16.52 120.83 56.08 14.84 119.68 56.64 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 6.41 122.44 58.21 4.75 122.21 56.90 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 6.66 128.09 55.52 5.74 122.11 53.55 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 D 88 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 89 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 92 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 115 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 16.10 122.43 61.36 15.17 120.52 61.32 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 16.52 120.83 56.08 14.84 119.68 56.64 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 6.41 122.44 58.21 4.75 122.21 56.90 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 6.66 128.09 55.52 5.74 122.11 53.55 -21.36 39.39 22.00 -17.64 41.95 19.02 1a95_c03 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 2 hits 1a95_c03 naa= 4 ULMN 4 1ddj_c04 PLASMINOGEN user 1 4 # 1 A 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 646 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 741 ALA A 64 ALA.? 37.27 N6 ADP C1001 A 742 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1ddj_c04 PLASMINOGEN user 2 4 # 2 A 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 646 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 741 ALA B 64 ALA.? 15.41 N1 ADP C1001 A 742 GLY B 63 GLY.? 19.32 N1 ADP C1001 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -22.22 17.81 20.01 -22.67 17.81 18.54 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -21.09 14.83 22.17 -21.52 14.99 21.54 ULMN 4 1ddj_c04 PLASMINOGEN user 3 4 # 3 A 603 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 646 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 741 ALA C 64 ALA.? 14.62 N1 ADP C1001 A 742 GLY C 63 GLY.? 18.10 N1 ADP C1001 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -21.29 34.81 25.43 -22.58 35.15 26.14 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -18.24 37.08 25.10 -19.00 37.10 25.28 ULMN 4 1ddj_c04 PLASMINOGEN user 4 4 # 4 A 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 646 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 741 ALA D 64 ALA.? 26.15 N6 ADP C1001 A 742 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -16.76 49.68 19.26 -17.00 50.74 18.25 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -19.39 47.07 20.40 -19.28 47.74 19.95 1ddj_c04 source 1ddj PLASMINOGEN : 4 hits 1ddj_c04 naa= 4 ULMN 4 1ddj_c05 PLASMINOGEN user 1 4 # 1 B 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 646 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 741 ALA A 64 ALA.? 37.27 N6 ADP C1001 B 742 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1ddj_c05 PLASMINOGEN user 2 4 # 2 B 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 646 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 741 ALA B 64 ALA.? 15.41 N1 ADP C1001 B 742 GLY B 63 GLY.? 19.32 N1 ADP C1001 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -22.22 17.81 20.01 -22.67 17.81 18.54 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -21.09 14.83 22.17 -21.52 14.99 21.54 ULMN 4 1ddj_c05 PLASMINOGEN user 3 4 # 3 B 603 HIS C 62 HIS~? 21.13 N1 ADP C1001 B 646 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 741 ALA C 64 ALA.? 14.62 N1 ADP C1001 B 742 GLY C 63 GLY.? 18.10 N1 ADP C1001 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -21.29 34.81 25.43 -22.58 35.15 26.14 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -18.24 37.08 25.10 -19.00 37.10 25.28 ULMN 4 1ddj_c05 PLASMINOGEN user 4 4 # 4 B 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 646 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 741 ALA D 64 ALA.? 26.15 N6 ADP C1001 B 742 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -16.76 49.68 19.26 -17.00 50.74 18.25 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -19.39 47.07 20.40 -19.28 47.74 19.95 1ddj_c05 source 1ddj PLASMINOGEN : 4 hits 1ddj_c05 naa= 4 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 1 4 # 1 B 92 TYR B 70 TYR.? 11.71 N6 ADP C1001 B 112 PHE B 21 PHE.? 12.47 N7 ADP C1001 B 178 PHE B 27 PHE^? 16.30 N6 ADP C1001 B 333 TRP B 113 TRP.? 6.23 N7 ADP C1001 coo 99.56 54.98 23.15 101.17 54.32 25.32 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 95.53 46.26 28.54 97.54 48.18 28.09 -31.61 18.24 11.10 -30.96 16.75 13.38 coo 102.10 41.65 23.98 100.86 42.71 26.26 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 96.01 57.16 30.39 98.35 54.06 31.01 -33.53 30.14 7.96 -35.79 27.09 9.08 1di1_c01 source 1di1 ARISTOLOCHENE SYNTHASE : 1 hits 1di1_c01 naa= 4 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 1 4 # 1 A 132 GLU C 44 GLU^? 27.03 C2 ADP C1001 A 136 ARG C 25 ARG.? 26.50 C2 ADP C1001 A 275 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 435 GLU C 48 GLU.? 22.51 O2' ADP C1001 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 -28.75 47.24 35.01 -29.12 48.55 36.63 coo -4.99 57.22 1.82 -7.93 56.43 2.21 -32.85 47.91 34.77 -31.37 50.53 33.86 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 -33.52 53.52 23.97 -33.48 52.09 22.33 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 2 4 # 2 A 132 GLU C 44 GLU^? 27.03 C2 ADP C1001 A 136 ARG C 25 ARG.? 26.50 C2 ADP C1001 A 275 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 435 GLU C 48 GLU.? 22.51 O2' ADP C1001 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 -28.75 47.24 35.01 -29.12 48.55 36.63 coo -4.99 57.22 1.82 -7.93 56.43 2.21 -32.85 47.91 34.77 -31.37 50.53 33.86 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 -33.52 53.52 23.97 -33.48 52.09 22.33 1dl2_c00 source 1dl2 CLASS I ALPHA-1,2-MANNOSIDASE : 2 hits 1dl2_c00 naa= 4 ULMN 4 1e6e_c01 ADRENODOXIN user 1 4 # 1 C 55 HIS C 50 HIS.? 17.04 O2' ADP C1001 C 159 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 376 ILE C 72 ILE.? 7.13 O2' ADP C1001 C 377 THR C 69 THR.? 8.25 C2 ADP C1001 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -36.38 48.00 21.35 -37.79 46.44 21.40 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -36.14 35.80 22.16 -34.87 35.47 21.60 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -34.19 32.67 26.93 -33.84 33.77 25.09 1e6e_c01 source 1e6e ADRENODOXIN : 1 hits 1e6e_c01 naa= 4 ULMN 4 1ec9_c10 GLUCARATE DEHYDRATASE user 1 4 # 1 C 207 LYS A 14 LYS~? 28.69 N1 ADP C1001 C 313 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 339 HIS B 62 HIS~? 22.43 N1 ADP C1001 C 373 GLU B 33 GLU^? 22.82 N1 ADP C1001 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -12.97 3.35 18.51 -15.05 7.51 22.75 coo 14.38 -3.57 -21.43 15.64 -4.13 -22.99 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 16.32 -0.08 -20.39 18.30 -0.81 -20.35 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 19.17 4.23 -38.89 19.57 5.42 -40.57 -10.19 23.43 20.85 -11.43 22.93 22.49 1ec9_c10 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c10 naa= 4 ULMN 4 1f6d_c00 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 4 # 1 A 95 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 117 GLU B 8 GLU.? 21.08 N6 ADP C1001 A 131 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 213 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 46.83 58.85 1.64 47.10 59.61 -0.35 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 53.79 54.48 -1.23 52.45 55.58 -2.50 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 44.71 62.22 -0.37 43.17 63.49 -1.03 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 48.73 68.19 -10.10 50.09 67.84 -8.53 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 4 1f6d_c00 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 4 # 2 A 95 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 117 GLU C 78 GLU~? 9.17 N6 ADP C1001 A 131 GLU B 115 GLU.? 12.48 O1B ADP C1001 A 213 HIS B 20 HIS.? 13.19 O1A ADP C1001 coo 46.83 58.85 1.64 47.10 59.61 -0.35 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 53.79 54.48 -1.23 52.45 55.58 -2.50 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 44.71 62.22 -0.37 43.17 63.49 -1.03 -39.49 31.51 1.54 -40.33 32.66 0.02 coo 48.73 68.19 -10.10 50.09 67.84 -8.53 -35.44 19.24 3.79 -36.86 20.32 2.70 1f6d_c00 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 2 hits 1f6d_c00 naa= 4 ULMN 4 1f6d_c03 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 4 # 1 D 95 ASP B 10 ASP.? 28.32 N6 ADP C1001 D 117 GLU B 8 GLU.? 21.08 N6 ADP C1001 D 131 GLU A 41 GLU^? 26.55 N6 ADP C1001 D 213 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 60.45 59.04 95.56 60.08 59.57 97.62 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 53.51 54.68 98.43 54.65 55.64 99.96 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 62.34 62.21 97.48 63.80 63.61 98.07 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 57.94 68.02 108.20 56.70 67.43 106.62 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 4 1f6d_c03 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 4 # 2 D 95 ASP B 112 ASP.? 11.36 O1B ADP C1001 D 117 GLU C 78 GLU~? 9.17 N6 ADP C1001 D 131 GLU B 115 GLU.? 12.48 O1B ADP C1001 D 213 HIS B 20 HIS.? 13.19 O1A ADP C1001 coo 60.45 59.04 95.56 60.08 59.57 97.62 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 53.51 54.68 98.43 54.65 55.64 99.96 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 62.34 62.21 97.48 63.80 63.61 98.07 -39.49 31.51 1.54 -40.33 32.66 0.02 coo 57.94 68.02 108.20 56.70 67.43 106.62 -35.44 19.24 3.79 -36.86 20.32 2.70 1f6d_c03 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 2 hits 1f6d_c03 naa= 4 ULMN 4 1f8x_c00 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 1 4 # 1 A 7 TYR B 26 TYR^? 24.12 N6 ADP C1001 A 72 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 92 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 98 GLU B 44 GLU^? 27.54 N6 ADP C1001 coo 56.63 3.26 -21.57 57.90 0.91 -22.38 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 61.98 -0.44 -23.69 61.13 -1.42 -25.38 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 53.63 -9.21 -18.97 55.21 -8.90 -20.38 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 58.86 -2.50 -18.61 57.78 -2.67 -20.39 -24.18 6.66 6.64 -23.83 5.58 4.84 1f8x_c00 source 1f8x NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE : 1 hits 1f8x_c00 naa= 4 ULMN 4 1f8x_c01 NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASEuser 1 4 # 1 B 207 TYR B 26 TYR^? 24.12 N6 ADP C1001 B 272 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 292 ASP A 10 ASP.? 29.48 N1 ADP C1001 B 298 GLU B 44 GLU^? 27.54 N6 ADP C1001 coo 65.34 -9.96 -1.84 62.54 -9.98 -1.80 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 59.10 -7.54 -0.32 58.10 -9.33 0.15 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 57.21 -14.68 -11.04 55.94 -13.90 -9.53 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 60.44 -8.22 -6.20 60.22 -10.11 -5.29 -24.18 6.66 6.64 -23.83 5.58 4.84 1f8x_c01 source 1f8x NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE : 1 hits 1f8x_c01 naa= 4 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 1 4 # 1 129 TYR C 79 TYR~? 13.12 N6 ADP C1001 157 ASP D 61 ASP~? 23.08 N1 ADP C1001 254 HIS D 62 HIS.? 20.37 N6 ADP C1001 257 ARG D 2 ARG^? 19.52 N6 ADP C1001 coo 42.78 52.38 24.86 44.83 53.69 23.54 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 49.25 58.21 29.45 50.12 57.23 27.75 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 50.92 56.96 24.04 49.24 56.15 23.09 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 53.31 58.10 18.81 51.90 57.61 16.26 -16.51 45.11 16.54 -19.16 44.24 15.23 1gox_c01 source 1gox GLYCOLATE OXIDASE : 1 hits 1gox_c01 naa= 4 ULMN 4 1hpl_c00 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 1 4 # 1 A 77 PHE A 27 PHE^? 37.41 N6 ADP C1001 A 153 LEU A 55 LEU~? 40.94 N6 ADP C1001 A 176 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 263 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 49.46 51.93 11.85 50.12 53.23 14.23 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 48.47 51.01 3.83 49.10 52.90 2.99 -15.73 -4.74 -1.28 -16.63 -4.61 0.71 coo 40.04 48.33 9.02 39.08 50.19 9.48 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 43.45 51.20 11.32 44.32 50.94 9.50 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 4 1hpl_c00 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 2 4 # 2 A 77 PHE B 27 PHE^? 16.30 N6 ADP C1001 A 153 LEU B 55 LEU~? 16.31 O4' ADP C1001 A 176 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 263 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 49.46 51.93 11.85 50.12 53.23 14.23 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 48.47 51.01 3.83 49.10 52.90 2.99 -31.87 12.92 14.06 -31.30 12.59 11.98 coo 40.04 48.33 9.02 39.08 50.19 9.48 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 43.45 51.20 11.32 44.32 50.94 9.50 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 4 1hpl_c00 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 3 4 # 3 A 77 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 153 LEU C 55 LEU~? 15.31 C2 ADP C1001 A 176 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 263 HIS C 62 HIS~? 21.13 N1 ADP C1001 coo 49.46 51.93 11.85 50.12 53.23 14.23 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 48.47 51.01 3.83 49.10 52.90 2.99 -30.41 42.77 23.50 -31.26 43.18 25.42 coo 40.04 48.33 9.02 39.08 50.19 9.48 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 43.45 51.20 11.32 44.32 50.94 9.50 -20.79 41.45 28.58 -20.89 43.35 29.47 1hpl_c00 source 1hpl LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROL HYDROLAS: 3 hits 1hpl_c00 naa= 4 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 4 # 1 166 LYS B 14 LYS~? 27.17 N6 ADP C1001 270 ASP A 61 ASP~? 37.71 N6 ADP C1001 297 HIS A 62 HIS~? 32.10 N6 ADP C1001 317 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 27.27 1.43 25.09 29.18 5.25 22.89 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 29.40 9.25 9.79 31.51 9.14 10.05 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 29.05 8.65 14.00 30.25 7.04 14.30 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 29.25 11.66 19.43 29.42 9.79 18.51 -16.06 9.21 5.46 -17.05 10.76 4.34 1mdr_c00 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 1 hits 1mdr_c00 naa= 4 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 A 192 LYS B 38 LYS.? 29.47 N6 ADP C1001 A 268 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 302 SER B 15 SER~? 20.97 N6 ADP C1001 A 399 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 85.01 60.31 56.44 83.15 64.89 56.44 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 71.86 54.60 60.61 70.38 53.71 61.84 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 68.68 62.06 66.08 69.52 59.75 65.97 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 66.34 67.16 63.84 67.47 65.57 63.06 -24.54 18.07 0.49 -24.62 18.94 -1.46 1o04_c00 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c00 naa= 4 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 B 192 LYS B 38 LYS.? 29.47 N6 ADP C1001 B 268 GLU A 41 GLU^? 26.55 N6 ADP C1001 B 302 SER B 15 SER~? 20.97 N6 ADP C1001 B 399 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 54.45 47.08 36.74 56.53 48.29 32.40 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 67.17 40.71 41.61 68.49 39.13 42.13 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 70.41 37.34 33.01 69.41 36.86 35.23 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 73.06 40.82 28.87 71.88 41.23 30.58 -24.54 18.07 0.49 -24.62 18.94 -1.46 1o04_c01 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c01 naa= 4 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 C 192 LYS B 38 LYS.? 29.47 N6 ADP C1001 C 268 GLU A 41 GLU^? 26.55 N6 ADP C1001 C 302 SER B 15 SER~? 20.97 N6 ADP C1001 C 399 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 83.30 16.28 88.61 85.25 11.75 88.79 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 79.88 15.02 74.11 80.06 15.36 72.02 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 87.46 9.36 71.39 86.33 11.53 71.37 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 87.65 3.44 72.32 86.49 4.99 73.13 -24.54 18.07 0.49 -24.62 18.94 -1.46 1o04_c02 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c02 naa= 4 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 D 192 LYS B 38 LYS.? 29.47 N6 ADP C1001 D 268 GLU A 41 GLU^? 26.55 N6 ADP C1001 D 302 SER B 15 SER~? 20.97 N6 ADP C1001 D 399 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 51.91 3.68 69.52 49.61 2.30 73.71 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 55.94 16.93 75.09 55.86 19.04 75.37 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 48.09 18.43 80.84 49.40 18.94 78.77 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 47.32 15.81 86.19 48.62 15.41 84.58 -24.54 18.07 0.49 -24.62 18.94 -1.46 1o04_c03 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c03 naa= 4 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 E 192 LYS B 38 LYS.? 29.47 N6 ADP C1001 E 268 GLU A 41 GLU^? 26.55 N6 ADP C1001 E 302 SER B 15 SER~? 20.97 N6 ADP C1001 E 399 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 52.46 147.49 107.94 50.14 148.75 103.77 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 57.01 134.41 102.36 57.01 132.29 102.10 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 49.26 132.62 96.59 50.54 132.08 98.67 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 48.52 135.25 91.24 49.73 135.67 92.87 -24.54 18.07 0.49 -24.62 18.94 -1.46 1o04_c04 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c04 naa= 4 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 F 192 LYS B 38 LYS.? 29.47 N6 ADP C1001 F 268 GLU A 41 GLU^? 26.55 N6 ADP C1001 F 302 SER B 15 SER~? 20.97 N6 ADP C1001 F 399 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 84.18 136.24 88.80 85.96 140.90 88.66 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 80.72 137.29 103.27 80.90 136.95 105.39 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 87.99 143.28 106.06 86.95 141.03 106.01 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 87.94 149.19 105.12 86.87 147.57 104.33 -24.54 18.07 0.49 -24.62 18.94 -1.46 1o04_c05 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c05 naa= 4 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 G 192 LYS B 38 LYS.? 29.47 N6 ADP C1001 G 268 GLU A 41 GLU^? 26.55 N6 ADP C1001 G 302 SER B 15 SER~? 20.97 N6 ADP C1001 G 399 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 56.79 103.91 140.42 58.85 102.76 144.77 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 69.06 110.82 135.59 70.39 112.47 135.16 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 72.18 114.35 144.24 71.25 114.81 141.99 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 75.14 110.89 148.28 73.91 110.46 146.63 -24.54 18.07 0.49 -24.62 18.94 -1.46 1o04_c06 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c06 naa= 4 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 H 192 LYS B 38 LYS.? 29.47 N6 ADP C1001 H 268 GLU A 41 GLU^? 26.55 N6 ADP C1001 H 302 SER B 15 SER~? 20.97 N6 ADP C1001 H 399 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 87.99 92.28 120.76 86.42 87.51 120.70 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 74.53 97.35 116.61 73.03 98.14 115.35 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 71.83 89.76 111.02 72.57 92.08 111.26 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 69.74 84.60 113.28 70.77 86.22 114.09 -24.54 18.07 0.49 -24.62 18.94 -1.46 1o04_c07 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c07 naa= 4 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 1 4 # 1 A 36 LYS B 19 LYS.? 15.59 N6 ADP C1001 A 108 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 211 ARG B 23 ARG.? 16.12 O1A ADP C1001 A 319 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 26.40 -0.07 5.65 25.70 1.89 10.82 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 13.95 1.15 16.48 15.65 1.17 15.18 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 30.30 5.19 11.85 28.49 2.83 12.64 -35.24 15.53 3.08 -37.20 16.95 1.17 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 2 4 # 2 A 36 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 108 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 211 ARG C 2 ARG^? 21.46 C2 ADP C1001 A 319 GLU C 49 GLU.? 21.81 N1 ADP C1001 coo 26.40 -0.07 5.65 25.70 1.89 10.82 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 13.95 1.15 16.48 15.65 1.17 15.18 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 30.30 5.19 11.85 28.49 2.83 12.64 -18.93 34.99 28.58 -17.63 35.83 31.18 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 -30.22 47.91 25.82 -28.66 49.28 25.41 1p4n_c00 source 1p4n UDP-MURNAC-PENTAPEPTIDE : 2 hits 1p4n_c00 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL A 3 VAL^? 38.03 N6 ADP C1001 A 194 GLY A 63 GLY.? 35.61 N6 ADP C1001 A 417 ILE C 59 ILE~? 13.60 N1 ADP C1001 A 457 ALA C 64 ALA.? 14.62 N1 ADP C1001 coo 60.43 93.31 8.03 62.16 94.30 8.93 -6.45 4.91 4.30 -4.70 4.31 5.42 coo 59.34 89.99 13.88 59.24 89.18 13.73 -10.41 7.85 -2.69 -10.52 7.16 -2.28 coo 39.61 128.90 22.54 40.04 128.24 23.80 -25.26 38.92 24.31 -26.26 38.42 24.64 coo 43.27 124.32 20.47 43.79 125.29 21.53 -21.29 34.81 25.43 -22.58 35.15 26.14 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL B 42 VAL^? 23.32 N6 ADP C1001 A 194 GLY B 12 GLY~? 22.61 N6 ADP C1001 A 417 ILE D 85 ILE.? 30.37 N1 ADP C1001 A 457 ALA D 64 ALA.? 26.15 N6 ADP C1001 coo 60.43 93.31 8.03 62.16 94.30 8.93 -17.95 12.57 9.46 -17.80 12.68 7.30 coo 59.34 89.99 13.88 59.24 89.18 13.73 -17.91 15.52 4.82 -17.88 16.00 4.18 coo 39.61 128.90 22.54 40.04 128.24 23.80 -16.27 55.03 23.17 -17.01 54.41 22.13 coo 43.27 124.32 20.47 43.79 125.29 21.53 -16.76 49.68 19.26 -17.00 50.74 18.25 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 151 VAL D 37 VAL^? 27.71 N6 ADP C1001 A 194 GLY D 34 GLY.? 30.79 N6 ADP C1001 A 417 ILE A 59 ILE~? 38.52 N6 ADP C1001 A 457 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 60.43 93.31 8.03 62.16 94.30 8.93 -8.01 42.15 11.20 -8.53 43.67 9.78 coo 59.34 89.99 13.88 59.24 89.18 13.73 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 39.61 128.90 22.54 40.04 128.24 23.80 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 43.27 124.32 20.47 43.79 125.29 21.53 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 151 VAL D 37 VAL^? 27.71 N6 ADP C1001 A 194 GLY D 34 GLY.? 30.79 N6 ADP C1001 A 417 ILE A 85 ILE.? 43.13 N6 ADP C1001 A 457 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 60.43 93.31 8.03 62.16 94.30 8.93 -8.01 42.15 11.20 -8.53 43.67 9.78 coo 59.34 89.99 13.88 59.24 89.18 13.73 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 39.61 128.90 22.54 40.04 128.24 23.80 -6.22 0.01 -3.90 -7.42 0.56 -3.31 coo 43.27 124.32 20.47 43.79 125.29 21.53 -8.60 5.30 -0.48 -9.23 4.31 0.41 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 4 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL D 37 VAL^? 27.71 N6 ADP C1001 B 194 GLY D 34 GLY.? 30.79 N6 ADP C1001 B 417 ILE A 59 ILE~? 38.52 N6 ADP C1001 B 457 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 52.95 126.71 13.21 51.34 125.24 13.19 -8.01 42.15 11.20 -8.53 43.67 9.78 coo 50.40 126.23 20.48 50.46 127.00 20.75 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 68.38 85.45 19.33 67.41 85.52 20.41 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 65.50 91.13 17.77 64.65 89.88 18.00 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL D 37 VAL^? 27.71 N6 ADP C1001 B 194 GLY D 34 GLY.? 30.79 N6 ADP C1001 B 417 ILE A 85 ILE.? 43.13 N6 ADP C1001 B 457 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 52.95 126.71 13.21 51.34 125.24 13.19 -8.01 42.15 11.20 -8.53 43.67 9.78 coo 50.40 126.23 20.48 50.46 127.00 20.75 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 68.38 85.45 19.33 67.41 85.52 20.41 -6.22 0.01 -3.90 -7.42 0.56 -3.31 coo 65.50 91.13 17.77 64.65 89.88 18.00 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 B 151 VAL D 98 VAL~? 36.45 N6 ADP C1001 B 194 GLY D 104 GLY~? 38.97 N6 ADP C1001 B 417 ILE B 59 ILE~? 15.13 N1 ADP C1001 B 457 ALA B 4 ALA^? 14.54 N6 ADP C1001 coo 52.95 126.71 13.21 51.34 125.24 13.19 -5.69 53.69 7.95 -6.96 55.30 8.57 coo 50.40 126.23 20.48 50.46 127.00 20.75 1.45 49.17 12.44 0.89 49.55 12.90 coo 68.38 85.45 19.33 67.41 85.52 20.41 -26.69 15.15 17.37 -26.90 15.90 16.49 coo 65.50 91.13 17.77 64.65 89.88 18.00 -22.49 19.03 14.42 -23.52 18.15 15.03 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 3 hits 1pix_c01 naa= 4 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 1 4 # 1 A 10 ASP D 9 ASP.? 34.87 N6 ADP C1001 A 41 ARG D 25 ARG.? 35.20 N6 ADP C1001 A 118 SER D 15 SER~? 33.93 N6 ADP C1001 A 180 ASP D 10 ASP.? 31.49 N6 ADP C1001 coo 20.70 13.03 9.13 22.27 11.81 9.81 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 23.00 19.17 17.85 22.49 17.70 15.19 -26.42 60.33 5.19 -27.57 62.82 3.77 coo 17.70 9.25 13.10 16.68 11.30 13.99 -14.05 55.07 1.32 -15.85 56.53 2.06 coo 26.47 11.43 10.70 25.16 9.82 11.06 -22.28 53.80 0.05 -22.17 54.33 -2.00 1qh9_c01 source 1qh9 2-HALOACID DEHALOGENASE : 1 hits 1qh9_c01 naa= 4 ULMN 4 1qq5_c02 L-2-HALOACID DEHALOGENASE user 1 4 # 1 A 8 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 39 ARG A 2 ARG^? 31.43 N6 ADP C1001 A 114 SER B 15 SER~? 20.97 N6 ADP C1001 A 176 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 11.74 10.89 36.46 11.22 9.07 35.52 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 9.95 2.30 29.39 10.16 4.06 31.89 -10.05 8.79 1.44 -11.10 11.55 0.50 coo 14.04 6.15 40.29 15.11 4.90 38.49 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 6.71 9.84 37.08 8.21 10.00 38.54 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 4 1qq5_c02 L-2-HALOACID DEHALOGENASE user 2 4 # 2 A 8 ASP D 9 ASP.? 34.87 N6 ADP C1001 A 39 ARG D 25 ARG.? 35.20 N6 ADP C1001 A 114 SER D 15 SER~? 33.93 N6 ADP C1001 A 176 ASP D 10 ASP.? 31.49 N6 ADP C1001 coo 11.74 10.89 36.46 11.22 9.07 35.52 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 9.95 2.30 29.39 10.16 4.06 31.89 -26.42 60.33 5.19 -27.57 62.82 3.77 coo 14.04 6.15 40.29 15.11 4.90 38.49 -14.05 55.07 1.32 -15.85 56.53 2.06 coo 6.71 9.84 37.08 8.21 10.00 38.54 -22.28 53.80 0.05 -22.17 54.33 -2.00 1qq5_c02 source 1qq5 L-2-HALOACID DEHALOGENASE : 2 hits 1qq5_c02 naa= 4 ULMN 4 1qq5_c03 L-2-HALOACID DEHALOGENASE user 1 4 # 1 B 8 ASP B 9 ASP.? 24.63 N6 ADP C1001 B 39 ARG A 2 ARG^? 31.43 N6 ADP C1001 B 114 SER B 15 SER~? 20.97 N6 ADP C1001 B 176 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo -12.56 -11.18 35.50 -11.97 -9.35 34.62 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -10.21 -2.50 28.59 -10.64 -4.26 31.07 -10.05 8.79 1.44 -11.10 11.55 0.50 coo -15.18 -6.47 39.05 -16.09 -5.31 37.09 -19.71 18.90 1.41 -21.68 17.51 1.61 coo -7.57 -10.16 36.43 -9.20 -10.33 37.73 -19.64 10.11 1.49 -19.54 9.87 -0.69 1qq5_c03 source 1qq5 L-2-HALOACID DEHALOGENASE : 1 hits 1qq5_c03 naa= 4 ULMN 4 1s9c_c00 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 A 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 A 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo -25.64 37.57 50.43 -27.52 38.11 49.72 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -26.61 43.40 47.77 -28.25 42.95 49.00 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -29.07 48.69 48.27 -30.50 48.49 48.03 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo -28.94 44.64 55.14 -28.25 44.15 55.05 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c00 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 A 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 A 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo -25.64 37.57 50.43 -27.52 38.11 49.72 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -26.61 43.40 47.77 -28.25 42.95 49.00 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -29.07 48.69 48.27 -30.50 48.49 48.03 -20.30 54.25 17.65 -19.56 54.69 16.84 coo -28.94 44.64 55.14 -28.25 44.15 55.05 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c00 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c00 naa= 4 ULMN 4 1s9c_c01 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 B 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 B 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo 1.52 35.97 51.01 3.42 36.23 51.87 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 3.06 41.23 54.47 4.67 40.76 53.22 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 6.05 46.28 54.73 7.44 45.87 54.95 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 5.61 43.23 47.37 4.87 42.82 47.40 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c01 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 B 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 B 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo 1.52 35.97 51.01 3.42 36.23 51.87 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 3.06 41.23 54.47 4.67 40.76 53.22 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 6.05 46.28 54.73 7.44 45.87 54.95 -20.30 54.25 17.65 -19.56 54.69 16.84 coo 5.61 43.23 47.37 4.87 42.82 47.40 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c01 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c01 naa= 4 ULMN 4 1s9c_c02 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 C 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 C 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 C 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo 26.46 18.93 101.93 27.13 17.27 102.99 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 26.20 12.95 99.46 25.62 12.88 101.47 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 23.69 7.66 99.55 24.24 7.05 100.75 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 19.59 13.22 103.55 19.80 13.92 103.14 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c02 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 C 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 C 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 C 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo 26.46 18.93 101.93 27.13 17.27 102.99 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 26.20 12.95 99.46 25.62 12.88 101.47 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 23.69 7.66 99.55 24.24 7.05 100.75 -20.30 54.25 17.65 -19.56 54.69 16.84 coo 19.59 13.22 103.55 19.80 13.92 103.14 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c02 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c02 naa= 4 ULMN 4 1s9c_c03 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 D 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 D 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 D 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 D 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo 22.93 34.69 80.15 21.89 35.84 78.73 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 17.26 32.67 77.83 18.39 33.45 76.24 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 14.30 30.49 73.19 14.11 31.61 72.28 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 22.18 30.03 72.32 22.45 29.98 73.13 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c03 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 D 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 D 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo 22.93 34.69 80.15 21.89 35.84 78.73 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 17.26 32.67 77.83 18.39 33.45 76.24 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 14.30 30.49 73.19 14.11 31.61 72.28 -20.30 54.25 17.65 -19.56 54.69 16.84 coo 22.18 30.03 72.32 22.45 29.98 73.13 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c03 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c03 naa= 4 ULMN 4 1s9c_c04 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 E 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 E 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 E 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 E 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo -14.23 77.96 91.10 -14.70 79.73 90.12 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -20.22 79.11 88.88 -18.84 79.78 87.45 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -23.73 79.55 84.17 -23.38 80.85 83.62 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo -16.74 76.18 82.54 -16.53 75.82 83.27 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c04 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 E 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 E 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 E 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 E 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo -14.23 77.96 91.10 -14.70 79.73 90.12 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -20.22 79.11 88.88 -18.84 79.78 87.45 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -23.73 79.55 84.17 -23.38 80.85 83.62 -20.30 54.25 17.65 -19.56 54.69 16.84 coo -16.74 76.18 82.54 -16.53 75.82 83.27 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c04 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c04 naa= 4 ULMN 4 1s9c_c05 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 F 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 F 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 F 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 F 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo -18.25 57.48 108.33 -18.41 55.48 108.97 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -20.93 52.93 104.64 -21.55 52.62 106.62 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -25.53 49.40 103.76 -25.37 48.32 104.73 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo -27.00 55.06 109.12 -26.48 55.68 108.90 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c05 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 F 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 F 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 F 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 F 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo -18.25 57.48 108.33 -18.41 55.48 108.97 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -20.93 52.93 104.64 -21.55 52.62 106.62 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -25.53 49.40 103.76 -25.37 48.32 104.73 -20.30 54.25 17.65 -19.56 54.69 16.84 coo -27.00 55.06 109.12 -26.48 55.68 108.90 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c05 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c05 naa= 4 ULMN 4 1s9c_c06 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 G 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 G 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 G 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 G 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo 31.01 -15.97 51.91 29.11 -16.30 51.09 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 28.35 -11.70 47.82 26.87 -12.37 49.15 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 24.31 -7.55 46.85 23.07 -8.31 46.69 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 25.28 -9.39 54.51 26.09 -9.63 54.54 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c06 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 G 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 G 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 G 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 G 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo 31.01 -15.97 51.91 29.11 -16.30 51.09 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 28.35 -11.70 47.82 26.87 -12.37 49.15 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 24.31 -7.55 46.85 23.07 -8.31 46.69 -20.30 54.25 17.65 -19.56 54.69 16.84 coo 25.28 -9.39 54.51 26.09 -9.63 54.54 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c06 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c06 naa= 4 ULMN 4 1s9c_c07 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 H 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 H 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 H 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 H 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo 56.89 -8.41 52.19 58.53 -7.31 52.86 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 56.47 -2.13 53.79 58.22 -2.43 52.68 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 57.68 3.63 52.38 59.09 3.79 52.64 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 58.74 -1.51 46.37 58.19 -2.12 46.55 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c07 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 H 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 H 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 H 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 H 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo 56.89 -8.41 52.19 58.53 -7.31 52.86 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 56.47 -2.13 53.79 58.22 -2.43 52.68 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 57.68 3.63 52.38 59.09 3.79 52.64 -20.30 54.25 17.65 -19.56 54.69 16.84 coo 58.74 -1.51 46.37 58.19 -2.12 46.55 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c07 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c07 naa= 4 ULMN 4 1s9c_c08 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 I 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 I 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 I 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 I 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo 39.46 21.14 4.79 39.51 23.13 5.47 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 45.01 23.79 6.80 43.47 24.37 8.09 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 48.28 25.70 11.29 47.68 27.01 11.63 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 41.95 21.43 13.48 41.85 20.90 12.82 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c08 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 I 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 I 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 I 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 I 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo 39.46 21.14 4.79 39.51 23.13 5.47 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 45.01 23.79 6.80 43.47 24.37 8.09 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 48.28 25.70 11.29 47.68 27.01 11.63 -20.30 54.25 17.65 -19.56 54.69 16.84 coo 41.95 21.43 13.48 41.85 20.90 12.82 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c08 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c08 naa= 4 ULMN 4 1s9c_c09 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 J 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 J 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 J 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 J 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo 48.44 -1.06 -7.97 49.08 -3.04 -8.13 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 52.02 -3.92 -3.42 52.78 -4.50 -5.28 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 57.28 -5.96 -1.91 57.41 -7.26 -2.62 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 57.52 -1.45 -8.41 56.87 -0.93 -8.30 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c09 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 J 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 J 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 J 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 J 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo 48.44 -1.06 -7.97 49.08 -3.04 -8.13 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 52.02 -3.92 -3.42 52.78 -4.50 -5.28 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 57.28 -5.96 -1.91 57.41 -7.26 -2.62 -20.30 54.25 17.65 -19.56 54.69 16.84 coo 57.52 -1.45 -8.41 56.87 -0.93 -8.30 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c09 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c09 naa= 4 ULMN 4 1s9c_c10 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 K 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 K 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 K 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 K 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo 99.11 27.84 -4.51 100.20 26.72 -3.12 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 100.44 21.59 -5.53 99.91 21.83 -3.52 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 99.47 16.04 -4.15 100.16 15.85 -2.89 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 94.04 21.15 -1.26 94.03 21.76 -1.84 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c10 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 K 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 K 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 K 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 K 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo 99.11 27.84 -4.51 100.20 26.72 -3.12 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 100.44 21.59 -5.53 99.91 21.83 -3.52 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 99.47 16.04 -4.15 100.16 15.85 -2.89 -20.30 54.25 17.65 -19.56 54.69 16.84 coo 94.04 21.15 -1.26 94.03 21.76 -1.84 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c10 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c10 naa= 4 ULMN 4 1s9c_c11 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 1 4 # 1 L 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 L 198 HIS A 62 HIS~? 32.10 N6 ADP C1001 L 213 ILE A 59 ILE~? 38.52 N6 ADP C1001 L 216 GLY A 63 GLY.? 35.61 N6 ADP C1001 coo 91.32 35.62 -29.35 89.97 35.96 -30.92 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 86.50 31.53 -30.59 87.38 32.10 -32.41 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 84.29 27.52 -34.04 83.80 28.26 -35.21 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo 91.99 29.03 -35.45 92.27 29.27 -34.69 -10.41 7.85 -2.69 -10.52 7.16 -2.28 ULMN 4 1s9c_c11 PEROXISOMAL MULTIFUNCTIONAL ENZYME Tuser 2 4 # 2 L 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 L 198 HIS D 62 HIS.? 20.37 N6 ADP C1001 L 213 ILE D 59 ILE~? 27.70 N6 ADP C1001 L 216 GLY D 63 GLY.? 22.25 N6 ADP C1001 coo 91.32 35.62 -29.35 89.97 35.96 -30.92 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 86.50 31.53 -30.59 87.38 32.10 -32.41 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 84.29 27.52 -34.04 83.80 28.26 -35.21 -20.30 54.25 17.65 -19.56 54.69 16.84 coo 91.99 29.03 -35.45 92.27 29.27 -34.69 -19.39 47.07 20.40 -19.28 47.74 19.95 1s9c_c11 source 1s9c PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 : 2 hits 1s9c_c11 naa= 4 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 1 4 # 1 130 GLY A 12 GLY~? 30.18 N6 ADP C1001 183 LYS A 38 LYS^? 31.29 N6 ADP C1001 187 ASN A 39 ASN^? 26.27 N6 ADP C1001 190 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 17.10 29.44 43.85 16.37 29.12 43.58 -15.34 4.79 13.98 -15.18 4.16 14.49 coo 19.89 26.71 31.12 19.64 27.76 36.18 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 24.07 30.35 34.20 22.74 29.43 35.67 -10.50 14.02 7.34 -12.57 14.30 7.00 coo 22.71 35.39 36.78 22.54 33.56 37.82 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 2 4 # 2 130 GLY A 63 GLY.? 35.61 N6 ADP C1001 183 LYS A 38 LYS^? 31.29 N6 ADP C1001 187 ASN A 39 ASN^? 26.27 N6 ADP C1001 190 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 17.10 29.44 43.85 16.37 29.12 43.58 -10.41 7.85 -2.69 -10.52 7.16 -2.28 coo 19.89 26.71 31.12 19.64 27.76 36.18 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 24.07 30.35 34.20 22.74 29.43 35.67 -10.50 14.02 7.34 -12.57 14.30 7.00 coo 22.71 35.39 36.78 22.54 33.56 37.82 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 3 4 # 3 130 GLY B 12 GLY~? 22.61 N6 ADP C1001 183 LYS B 38 LYS.? 29.47 N6 ADP C1001 187 ASN B 39 ASN.? 27.14 N6 ADP C1001 190 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 17.10 29.44 43.85 16.37 29.12 43.58 -17.91 15.52 4.82 -17.88 16.00 4.18 coo 19.89 26.71 31.12 19.64 27.76 36.18 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 24.07 30.35 34.20 22.74 29.43 35.67 -11.13 15.65 16.64 -9.36 15.49 17.83 coo 22.71 35.39 36.78 22.54 33.56 37.82 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 4 4 # 4 130 GLY B 63 GLY.? 19.32 N1 ADP C1001 183 LYS B 38 LYS.? 29.47 N6 ADP C1001 187 ASN B 39 ASN.? 27.14 N6 ADP C1001 190 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 17.10 29.44 43.85 16.37 29.12 43.58 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 19.89 26.71 31.12 19.64 27.76 36.18 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 24.07 30.35 34.20 22.74 29.43 35.67 -11.13 15.65 16.64 -9.36 15.49 17.83 coo 22.71 35.39 36.78 22.54 33.56 37.82 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 5 4 # 5 130 GLY C 53 GLY~? 15.49 N6 ADP C1001 183 LYS D 60 LYS~? 25.96 N1 ADP C1001 187 ASN D 57 ASN~? 28.49 N1 ADP C1001 190 GLU C 48 GLU.? 22.51 O2' ADP C1001 coo 17.10 29.44 43.85 16.37 29.12 43.58 -29.67 44.87 17.26 -30.14 45.11 17.88 coo 19.89 26.71 31.12 19.64 27.76 36.18 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 24.07 30.35 34.20 22.74 29.43 35.67 -26.50 55.76 21.71 -26.74 56.60 23.67 coo 22.71 35.39 36.78 22.54 33.56 37.82 -33.52 53.52 23.97 -33.48 52.09 22.33 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 6 4 # 6 130 GLY C 63 GLY.? 18.10 N1 ADP C1001 183 LYS C 38 LYS^? 29.32 C2 ADP C1001 187 ASN C 39 ASN^? 25.44 C2 ADP C1001 190 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 17.10 29.44 43.85 16.37 29.12 43.58 -18.24 37.08 25.10 -19.00 37.10 25.28 coo 19.89 26.71 31.12 19.64 27.76 36.18 -16.18 28.34 36.63 -11.47 27.59 37.59 coo 24.07 30.35 34.20 22.74 29.43 35.67 -16.77 32.66 36.54 -17.11 34.71 36.97 coo 22.71 35.39 36.78 22.54 33.56 37.82 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 7 4 # 7 130 GLY D 63 GLY.? 22.25 N6 ADP C1001 183 LYS B 106 LYS.? 18.25 N6 ADP C1001 187 ASN D 39 ASN^? 19.52 N6 ADP C1001 190 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 17.10 29.44 43.85 16.37 29.12 43.58 -19.39 47.07 20.40 -19.28 47.74 19.95 coo 19.89 26.71 31.12 19.64 27.76 36.18 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 24.07 30.35 34.20 22.74 29.43 35.67 -14.81 40.52 11.20 -15.13 38.43 11.40 coo 22.71 35.39 36.78 22.54 33.56 37.82 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 8 4 # 8 130 GLY D 63 GLY.? 22.25 N6 ADP C1001 183 LYS D 38 LYS^? 26.03 N6 ADP C1001 187 ASN D 39 ASN^? 19.52 N6 ADP C1001 190 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 17.10 29.44 43.85 16.37 29.12 43.58 -19.39 47.07 20.40 -19.28 47.74 19.95 coo 19.89 26.71 31.12 19.64 27.76 36.18 -10.44 39.35 12.00 -7.01 36.04 14.36 coo 24.07 30.35 34.20 22.74 29.43 35.67 -14.81 40.52 11.20 -15.13 38.43 11.40 coo 22.71 35.39 36.78 22.54 33.56 37.82 -19.13 44.82 10.40 -20.77 44.03 11.36 2pgd_c00 source 2pgd 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-PGDH) (E.C: 8 hits 2pgd_c00 naa= 4 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 1 4 # 1 A 71 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 123 PHE C 58 PHE~? 19.35 C2 ADP C1001 A 214 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 381 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo -18.26 14.59 1.38 -20.32 13.94 3.12 -30.56 25.72 4.57 -31.82 27.56 2.83 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 2 4 # 2 A 71 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 123 PHE C 58 PHE~? 19.35 C2 ADP C1001 A 214 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 381 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo -18.26 14.59 1.38 -20.32 13.94 3.12 -30.56 25.72 4.57 -31.82 27.56 2.83 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 3 4 # 3 A 71 TYR C 70 TYR.? 10.33 O3' ADP C1001 A 123 PHE B 58 PHE~? 21.02 N6 ADP C1001 A 214 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 381 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo -18.26 14.59 1.38 -20.32 13.94 3.12 -40.11 31.99 28.67 -42.64 30.90 28.52 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -26.58 9.98 15.28 -24.37 9.78 13.51 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 4 4 # 4 A 71 TYR D 70 TYR.? 43.17 N6 ADP C1001 A 123 PHE C 58 PHE~? 19.35 C2 ADP C1001 A 214 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 381 ARG C 2 ARG^? 21.46 C2 ADP C1001 coo -18.26 14.59 1.38 -20.32 13.94 3.12 -10.19 64.81 9.49 -8.66 67.08 8.77 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 -18.93 34.99 28.58 -17.63 35.83 31.18 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 5 4 # 5 A 71 TYR D 70 TYR.? 43.17 N6 ADP C1001 A 123 PHE C 58 PHE~? 19.35 C2 ADP C1001 A 214 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 381 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo -18.26 14.59 1.38 -20.32 13.94 3.12 -10.19 64.81 9.49 -8.66 67.08 8.77 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 -32.85 47.91 34.77 -31.37 50.53 33.86 2tpl_c02 source 2tpl TYROSINE PHENOL-LYASE : 5 hits 2tpl_c02 naa= 4 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 1 4 # 1 B 71 TYR B 70 TYR.? 11.71 N6 ADP C1001 B 123 PHE C 58 PHE~? 19.35 C2 ADP C1001 B 214 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 381 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 -30.56 25.72 4.57 -31.82 27.56 2.83 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -23.89 24.28 2.03 -24.86 21.74 0.63 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 2 4 # 2 B 71 TYR B 70 TYR.? 11.71 N6 ADP C1001 B 123 PHE C 58 PHE~? 19.35 C2 ADP C1001 B 214 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 381 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 -30.56 25.72 4.57 -31.82 27.56 2.83 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -23.89 24.28 2.03 -24.86 21.74 0.63 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 3 4 # 3 B 71 TYR C 70 TYR.? 10.33 O3' ADP C1001 B 123 PHE B 58 PHE~? 21.02 N6 ADP C1001 B 214 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 381 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 -40.11 31.99 28.67 -42.64 30.90 28.52 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -26.58 9.98 15.28 -24.37 9.78 13.51 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -23.89 24.28 2.03 -24.86 21.74 0.63 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 4 4 # 4 B 71 TYR D 70 TYR.? 43.17 N6 ADP C1001 B 123 PHE C 58 PHE~? 19.35 C2 ADP C1001 B 214 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 381 ARG C 2 ARG^? 21.46 C2 ADP C1001 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 -10.19 64.81 9.49 -8.66 67.08 8.77 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -23.89 24.28 2.03 -24.86 21.74 0.63 -18.93 34.99 28.58 -17.63 35.83 31.18 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 5 4 # 5 B 71 TYR D 70 TYR.? 43.17 N6 ADP C1001 B 123 PHE C 58 PHE~? 19.35 C2 ADP C1001 B 214 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 381 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 -10.19 64.81 9.49 -8.66 67.08 8.77 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -23.89 24.28 2.03 -24.86 21.74 0.63 -32.85 47.91 34.77 -31.37 50.53 33.86 2tpl_c03 source 2tpl TYROSINE PHENOL-LYASE : 5 hits 2tpl_c03 naa= 4 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 70 TYR.? 48.30 N6 ADP C1001 B 190 LYS A 114 LYS.? 56.27 N6 ADP C1001 B 222 ASP A 112 ASP.? 58.40 N6 ADP C1001 coo 7.17 16.59 41.26 8.01 19.20 40.73 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 13.38 20.00 35.06 11.43 22.49 39.53 -4.38 -17.33 7.81 -3.33 -16.78 2.19 coo 9.76 26.58 38.10 11.63 25.78 38.76 -0.40 -16.97 12.76 1.53 -17.82 13.03 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR B 70 TYR.? 11.71 N6 ADP C1001 B 190 LYS B 114 LYS.? -3.14 O1A ADP C1001s B 222 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 7.17 16.59 41.26 8.01 19.20 40.73 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 13.38 20.00 35.06 11.43 22.49 39.53 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 9.76 26.58 38.10 11.63 25.78 38.76 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR B 70 TYR.? 11.71 N6 ADP C1001 B 190 LYS B 116 LYS.? 13.79 O2B ADP C1001 B 222 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 7.17 16.59 41.26 8.01 19.20 40.73 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 13.38 20.00 35.06 11.43 22.49 39.53 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 9.76 26.58 38.10 11.63 25.78 38.76 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR C 70 TYR.? 10.33 O3' ADP C1001 B 190 LYS C 114 LYS.? -2.76 O3B ADP C1001s B 222 ASP C 112 ASP.? 10.30 O3' ADP C1001 coo 7.17 16.59 41.26 8.01 19.20 40.73 -40.11 31.99 28.67 -42.64 30.90 28.52 coo 13.38 20.00 35.06 11.43 22.49 39.53 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 9.76 26.58 38.10 11.63 25.78 38.76 -47.22 26.04 24.41 -47.86 24.10 23.79 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR C 70 TYR.? 10.33 O3' ADP C1001 B 190 LYS C 116 LYS.? 13.74 O3' ADP C1001 B 222 ASP C 112 ASP.? 10.30 O3' ADP C1001 coo 7.17 16.59 41.26 8.01 19.20 40.73 -40.11 31.99 28.67 -42.64 30.90 28.52 coo 13.38 20.00 35.06 11.43 22.49 39.53 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 9.76 26.58 38.10 11.63 25.78 38.76 -47.22 26.04 24.41 -47.86 24.10 23.79 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 140 TYR D 70 TYR.? 43.17 N6 ADP C1001 B 190 LYS D 114 LYS.? 50.69 N6 ADP C1001 B 222 ASP D 112 ASP.? 52.73 N6 ADP C1001 coo 7.17 16.59 41.26 8.01 19.20 40.73 -10.19 64.81 9.49 -8.66 67.08 8.77 coo 13.38 20.00 35.06 11.43 22.49 39.53 -9.33 71.95 14.33 -7.85 74.07 18.29 coo 9.76 26.58 38.10 11.63 25.78 38.76 -3.02 71.97 12.29 -1.27 72.40 13.41 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 6 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 114 LYS.? 56.27 N6 ADP C1001 A 222 ASP A 112 ASP.? 58.40 N6 ADP C1001 B 140 TYR A 70 TYR.? 48.30 N6 ADP C1001 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -4.38 -17.33 7.81 -3.33 -16.78 2.19 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 1.51 16.60 24.17 0.82 19.23 24.79 -7.30 -10.03 11.13 -6.31 -12.30 12.53 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS B 114 LYS.? -3.14 O1A ADP C1001s A 222 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 140 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -38.05 28.30 5.66 -42.50 28.99 10.13 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 1.51 16.60 24.17 0.82 19.23 24.79 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS B 116 LYS.? 13.79 O2B ADP C1001 A 222 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 140 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -38.53 26.18 0.73 -35.66 28.79 0.03 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 1.51 16.60 24.17 0.82 19.23 24.79 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS C 114 LYS.? -2.76 O3B ADP C1001s A 222 ASP C 112 ASP.? 10.30 O3' ADP C1001 B 140 TYR C 70 TYR.? 10.33 O3' ADP C1001 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -44.82 31.28 21.50 -43.38 31.47 16.20 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 1.51 16.60 24.17 0.82 19.23 24.79 -40.11 31.99 28.67 -42.64 30.90 28.52 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 190 LYS C 116 LYS.? 13.74 O3' ADP C1001 A 222 ASP C 112 ASP.? 10.30 O3' ADP C1001 B 140 TYR C 70 TYR.? 10.33 O3' ADP C1001 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -48.64 32.02 26.16 -47.11 28.29 30.57 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 1.51 16.60 24.17 0.82 19.23 24.79 -40.11 31.99 28.67 -42.64 30.90 28.52 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 190 LYS D 114 LYS.? 50.69 N6 ADP C1001 A 222 ASP D 112 ASP.? 52.73 N6 ADP C1001 B 140 TYR D 70 TYR.? 43.17 N6 ADP C1001 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -9.33 71.95 14.33 -7.85 74.07 18.29 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 1.51 16.60 24.17 0.82 19.23 24.79 -10.19 64.81 9.49 -8.66 67.08 8.77 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 6 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 102 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 193 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 25.57 41.22 61.68 24.18 39.98 62.50 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 22.33 45.48 59.73 23.35 43.67 60.06 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 22.57 32.23 64.13 21.98 32.82 64.22 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 102 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 193 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo 25.57 41.22 61.68 24.18 39.98 62.50 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 22.33 45.48 59.73 23.35 43.67 60.06 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 22.57 32.23 64.13 21.98 32.82 64.22 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS C 50 HIS.? 17.04 O2' ADP C1001 A 102 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 193 GLY C 73 GLY~? 7.38 O2' ADP C1001 coo 25.57 41.22 61.68 24.18 39.98 62.50 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 22.33 45.48 59.73 23.35 43.67 60.06 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.52 37.92 18.83 -37.81 37.51 18.99 1a0j_c12 source 1a0j TRYPSIN : 3 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 102 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 193 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 44.08 45.58 52.81 45.86 46.55 52.85 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 43.04 44.75 47.18 43.31 45.51 49.13 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 50.46 51.91 56.90 50.65 51.62 56.14 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 102 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 193 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo 44.08 45.58 52.81 45.86 46.55 52.85 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 43.04 44.75 47.18 43.31 45.51 49.13 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 50.46 51.91 56.90 50.65 51.62 56.14 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS C 50 HIS.? 17.04 O2' ADP C1001 B 102 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 193 GLY C 73 GLY~? 7.38 O2' ADP C1001 coo 44.08 45.58 52.81 45.86 46.55 52.85 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 43.04 44.75 47.18 43.31 45.51 49.13 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 50.46 51.91 56.90 50.65 51.62 56.14 -38.52 37.92 18.83 -37.81 37.51 18.99 1a0j_c13 source 1a0j TRYPSIN : 3 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 62 HIS~? 32.10 N6 ADP C1001 C 102 ASP A 61 ASP~? 37.71 N6 ADP C1001 C 193 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 34.37 41.18 73.21 34.04 43.09 73.87 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 34.89 38.34 78.12 35.11 39.59 76.42 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 35.43 51.03 72.12 35.20 50.72 72.87 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS B 62 HIS~? 22.43 N1 ADP C1001 C 102 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 193 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo 34.37 41.18 73.21 34.04 43.09 73.87 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 34.89 38.34 78.12 35.11 39.59 76.42 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 35.43 51.03 72.12 35.20 50.72 72.87 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS C 50 HIS.? 17.04 O2' ADP C1001 C 102 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 193 GLY C 73 GLY~? 7.38 O2' ADP C1001 coo 34.37 41.18 73.21 34.04 43.09 73.87 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 34.89 38.34 78.12 35.11 39.59 76.42 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.52 37.92 18.83 -37.81 37.51 18.99 1a0j_c14 source 1a0j TRYPSIN : 3 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 62 HIS~? 32.10 N6 ADP C1001 D 102 ASP A 61 ASP~? 37.71 N6 ADP C1001 D 193 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 8.19 15.01 95.72 7.78 16.53 97.01 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 13.53 16.28 93.98 11.45 16.21 94.40 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 1.80 21.25 100.04 2.61 21.42 100.18 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS B 62 HIS~? 22.43 N1 ADP C1001 D 102 ASP B 61 ASP~? 21.98 C2 ADP C1001 D 193 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo 8.19 15.01 95.72 7.78 16.53 97.01 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 13.53 16.28 93.98 11.45 16.21 94.40 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 1.80 21.25 100.04 2.61 21.42 100.18 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS C 50 HIS.? 17.04 O2' ADP C1001 D 102 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 193 GLY C 73 GLY~? 7.38 O2' ADP C1001 coo 8.19 15.01 95.72 7.78 16.53 97.01 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 13.53 16.28 93.98 11.45 16.21 94.40 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 1.80 21.25 100.04 2.61 21.42 100.18 -38.52 37.92 18.83 -37.81 37.51 18.99 1a0j_c15 source 1a0j TRYPSIN : 3 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG C 75 ARG~? 8.05 O3B ADP C1001 265 HIS C 50 HIS.? 17.04 O2' ADP C1001 274 TYR C 70 TYR.? 10.33 O3' ADP C1001 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -38.47 40.65 15.33 -40.88 39.19 16.61 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 0.94 52.26 9.16 1.95 54.78 9.91 -40.11 31.99 28.67 -42.64 30.90 28.52 1a41_c01 source 1a41 TOPOISOMERASE I : 1 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 60 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 175 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 46.10 28.27 19.27 45.48 26.99 20.84 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 56.42 28.06 12.93 55.01 27.92 14.50 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 45.02 22.04 15.38 46.16 24.00 13.76 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 60 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 175 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 46.10 28.27 19.27 45.48 26.99 20.84 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 56.42 28.06 12.93 55.01 27.92 14.50 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 45.02 22.04 15.38 46.16 24.00 13.76 -23.26 11.23 5.07 -23.26 9.04 3.31 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 2 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR C 79 TYR~? 13.12 N6 ADP C1001 A 125 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 156 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -21.36 39.39 22.00 -17.64 41.95 19.02 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR C 79 TYR~? 13.12 N6 ADP C1001 B 125 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 156 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -21.36 39.39 22.00 -17.64 41.95 19.02 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c01 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR C 79 TYR~? 13.12 N6 ADP C1001 D 125 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 156 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 54.10 1.42 85.16 54.14 4.17 85.62 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 61.27 5.43 85.32 62.73 6.38 86.49 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 60.28 4.62 76.00 58.35 6.41 80.65 -21.36 39.39 22.00 -17.64 41.95 19.02 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c03 naa= 3 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 1 3 # 1 44 LYS B 14 LYS~? 27.17 N6 ADP C1001 141 HIS B 20 HIS.? 13.19 O1A ADP C1001 333 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 69.56 26.03 31.04 72.53 30.39 31.84 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 85.95 39.62 33.57 84.70 40.34 35.09 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 87.31 36.08 32.89 89.57 36.58 34.95 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 2 3 # 2 44 LYS B 60 LYS~? 21.40 C2 ADP C1001 141 HIS B 20 HIS.? 13.19 O1A ADP C1001 333 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 69.56 26.03 31.04 72.53 30.39 31.84 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 85.95 39.62 33.57 84.70 40.34 35.09 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 87.31 36.08 32.89 89.57 36.58 34.95 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 3 3 # 3 44 LYS C 60 LYS~? 19.47 N6 ADP C1001 141 HIS C 20 HIS.? 13.76 O2' ADP C1001 333 ARG C 23 ARG.? 19.01 O2' ADP C1001 coo 69.56 26.03 31.04 72.53 30.39 31.84 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 85.95 39.62 33.57 84.70 40.34 35.09 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 87.31 36.08 32.89 89.57 36.58 34.95 -41.38 43.66 27.78 -43.67 44.44 29.75 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 4 3 # 4 44 LYS D 60 LYS~? 25.96 N1 ADP C1001 141 HIS D 20 HIS.? 42.10 N6 ADP C1001 333 ARG D 23 ARG.? 42.28 N6 ADP C1001 coo 69.56 26.03 31.04 72.53 30.39 31.84 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 85.95 39.62 33.57 84.70 40.34 35.09 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 87.31 36.08 32.89 89.57 36.58 34.95 -21.76 67.41 8.31 -21.73 70.32 9.28 1aa6_c01 source 1aa6 FORMATE DEHYDROGENASE H : 4 hits 1aa6_c01 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 113 TRP.? 51.98 N6 ADP C1001 223 ASP A 112 ASP.? 58.40 N6 ADP C1001 258 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 127.19 33.46 26.14 126.78 36.79 28.15 -2.27 -12.30 8.14 -4.73 -13.16 5.16 coo 126.95 41.66 23.38 128.48 40.72 24.51 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 138.83 37.95 25.17 133.50 36.37 26.52 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP B 113 TRP.? 6.23 N7 ADP C1001 223 ASP B 112 ASP.? 11.36 O1B ADP C1001 258 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 127.19 33.46 26.14 126.78 36.79 28.15 -33.53 30.14 7.96 -35.79 27.09 9.08 coo 126.95 41.66 23.38 128.48 40.72 24.51 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 138.83 37.95 25.17 133.50 36.37 26.52 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 3 3 # 3 142 TRP C 113 TRP.? -4.31 O3' ADP C1001s 223 ASP C 112 ASP.? 10.30 O3' ADP C1001 258 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 127.19 33.46 26.14 126.78 36.79 28.15 -41.02 28.74 23.55 -40.73 32.19 21.60 coo 126.95 41.66 23.38 128.48 40.72 24.51 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 138.83 37.95 25.17 133.50 36.37 26.52 -37.26 21.98 30.89 -34.43 24.41 31.94 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 3 hits 1aam_c01 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG C 2 ARG^? 21.46 C2 ADP C1001 78 HIS C 62 HIS~? 21.13 N1 ADP C1001 122 TYR D 79 TYR~? 36.26 N1 ADP C1001 coo 48.32 72.26 30.89 48.69 69.28 31.53 -18.93 34.99 28.58 -17.63 35.83 31.18 coo 53.63 68.24 34.99 53.08 69.10 33.16 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 75.01 61.87 32.93 75.34 59.26 31.96 -22.76 62.70 24.87 -24.61 64.61 25.82 1ab4_c00 source 1ab4 GYRASE A : 1 hits 1ab4_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 36 ASP^? 33.81 N6 ADP C1001 214 ASP A 54 ASP~? 42.89 N6 ADP C1001 289 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 26.86 59.76 46.36 25.42 58.23 45.92 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 9.42 68.07 30.27 7.35 68.27 30.10 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 54 ASP~? 42.89 N6 ADP C1001 214 ASP A 36 ASP^? 33.81 N6 ADP C1001 289 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 26.86 59.76 46.36 25.42 58.23 45.92 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 54 ASP~? 42.89 N6 ADP C1001 214 ASP B 97 ASP~? 21.13 N6 ADP C1001 289 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 26.86 59.76 46.36 25.42 58.23 45.92 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 61 ASP~? 37.71 N6 ADP C1001 214 ASP B 36 ASP^? 26.54 N6 ADP C1001 289 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 26.86 59.76 46.36 25.42 58.23 45.92 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 61 ASP~? 37.71 N6 ADP C1001 214 ASP B 110 ASP.? 12.77 N6 ADP C1001 289 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 26.86 59.76 46.36 25.42 58.23 45.92 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 36 ASP^? 26.54 N6 ADP C1001 214 ASP B 54 ASP~? 20.52 O4' ADP C1001 289 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 26.86 59.76 46.36 25.42 58.23 45.92 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 54 ASP~? 20.52 O4' ADP C1001 214 ASP A 36 ASP^? 33.81 N6 ADP C1001 289 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 26.86 59.76 46.36 25.42 58.23 45.92 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP B 54 ASP~? 20.52 O4' ADP C1001 214 ASP B 36 ASP^? 26.54 N6 ADP C1001 289 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 26.86 59.76 46.36 25.42 58.23 45.92 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP B 54 ASP~? 20.52 O4' ADP C1001 214 ASP C 31 ASP^? 21.62 C2 ADP C1001 289 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 26.86 59.76 46.36 25.42 58.23 45.92 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP B 61 ASP~? 21.98 C2 ADP C1001 214 ASP A 110 ASP.? 52.32 N6 ADP C1001 289 ASP A 10 ASP.? 29.48 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 26.86 59.76 46.36 25.42 58.23 45.92 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 9.42 68.07 30.27 7.35 68.27 30.10 -21.48 2.08 13.35 -22.87 1.76 14.94 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP C 36 ASP^? 27.15 C2 ADP C1001 214 ASP C 54 ASP~? 20.12 N1 ADP C1001 289 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.89 23.06 36.75 -16.41 21.35 37.85 coo 26.86 59.76 46.36 25.42 58.23 45.92 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP C 36 ASP^? 27.15 C2 ADP C1001 214 ASP D 36 ASP^? 31.16 N6 ADP C1001 289 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.89 23.06 36.75 -16.41 21.35 37.85 coo 26.86 59.76 46.36 25.42 58.23 45.92 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 9.42 68.07 30.27 7.35 68.27 30.10 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP C 36 ASP^? 27.15 C2 ADP C1001 214 ASP D 61 ASP~? 23.08 N1 ADP C1001 289 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.89 23.06 36.75 -16.41 21.35 37.85 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 9.42 68.07 30.27 7.35 68.27 30.10 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP C 54 ASP~? 20.12 N1 ADP C1001 214 ASP B 31 ASP^? 22.05 N1 ADP C1001 289 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 26.86 59.76 46.36 25.42 58.23 45.92 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP C 54 ASP~? 20.12 N1 ADP C1001 214 ASP B 36 ASP^? 26.54 N6 ADP C1001 289 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 26.86 59.76 46.36 25.42 58.23 45.92 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP C 54 ASP~? 20.12 N1 ADP C1001 214 ASP C 36 ASP^? 27.15 C2 ADP C1001 289 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 26.86 59.76 46.36 25.42 58.23 45.92 -16.89 23.06 36.75 -16.41 21.35 37.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP C 61 ASP~? 22.05 N1 ADP C1001 214 ASP D 110 ASP.? 48.95 N6 ADP C1001 289 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP D 36 ASP^? 31.16 N6 ADP C1001 214 ASP B 112 ASP.? 11.36 O1B ADP C1001 289 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 26.86 59.76 46.36 25.42 58.23 45.92 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP D 36 ASP^? 31.16 N6 ADP C1001 214 ASP D 54 ASP~? 30.93 N6 ADP C1001 289 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 26.86 59.76 46.36 25.42 58.23 45.92 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP D 54 ASP~? 30.93 N6 ADP C1001 214 ASP B 110 ASP.? 12.77 N6 ADP C1001 289 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 26.86 59.76 46.36 25.42 58.23 45.92 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP D 54 ASP~? 30.93 N6 ADP C1001 214 ASP B 112 ASP.? 11.36 O1B ADP C1001 289 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 26.86 59.76 46.36 25.42 58.23 45.92 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP D 54 ASP~? 30.93 N6 ADP C1001 214 ASP D 36 ASP^? 31.16 N6 ADP C1001 289 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 26.86 59.76 46.36 25.42 58.23 45.92 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 9.42 68.07 30.27 7.35 68.27 30.10 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP D 61 ASP~? 23.08 N1 ADP C1001 214 ASP B 31 ASP^? 22.05 N1 ADP C1001 289 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 26.86 59.76 46.36 25.42 58.23 45.92 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 24 3 # 24 179 ASP D 61 ASP~? 23.08 N1 ADP C1001 214 ASP B 36 ASP^? 26.54 N6 ADP C1001 289 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 26.86 59.76 46.36 25.42 58.23 45.92 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 25 3 # 25 179 ASP D 61 ASP~? 23.08 N1 ADP C1001 214 ASP C 36 ASP^? 27.15 C2 ADP C1001 289 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 26.86 59.76 46.36 25.42 58.23 45.92 -16.89 23.06 36.75 -16.41 21.35 37.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 26 3 # 26 179 ASP D 61 ASP~? 23.08 N1 ADP C1001 214 ASP C 97 ASP~? 22.56 C2 ADP C1001 289 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 26.86 59.76 46.36 25.42 58.23 45.92 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.25 43.54 24.10 -19.06 45.03 24.94 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 26 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 31 ASP^? 31.30 N6 ADP C1001 204 GLU A 33 GLU^? 35.51 N6 ADP C1001 289 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 4.34 62.44 32.05 4.22 64.48 32.53 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP C 31 ASP^? 21.62 C2 ADP C1001 204 GLU C 33 GLU^? 22.62 N1 ADP C1001 289 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 4.34 62.44 32.05 4.22 64.48 32.53 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP D 31 ASP^? 21.52 N6 ADP C1001 204 GLU D 33 GLU^? 24.81 N6 ADP C1001 289 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 4.34 62.44 32.05 4.22 64.48 32.53 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -4.58 39.61 12.64 -2.59 38.96 12.51 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 3 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 36 ASP^? 33.81 N6 ADP C1001 227 GLU B 33 GLU^? 22.82 N1 ADP C1001 289 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 3.96 55.76 41.24 4.83 57.69 41.17 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 9.42 68.07 30.27 7.35 68.27 30.10 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 61 ASP~? 37.71 N6 ADP C1001 227 GLU B 44 GLU^? 27.54 N6 ADP C1001 289 ASP A 54 ASP~? 42.89 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 3.96 55.76 41.24 4.83 57.69 41.17 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 9.42 68.07 30.27 7.35 68.27 30.10 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 31 ASP^? 22.05 N1 ADP C1001 227 GLU A 33 GLU^? 35.51 N6 ADP C1001 289 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 3.96 55.76 41.24 4.83 57.69 41.17 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 31 ASP^? 22.05 N1 ADP C1001 227 GLU C 33 GLU^? 22.62 N1 ADP C1001 289 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 3.96 55.76 41.24 4.83 57.69 41.17 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 9.42 68.07 30.27 7.35 68.27 30.10 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 36 ASP^? 26.54 N6 ADP C1001 227 GLU A 33 GLU^? 35.51 N6 ADP C1001 289 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 3.96 55.76 41.24 4.83 57.69 41.17 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 54 ASP~? 20.52 O4' ADP C1001 227 GLU A 44 GLU^? 29.72 N6 ADP C1001 289 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 3.96 55.76 41.24 4.83 57.69 41.17 -23.95 2.54 6.45 -25.82 1.78 7.26 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 31 ASP^? 21.62 C2 ADP C1001 227 GLU B 33 GLU^? 22.82 N1 ADP C1001 289 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 9.42 68.07 30.27 7.35 68.27 30.10 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 36 ASP^? 27.15 C2 ADP C1001 227 GLU B 33 GLU^? 22.82 N1 ADP C1001 289 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.89 23.06 36.75 -16.41 21.35 37.85 coo 3.96 55.76 41.24 4.83 57.69 41.17 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 9.42 68.07 30.27 7.35 68.27 30.10 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP D 54 ASP~? 30.93 N6 ADP C1001 227 GLU D 78 GLU~? 42.25 N1 ADP C1001 289 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 3.96 55.76 41.24 4.83 57.69 41.17 -17.63 66.44 26.22 -18.72 68.28 26.46 coo 9.42 68.07 30.27 7.35 68.27 30.10 -25.68 50.03 20.54 -26.38 51.13 22.17 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 9 hits 1amy_c06 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS C 20 HIS.? 13.76 O2' ADP C1001 254 LYS C 114 LYS.? -2.76 O3B ADP C1001s 333 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 26.09 4.87 14.60 27.89 3.33 10.26 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 37.35 7.47 11.84 34.90 6.11 10.60 -38.47 40.65 15.33 -40.88 39.19 16.61 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 1 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 15 SER~? 35.42 N1 ADP C1001 A 292 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 322 HIS A 20 HIS.? 47.81 N6 ADP C1001 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo 19.73 19.18 41.39 21.50 18.65 40.34 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 41.69 45.14 46.60 41.78 47.19 46.18 -13.99 -12.93 8.41 -13.37 -14.79 9.16 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 96 SER~? 35.53 N1 ADP C1001 A 292 ASP A 112 ASP.? 58.40 N6 ADP C1001 A 322 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 36.34 32.23 39.60 36.43 34.62 39.93 -7.24 4.52 16.66 -7.72 4.23 19.06 coo 19.73 19.18 41.39 21.50 18.65 40.34 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER B 15 SER~? 20.97 N6 ADP C1001 A 292 ASP A 36 ASP^? 33.81 N6 ADP C1001 A 322 HIS B 20 HIS.? 13.19 O1A ADP C1001 coo 36.34 32.23 39.60 36.43 34.62 39.93 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 19.73 19.18 41.39 21.50 18.65 40.34 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 41.69 45.14 46.60 41.78 47.19 46.18 -35.44 19.24 3.79 -36.86 20.32 2.70 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER B 24 SER.? 17.25 N6 ADP C1001 A 292 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 322 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 36.34 32.23 39.60 36.43 34.62 39.93 -29.56 14.13 6.20 -27.58 15.07 7.20 coo 19.73 19.18 41.39 21.50 18.65 40.34 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 41.69 45.14 46.60 41.78 47.19 46.18 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER B 86 SER^? 6.21 N1 ADP C1001 A 292 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 322 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 36.34 32.23 39.60 36.43 34.62 39.93 -28.54 24.76 20.78 -28.08 27.14 20.69 coo 19.73 19.18 41.39 21.50 18.65 40.34 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER C 86 SER^? 7.39 N1 ADP C1001 A 292 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 322 HIS C 62 HIS~? 21.13 N1 ADP C1001 coo 36.34 32.23 39.60 36.43 34.62 39.93 -26.83 30.24 19.36 -25.45 28.48 18.57 coo 19.73 19.18 41.39 21.50 18.65 40.34 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -20.79 41.45 28.58 -20.89 43.35 29.47 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 6 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 96 SER~? 35.53 N1 ADP C1001 B 292 ASP A 112 ASP.? 58.40 N6 ADP C1001 B 322 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 35.42 71.28 22.94 36.24 69.06 22.37 -7.24 4.52 16.66 -7.72 4.23 19.06 coo 24.74 78.07 5.59 24.32 79.03 7.46 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 15 SER~? 20.97 N6 ADP C1001 B 292 ASP A 36 ASP^? 33.81 N6 ADP C1001 B 322 HIS B 20 HIS.? 13.19 O1A ADP C1001 coo 35.42 71.28 22.94 36.24 69.06 22.37 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 24.74 78.07 5.59 24.32 79.03 7.46 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 48.81 64.16 26.34 49.30 62.16 26.73 -35.44 19.24 3.79 -36.86 20.32 2.70 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 15 SER~? 20.97 N6 ADP C1001 B 292 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 322 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 35.42 71.28 22.94 36.24 69.06 22.37 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 24.74 78.07 5.59 24.32 79.03 7.46 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 48.81 64.16 26.34 49.30 62.16 26.73 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER B 24 SER.? 17.25 N6 ADP C1001 B 292 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 322 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 35.42 71.28 22.94 36.24 69.06 22.37 -29.56 14.13 6.20 -27.58 15.07 7.20 coo 24.74 78.07 5.59 24.32 79.03 7.46 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 48.81 64.16 26.34 49.30 62.16 26.73 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER B 86 SER^? 6.21 N1 ADP C1001 B 292 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 322 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 35.42 71.28 22.94 36.24 69.06 22.37 -28.54 24.76 20.78 -28.08 27.14 20.69 coo 24.74 78.07 5.59 24.32 79.03 7.46 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER C 86 SER^? 7.39 N1 ADP C1001 B 292 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 322 HIS C 62 HIS~? 21.13 N1 ADP C1001 coo 35.42 71.28 22.94 36.24 69.06 22.37 -26.83 30.24 19.36 -25.45 28.48 18.57 coo 24.74 78.07 5.59 24.32 79.03 7.46 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -20.79 41.45 28.58 -20.89 43.35 29.47 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 6 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG B 25 ARG.? 26.72 N7 ADP C1001 B 342 ASP B 9 ASP.? 24.63 N6 ADP C1001 B 531 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 25 ARG.? 26.72 N7 ADP C1001 B 342 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 531 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG B 25 ARG.? 26.72 N7 ADP C1001 B 342 ASP B 54 ASP~? 20.52 O4' ADP C1001 B 531 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG C 25 ARG.? 26.50 C2 ADP C1001 B 342 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 531 ARG C 23 ARG.? 19.01 O2' ADP C1001 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -32.85 47.91 34.77 -31.37 50.53 33.86 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -41.38 43.66 27.78 -43.67 44.44 29.75 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG C 75 ARG~? 8.05 O3B ADP C1001 B 342 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 531 ARG C 23 ARG.? 19.01 O2' ADP C1001 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -41.38 43.66 27.78 -43.67 44.44 29.75 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 5 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG B 25 ARG.? 26.72 N7 ADP C1001 A 342 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 531 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG B 25 ARG.? 26.72 N7 ADP C1001 A 342 ASP B 54 ASP~? 20.52 O4' ADP C1001 A 531 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG C 23 ARG.? 19.01 O2' ADP C1001 A 342 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 531 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -41.38 43.66 27.78 -43.67 44.44 29.75 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG C 23 ARG.? 19.01 O2' ADP C1001 A 342 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 531 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -41.38 43.66 27.78 -43.67 44.44 29.75 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG C 25 ARG.? 26.50 C2 ADP C1001 A 342 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 531 ARG C 23 ARG.? 19.01 O2' ADP C1001 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -32.85 47.91 34.77 -31.37 50.53 33.86 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -41.38 43.66 27.78 -43.67 44.44 29.75 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG C 75 ARG~? 8.05 O3B ADP C1001 A 342 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 531 ARG C 23 ARG.? 19.01 O2' ADP C1001 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -41.38 43.66 27.78 -43.67 44.44 29.75 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 6 hits 1asy_c01 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 102 PHE~? 42.29 N6 ADP C1001 A 223 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 265 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -0.48 3.09 8.71 -0.12 3.21 5.93 coo 30.70 47.50 67.53 29.83 49.47 67.39 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 19.99 54.53 64.11 20.55 58.78 68.33 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE B 27 PHE^? 16.30 N6 ADP C1001 A 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 265 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 30.70 47.50 67.53 29.83 49.47 67.39 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 19.99 54.53 64.11 20.55 58.78 68.33 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE B 27 PHE^? 16.30 N6 ADP C1001 A 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 265 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 30.70 47.50 67.53 29.83 49.47 67.39 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 19.99 54.53 64.11 20.55 58.78 68.33 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 265 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 30.70 47.50 67.53 29.83 49.47 67.39 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 19.99 54.53 64.11 20.55 58.78 68.33 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 47 PHE.? 28.85 O4' ADP C1001 A 223 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 265 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -29.91 1.80 9.18 -28.86 -0.57 10.37 coo 30.70 47.50 67.53 29.83 49.47 67.39 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 19.99 54.53 64.11 20.55 58.78 68.33 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 102 PHE~? 12.24 N6 ADP C1001 A 223 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 265 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -19.65 28.55 14.45 -20.63 28.01 16.97 coo 30.70 47.50 67.53 29.83 49.47 67.39 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 19.99 54.53 64.11 20.55 58.78 68.33 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE B 102 PHE~? 12.24 N6 ADP C1001 A 223 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 265 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -19.65 28.55 14.45 -20.63 28.01 16.97 coo 30.70 47.50 67.53 29.83 49.47 67.39 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 19.99 54.53 64.11 20.55 58.78 68.33 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 265 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 30.70 47.50 67.53 29.83 49.47 67.39 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 19.99 54.53 64.11 20.55 58.78 68.33 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE C 29 PHE^? 17.94 C2 ADP C1001 A 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 265 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -22.69 37.33 30.80 -23.71 39.19 28.97 coo 30.70 47.50 67.53 29.83 49.47 67.39 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 19.99 54.53 64.11 20.55 58.78 68.33 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE C 47 PHE.? 25.87 O2' ADP C1001 A 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -33.84 53.41 29.52 -36.47 53.88 28.66 coo 30.70 47.50 67.53 29.83 49.47 67.39 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 19.99 54.53 64.11 20.55 58.78 68.33 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE C 47 PHE.? 25.87 O2' ADP C1001 A 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 265 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -33.84 53.41 29.52 -36.47 53.88 28.66 coo 30.70 47.50 67.53 29.83 49.47 67.39 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 19.99 54.53 64.11 20.55 58.78 68.33 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE D 27 PHE^? 29.27 N6 ADP C1001 A 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -19.87 54.80 11.53 -19.94 57.47 12.38 coo 30.70 47.50 67.53 29.83 49.47 67.39 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 19.99 54.53 64.11 20.55 58.78 68.33 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c04 TRYPTOPHANASE user 13 3 # 13 A 130 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 265 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 30.70 47.50 67.53 29.83 49.47 67.39 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 19.99 54.53 64.11 20.55 58.78 68.33 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1ax4_c04 TRYPTOPHANASE user 14 3 # 14 A 130 PHE D 47 PHE.? 27.02 N6 ADP C1001 A 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -29.38 57.47 13.70 -28.51 55.69 15.67 coo 30.70 47.50 67.53 29.83 49.47 67.39 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 19.99 54.53 64.11 20.55 58.78 68.33 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c04 TRYPTOPHANASE user 15 3 # 15 A 130 PHE D 47 PHE.? 27.02 N6 ADP C1001 A 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 265 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -29.38 57.47 13.70 -28.51 55.69 15.67 coo 30.70 47.50 67.53 29.83 49.47 67.39 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 19.99 54.53 64.11 20.55 58.78 68.33 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1ax4_c04 TRYPTOPHANASE user 16 3 # 16 A 130 PHE D 80 PHE~? 32.28 N6 ADP C1001 A 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -17.84 58.74 21.22 -19.00 58.24 18.75 coo 30.70 47.50 67.53 29.83 49.47 67.39 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 19.99 54.53 64.11 20.55 58.78 68.33 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c04 TRYPTOPHANASE user 17 3 # 17 A 130 PHE D 102 PHE~? 33.92 N6 ADP C1001 A 223 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 39.74 52.86 65.74 41.15 55.14 66.52 -5.47 51.33 14.45 -6.43 50.98 17.07 coo 30.70 47.50 67.53 29.83 49.47 67.39 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 19.99 54.53 64.11 20.55 58.78 68.33 -21.36 39.39 22.00 -17.64 41.95 19.02 1ax4_c04 source 1ax4 TRYPTOPHANASE : 17 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 102 PHE~? 42.29 N6 ADP C1001 B 223 ASP A 31 ASP^? 31.30 N6 ADP C1001 B 265 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -0.48 3.09 8.71 -0.12 3.21 5.93 coo 10.43 61.66 91.81 9.80 60.04 90.61 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 5.43 58.06 80.08 8.57 53.00 79.37 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE B 27 PHE^? 16.30 N6 ADP C1001 B 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 265 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 10.43 61.66 91.81 9.80 60.04 90.61 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 5.43 58.06 80.08 8.57 53.00 79.37 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE B 27 PHE^? 16.30 N6 ADP C1001 B 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 265 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 10.43 61.66 91.81 9.80 60.04 90.61 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 5.43 58.06 80.08 8.57 53.00 79.37 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE B 29 PHE^? 19.13 N6 ADP C1001 B 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 265 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 10.43 61.66 91.81 9.80 60.04 90.61 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 5.43 58.06 80.08 8.57 53.00 79.37 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 47 PHE.? 28.85 O4' ADP C1001 B 223 ASP A 10 ASP.? 29.48 N1 ADP C1001 B 265 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -29.91 1.80 9.18 -28.86 -0.57 10.37 coo 10.43 61.66 91.81 9.80 60.04 90.61 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 5.43 58.06 80.08 8.57 53.00 79.37 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 102 PHE~? 12.24 N6 ADP C1001 B 223 ASP B 31 ASP^? 22.05 N1 ADP C1001 B 265 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -19.65 28.55 14.45 -20.63 28.01 16.97 coo 10.43 61.66 91.81 9.80 60.04 90.61 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 5.43 58.06 80.08 8.57 53.00 79.37 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE B 102 PHE~? 12.24 N6 ADP C1001 B 223 ASP B 36 ASP^? 26.54 N6 ADP C1001 B 265 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -19.65 28.55 14.45 -20.63 28.01 16.97 coo 10.43 61.66 91.81 9.80 60.04 90.61 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 5.43 58.06 80.08 8.57 53.00 79.37 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE C 27 PHE^? 15.44 C2 ADP C1001 B 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 265 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 10.43 61.66 91.81 9.80 60.04 90.61 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 5.43 58.06 80.08 8.57 53.00 79.37 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE C 29 PHE^? 17.94 C2 ADP C1001 B 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 265 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -22.69 37.33 30.80 -23.71 39.19 28.97 coo 10.43 61.66 91.81 9.80 60.04 90.61 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 5.43 58.06 80.08 8.57 53.00 79.37 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE C 47 PHE.? 25.87 O2' ADP C1001 B 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -33.84 53.41 29.52 -36.47 53.88 28.66 coo 10.43 61.66 91.81 9.80 60.04 90.61 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 5.43 58.06 80.08 8.57 53.00 79.37 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE C 47 PHE.? 25.87 O2' ADP C1001 B 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 265 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -33.84 53.41 29.52 -36.47 53.88 28.66 coo 10.43 61.66 91.81 9.80 60.04 90.61 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 5.43 58.06 80.08 8.57 53.00 79.37 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE D 27 PHE^? 29.27 N6 ADP C1001 B 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -19.87 54.80 11.53 -19.94 57.47 12.38 coo 10.43 61.66 91.81 9.80 60.04 90.61 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 5.43 58.06 80.08 8.57 53.00 79.37 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c05 TRYPTOPHANASE user 13 3 # 13 B 130 PHE D 29 PHE^? 23.81 N6 ADP C1001 B 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 265 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 10.43 61.66 91.81 9.80 60.04 90.61 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 5.43 58.06 80.08 8.57 53.00 79.37 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1ax4_c05 TRYPTOPHANASE user 14 3 # 14 B 130 PHE D 47 PHE.? 27.02 N6 ADP C1001 B 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -29.38 57.47 13.70 -28.51 55.69 15.67 coo 10.43 61.66 91.81 9.80 60.04 90.61 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 5.43 58.06 80.08 8.57 53.00 79.37 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c05 TRYPTOPHANASE user 15 3 # 15 B 130 PHE D 47 PHE.? 27.02 N6 ADP C1001 B 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 265 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -29.38 57.47 13.70 -28.51 55.69 15.67 coo 10.43 61.66 91.81 9.80 60.04 90.61 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 5.43 58.06 80.08 8.57 53.00 79.37 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1ax4_c05 TRYPTOPHANASE user 16 3 # 16 B 130 PHE D 80 PHE~? 32.28 N6 ADP C1001 B 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -17.84 58.74 21.22 -19.00 58.24 18.75 coo 10.43 61.66 91.81 9.80 60.04 90.61 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 5.43 58.06 80.08 8.57 53.00 79.37 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c05 TRYPTOPHANASE user 17 3 # 17 B 130 PHE D 102 PHE~? 33.92 N6 ADP C1001 B 223 ASP D 31 ASP^? 21.52 N6 ADP C1001 B 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 7.48 54.94 99.62 7.67 52.27 100.42 -5.47 51.33 14.45 -6.43 50.98 17.07 coo 10.43 61.66 91.81 9.80 60.04 90.61 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 5.43 58.06 80.08 8.57 53.00 79.37 -21.36 39.39 22.00 -17.64 41.95 19.02 1ax4_c05 source 1ax4 TRYPTOPHANASE : 17 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 102 PHE~? 42.29 N6 ADP C1001 C 223 ASP A 31 ASP^? 31.30 N6 ADP C1001 C 265 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -0.48 3.09 8.71 -0.12 3.21 5.93 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -7.60 12.44 5.41 -8.89 12.13 3.85 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE B 27 PHE^? 16.30 N6 ADP C1001 C 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 265 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE B 27 PHE^? 16.30 N6 ADP C1001 C 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 265 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE B 29 PHE^? 19.13 N6 ADP C1001 C 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 265 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -19.97 14.78 14.91 -22.45 13.54 15.08 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 102 PHE~? 12.24 N6 ADP C1001 C 223 ASP B 31 ASP^? 22.05 N1 ADP C1001 C 265 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -19.65 28.55 14.45 -20.63 28.01 16.97 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.40 19.33 18.81 -14.28 17.40 18.97 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 102 PHE~? 12.24 N6 ADP C1001 C 223 ASP B 36 ASP^? 26.54 N6 ADP C1001 C 265 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -19.65 28.55 14.45 -20.63 28.01 16.97 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -7.49 25.66 16.69 -6.44 23.85 16.43 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE C 27 PHE^? 15.44 C2 ADP C1001 C 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 265 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE C 29 PHE^? 17.94 C2 ADP C1001 C 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 265 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -22.69 37.33 30.80 -23.71 39.19 28.97 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE C 47 PHE.? 25.87 O2' ADP C1001 C 223 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -33.84 53.41 29.52 -36.47 53.88 28.66 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE C 47 PHE.? 25.87 O2' ADP C1001 C 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -33.84 53.41 29.52 -36.47 53.88 28.66 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE C 47 PHE.? 25.87 O2' ADP C1001 C 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 265 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -33.84 53.41 29.52 -36.47 53.88 28.66 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE D 27 PHE^? 29.27 N6 ADP C1001 C 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c06 TRYPTOPHANASE user 13 3 # 13 C 130 PHE D 29 PHE^? 23.81 N6 ADP C1001 C 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 265 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -18.44 48.91 13.36 -20.46 50.71 14.19 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1ax4_c06 TRYPTOPHANASE user 14 3 # 14 C 130 PHE D 47 PHE.? 27.02 N6 ADP C1001 C 223 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -29.38 57.47 13.70 -28.51 55.69 15.67 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c06 TRYPTOPHANASE user 15 3 # 15 C 130 PHE D 47 PHE.? 27.02 N6 ADP C1001 C 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -29.38 57.47 13.70 -28.51 55.69 15.67 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c06 TRYPTOPHANASE user 16 3 # 16 C 130 PHE D 47 PHE.? 27.02 N6 ADP C1001 C 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 265 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -29.38 57.47 13.70 -28.51 55.69 15.67 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1ax4_c06 TRYPTOPHANASE user 17 3 # 17 C 130 PHE D 80 PHE~? 32.28 N6 ADP C1001 C 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -17.84 58.74 21.22 -19.00 58.24 18.75 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c06 TRYPTOPHANASE user 18 3 # 18 C 130 PHE D 102 PHE~? 33.92 N6 ADP C1001 C 223 ASP D 31 ASP^? 21.52 N6 ADP C1001 C 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -5.47 51.33 14.45 -6.43 50.98 17.07 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.15 42.40 14.58 -15.11 42.76 15.19 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -21.36 39.39 22.00 -17.64 41.95 19.02 1ax4_c06 source 1ax4 TRYPTOPHANASE : 18 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 102 PHE~? 42.29 N6 ADP C1001 D 223 ASP A 31 ASP^? 31.30 N6 ADP C1001 D 265 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -0.48 3.09 8.71 -0.12 3.21 5.93 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -7.60 12.44 5.41 -8.89 12.13 3.85 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE B 27 PHE^? 16.30 N6 ADP C1001 D 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 D 265 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE B 27 PHE^? 16.30 N6 ADP C1001 D 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 D 265 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE B 29 PHE^? 19.13 N6 ADP C1001 D 223 ASP B 61 ASP~? 21.98 C2 ADP C1001 D 265 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -19.97 14.78 14.91 -22.45 13.54 15.08 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 102 PHE~? 12.24 N6 ADP C1001 D 223 ASP B 31 ASP^? 22.05 N1 ADP C1001 D 265 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -19.65 28.55 14.45 -20.63 28.01 16.97 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -13.40 19.33 18.81 -14.28 17.40 18.97 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 102 PHE~? 12.24 N6 ADP C1001 D 223 ASP B 36 ASP^? 26.54 N6 ADP C1001 D 265 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -19.65 28.55 14.45 -20.63 28.01 16.97 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -7.49 25.66 16.69 -6.44 23.85 16.43 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE C 27 PHE^? 15.44 C2 ADP C1001 D 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 265 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE C 29 PHE^? 17.94 C2 ADP C1001 D 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 265 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -22.69 37.33 30.80 -23.71 39.19 28.97 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE C 47 PHE.? 25.87 O2' ADP C1001 D 223 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -33.84 53.41 29.52 -36.47 53.88 28.66 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE C 47 PHE.? 25.87 O2' ADP C1001 D 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -33.84 53.41 29.52 -36.47 53.88 28.66 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE C 47 PHE.? 25.87 O2' ADP C1001 D 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 265 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -33.84 53.41 29.52 -36.47 53.88 28.66 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE D 27 PHE^? 29.27 N6 ADP C1001 D 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c07 TRYPTOPHANASE user 13 3 # 13 D 130 PHE D 29 PHE^? 23.81 N6 ADP C1001 D 223 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 265 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -18.44 48.91 13.36 -20.46 50.71 14.19 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1ax4_c07 TRYPTOPHANASE user 14 3 # 14 D 130 PHE D 47 PHE.? 27.02 N6 ADP C1001 D 223 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -29.38 57.47 13.70 -28.51 55.69 15.67 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c07 TRYPTOPHANASE user 15 3 # 15 D 130 PHE D 47 PHE.? 27.02 N6 ADP C1001 D 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -29.38 57.47 13.70 -28.51 55.69 15.67 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c07 TRYPTOPHANASE user 16 3 # 16 D 130 PHE D 47 PHE.? 27.02 N6 ADP C1001 D 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 265 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -29.38 57.47 13.70 -28.51 55.69 15.67 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1ax4_c07 TRYPTOPHANASE user 17 3 # 17 D 130 PHE D 80 PHE~? 32.28 N6 ADP C1001 D 223 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -17.84 58.74 21.22 -19.00 58.24 18.75 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ax4_c07 TRYPTOPHANASE user 18 3 # 18 D 130 PHE D 102 PHE~? 33.92 N6 ADP C1001 D 223 ASP D 31 ASP^? 21.52 N6 ADP C1001 D 265 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -5.47 51.33 14.45 -6.43 50.98 17.07 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -13.15 42.40 14.58 -15.11 42.76 15.19 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -21.36 39.39 22.00 -17.64 41.95 19.02 1ax4_c07 source 1ax4 TRYPTOPHANASE : 18 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 113 TRP.? 51.98 N6 ADP C1001 B 222 ASP A 112 ASP.? 58.40 N6 ADP C1001 B 258 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 103.45 44.39 16.20 102.66 41.02 14.32 -2.27 -12.30 8.14 -4.73 -13.16 5.16 coo 110.10 38.66 15.58 108.40 39.41 14.53 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 107.51 45.54 4.76 105.41 44.51 10.25 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP C 113 TRP.? -4.31 O3' ADP C1001s B 222 ASP C 112 ASP.? 10.30 O3' ADP C1001 B 258 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 103.45 44.39 16.20 102.66 41.02 14.32 -41.02 28.74 23.55 -40.73 32.19 21.60 coo 110.10 38.66 15.58 108.40 39.41 14.53 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 107.51 45.54 4.76 105.41 44.51 10.25 -37.26 21.98 30.89 -34.43 24.41 31.94 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 2 hits 1ay4_c03 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 171 ARG B 74 ARG~? -6.26 O2A ADP C1001s A 190 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 22.59 2.26 43.22 21.17 3.47 42.27 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 13.63 3.81 28.83 14.49 2.91 31.59 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 24.97 7.47 37.69 21.24 10.69 35.89 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 171 ARG B 75 ARG~? 7.41 O2A ADP C1001 A 190 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 22.59 2.26 43.22 21.17 3.47 42.27 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 13.63 3.81 28.83 14.49 2.91 31.59 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 24.97 7.47 37.69 21.24 10.69 35.89 -38.05 28.30 5.66 -42.50 28.99 10.13 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 2 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS B 20 HIS.? 13.19 O1A ADP C1001 B 171 ARG B 74 ARG~? -6.26 O2A ADP C1001s B 190 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 2.83 4.83 10.84 1.96 4.32 7.97 -43.21 24.74 16.58 -45.29 23.99 18.72 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS B 20 HIS.? 13.19 O1A ADP C1001 B 171 ARG B 75 ARG~? 7.41 O2A ADP C1001 B 190 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 2.83 4.83 10.84 1.96 4.32 7.97 -43.83 18.61 16.41 -46.11 20.56 15.85 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -38.05 28.30 5.66 -42.50 28.99 10.13 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 2 hits 1azy_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 182 GLU C 49 GLU.? 21.81 N1 ADP C1001 A 286 ASN D 57 ASN~? 28.49 N1 ADP C1001 coo 26.03 44.66 108.90 25.67 42.61 108.82 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 18.06 44.02 105.38 18.08 45.37 107.03 -30.22 47.91 25.82 -28.66 49.28 25.41 coo 25.47 38.28 112.06 27.26 39.30 111.54 -26.50 55.76 21.71 -26.74 56.60 23.67 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 1 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 182 GLU C 48 GLU.? 22.51 O2' ADP C1001 B 286 ASN C 57 ASN~? 16.68 N6 ADP C1001 coo 13.82 69.26 132.27 11.87 70.14 132.51 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 8.74 63.05 136.42 9.87 62.19 134.79 -33.52 53.52 23.97 -33.48 52.09 22.33 coo 8.26 72.60 129.22 10.14 73.45 129.80 -24.16 44.44 19.70 -24.30 44.19 17.59 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 182 GLU C 48 GLU.? 22.51 O2' ADP C1001 B 286 ASN C 57 ASN~? 16.68 N6 ADP C1001 coo 13.82 69.26 132.27 11.87 70.14 132.51 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 8.74 63.05 136.42 9.87 62.19 134.79 -33.52 53.52 23.97 -33.48 52.09 22.33 coo 8.26 72.60 129.22 10.14 73.45 129.80 -24.16 44.44 19.70 -24.30 44.19 17.59 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 2 hits 1b57_c01 naa= 3 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 1 3 # 1 124 ASP A 61 ASP~? 37.71 N6 ADP C1001 260 ASP B 10 ASP.? 28.32 N6 ADP C1001 289 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 30.43 27.27 28.31 29.04 28.69 29.00 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 34.79 33.03 22.11 33.47 32.83 23.76 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 30.83 30.57 23.91 30.62 30.06 25.92 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1b6g_c00 HALOALKANE DEHALOGENASE user 2 3 # 2 124 ASP B 10 ASP.? 28.32 N6 ADP C1001 260 ASP A 61 ASP~? 37.71 N6 ADP C1001 289 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 30.43 27.27 28.31 29.04 28.69 29.00 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 34.79 33.03 22.11 33.47 32.83 23.76 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 30.83 30.57 23.91 30.62 30.06 25.92 -15.84 6.06 -0.29 -17.94 5.95 -0.14 1b6g_c00 source 1b6g HALOALKANE DEHALOGENASE : 2 hits 1b6g_c00 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 70 TYR.? 48.30 N6 ADP C1001 A 230 ASP A 112 ASP.? 58.40 N6 ADP C1001 A 273 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 1.45 22.80 104.16 2.58 21.02 104.01 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 2.97 11.64 107.87 6.59 15.13 107.03 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 79 TYR~? 47.68 N6 ADP C1001 A 230 ASP A 54 ASP~? 42.89 N6 ADP C1001 A 273 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 1.45 22.80 104.16 2.58 21.02 104.01 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 2.97 11.64 107.87 6.59 15.13 107.03 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR A 92 TYR.? 47.39 N1 ADP C1001 A 230 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 273 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 1.45 22.80 104.16 2.58 21.02 104.01 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 2.97 11.64 107.87 6.59 15.13 107.03 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 A 145 TYR A 111 TYR.? 55.51 N6 ADP C1001 A 230 ASP A 110 ASP.? 52.32 N6 ADP C1001 A 273 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 1.45 22.80 104.16 2.58 21.02 104.01 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 2.97 11.64 107.87 6.59 15.13 107.03 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 A 145 TYR B 26 TYR^? 24.12 N6 ADP C1001 A 230 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 273 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 1.45 22.80 104.16 2.58 21.02 104.01 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 2.97 11.64 107.87 6.59 15.13 107.03 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 A 145 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 230 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 273 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 1.45 22.80 104.16 2.58 21.02 104.01 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 2.97 11.64 107.87 6.59 15.13 107.03 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 A 145 TYR B 79 TYR~? 13.34 O4' ADP C1001 A 230 ASP B 54 ASP~? 20.52 O4' ADP C1001 A 273 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 1.45 22.80 104.16 2.58 21.02 104.01 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 2.97 11.64 107.87 6.59 15.13 107.03 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 A 145 TYR B 92 TYR.? 14.20 N6 ADP C1001 A 230 ASP B 97 ASP~? 21.13 N6 ADP C1001 A 273 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 1.45 22.80 104.16 2.58 21.02 104.01 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 2.97 11.64 107.87 6.59 15.13 107.03 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 A 145 TYR C 70 TYR.? 10.33 O3' ADP C1001 A 230 ASP C 112 ASP.? 10.30 O3' ADP C1001 A 273 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -40.11 31.99 28.67 -42.64 30.90 28.52 coo 1.45 22.80 104.16 2.58 21.02 104.01 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 2.97 11.64 107.87 6.59 15.13 107.03 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 A 145 TYR C 79 TYR~? 13.12 N6 ADP C1001 A 230 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 273 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 1.45 22.80 104.16 2.58 21.02 104.01 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 2.97 11.64 107.87 6.59 15.13 107.03 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 A 145 TYR C 92 TYR.? 13.82 O3' ADP C1001 A 230 ASP C 97 ASP~? 22.56 C2 ADP C1001 A 273 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 1.45 22.80 104.16 2.58 21.02 104.01 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 2.97 11.64 107.87 6.59 15.13 107.03 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 A 145 TYR C 111 TYR.? 9.78 O3' ADP C1001 A 230 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 273 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 1.45 22.80 104.16 2.58 21.02 104.01 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 2.97 11.64 107.87 6.59 15.13 107.03 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 13 3 # 13 A 145 TYR D 79 TYR~? 36.26 N1 ADP C1001 A 230 ASP D 54 ASP~? 30.93 N6 ADP C1001 A 273 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 1.45 22.80 104.16 2.58 21.02 104.01 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 2.97 11.64 107.87 6.59 15.13 107.03 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 14 3 # 14 A 145 TYR D 92 TYR.? 44.20 N6 ADP C1001 A 230 ASP D 97 ASP~? 39.15 N6 ADP C1001 A 273 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 9.23 21.44 106.88 10.18 19.34 105.31 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 1.45 22.80 104.16 2.58 21.02 104.01 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 2.97 11.64 107.87 6.59 15.13 107.03 1.94 54.62 12.82 6.05 51.27 9.45 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 14 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 70 TYR.? 48.30 N6 ADP C1001 B 230 ASP A 112 ASP.? 58.40 N6 ADP C1001 B 273 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 19.17 11.01 76.14 17.26 10.42 76.77 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 11.10 2.31 76.60 10.24 7.24 75.62 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 79 TYR~? 47.68 N6 ADP C1001 B 230 ASP A 54 ASP~? 42.89 N6 ADP C1001 B 273 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 19.17 11.01 76.14 17.26 10.42 76.77 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 11.10 2.31 76.60 10.24 7.24 75.62 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR A 92 TYR.? 47.39 N1 ADP C1001 B 230 ASP A 97 ASP~? 39.49 N1 ADP C1001 B 273 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 19.17 11.01 76.14 17.26 10.42 76.77 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 11.10 2.31 76.60 10.24 7.24 75.62 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR A 111 TYR.? 55.51 N6 ADP C1001 B 230 ASP A 110 ASP.? 52.32 N6 ADP C1001 B 273 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 19.17 11.01 76.14 17.26 10.42 76.77 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 11.10 2.31 76.60 10.24 7.24 75.62 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 B 145 TYR B 26 TYR^? 24.12 N6 ADP C1001 B 230 ASP B 9 ASP.? 24.63 N6 ADP C1001 B 273 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 19.17 11.01 76.14 17.26 10.42 76.77 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 11.10 2.31 76.60 10.24 7.24 75.62 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 B 145 TYR B 70 TYR.? 11.71 N6 ADP C1001 B 230 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 273 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 19.17 11.01 76.14 17.26 10.42 76.77 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 11.10 2.31 76.60 10.24 7.24 75.62 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 B 145 TYR B 79 TYR~? 13.34 O4' ADP C1001 B 230 ASP B 54 ASP~? 20.52 O4' ADP C1001 B 273 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 19.17 11.01 76.14 17.26 10.42 76.77 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 11.10 2.31 76.60 10.24 7.24 75.62 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 B 145 TYR B 92 TYR.? 14.20 N6 ADP C1001 B 230 ASP B 97 ASP~? 21.13 N6 ADP C1001 B 273 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 19.17 11.01 76.14 17.26 10.42 76.77 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 11.10 2.31 76.60 10.24 7.24 75.62 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 B 145 TYR C 70 TYR.? 10.33 O3' ADP C1001 B 230 ASP C 112 ASP.? 10.30 O3' ADP C1001 B 273 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -40.11 31.99 28.67 -42.64 30.90 28.52 coo 19.17 11.01 76.14 17.26 10.42 76.77 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 11.10 2.31 76.60 10.24 7.24 75.62 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 B 145 TYR C 79 TYR~? 13.12 N6 ADP C1001 B 230 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 273 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 19.17 11.01 76.14 17.26 10.42 76.77 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 11.10 2.31 76.60 10.24 7.24 75.62 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 B 145 TYR C 92 TYR.? 13.82 O3' ADP C1001 B 230 ASP C 97 ASP~? 22.56 C2 ADP C1001 B 273 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 19.17 11.01 76.14 17.26 10.42 76.77 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 11.10 2.31 76.60 10.24 7.24 75.62 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 B 145 TYR C 111 TYR.? 9.78 O3' ADP C1001 B 230 ASP C 110 ASP.? 10.54 O3' ADP C1001 B 273 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 19.17 11.01 76.14 17.26 10.42 76.77 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 11.10 2.31 76.60 10.24 7.24 75.62 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 13 3 # 13 B 145 TYR D 79 TYR~? 36.26 N1 ADP C1001 B 230 ASP D 54 ASP~? 30.93 N6 ADP C1001 B 273 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 19.17 11.01 76.14 17.26 10.42 76.77 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 11.10 2.31 76.60 10.24 7.24 75.62 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 14 3 # 14 B 145 TYR D 92 TYR.? 44.20 N6 ADP C1001 B 230 ASP D 97 ASP~? 39.15 N6 ADP C1001 B 273 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 11.81 13.41 73.03 10.00 13.03 75.12 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 19.17 11.01 76.14 17.26 10.42 76.77 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 11.10 2.31 76.60 10.24 7.24 75.62 1.94 54.62 12.82 6.05 51.27 9.45 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 14 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 27 PHE^? 37.41 N6 ADP C1001 A 159 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 188 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 20.97 28.40 16.26 20.19 30.15 15.34 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 22.55 41.65 15.60 18.92 37.20 14.63 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 159 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 188 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 20.97 28.40 16.26 20.19 30.15 15.34 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 22.55 41.65 15.60 18.92 37.20 14.63 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 159 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 188 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 20.97 28.40 16.26 20.19 30.15 15.34 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 22.55 41.65 15.60 18.92 37.20 14.63 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 159 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 188 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 20.97 28.40 16.26 20.19 30.15 15.34 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 22.55 41.65 15.60 18.92 37.20 14.63 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 159 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 188 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 22.55 41.65 15.60 18.92 37.20 14.63 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 159 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 188 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 20.97 28.40 16.26 20.19 30.15 15.34 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 22.55 41.65 15.60 18.92 37.20 14.63 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 159 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 188 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 20.97 28.40 16.26 20.19 30.15 15.34 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 22.55 41.65 15.60 18.92 37.20 14.63 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE C 29 PHE^? 17.94 C2 ADP C1001 A 159 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 188 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -22.69 37.33 30.80 -23.71 39.19 28.97 coo 20.97 28.40 16.26 20.19 30.15 15.34 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 22.55 41.65 15.60 18.92 37.20 14.63 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 159 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 188 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 22.55 41.65 15.60 18.92 37.20 14.63 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 159 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 188 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 22.55 41.65 15.60 18.92 37.20 14.63 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 159 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 188 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 22.55 41.65 15.60 18.92 37.20 14.63 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 12 3 # 12 A 88 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 159 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 188 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 13.91 34.58 14.67 12.95 36.00 12.47 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 22.55 41.65 15.60 18.92 37.20 14.63 -14.21 50.71 21.89 -14.80 46.21 24.73 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 12 hits 1b9h_c02 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 61 ASP~? 37.71 N6 ADP C1001 16 HIS A 62 HIS~? 32.10 N6 ADP C1001 67 GLY A 71 GLY.? 48.26 N6 ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.06 -11.19 6.84 -8.36 -10.42 6.74 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 61 ASP~? 37.71 N6 ADP C1001 16 HIS A 62 HIS~? 32.10 N6 ADP C1001 67 GLY A 73 GLY~? 50.94 N6 ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -9.03 -13.13 0.27 -8.69 -12.39 0.23 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 61 ASP~? 37.71 N6 ADP C1001 16 HIS A 62 HIS~? 32.10 N6 ADP C1001 67 GLY B 93 GLY.? 16.72 N6 ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -22.84 26.20 1.59 -22.97 25.70 2.25 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP B 10 ASP.? 28.32 N6 ADP C1001 16 HIS A 62 HIS~? 32.10 N6 ADP C1001 67 GLY A 34 GLY.? 38.98 N6 ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 2.49 13.62 7.79 1.75 13.25 7.94 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP B 61 ASP~? 21.98 C2 ADP C1001 16 HIS B 62 HIS~? 22.43 N1 ADP C1001 67 GLY A 93 GLY.? 42.20 N1 ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -7.00 -4.03 17.29 -7.39 -3.85 16.59 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP B 61 ASP~? 21.98 C2 ADP C1001 16 HIS B 62 HIS~? 22.43 N1 ADP C1001 67 GLY B 71 GLY.? 8.94 N7 ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -33.60 23.98 7.54 -33.01 23.50 7.82 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP B 61 ASP~? 21.98 C2 ADP C1001 16 HIS B 62 HIS~? 22.43 N1 ADP C1001 67 GLY B 73 GLY~? 6.44 O1A ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -38.60 21.75 11.85 -37.95 21.79 12.31 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 8 3 # 8 14 ASP C 54 ASP~? 20.12 N1 ADP C1001 16 HIS C 50 HIS.? 17.04 O2' ADP C1001 67 GLY C 90 GLY.? 7.38 O3' ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -38.81 28.40 25.98 -38.10 28.54 26.21 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 9 3 # 9 14 ASP C 54 ASP~? 20.12 N1 ADP C1001 16 HIS D 62 HIS.? 20.37 N6 ADP C1001 67 GLY B 90 GLY.? 7.42 N6 ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -30.30 29.32 7.79 -29.71 28.87 8.11 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 10 3 # 10 14 ASP C 54 ASP~? 20.12 N1 ADP C1001 16 HIS D 62 HIS.? 20.37 N6 ADP C1001 67 GLY D 73 GLY~? 41.01 N6 ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -17.60 67.96 17.85 -17.21 67.25 18.06 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 11 3 # 11 14 ASP C 61 ASP~? 22.05 N1 ADP C1001 16 HIS C 62 HIS~? 21.13 N1 ADP C1001 67 GLY C 71 GLY.? 8.01 O2' ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -39.43 34.32 24.82 -38.66 34.55 25.11 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 12 3 # 12 14 ASP D 61 ASP~? 23.08 N1 ADP C1001 16 HIS D 62 HIS.? 20.37 N6 ADP C1001 67 GLY D 71 GLY.? 41.01 N6 ADP C1001 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -13.14 65.99 12.80 -13.46 65.22 12.77 1be1_c02 source 1be1 GLUTAMATE MUTASE : 12 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 31 ASP^? 31.30 N6 ADP C1001 435 GLU A 33 GLU^? 35.51 N6 ADP C1001 510 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 88.62 69.90 41.16 89.05 70.67 43.04 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 89.52 76.11 40.17 89.01 75.16 41.97 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 84.89 77.60 46.67 85.63 75.79 46.03 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP C 31 ASP^? 21.62 C2 ADP C1001 435 GLU C 33 GLU^? 22.62 N1 ADP C1001 510 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo 88.62 69.90 41.16 89.05 70.67 43.04 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 89.52 76.11 40.17 89.01 75.16 41.97 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 84.89 77.60 46.67 85.63 75.79 46.03 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP D 31 ASP^? 21.52 N6 ADP C1001 435 GLU D 33 GLU^? 24.81 N6 ADP C1001 510 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 88.62 69.90 41.16 89.05 70.67 43.04 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 89.52 76.11 40.17 89.01 75.16 41.97 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 84.89 77.60 46.67 85.63 75.79 46.03 -4.58 39.61 12.64 -2.59 38.96 12.51 1bf2_c00 source 1bf2 ISOAMYLASE : 3 hits 1bf2_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 503 TYR B 26 TYR^? 24.12 N6 ADP C1001 A 537 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 24.06 146.21 11.09 22.89 146.18 9.36 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 15.91 140.69 8.32 15.71 143.39 9.13 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 16.65 144.44 13.24 18.34 145.22 12.33 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU C 49 GLU.? 21.81 N1 ADP C1001 A 503 TYR C 26 TYR^? 24.03 C2 ADP C1001 A 537 GLU C 44 GLU^? 27.03 C2 ADP C1001 coo 24.06 146.21 11.09 22.89 146.18 9.36 -30.22 47.91 25.82 -28.66 49.28 25.41 coo 15.91 140.69 8.32 15.71 143.39 9.13 -30.56 43.06 36.03 -31.04 45.27 37.68 coo 16.65 144.44 13.24 18.34 145.22 12.33 -28.75 47.24 35.01 -29.12 48.55 36.63 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 2 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 504 TYR B 26 TYR^? 24.12 N6 ADP C1001 A 540 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 81.34 87.29 87.22 82.36 86.09 88.61 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 80.85 81.34 94.77 81.70 80.16 92.41 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 79.94 80.46 88.84 81.11 81.36 87.27 -16.06 9.21 5.46 -17.05 10.76 4.34 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c02 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 2 ARG^? 31.43 N6 ADP C1001 183 LYS A 38 LYS^? 31.29 N6 ADP C1001 317 ARG A 94 ARG~? 34.60 N1 ADP C1001 coo 76.57 109.19 73.41 73.86 110.26 72.16 -10.05 8.79 1.44 -11.10 11.55 0.50 coo 82.09 117.51 66.37 80.60 114.32 71.44 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 65.21 120.62 58.76 63.62 123.14 59.66 -9.32 1.83 20.70 -11.98 2.20 22.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 2 ARG^? 31.43 N6 ADP C1001 183 LYS B 14 LYS~? 27.17 N6 ADP C1001 317 ARG B 2 ARG^? 22.13 N1 ADP C1001 coo 76.57 109.19 73.41 73.86 110.26 72.16 -10.05 8.79 1.44 -11.10 11.55 0.50 coo 82.09 117.51 66.37 80.60 114.32 71.44 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -18.09 16.69 18.57 -16.32 14.84 20.16 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 25 ARG.? 39.86 N6 ADP C1001 183 LYS A 19 LYS.? 46.12 N1 ADP C1001 317 ARG A 75 ARG~? 52.31 N6 ADP C1001 coo 76.57 109.19 73.41 73.86 110.26 72.16 -23.17 -5.31 5.72 -21.44 -6.89 3.60 coo 82.09 117.51 66.37 80.60 114.32 71.44 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 65.21 120.62 58.76 63.62 123.14 59.66 -9.93 -13.21 -7.89 -9.68 -10.57 -9.55 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG A 94 ARG~? 34.60 N1 ADP C1001 183 LYS A 100 LYS~? 39.84 N1 ADP C1001 317 ARG A 2 ARG^? 31.43 N6 ADP C1001 coo 76.57 109.19 73.41 73.86 110.26 72.16 -9.32 1.83 20.70 -11.98 2.20 22.31 coo 82.09 117.51 66.37 80.60 114.32 71.44 -1.03 5.78 15.30 1.15 8.50 19.55 coo 65.21 120.62 58.76 63.62 123.14 59.66 -10.05 8.79 1.44 -11.10 11.55 0.50 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG B 25 ARG.? 26.72 N7 ADP C1001 183 LYS B 19 LYS.? 15.59 N6 ADP C1001 317 ARG B 2 ARG^? 22.13 N1 ADP C1001 coo 76.57 109.19 73.41 73.86 110.26 72.16 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 82.09 117.51 66.37 80.60 114.32 71.44 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 65.21 120.62 58.76 63.62 123.14 59.66 -18.09 16.69 18.57 -16.32 14.84 20.16 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG B 25 ARG.? 26.72 N7 ADP C1001 183 LYS B 19 LYS.? 15.59 N6 ADP C1001 317 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 76.57 109.19 73.41 73.86 110.26 72.16 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 82.09 117.51 66.37 80.60 114.32 71.44 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 65.21 120.62 58.76 63.62 123.14 59.66 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG C 2 ARG^? 21.46 C2 ADP C1001 183 LYS C 38 LYS^? 29.32 C2 ADP C1001 317 ARG C 94 ARG~? 23.82 O3' ADP C1001 coo 76.57 109.19 73.41 73.86 110.26 72.16 -18.93 34.99 28.58 -17.63 35.83 31.18 coo 82.09 117.51 66.37 80.60 114.32 71.44 -16.18 28.34 36.63 -11.47 27.59 37.59 coo 65.21 120.62 58.76 63.62 123.14 59.66 -33.86 30.07 42.29 -36.45 31.77 42.05 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 8 3 # 8 118 ARG C 94 ARG~? 23.82 O3' ADP C1001 183 LYS C 100 LYS~? 22.69 C2 ADP C1001 317 ARG C 2 ARG^? 21.46 C2 ADP C1001 coo 76.57 109.19 73.41 73.86 110.26 72.16 -33.86 30.07 42.29 -36.45 31.77 42.05 coo 82.09 117.51 66.37 80.60 114.32 71.44 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 65.21 120.62 58.76 63.62 123.14 59.66 -18.93 34.99 28.58 -17.63 35.83 31.18 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 9 3 # 9 118 ARG D 2 ARG^? 19.52 N6 ADP C1001 183 LYS B 106 LYS.? 18.25 N6 ADP C1001 317 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 76.57 109.19 73.41 73.86 110.26 72.16 -16.51 45.11 16.54 -19.16 44.24 15.23 coo 82.09 117.51 66.37 80.60 114.32 71.44 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 65.21 120.62 58.76 63.62 123.14 59.66 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 10 3 # 10 118 ARG D 25 ARG.? 35.20 N6 ADP C1001 183 LYS D 19 LYS.? 44.78 N6 ADP C1001 317 ARG D 75 ARG~? 42.87 N1 ADP C1001 coo 76.57 109.19 73.41 73.86 110.26 72.16 -26.42 60.33 5.19 -27.57 62.82 3.77 coo 82.09 117.51 66.37 80.60 114.32 71.44 -14.01 64.85 7.32 -9.19 66.73 4.57 coo 65.21 120.62 58.76 63.62 123.14 59.66 -22.47 67.51 24.43 -22.92 70.53 24.84 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 10 hits 1bib_c00 naa= 3 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 1 3 # 1 A 102 TRP A 113 TRP.? 51.98 N6 ADP C1001 A 174 ASP A 112 ASP.? 58.40 N6 ADP C1001 A 198 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 21.59 67.76 35.19 19.10 64.95 36.34 -2.27 -12.30 8.14 -4.73 -13.16 5.16 coo 19.39 73.14 39.98 19.70 71.07 40.14 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 27.94 65.10 43.55 24.20 64.94 40.01 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 2 3 # 2 A 102 TRP A 113 TRP.? 51.98 N6 ADP C1001 A 174 ASP A 112 ASP.? 58.40 N6 ADP C1001 A 198 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 21.59 67.76 35.19 19.10 64.95 36.34 -2.27 -12.30 8.14 -4.73 -13.16 5.16 coo 19.39 73.14 39.98 19.70 71.07 40.14 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 27.94 65.10 43.55 24.20 64.94 40.01 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 3 3 # 3 A 102 TRP B 113 TRP.? 6.23 N7 ADP C1001 A 174 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 198 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 21.59 67.76 35.19 19.10 64.95 36.34 -33.53 30.14 7.96 -35.79 27.09 9.08 coo 19.39 73.14 39.98 19.70 71.07 40.14 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 27.94 65.10 43.55 24.20 64.94 40.01 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 4 3 # 4 A 102 TRP B 113 TRP.? 6.23 N7 ADP C1001 A 174 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 198 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 21.59 67.76 35.19 19.10 64.95 36.34 -33.53 30.14 7.96 -35.79 27.09 9.08 coo 19.39 73.14 39.98 19.70 71.07 40.14 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 27.94 65.10 43.55 24.20 64.94 40.01 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 5 3 # 5 A 102 TRP C 113 TRP.? -4.31 O3' ADP C1001s A 174 ASP C 112 ASP.? 10.30 O3' ADP C1001 A 198 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.02 28.74 23.55 -40.73 32.19 21.60 coo 19.39 73.14 39.98 19.70 71.07 40.14 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 27.94 65.10 43.55 24.20 64.94 40.01 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 6 3 # 6 A 102 TRP C 113 TRP.? -4.31 O3' ADP C1001s A 174 ASP C 112 ASP.? 10.30 O3' ADP C1001 A 198 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 21.59 67.76 35.19 19.10 64.95 36.34 -41.02 28.74 23.55 -40.73 32.19 21.60 coo 19.39 73.14 39.98 19.70 71.07 40.14 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 27.94 65.10 43.55 24.20 64.94 40.01 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 7 3 # 7 A 102 TRP D 113 TRP.? 44.54 N6 ADP C1001 A 174 ASP D 110 ASP.? 48.95 N6 ADP C1001 A 198 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 21.59 67.76 35.19 19.10 64.95 36.34 -7.24 67.37 14.19 -10.84 68.18 15.49 coo 19.39 73.14 39.98 19.70 71.07 40.14 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 27.94 65.10 43.55 24.20 64.94 40.01 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 8 3 # 8 A 102 TRP D 113 TRP.? 44.54 N6 ADP C1001 A 174 ASP D 112 ASP.? 52.73 N6 ADP C1001 A 198 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 21.59 67.76 35.19 19.10 64.95 36.34 -7.24 67.37 14.19 -10.84 68.18 15.49 coo 19.39 73.14 39.98 19.70 71.07 40.14 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 27.94 65.10 43.55 24.20 64.94 40.01 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 9 3 # 9 A 102 TRP D 113 TRP.? 44.54 N6 ADP C1001 A 174 ASP D 112 ASP.? 52.73 N6 ADP C1001 A 198 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo 21.59 67.76 35.19 19.10 64.95 36.34 -7.24 67.37 14.19 -10.84 68.18 15.49 coo 19.39 73.14 39.98 19.70 71.07 40.14 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 27.94 65.10 43.55 24.20 64.94 40.01 -0.82 59.67 9.89 3.99 59.45 8.43 1bjo_c00 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 9 hits 1bjo_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 12 GLY~? 30.18 N6 ADP C1001 48 HIS B 62 HIS~? 22.43 N1 ADP C1001 99 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 12.38 5.55 24.25 13.27 5.59 24.39 -15.34 4.79 13.98 -15.18 4.16 14.49 coo 18.80 12.68 24.53 17.69 13.54 26.08 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 17.07 18.51 26.62 16.67 17.07 28.09 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY B 12 GLY~? 22.61 N6 ADP C1001 48 HIS A 62 HIS~? 32.10 N6 ADP C1001 99 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo 12.38 5.55 24.25 13.27 5.59 24.39 -17.91 15.52 4.82 -17.88 16.00 4.18 coo 18.80 12.68 24.53 17.69 13.54 26.08 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 17.07 18.51 26.62 16.67 17.07 28.09 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY C 73 GLY~? 7.38 O2' ADP C1001 48 HIS C 50 HIS.? 17.04 O2' ADP C1001 99 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 12.38 5.55 24.25 13.27 5.59 24.39 -38.52 37.92 18.83 -37.81 37.51 18.99 coo 18.80 12.68 24.53 17.69 13.54 26.08 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 17.07 18.51 26.62 16.67 17.07 28.09 -29.26 47.42 21.46 -29.58 49.13 20.24 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 3 hits 1bp2_c00 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 168 ARG B 74 ARG~? -6.26 O2A ADP C1001s A 187 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 62.47 12.00 59.65 61.76 10.14 60.31 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 55.10 8.37 73.00 55.48 9.59 70.20 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 66.76 10.09 66.23 61.80 8.06 65.82 -38.05 28.30 5.66 -42.50 28.99 10.13 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 168 ARG B 75 ARG~? 7.41 O2A ADP C1001 A 187 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 62.47 12.00 59.65 61.76 10.14 60.31 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 55.10 8.37 73.00 55.48 9.59 70.20 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 66.76 10.09 66.23 61.80 8.06 65.82 -38.05 28.30 5.66 -42.50 28.99 10.13 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 2 hits 1brw_c00 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 21 PHE.? 42.86 N6 ADP C1001 A 205 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 236 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 27 PHE^? 37.41 N6 ADP C1001 A 205 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 236 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 205 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 236 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 58 PHE~? 34.92 N6 ADP C1001 A 205 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 236 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -17.56 0.82 -0.93 -18.36 2.22 1.34 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE B 21 PHE.? 12.47 N7 ADP C1001 A 205 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 236 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -31.61 18.24 11.10 -30.96 16.75 13.38 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE B 21 PHE.? 12.47 N7 ADP C1001 A 205 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 236 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -31.61 18.24 11.10 -30.96 16.75 13.38 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE B 27 PHE^? 16.30 N6 ADP C1001 A 205 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 236 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 205 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 236 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 205 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 236 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 205 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 236 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE B 58 PHE~? 21.02 N6 ADP C1001 A 205 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 236 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -26.58 9.98 15.28 -24.37 9.78 13.51 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 12 3 # 12 A 109 PHE B 102 PHE~? 12.24 N6 ADP C1001 A 205 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 236 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -19.65 28.55 14.45 -20.63 28.01 16.97 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 13 3 # 13 A 109 PHE C 21 PHE.? 11.41 C2 ADP C1001 A 205 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 236 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 14 3 # 14 A 109 PHE C 21 PHE.? 11.41 C2 ADP C1001 A 205 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 236 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 15 3 # 15 A 109 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 205 ASP C 31 ASP^? 21.62 C2 ADP C1001 A 236 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 16 3 # 16 A 109 PHE C 29 PHE^? 17.94 C2 ADP C1001 A 205 ASP C 10 ASP.? 28.10 C2 ADP C1001 A 236 LYS C 14 LYS.? 27.01 C2 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -22.69 37.33 30.80 -23.71 39.19 28.97 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -29.82 42.88 40.75 -30.96 43.09 42.54 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -31.38 33.30 42.44 -27.73 35.10 43.96 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 17 3 # 17 A 109 PHE C 47 PHE.? 25.87 O2' ADP C1001 A 205 ASP D 54 ASP~? 30.93 N6 ADP C1001 A 236 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -33.84 53.41 29.52 -36.47 53.88 28.66 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 18 3 # 18 A 109 PHE C 58 PHE~? 19.35 C2 ADP C1001 A 205 ASP C 31 ASP^? 21.62 C2 ADP C1001 A 236 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 19 3 # 19 A 109 PHE C 58 PHE~? 19.35 C2 ADP C1001 A 205 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 236 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 20 3 # 20 A 109 PHE D 21 PHE.? 33.63 N6 ADP C1001 A 205 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 236 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 21 3 # 21 A 109 PHE D 27 PHE^? 29.27 N6 ADP C1001 A 205 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 236 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -19.87 54.80 11.53 -19.94 57.47 12.38 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 22 3 # 22 A 109 PHE D 27 PHE^? 29.27 N6 ADP C1001 A 205 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 236 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -19.87 54.80 11.53 -19.94 57.47 12.38 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 23 3 # 23 A 109 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 205 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 236 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 24 3 # 24 A 109 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 205 ASP D 10 ASP.? 31.49 N6 ADP C1001 A 236 LYS D 14 LYS~? 32.56 N6 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -12.53 51.88 -0.15 -12.30 47.61 -3.60 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 25 3 # 25 A 109 PHE D 58 PHE~? 24.52 N6 ADP C1001 A 205 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 236 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -24.99 53.85 15.24 -24.47 52.34 12.98 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 26 3 # 26 A 109 PHE D 58 PHE~? 24.52 N6 ADP C1001 A 205 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 236 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 4.14 2.10 36.34 6.69 3.08 36.92 -24.99 53.85 15.24 -24.47 52.34 12.98 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -14.21 50.71 21.89 -14.80 46.21 24.73 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 26 hits 1bs0_c01 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 354 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 421 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 31.05 49.37 64.51 31.97 51.11 63.85 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 29.07 50.42 58.36 29.02 52.18 59.49 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 30.82 59.76 58.47 31.12 59.02 60.40 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 354 GLU C 48 GLU.? 22.51 O2' ADP C1001 A 421 ASP D 54 ASP~? 30.93 N6 ADP C1001 coo 31.05 49.37 64.51 31.97 51.11 63.85 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 29.07 50.42 58.36 29.02 52.18 59.49 -33.52 53.52 23.97 -33.48 52.09 22.33 coo 30.82 59.76 58.47 31.12 59.02 60.40 -28.33 59.98 17.64 -30.29 60.47 18.21 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 354 GLU A 41 GLU^? 26.55 N6 ADP C1001 B 421 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 25.90 8.19 53.87 25.36 6.97 52.29 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 27.87 10.66 47.95 27.82 8.60 48.27 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 26.02 1.87 43.38 25.90 1.97 45.49 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 354 GLU C 48 GLU.? 22.51 O2' ADP C1001 B 421 ASP D 54 ASP~? 30.93 N6 ADP C1001 coo 25.90 8.19 53.87 25.36 6.97 52.29 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 27.87 10.66 47.95 27.82 8.60 48.27 -33.52 53.52 23.97 -33.48 52.09 22.33 coo 26.02 1.87 43.38 25.90 1.97 45.49 -28.33 59.98 17.64 -30.29 60.47 18.21 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c09 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 57 ASN~? 43.07 N6 ADP C1001 192 ASP B 10 ASP.? 28.32 N6 ADP C1001 195 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -15.73 -0.75 -7.31 -14.92 -1.39 -9.21 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN B 39 ASN.? 27.14 N6 ADP C1001 192 ASP B 61 ASP~? 21.98 C2 ADP C1001 195 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -11.13 15.65 16.64 -9.36 15.49 17.83 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -21.68 10.95 17.44 -21.09 9.22 16.39 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 2 hits 1bwp_c01 naa= 3 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN C 57 ASN~? 16.68 N6 ADP C1001 A 108 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 144 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 16.88 2.43 18.09 16.20 3.65 19.72 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 16.00 9.54 19.61 16.53 10.80 21.20 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 20.15 8.89 19.42 18.82 8.12 20.82 -25.68 50.03 20.54 -26.38 51.13 22.17 1c2t_c02 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 1 hits 1c2t_c02 naa= 3 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN C 57 ASN~? 16.68 N6 ADP C1001 B 108 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 144 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 35.12 16.22 2.69 37.05 17.04 2.40 -25.68 50.03 20.54 -26.38 51.13 22.17 1c2t_c03 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 1 hits 1c2t_c03 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 20 HIS.? 47.81 N6 ADP C1001 A 408 TYR A 70 TYR.? 48.30 N6 ADP C1001 A 480 ARG A 94 ARG~? 34.60 N1 ADP C1001 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -9.32 1.83 20.70 -11.98 2.20 22.31 1c82_c02 source 1c82 HYALURONATE LYASE : 1 hits 1c82_c02 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 16 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 67 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -17.91 15.52 4.82 -17.88 16.00 4.18 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 1 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 16 HIS A 62 HIS~? 32.10 N6 ADP C1001 C 67 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 10.04 44.27 88.44 9.47 42.32 89.03 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 6.38 39.80 88.71 6.88 38.89 86.87 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 17.63 42.50 89.25 18.11 42.29 88.64 -17.91 15.52 4.82 -17.88 16.00 4.18 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 1 hits 1cb7_c07 naa= 3 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN C 57 ASN~? 16.68 N6 ADP C1001 108 HIS D 62 HIS.? 20.37 N6 ADP C1001 144 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -25.68 50.03 20.54 -26.38 51.13 22.17 1cde_c04 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 1 hits 1cde_c04 naa= 3 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN C 57 ASN~? 16.68 N6 ADP C1001 108 HIS D 62 HIS.? 20.37 N6 ADP C1001 144 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -25.68 50.03 20.54 -26.38 51.13 22.17 1cde_c05 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 1 hits 1cde_c05 naa= 3 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN C 57 ASN~? 16.68 N6 ADP C1001 108 HIS D 62 HIS.? 20.37 N6 ADP C1001 144 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -25.68 50.03 20.54 -26.38 51.13 22.17 1cde_c06 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 1 hits 1cde_c06 naa= 3 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN C 57 ASN~? 16.68 N6 ADP C1001 108 HIS D 62 HIS.? 20.37 N6 ADP C1001 144 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -25.68 50.03 20.54 -26.38 51.13 22.17 1cde_c07 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 1 hits 1cde_c07 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 31 ASP^? 31.30 N6 ADP C1001 264 GLU B 33 GLU^? 22.82 N1 ADP C1001 328 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 59.69 92.71 39.85 58.53 92.03 41.47 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 45.39 90.72 40.63 45.07 89.14 41.90 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 61 ASP~? 37.71 N6 ADP C1001 264 GLU A 78 GLU~? 55.68 N6 ADP C1001 328 ASP A 54 ASP~? 42.89 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 59.69 92.71 39.85 58.53 92.03 41.47 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 coo 45.39 90.72 40.63 45.07 89.14 41.90 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 61 ASP~? 37.71 N6 ADP C1001 264 GLU B 41 GLU^? 24.52 N6 ADP C1001 328 ASP B 9 ASP.? 24.63 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 59.69 92.71 39.85 58.53 92.03 41.47 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 45.39 90.72 40.63 45.07 89.14 41.90 -21.79 14.69 -0.26 -22.78 14.66 -2.05 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 61 ASP~? 37.71 N6 ADP C1001 264 GLU B 41 GLU^? 24.52 N6 ADP C1001 328 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 59.69 92.71 39.85 58.53 92.03 41.47 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 45.39 90.72 40.63 45.07 89.14 41.90 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 31 ASP^? 22.05 N1 ADP C1001 264 GLU A 33 GLU^? 35.51 N6 ADP C1001 328 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 59.69 92.71 39.85 58.53 92.03 41.47 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 45.39 90.72 40.63 45.07 89.14 41.90 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 31 ASP^? 22.05 N1 ADP C1001 264 GLU D 33 GLU^? 24.81 N6 ADP C1001 328 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 59.69 92.71 39.85 58.53 92.03 41.47 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP C 61 ASP~? 22.05 N1 ADP C1001 264 GLU C 78 GLU~? 9.17 N6 ADP C1001 328 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 59.69 92.71 39.85 58.53 92.03 41.47 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 45.39 90.72 40.63 45.07 89.14 41.90 -29.26 47.42 21.46 -29.58 49.13 20.24 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP D 54 ASP~? 30.93 N6 ADP C1001 264 GLU D 41 GLU^? 18.65 N6 ADP C1001 328 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 59.69 92.71 39.85 58.53 92.03 41.47 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 45.39 90.72 40.63 45.07 89.14 41.90 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP D 61 ASP~? 23.08 N1 ADP C1001 264 GLU D 33 GLU^? 24.81 N6 ADP C1001 328 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 59.69 92.71 39.85 58.53 92.03 41.47 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP D 61 ASP~? 23.08 N1 ADP C1001 264 GLU D 78 GLU~? 42.25 N1 ADP C1001 328 ASP D 54 ASP~? 30.93 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 59.69 92.71 39.85 58.53 92.03 41.47 -17.63 66.44 26.22 -18.72 68.28 26.46 coo 45.39 90.72 40.63 45.07 89.14 41.90 -28.33 59.98 17.64 -30.29 60.47 18.21 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 10 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 31 ASP^? 31.30 N6 ADP C1001 257 GLU A 33 GLU^? 35.51 N6 ADP C1001 328 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 48.97 85.16 40.39 47.18 86.25 40.47 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 45.39 90.72 40.63 45.07 89.14 41.90 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 36 ASP^? 33.81 N6 ADP C1001 257 GLU A 33 GLU^? 35.51 N6 ADP C1001 328 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 48.97 85.16 40.39 47.18 86.25 40.47 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 45.39 90.72 40.63 45.07 89.14 41.90 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 31 ASP^? 22.05 N1 ADP C1001 257 GLU B 33 GLU^? 22.82 N1 ADP C1001 328 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 48.97 85.16 40.39 47.18 86.25 40.47 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 45.39 90.72 40.63 45.07 89.14 41.90 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 36 ASP^? 26.54 N6 ADP C1001 257 GLU B 33 GLU^? 22.82 N1 ADP C1001 328 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 48.97 85.16 40.39 47.18 86.25 40.47 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 45.39 90.72 40.63 45.07 89.14 41.90 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP D 31 ASP^? 21.52 N6 ADP C1001 257 GLU D 33 GLU^? 24.81 N6 ADP C1001 328 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 48.97 85.16 40.39 47.18 86.25 40.47 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP D 36 ASP^? 31.16 N6 ADP C1001 257 GLU D 33 GLU^? 24.81 N6 ADP C1001 328 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 45.62 80.42 43.69 45.65 82.01 45.07 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 48.97 85.16 40.39 47.18 86.25 40.47 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -13.15 42.40 14.58 -15.11 42.76 15.19 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 6 hits 1cdg_c04 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 93 GLY.? 42.20 N1 ADP C1001 A 228 SER A 15 SER~? 35.42 N1 ADP C1001 A 549 ASP A 9 ASP.? 35.63 N1 ADP C1001 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -7.00 -4.03 17.29 -7.39 -3.85 16.59 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -18.49 -1.48 16.12 -18.32 -3.14 17.40 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY B 93 GLY.? 16.72 N6 ADP C1001 A 228 SER B 15 SER~? 20.97 N6 ADP C1001 A 549 ASP B 9 ASP.? 24.63 N6 ADP C1001 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -22.84 26.20 1.59 -22.97 25.70 2.25 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -21.79 14.69 -0.26 -22.78 14.66 -2.05 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 93 GLY.? 42.20 N1 ADP C1001 B1228 SER A 15 SER~? 35.42 N1 ADP C1001 B1549 ASP A 9 ASP.? 35.63 N1 ADP C1001 coo 126.34 72.75 125.66 125.95 73.27 126.11 -7.00 -4.03 17.29 -7.39 -3.85 16.59 coo 131.65 74.68 129.41 130.31 72.73 128.82 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo 134.72 69.43 130.42 133.03 70.65 130.08 -18.49 -1.48 16.12 -18.32 -3.14 17.40 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY B 93 GLY.? 16.72 N6 ADP C1001 B1228 SER B 15 SER~? 20.97 N6 ADP C1001 B1549 ASP B 9 ASP.? 24.63 N6 ADP C1001 coo 126.34 72.75 125.66 125.95 73.27 126.11 -22.84 26.20 1.59 -22.97 25.70 2.25 coo 131.65 74.68 129.41 130.31 72.73 128.82 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 134.72 69.43 130.42 133.03 70.65 130.08 -21.79 14.69 -0.26 -22.78 14.66 -2.05 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU C 44 GLU^? 27.03 C2 ADP C1001 A 89 GLU C 8 GLU.? 21.29 O3' ADP C1001 A 120 SER C 24 SER.? 15.73 O2' ADP C1001 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -28.75 47.24 35.01 -29.12 48.55 36.63 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -38.22 39.03 36.55 -39.65 38.08 37.81 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -34.60 42.57 30.36 -34.63 40.35 29.52 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU C 44 GLU^? 27.03 C2 ADP C1001 A 89 GLU C 49 GLU.? 21.81 N1 ADP C1001 A 120 SER C 24 SER.? 15.73 O2' ADP C1001 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -28.75 47.24 35.01 -29.12 48.55 36.63 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -30.22 47.91 25.82 -28.66 49.28 25.41 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -34.60 42.57 30.36 -34.63 40.35 29.52 1cns_c00 source 1cns CHITINASE : 2 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU B 44 GLU^? 27.54 N6 ADP C1001 B 89 GLU B 8 GLU.? 21.08 N6 ADP C1001 B 120 SER B 24 SER.? 17.25 N6 ADP C1001 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -29.56 14.13 6.20 -27.58 15.07 7.20 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU C 48 GLU.? 22.51 O2' ADP C1001 B 89 GLU C 44 GLU^? 27.03 C2 ADP C1001 B 120 SER C 24 SER.? 15.73 O2' ADP C1001 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -33.52 53.52 23.97 -33.48 52.09 22.33 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -28.75 47.24 35.01 -29.12 48.55 36.63 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -34.60 42.57 30.36 -34.63 40.35 29.52 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU D 44 GLU^? 25.61 N6 ADP C1001 B 89 GLU D 8 GLU.? 38.64 N6 ADP C1001 B 120 SER D 24 SER.? 31.80 N6 ADP C1001 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -26.92 53.16 5.77 -28.08 52.58 4.08 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -21.41 60.30 8.38 -19.94 58.41 8.67 1cns_c01 source 1cns CHITINASE : 3 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR B 79 TYR~? 13.34 O4' ADP C1001 A 173 ASP B 54 ASP~? 20.52 O4' ADP C1001 C 48 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 24.35 4.55 25.11 25.94 3.23 25.53 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 173 ASP B 110 ASP.? 12.77 N6 ADP C1001 C 48 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 24.35 4.55 25.11 25.94 3.23 25.53 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 173 ASP B 112 ASP.? 11.36 O1B ADP C1001 C 48 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 24.35 4.55 25.11 25.94 3.23 25.53 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR C 79 TYR~? 13.12 N6 ADP C1001 A 173 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 48 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 24.35 4.55 25.11 25.94 3.23 25.53 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR C 111 TYR.? 9.78 O3' ADP C1001 A 173 ASP C 110 ASP.? 10.54 O3' ADP C1001 C 48 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 24.35 4.55 25.11 25.94 3.23 25.53 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -43.83 18.61 16.41 -46.11 20.56 15.85 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG B 75 ARG~? 7.41 O2A ADP C1001 C 101 TYR B 79 TYR~? 13.34 O4' ADP C1001 C 173 ASP B 54 ASP~? 20.52 O4' ADP C1001 coo 32.27 5.62 48.15 31.93 6.48 51.06 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 29.64 3.64 57.39 31.22 5.14 55.65 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -33.59 8.19 15.94 -35.17 6.84 16.43 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 75 ARG~? 7.41 O2A ADP C1001 C 101 TYR C 111 TYR.? 9.78 O3' ADP C1001 C 173 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 32.27 5.62 48.15 31.93 6.48 51.06 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 29.64 3.64 57.39 31.22 5.14 55.65 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG C 74 ARG~? 5.25 O1B ADP C1001 C 101 TYR B 111 TYR.? 10.00 N6 ADP C1001 C 173 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 32.27 5.62 48.15 31.93 6.48 51.06 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 29.64 3.64 57.39 31.22 5.14 55.65 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG C 75 ARG~? 8.05 O3B ADP C1001 C 101 TYR B 111 TYR.? 10.00 N6 ADP C1001 C 173 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 32.27 5.62 48.15 31.93 6.48 51.06 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 29.64 3.64 57.39 31.22 5.14 55.65 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG C 75 ARG~? 8.05 O3B ADP C1001 C 101 TYR C 79 TYR~? 13.12 N6 ADP C1001 C 173 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 32.27 5.62 48.15 31.93 6.48 51.06 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 29.64 3.64 57.39 31.22 5.14 55.65 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -29.26 47.42 21.46 -29.58 49.13 20.24 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 25 ARG.? 39.86 N6 ADP C1001 D 101 TYR A 26 TYR^? 32.13 N6 ADP C1001 D 173 ASP A 9 ASP.? 35.63 N1 ADP C1001 coo 69.08 8.58 32.60 69.70 10.81 30.58 -23.17 -5.31 5.72 -21.44 -6.89 3.60 coo 71.77 11.86 24.26 70.23 12.22 26.56 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 71.60 6.14 19.25 70.26 6.87 20.69 -18.49 -1.48 16.12 -18.32 -3.14 17.40 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 75 ARG~? 7.41 O2A ADP C1001 D 101 TYR B 79 TYR~? 13.34 O4' ADP C1001 D 173 ASP B 54 ASP~? 20.52 O4' ADP C1001 coo 69.08 8.58 32.60 69.70 10.81 30.58 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 71.77 11.86 24.26 70.23 12.22 26.56 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 71.60 6.14 19.25 70.26 6.87 20.69 -33.59 8.19 15.94 -35.17 6.84 16.43 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG B 75 ARG~? 7.41 O2A ADP C1001 D 101 TYR C 111 TYR.? 9.78 O3' ADP C1001 D 173 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 69.08 8.58 32.60 69.70 10.81 30.58 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 71.77 11.86 24.26 70.23 12.22 26.56 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 71.60 6.14 19.25 70.26 6.87 20.69 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG C 74 ARG~? 5.25 O1B ADP C1001 D 101 TYR B 111 TYR.? 10.00 N6 ADP C1001 D 173 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 69.08 8.58 32.60 69.70 10.81 30.58 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 71.77 11.86 24.26 70.23 12.22 26.56 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 71.60 6.14 19.25 70.26 6.87 20.69 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG C 75 ARG~? 8.05 O3B ADP C1001 D 101 TYR B 111 TYR.? 10.00 N6 ADP C1001 D 173 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 69.08 8.58 32.60 69.70 10.81 30.58 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 71.77 11.86 24.26 70.23 12.22 26.56 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 71.60 6.14 19.25 70.26 6.87 20.69 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG C 75 ARG~? 8.05 O3B ADP C1001 D 101 TYR C 79 TYR~? 13.12 N6 ADP C1001 D 173 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 69.08 8.58 32.60 69.70 10.81 30.58 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 71.77 11.86 24.26 70.23 12.22 26.56 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 71.60 6.14 19.25 70.26 6.87 20.69 -29.26 47.42 21.46 -29.58 49.13 20.24 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR B 79 TYR~? 13.34 O4' ADP C1001 B 173 ASP B 54 ASP~? 20.52 O4' ADP C1001 D 48 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 111 TYR.? 10.00 N6 ADP C1001 B 173 ASP B 110 ASP.? 12.77 N6 ADP C1001 D 48 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR B 111 TYR.? 10.00 N6 ADP C1001 B 173 ASP B 112 ASP.? 11.36 O1B ADP C1001 D 48 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR C 79 TYR~? 13.12 N6 ADP C1001 B 173 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 48 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR C 111 TYR.? 9.78 O3' ADP C1001 B 173 ASP C 110 ASP.? 10.54 O3' ADP C1001 D 48 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -43.83 18.61 16.41 -46.11 20.56 15.85 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP B 10 ASP.? 28.32 N6 ADP C1001 315 GLU A 41 GLU^? 26.55 N6 ADP C1001 390 TYR A 26 TYR^? 32.13 N6 ADP C1001 coo 32.46 99.13 19.34 30.94 100.38 20.07 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 32.04 94.22 18.23 30.57 94.75 16.88 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 21.10 94.74 18.36 23.09 96.71 18.59 -20.23 -0.15 10.23 -22.87 -0.31 11.21 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 1 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 340 GLU D 33 GLU^? 24.81 N6 ADP C1001 A 395 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -13.15 42.40 14.58 -15.11 42.76 15.19 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -9.58 39.62 17.74 -10.11 39.83 19.83 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -4.58 39.61 12.64 -2.59 38.96 12.51 1cwy_c00 source 1cwy AMYLOMALTASE : 1 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 56 ILE A 109 ILE.? 50.48 N6 ADP C1001 A 82 TYR A 92 TYR.? 47.39 N1 ADP C1001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 1.93 -7.80 11.11 1.13 -7.17 10.23 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -4.46 -7.57 15.71 -2.05 -7.82 17.04 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 112 ASP.? 58.40 N6 ADP C1001 A 56 ILE A 109 ILE.? 50.48 N6 ADP C1001 A 82 TYR A 92 TYR.? 47.39 N1 ADP C1001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 1.93 -7.80 11.11 1.13 -7.17 10.23 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -4.46 -7.57 15.71 -2.05 -7.82 17.04 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP B 97 ASP~? 21.13 N6 ADP C1001 A 56 ILE B 109 ILE.? 8.16 N6 ADP C1001 A 82 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -27.70 33.33 8.38 -27.98 33.04 9.59 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 56 ILE B 109 ILE.? 8.16 N6 ADP C1001 A 82 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -27.70 33.33 8.38 -27.98 33.04 9.59 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP C 97 ASP~? 22.56 C2 ADP C1001 A 56 ILE C 109 ILE.? 9.05 O3' ADP C1001 A 82 TYR C 92 TYR.? 13.82 O3' ADP C1001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -38.02 23.33 26.43 -37.19 24.19 25.39 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -39.98 27.63 32.25 -40.82 24.99 32.44 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP C 112 ASP.? 10.30 O3' ADP C1001 A 56 ILE C 109 ILE.? 9.05 O3' ADP C1001 A 82 TYR C 92 TYR.? 13.82 O3' ADP C1001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -38.02 23.33 26.43 -37.19 24.19 25.39 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -39.98 27.63 32.25 -40.82 24.99 32.44 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP D 97 ASP~? 39.15 N6 ADP C1001 A 56 ILE D 109 ILE.? 43.79 N6 ADP C1001 A 82 TYR D 92 TYR.? 44.20 N6 ADP C1001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -2.12 62.38 13.45 -3.38 61.83 14.02 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -5.36 62.57 6.57 -2.60 62.73 6.26 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP D 112 ASP.? 52.73 N6 ADP C1001 A 56 ILE D 109 ILE.? 43.79 N6 ADP C1001 A 82 TYR D 92 TYR.? 44.20 N6 ADP C1001 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -2.12 62.38 13.45 -3.38 61.83 14.02 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -5.36 62.57 6.57 -2.60 62.73 6.26 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 8 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 97 ASP~? 39.49 N1 ADP C1001 B 56 ILE A 109 ILE.? 50.48 N6 ADP C1001 B 82 TYR A 92 TYR.? 47.39 N1 ADP C1001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 1.93 -7.80 11.11 1.13 -7.17 10.23 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -4.46 -7.57 15.71 -2.05 -7.82 17.04 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 112 ASP.? 58.40 N6 ADP C1001 B 56 ILE A 109 ILE.? 50.48 N6 ADP C1001 B 82 TYR A 92 TYR.? 47.39 N1 ADP C1001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 1.93 -7.80 11.11 1.13 -7.17 10.23 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -4.46 -7.57 15.71 -2.05 -7.82 17.04 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP B 97 ASP~? 21.13 N6 ADP C1001 B 56 ILE B 109 ILE.? 8.16 N6 ADP C1001 B 82 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -27.70 33.33 8.38 -27.98 33.04 9.59 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 56 ILE B 109 ILE.? 8.16 N6 ADP C1001 B 82 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -27.70 33.33 8.38 -27.98 33.04 9.59 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP C 97 ASP~? 22.56 C2 ADP C1001 B 56 ILE C 109 ILE.? 9.05 O3' ADP C1001 B 82 TYR C 92 TYR.? 13.82 O3' ADP C1001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -38.02 23.33 26.43 -37.19 24.19 25.39 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -39.98 27.63 32.25 -40.82 24.99 32.44 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP C 112 ASP.? 10.30 O3' ADP C1001 B 56 ILE C 109 ILE.? 9.05 O3' ADP C1001 B 82 TYR C 92 TYR.? 13.82 O3' ADP C1001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -38.02 23.33 26.43 -37.19 24.19 25.39 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -39.98 27.63 32.25 -40.82 24.99 32.44 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 7 3 # 7 B 37 ASP D 97 ASP~? 39.15 N6 ADP C1001 B 56 ILE D 109 ILE.? 43.79 N6 ADP C1001 B 82 TYR D 92 TYR.? 44.20 N6 ADP C1001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -2.12 62.38 13.45 -3.38 61.83 14.02 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -5.36 62.57 6.57 -2.60 62.73 6.26 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 8 3 # 8 B 37 ASP D 112 ASP.? 52.73 N6 ADP C1001 B 56 ILE D 109 ILE.? 43.79 N6 ADP C1001 B 82 TYR D 92 TYR.? 44.20 N6 ADP C1001 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -2.12 62.38 13.45 -3.38 61.83 14.02 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -5.36 62.57 6.57 -2.60 62.73 6.26 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 8 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP A 113 TRP.? 51.98 N6 ADP C1001 A 243 ASP A 112 ASP.? 58.40 N6 ADP C1001 A 272 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 18.21 54.75 18.05 19.91 55.17 21.59 -2.27 -12.30 8.14 -4.73 -13.16 5.16 coo 16.93 55.67 9.65 17.16 54.23 11.19 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 14.13 45.79 13.40 14.25 49.41 18.30 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 138 TRP B 113 TRP.? 6.23 N7 ADP C1001 A 243 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 272 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 18.21 54.75 18.05 19.91 55.17 21.59 -33.53 30.14 7.96 -35.79 27.09 9.08 coo 16.93 55.67 9.65 17.16 54.23 11.19 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 14.13 45.79 13.40 14.25 49.41 18.30 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 138 TRP C 113 TRP.? -4.31 O3' ADP C1001s A 243 ASP C 112 ASP.? 10.30 O3' ADP C1001 A 272 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 18.21 54.75 18.05 19.91 55.17 21.59 -41.02 28.74 23.55 -40.73 32.19 21.60 coo 16.93 55.67 9.65 17.16 54.23 11.19 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 14.13 45.79 13.40 14.25 49.41 18.30 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 138 TRP D 113 TRP.? 44.54 N6 ADP C1001 A 243 ASP D 112 ASP.? 52.73 N6 ADP C1001 A 272 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo 18.21 54.75 18.05 19.91 55.17 21.59 -7.24 67.37 14.19 -10.84 68.18 15.49 coo 16.93 55.67 9.65 17.16 54.23 11.19 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 14.13 45.79 13.40 14.25 49.41 18.30 -0.82 59.67 9.89 3.99 59.45 8.43 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 4 hits 1d7r_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 79 TYR~? 47.68 N6 ADP C1001 A 243 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 272 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 16.93 55.67 9.65 17.16 54.23 11.19 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 79 TYR~? 47.68 N6 ADP C1001 A 243 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 272 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 16.93 55.67 9.65 17.16 54.23 11.19 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 14.13 45.79 13.40 14.25 49.41 18.30 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 92 TYR.? 47.39 N1 ADP C1001 A 243 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 272 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 16.93 55.67 9.65 17.16 54.23 11.19 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 92 TYR.? 47.39 N1 ADP C1001 A 243 ASP A 36 ASP^? 33.81 N6 ADP C1001 A 272 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 16.93 55.67 9.65 17.16 54.23 11.19 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 14.13 45.79 13.40 14.25 49.41 18.30 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR B 26 TYR^? 24.12 N6 ADP C1001 A 243 ASP A 36 ASP^? 33.81 N6 ADP C1001 A 272 LYS A 100 LYS~? 39.84 N1 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 16.93 55.67 9.65 17.16 54.23 11.19 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 14.13 45.79 13.40 14.25 49.41 18.30 -1.03 5.78 15.30 1.15 8.50 19.55 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 243 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 272 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 16.93 55.67 9.65 17.16 54.23 11.19 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 14.13 45.79 13.40 14.25 49.41 18.30 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 79 TYR~? 13.34 O4' ADP C1001 A 243 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 272 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 16.93 55.67 9.65 17.16 54.23 11.19 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 14.13 45.79 13.40 14.25 49.41 18.30 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR B 92 TYR.? 14.20 N6 ADP C1001 A 243 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 272 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 16.93 55.67 9.65 17.16 54.23 11.19 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 14.13 45.79 13.40 14.25 49.41 18.30 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR B 92 TYR.? 14.20 N6 ADP C1001 A 243 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 272 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 16.93 55.67 9.65 17.16 54.23 11.19 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 14.13 45.79 13.40 14.25 49.41 18.30 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 243 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 272 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 16.93 55.67 9.65 17.16 54.23 11.19 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 14.13 45.79 13.40 14.25 49.41 18.30 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 243 ASP D 10 ASP.? 31.49 N6 ADP C1001 A 272 LYS D 14 LYS~? 32.56 N6 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 16.93 55.67 9.65 17.16 54.23 11.19 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 14.13 45.79 13.40 14.25 49.41 18.30 -12.53 51.88 -0.15 -12.30 47.61 -3.60 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR D 26 TYR^? 28.03 N6 ADP C1001 A 243 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 272 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 2.03 68.31 21.46 0.66 68.36 23.90 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 16.93 55.67 9.65 17.16 54.23 11.19 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 14.13 45.79 13.40 14.25 49.41 18.30 -21.73 32.18 22.71 -16.79 33.08 21.29 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 12 hits 1d7r_c02 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR B 89 THR.? -3.20 N6 ADP C1001s A 156 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 160 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 10.50 56.87 17.73 11.24 57.93 19.43 -30.78 27.78 11.26 -32.72 28.03 12.28 coo 11.64 63.07 23.95 11.76 62.47 21.20 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 5.78 61.30 21.65 8.04 62.89 17.54 -38.05 28.30 5.66 -42.50 28.99 10.13 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 1 hits 1db3_c01 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 646 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 739 GLY A 22 GLY.? 43.32 N6 ADP C1001 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -15.86 -8.41 2.68 -16.06 -8.23 3.51 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 646 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 739 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 11.37 50.89 2.29 11.05 51.63 2.25 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 646 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 739 GLY D 84 GLY.? 31.79 N1 ADP C1001 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 11.37 50.89 2.29 11.05 51.63 2.25 -16.24 54.50 27.95 -16.49 54.77 27.19 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 739 GLY D 53 GLY~? 32.56 N1 ADP C1001 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -26.31 61.10 21.77 -26.62 61.15 20.99 1ddj_c12 source 1ddj PLASMINOGEN : 4 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 646 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 739 GLY A 22 GLY.? 43.32 N6 ADP C1001 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -15.86 -8.41 2.68 -16.06 -8.23 3.51 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 646 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 739 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 739 GLY D 53 GLY~? 32.56 N1 ADP C1001 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -26.31 61.10 21.77 -26.62 61.15 20.99 1ddj_c13 source 1ddj PLASMINOGEN : 3 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 C 646 ASP A 61 ASP~? 37.71 N6 ADP C1001 C 739 GLY A 22 GLY.? 43.32 N6 ADP C1001 coo 15.33 59.81 59.60 13.98 60.99 60.69 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 16.06 55.72 54.73 15.97 56.49 56.70 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -15.86 -8.41 2.68 -16.06 -8.23 3.51 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 C 646 ASP A 61 ASP~? 37.71 N6 ADP C1001 C 739 GLY A 84 GLY.? 46.77 N6 ADP C1001 coo 15.33 59.81 59.60 13.98 60.99 60.69 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 16.06 55.72 54.73 15.97 56.49 56.70 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -3.69 0.62 -7.90 -4.33 0.30 -7.38 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 C 646 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 739 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo 15.33 59.81 59.60 13.98 60.99 60.69 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 16.06 55.72 54.73 15.97 56.49 56.70 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 9.38 49.29 65.28 9.01 50.03 65.31 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 C 646 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 739 GLY B 84 GLY.? 12.08 C2 ADP C1001 coo 15.33 59.81 59.60 13.98 60.99 60.69 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 16.06 55.72 54.73 15.97 56.49 56.70 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 9.38 49.29 65.28 9.01 50.03 65.31 -29.23 21.04 26.04 -29.32 20.71 25.30 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 C 646 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 739 GLY C 105 GLY.? 16.33 C2 ADP C1001 coo 15.33 59.81 59.60 13.98 60.99 60.69 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 16.06 55.72 54.73 15.97 56.49 56.70 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 9.38 49.29 65.28 9.01 50.03 65.31 -28.59 18.07 29.12 -28.98 18.05 29.83 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS C 62 HIS~? 21.13 N1 ADP C1001 C 646 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 739 GLY B 105 GLY.? 14.83 N6 ADP C1001 coo 15.33 59.81 59.60 13.98 60.99 60.69 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 16.06 55.72 54.73 15.97 56.49 56.70 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 9.38 49.29 65.28 9.01 50.03 65.31 -18.36 34.95 14.87 -18.15 34.98 14.15 ULMN 3 1ddj_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS C 62 HIS~? 21.13 N1 ADP C1001 C 646 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 739 GLY D 84 GLY.? 31.79 N1 ADP C1001 coo 15.33 59.81 59.60 13.98 60.99 60.69 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 16.06 55.72 54.73 15.97 56.49 56.70 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 9.38 49.29 65.28 9.01 50.03 65.31 -16.24 54.50 27.95 -16.49 54.77 27.19 ULMN 3 1ddj_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 C 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 739 GLY D 53 GLY~? 32.56 N1 ADP C1001 coo 15.33 59.81 59.60 13.98 60.99 60.69 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -26.31 61.10 21.77 -26.62 61.15 20.99 ULMN 3 1ddj_c14 PLASMINOGEN user 9 3 # 9 C 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 C 646 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 739 GLY D 84 GLY.? 31.79 N1 ADP C1001 coo 15.33 59.81 59.60 13.98 60.99 60.69 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 9.38 49.29 65.28 9.01 50.03 65.31 -16.24 54.50 27.95 -16.49 54.77 27.19 1ddj_c14 source 1ddj PLASMINOGEN : 9 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 D 646 ASP A 61 ASP~? 37.71 N6 ADP C1001 D 739 GLY A 22 GLY.? 43.32 N6 ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -15.86 -8.41 2.68 -16.06 -8.23 3.51 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 D 646 ASP A 61 ASP~? 37.71 N6 ADP C1001 D 739 GLY A 84 GLY.? 46.77 N6 ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -3.69 0.62 -7.90 -4.33 0.30 -7.38 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 62 HIS~? 32.10 N6 ADP C1001 D 646 ASP B 10 ASP.? 28.32 N6 ADP C1001 D 739 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 D 646 ASP B 61 ASP~? 21.98 C2 ADP C1001 D 739 GLY B 22 GLY.? 14.86 O1A ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -33.99 15.05 9.19 -33.34 14.99 8.60 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 D 646 ASP B 61 ASP~? 21.98 C2 ADP C1001 D 739 GLY B 84 GLY.? 12.08 C2 ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -29.23 21.04 26.04 -29.32 20.71 25.30 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS C 62 HIS~? 21.13 N1 ADP C1001 D 646 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 739 GLY B 105 GLY.? 14.83 N6 ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -18.36 34.95 14.87 -18.15 34.98 14.15 ULMN 3 1ddj_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS C 62 HIS~? 21.13 N1 ADP C1001 D 646 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 739 GLY C 22 GLY.? 14.12 O2' ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -35.88 42.47 25.00 -35.89 42.36 25.87 ULMN 3 1ddj_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS C 62 HIS~? 21.13 N1 ADP C1001 D 646 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 739 GLY C 84 GLY.? 10.47 N6 ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -22.35 33.13 15.48 -22.85 33.59 15.97 ULMN 3 1ddj_c15 PLASMINOGEN user 9 3 # 9 D 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 646 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 739 GLY C 63 GLY.? 18.10 N1 ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -18.24 37.08 25.10 -19.00 37.10 25.28 ULMN 3 1ddj_c15 PLASMINOGEN user 10 3 # 10 D 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 646 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 739 GLY D 22 GLY.? 35.41 N6 ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -21.83 63.53 12.51 -21.57 63.23 11.74 ULMN 3 1ddj_c15 PLASMINOGEN user 11 3 # 11 D 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 646 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 739 GLY D 84 GLY.? 31.79 N1 ADP C1001 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -16.24 54.50 27.95 -16.49 54.77 27.19 1ddj_c15 source 1ddj PLASMINOGEN : 11 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 33 GLU^? 35.51 N6 ADP C1001 A 226 THR A 69 THR.? 44.69 N6 ADP C1001 A 229 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 9.66 102.78 70.07 9.79 101.18 71.42 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 7.24 97.46 49.60 8.11 95.69 48.80 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 10.53 97.56 43.71 9.33 93.71 47.17 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 35 GLU.? 41.16 N6 ADP C1001 A 226 THR A 69 THR.? 44.69 N6 ADP C1001 A 229 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 9.66 102.78 70.07 9.79 101.18 71.42 4.51 12.95 12.26 5.81 14.21 13.42 coo 7.24 97.46 49.60 8.11 95.69 48.80 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 10.53 97.56 43.71 9.33 93.71 47.17 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU B 33 GLU^? 22.82 N1 ADP C1001 A 226 THR B 69 THR.? 8.02 N6 ADP C1001 A 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 9.66 102.78 70.07 9.79 101.18 71.42 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 7.24 97.46 49.60 8.11 95.69 48.80 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 10.53 97.56 43.71 9.33 93.71 47.17 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU B 35 GLU.? 24.64 N6 ADP C1001 A 226 THR B 69 THR.? 8.02 N6 ADP C1001 A 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 9.66 102.78 70.07 9.79 101.18 71.42 -8.42 31.70 14.79 -7.88 32.87 13.09 coo 7.24 97.46 49.60 8.11 95.69 48.80 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 10.53 97.56 43.71 9.33 93.71 47.17 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU C 33 GLU^? 22.62 N1 ADP C1001 A 226 THR C 69 THR.? 8.25 C2 ADP C1001 A 229 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 9.66 102.78 70.07 9.79 101.18 71.42 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 7.24 97.46 49.60 8.11 95.69 48.80 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 10.53 97.56 43.71 9.33 93.71 47.17 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU C 35 GLU.? 24.58 C2 ADP C1001 A 226 THR C 69 THR.? 8.25 C2 ADP C1001 A 229 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 9.66 102.78 70.07 9.79 101.18 71.42 -21.26 18.31 34.64 -21.49 16.34 35.41 coo 7.24 97.46 49.60 8.11 95.69 48.80 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 10.53 97.56 43.71 9.33 93.71 47.17 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU D 33 GLU^? 24.81 N6 ADP C1001 A 226 THR D 69 THR.? 36.92 N6 ADP C1001 A 229 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 9.66 102.78 70.07 9.79 101.18 71.42 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 7.24 97.46 49.60 8.11 95.69 48.80 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 10.53 97.56 43.71 9.33 93.71 47.17 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU D 35 GLU.? 34.89 N6 ADP C1001 A 226 THR D 69 THR.? 36.92 N6 ADP C1001 A 229 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 9.66 102.78 70.07 9.79 101.18 71.42 -1.41 44.17 17.18 -1.59 46.26 17.19 coo 7.24 97.46 49.60 8.11 95.69 48.80 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 10.53 97.56 43.71 9.33 93.71 47.17 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU D 41 GLU^? 18.65 N6 ADP C1001 A 226 THR B 69 THR.? 8.02 N6 ADP C1001 A 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 9.66 102.78 70.07 9.79 101.18 71.42 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 7.24 97.46 49.60 8.11 95.69 48.80 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 10.53 97.56 43.71 9.33 93.71 47.17 -31.10 21.58 3.18 -29.68 25.32 0.22 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 9 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 33 GLU^? 35.51 N6 ADP C1001 B 226 THR A 69 THR.? 44.69 N6 ADP C1001 B 229 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 15.90 87.61 49.61 13.92 86.96 49.36 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 20.74 95.78 68.68 19.29 96.84 69.83 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 22.32 101.61 71.64 17.89 98.63 71.55 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 35 GLU.? 41.16 N6 ADP C1001 B 226 THR A 69 THR.? 44.69 N6 ADP C1001 B 229 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 15.90 87.61 49.61 13.92 86.96 49.36 4.51 12.95 12.26 5.81 14.21 13.42 coo 20.74 95.78 68.68 19.29 96.84 69.83 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 22.32 101.61 71.64 17.89 98.63 71.55 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU B 33 GLU^? 22.82 N1 ADP C1001 B 226 THR B 69 THR.? 8.02 N6 ADP C1001 B 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 15.90 87.61 49.61 13.92 86.96 49.36 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 20.74 95.78 68.68 19.29 96.84 69.83 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 22.32 101.61 71.64 17.89 98.63 71.55 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU B 35 GLU.? 24.64 N6 ADP C1001 B 226 THR B 69 THR.? 8.02 N6 ADP C1001 B 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 15.90 87.61 49.61 13.92 86.96 49.36 -8.42 31.70 14.79 -7.88 32.87 13.09 coo 20.74 95.78 68.68 19.29 96.84 69.83 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 22.32 101.61 71.64 17.89 98.63 71.55 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU C 33 GLU^? 22.62 N1 ADP C1001 B 226 THR C 69 THR.? 8.25 C2 ADP C1001 B 229 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 15.90 87.61 49.61 13.92 86.96 49.36 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 20.74 95.78 68.68 19.29 96.84 69.83 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 22.32 101.61 71.64 17.89 98.63 71.55 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU C 35 GLU.? 24.58 C2 ADP C1001 B 226 THR C 69 THR.? 8.25 C2 ADP C1001 B 229 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 15.90 87.61 49.61 13.92 86.96 49.36 -21.26 18.31 34.64 -21.49 16.34 35.41 coo 20.74 95.78 68.68 19.29 96.84 69.83 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 22.32 101.61 71.64 17.89 98.63 71.55 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU D 33 GLU^? 24.81 N6 ADP C1001 B 226 THR D 69 THR.? 36.92 N6 ADP C1001 B 229 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 15.90 87.61 49.61 13.92 86.96 49.36 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 20.74 95.78 68.68 19.29 96.84 69.83 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 22.32 101.61 71.64 17.89 98.63 71.55 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU D 35 GLU.? 34.89 N6 ADP C1001 B 226 THR D 69 THR.? 36.92 N6 ADP C1001 B 229 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 15.90 87.61 49.61 13.92 86.96 49.36 -1.41 44.17 17.18 -1.59 46.26 17.19 coo 20.74 95.78 68.68 19.29 96.84 69.83 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 22.32 101.61 71.64 17.89 98.63 71.55 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 57 GLU D 41 GLU^? 18.65 N6 ADP C1001 B 226 THR B 69 THR.? 8.02 N6 ADP C1001 B 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 15.90 87.61 49.61 13.92 86.96 49.36 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 20.74 95.78 68.68 19.29 96.84 69.83 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 22.32 101.61 71.64 17.89 98.63 71.55 -31.10 21.58 3.18 -29.68 25.32 0.22 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 9 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 33 GLU^? 35.51 N6 ADP C1001 C 226 THR A 69 THR.? 44.69 N6 ADP C1001 C 229 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 5.43 40.40 61.63 4.27 41.99 60.90 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 22.16 45.88 73.63 23.23 47.70 73.25 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 28.90 45.91 73.55 25.22 49.72 72.97 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 35 GLU.? 41.16 N6 ADP C1001 C 226 THR A 69 THR.? 44.69 N6 ADP C1001 C 229 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 5.43 40.40 61.63 4.27 41.99 60.90 4.51 12.95 12.26 5.81 14.21 13.42 coo 22.16 45.88 73.63 23.23 47.70 73.25 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 28.90 45.91 73.55 25.22 49.72 72.97 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU B 33 GLU^? 22.82 N1 ADP C1001 C 226 THR B 69 THR.? 8.02 N6 ADP C1001 C 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 5.43 40.40 61.63 4.27 41.99 60.90 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 22.16 45.88 73.63 23.23 47.70 73.25 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 28.90 45.91 73.55 25.22 49.72 72.97 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU B 35 GLU.? 24.64 N6 ADP C1001 C 226 THR B 69 THR.? 8.02 N6 ADP C1001 C 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 5.43 40.40 61.63 4.27 41.99 60.90 -8.42 31.70 14.79 -7.88 32.87 13.09 coo 22.16 45.88 73.63 23.23 47.70 73.25 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 28.90 45.91 73.55 25.22 49.72 72.97 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU C 33 GLU^? 22.62 N1 ADP C1001 C 226 THR C 69 THR.? 8.25 C2 ADP C1001 C 229 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 5.43 40.40 61.63 4.27 41.99 60.90 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 22.16 45.88 73.63 23.23 47.70 73.25 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 28.90 45.91 73.55 25.22 49.72 72.97 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU C 35 GLU.? 24.58 C2 ADP C1001 C 226 THR C 69 THR.? 8.25 C2 ADP C1001 C 229 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 5.43 40.40 61.63 4.27 41.99 60.90 -21.26 18.31 34.64 -21.49 16.34 35.41 coo 22.16 45.88 73.63 23.23 47.70 73.25 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 28.90 45.91 73.55 25.22 49.72 72.97 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU D 33 GLU^? 24.81 N6 ADP C1001 C 226 THR D 69 THR.? 36.92 N6 ADP C1001 C 229 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 5.43 40.40 61.63 4.27 41.99 60.90 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 22.16 45.88 73.63 23.23 47.70 73.25 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 28.90 45.91 73.55 25.22 49.72 72.97 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU D 35 GLU.? 34.89 N6 ADP C1001 C 226 THR D 69 THR.? 36.92 N6 ADP C1001 C 229 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 5.43 40.40 61.63 4.27 41.99 60.90 -1.41 44.17 17.18 -1.59 46.26 17.19 coo 22.16 45.88 73.63 23.23 47.70 73.25 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 28.90 45.91 73.55 25.22 49.72 72.97 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 57 GLU D 41 GLU^? 18.65 N6 ADP C1001 C 226 THR B 69 THR.? 8.02 N6 ADP C1001 C 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 5.43 40.40 61.63 4.27 41.99 60.90 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 22.16 45.88 73.63 23.23 47.70 73.25 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 28.90 45.91 73.55 25.22 49.72 72.97 -31.10 21.58 3.18 -29.68 25.32 0.22 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 9 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 33 GLU^? 35.51 N6 ADP C1001 D 226 THR A 69 THR.? 44.69 N6 ADP C1001 D 229 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 26.07 55.89 66.14 25.33 56.50 68.01 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 11.79 47.62 52.67 10.10 46.51 53.39 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 10.05 41.79 49.80 7.94 44.71 53.76 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 35 GLU.? 41.16 N6 ADP C1001 D 226 THR A 69 THR.? 44.69 N6 ADP C1001 D 229 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 26.07 55.89 66.14 25.33 56.50 68.01 4.51 12.95 12.26 5.81 14.21 13.42 coo 11.79 47.62 52.67 10.10 46.51 53.39 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 10.05 41.79 49.80 7.94 44.71 53.76 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU B 33 GLU^? 22.82 N1 ADP C1001 D 226 THR B 69 THR.? 8.02 N6 ADP C1001 D 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 26.07 55.89 66.14 25.33 56.50 68.01 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 11.79 47.62 52.67 10.10 46.51 53.39 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 10.05 41.79 49.80 7.94 44.71 53.76 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU B 35 GLU.? 24.64 N6 ADP C1001 D 226 THR B 69 THR.? 8.02 N6 ADP C1001 D 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 26.07 55.89 66.14 25.33 56.50 68.01 -8.42 31.70 14.79 -7.88 32.87 13.09 coo 11.79 47.62 52.67 10.10 46.51 53.39 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 10.05 41.79 49.80 7.94 44.71 53.76 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU C 33 GLU^? 22.62 N1 ADP C1001 D 226 THR C 69 THR.? 8.25 C2 ADP C1001 D 229 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 26.07 55.89 66.14 25.33 56.50 68.01 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 11.79 47.62 52.67 10.10 46.51 53.39 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 10.05 41.79 49.80 7.94 44.71 53.76 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU C 35 GLU.? 24.58 C2 ADP C1001 D 226 THR C 69 THR.? 8.25 C2 ADP C1001 D 229 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 26.07 55.89 66.14 25.33 56.50 68.01 -21.26 18.31 34.64 -21.49 16.34 35.41 coo 11.79 47.62 52.67 10.10 46.51 53.39 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 10.05 41.79 49.80 7.94 44.71 53.76 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU D 33 GLU^? 24.81 N6 ADP C1001 D 226 THR D 69 THR.? 36.92 N6 ADP C1001 D 229 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 26.07 55.89 66.14 25.33 56.50 68.01 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 11.79 47.62 52.67 10.10 46.51 53.39 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 10.05 41.79 49.80 7.94 44.71 53.76 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU D 35 GLU.? 34.89 N6 ADP C1001 D 226 THR D 69 THR.? 36.92 N6 ADP C1001 D 229 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 26.07 55.89 66.14 25.33 56.50 68.01 -1.41 44.17 17.18 -1.59 46.26 17.19 coo 11.79 47.62 52.67 10.10 46.51 53.39 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 10.05 41.79 49.80 7.94 44.71 53.76 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 57 GLU D 41 GLU^? 18.65 N6 ADP C1001 D 226 THR B 69 THR.? 8.02 N6 ADP C1001 D 229 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 26.07 55.89 66.14 25.33 56.50 68.01 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 11.79 47.62 52.67 10.10 46.51 53.39 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 10.05 41.79 49.80 7.94 44.71 53.76 -31.10 21.58 3.18 -29.68 25.32 0.22 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 9 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 20 HIS.? 47.81 N6 ADP C1001 A 200 ASP A 54 ASP~? 42.89 N6 ADP C1001 A 229 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 1.13 77.49 40.64 0.62 75.57 39.98 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 0.84 91.24 49.01 2.91 91.61 49.23 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 10.53 97.56 43.71 9.33 93.71 47.17 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 200 ASP B 54 ASP~? 20.52 O4' ADP C1001 A 229 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 1.13 77.49 40.64 0.62 75.57 39.98 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 0.84 91.24 49.01 2.91 91.61 49.23 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 200 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 229 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 1.13 77.49 40.64 0.62 75.57 39.98 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 0.84 91.24 49.01 2.91 91.61 49.23 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 10.53 97.56 43.71 9.33 93.71 47.17 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 123 HIS C 50 HIS.? 17.04 O2' ADP C1001 A 200 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 229 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 1.13 77.49 40.64 0.62 75.57 39.98 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 0.84 91.24 49.01 2.91 91.61 49.23 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 10.53 97.56 43.71 9.33 93.71 47.17 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 123 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 200 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 229 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 1.13 77.49 40.64 0.62 75.57 39.98 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 0.84 91.24 49.01 2.91 91.61 49.23 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 10.53 97.56 43.71 9.33 93.71 47.17 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 123 HIS D 20 HIS.? 42.10 N6 ADP C1001 A 200 ASP D 54 ASP~? 30.93 N6 ADP C1001 A 229 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 1.13 77.49 40.64 0.62 75.57 39.98 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 0.84 91.24 49.01 2.91 91.61 49.23 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 123 HIS D 20 HIS.? 42.10 N6 ADP C1001 A 200 ASP D 110 ASP.? 48.95 N6 ADP C1001 A 229 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 1.13 77.49 40.64 0.62 75.57 39.98 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 0.84 91.24 49.01 2.91 91.61 49.23 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 10.53 97.56 43.71 9.33 93.71 47.17 1.94 54.62 12.82 6.05 51.27 9.45 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 20 HIS.? 47.81 N6 ADP C1001 B 200 ASP A 54 ASP~? 42.89 N6 ADP C1001 B 229 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 9.24 94.26 88.22 8.02 94.07 89.92 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 17.54 90.31 75.01 17.17 92.01 73.80 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 22.32 101.61 71.64 17.89 98.63 71.55 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS B 20 HIS.? 13.19 O1A ADP C1001 B 200 ASP B 54 ASP~? 20.52 O4' ADP C1001 B 229 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 9.24 94.26 88.22 8.02 94.07 89.92 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 17.54 90.31 75.01 17.17 92.01 73.80 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS C 20 HIS.? 13.76 O2' ADP C1001 B 200 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 229 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 9.24 94.26 88.22 8.02 94.07 89.92 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 17.54 90.31 75.01 17.17 92.01 73.80 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 22.32 101.61 71.64 17.89 98.63 71.55 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 123 HIS C 50 HIS.? 17.04 O2' ADP C1001 B 200 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 229 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 9.24 94.26 88.22 8.02 94.07 89.92 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 17.54 90.31 75.01 17.17 92.01 73.80 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 22.32 101.61 71.64 17.89 98.63 71.55 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 123 HIS C 62 HIS~? 21.13 N1 ADP C1001 B 200 ASP D 31 ASP^? 21.52 N6 ADP C1001 B 229 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 9.24 94.26 88.22 8.02 94.07 89.92 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 17.54 90.31 75.01 17.17 92.01 73.80 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 22.32 101.61 71.64 17.89 98.63 71.55 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 123 HIS D 20 HIS.? 42.10 N6 ADP C1001 B 200 ASP D 54 ASP~? 30.93 N6 ADP C1001 B 229 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 9.24 94.26 88.22 8.02 94.07 89.92 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 17.54 90.31 75.01 17.17 92.01 73.80 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 123 HIS D 20 HIS.? 42.10 N6 ADP C1001 B 200 ASP D 110 ASP.? 48.95 N6 ADP C1001 B 229 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 9.24 94.26 88.22 8.02 94.07 89.92 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 17.54 90.31 75.01 17.17 92.01 73.80 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 22.32 101.61 71.64 17.89 98.63 71.55 1.94 54.62 12.82 6.05 51.27 9.45 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 20 HIS.? 47.81 N6 ADP C1001 C 200 ASP A 54 ASP~? 42.89 N6 ADP C1001 C 229 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 26.77 65.84 83.49 27.06 67.76 84.27 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 19.52 52.01 79.59 20.28 51.65 77.65 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 28.90 45.91 73.55 25.22 49.72 72.97 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS B 20 HIS.? 13.19 O1A ADP C1001 C 200 ASP B 54 ASP~? 20.52 O4' ADP C1001 C 229 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 26.77 65.84 83.49 27.06 67.76 84.27 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 19.52 52.01 79.59 20.28 51.65 77.65 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS C 20 HIS.? 13.76 O2' ADP C1001 C 200 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 229 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 26.77 65.84 83.49 27.06 67.76 84.27 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 19.52 52.01 79.59 20.28 51.65 77.65 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 28.90 45.91 73.55 25.22 49.72 72.97 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 123 HIS C 50 HIS.? 17.04 O2' ADP C1001 C 200 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 229 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 26.77 65.84 83.49 27.06 67.76 84.27 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 19.52 52.01 79.59 20.28 51.65 77.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 28.90 45.91 73.55 25.22 49.72 72.97 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 123 HIS C 62 HIS~? 21.13 N1 ADP C1001 C 200 ASP D 31 ASP^? 21.52 N6 ADP C1001 C 229 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 26.77 65.84 83.49 27.06 67.76 84.27 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 19.52 52.01 79.59 20.28 51.65 77.65 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 28.90 45.91 73.55 25.22 49.72 72.97 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 123 HIS D 20 HIS.? 42.10 N6 ADP C1001 C 200 ASP D 54 ASP~? 30.93 N6 ADP C1001 C 229 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 26.77 65.84 83.49 27.06 67.76 84.27 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 19.52 52.01 79.59 20.28 51.65 77.65 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 123 HIS D 20 HIS.? 42.10 N6 ADP C1001 C 200 ASP D 110 ASP.? 48.95 N6 ADP C1001 C 229 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 26.77 65.84 83.49 27.06 67.76 84.27 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 19.52 52.01 79.59 20.28 51.65 77.65 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 28.90 45.91 73.55 25.22 49.72 72.97 1.94 54.62 12.82 6.05 51.27 9.45 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 20 HIS.? 47.81 N6 ADP C1001 D 200 ASP A 54 ASP~? 42.89 N6 ADP C1001 D 229 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 4.60 52.95 52.50 5.57 51.29 53.40 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 10.05 41.79 49.80 7.94 44.71 53.76 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS B 20 HIS.? 13.19 O1A ADP C1001 D 200 ASP B 54 ASP~? 20.52 O4' ADP C1001 D 229 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 4.60 52.95 52.50 5.57 51.29 53.40 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS C 20 HIS.? 13.76 O2' ADP C1001 D 200 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 229 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 4.60 52.95 52.50 5.57 51.29 53.40 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 10.05 41.79 49.80 7.94 44.71 53.76 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 123 HIS C 50 HIS.? 17.04 O2' ADP C1001 D 200 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 229 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 4.60 52.95 52.50 5.57 51.29 53.40 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 10.05 41.79 49.80 7.94 44.71 53.76 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 123 HIS C 62 HIS~? 21.13 N1 ADP C1001 D 200 ASP D 31 ASP^? 21.52 N6 ADP C1001 D 229 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 4.60 52.95 52.50 5.57 51.29 53.40 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 10.05 41.79 49.80 7.94 44.71 53.76 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 123 HIS D 20 HIS.? 42.10 N6 ADP C1001 D 200 ASP D 54 ASP~? 30.93 N6 ADP C1001 D 229 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 4.60 52.95 52.50 5.57 51.29 53.40 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 123 HIS D 20 HIS.? 42.10 N6 ADP C1001 D 200 ASP D 110 ASP.? 48.95 N6 ADP C1001 D 229 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 4.60 52.95 52.50 5.57 51.29 53.40 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 10.05 41.79 49.80 7.94 44.71 53.76 1.94 54.62 12.82 6.05 51.27 9.45 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 69 THR.? 44.69 N6 ADP C1001 A 45 THR A 89 THR.? 50.21 N6 ADP C1001 A 161 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 27.73 89.90 76.08 29.24 91.46 75.95 -3.01 -7.90 5.97 -2.57 -9.33 4.41 coo 33.83 91.15 88.62 31.07 91.06 83.02 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 89 THR.? 50.21 N6 ADP C1001 A 45 THR A 69 THR.? 44.69 N6 ADP C1001 A 161 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -3.01 -7.90 5.97 -2.57 -9.33 4.41 coo 27.73 89.90 76.08 29.24 91.46 75.95 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 33.83 91.15 88.62 31.07 91.06 83.02 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR B 69 THR.? 8.02 N6 ADP C1001 A 45 THR B 89 THR.? -3.20 N6 ADP C1001s A 161 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 27.73 89.90 76.08 29.24 91.46 75.95 -30.78 27.78 11.26 -32.72 28.03 12.28 coo 33.83 91.15 88.62 31.07 91.06 83.02 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR B 69 THR.? 8.02 N6 ADP C1001 A 45 THR B 89 THR.? -3.20 N6 ADP C1001s A 161 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 27.73 89.90 76.08 29.24 91.46 75.95 -30.78 27.78 11.26 -32.72 28.03 12.28 coo 33.83 91.15 88.62 31.07 91.06 83.02 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR B 89 THR.? -3.20 N6 ADP C1001s A 45 THR B 69 THR.? 8.02 N6 ADP C1001 A 161 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -30.78 27.78 11.26 -32.72 28.03 12.28 coo 27.73 89.90 76.08 29.24 91.46 75.95 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 33.83 91.15 88.62 31.07 91.06 83.02 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR B 89 THR.? -3.20 N6 ADP C1001s A 45 THR B 69 THR.? 8.02 N6 ADP C1001 A 161 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -30.78 27.78 11.26 -32.72 28.03 12.28 coo 27.73 89.90 76.08 29.24 91.46 75.95 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 33.83 91.15 88.62 31.07 91.06 83.02 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 A 44 THR C 69 THR.? 8.25 C2 ADP C1001 A 45 THR C 89 THR.? 3.96 N3 ADP C1001 A 161 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 27.73 89.90 76.08 29.24 91.46 75.95 -36.03 29.56 23.55 -36.59 29.86 21.42 coo 33.83 91.15 88.62 31.07 91.06 83.02 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 A 44 THR C 69 THR.? 8.25 C2 ADP C1001 A 45 THR C 89 THR.? 3.96 N3 ADP C1001 A 161 LYS C 116 LYS.? 13.74 O3' ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 27.73 89.90 76.08 29.24 91.46 75.95 -36.03 29.56 23.55 -36.59 29.86 21.42 coo 33.83 91.15 88.62 31.07 91.06 83.02 -48.64 32.02 26.16 -47.11 28.29 30.57 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 A 44 THR C 89 THR.? 3.96 N3 ADP C1001 A 45 THR C 69 THR.? 8.25 C2 ADP C1001 A 161 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -36.03 29.56 23.55 -36.59 29.86 21.42 coo 27.73 89.90 76.08 29.24 91.46 75.95 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 33.83 91.15 88.62 31.07 91.06 83.02 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 A 44 THR C 89 THR.? 3.96 N3 ADP C1001 A 45 THR C 69 THR.? 8.25 C2 ADP C1001 A 161 LYS C 116 LYS.? 13.74 O3' ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -36.03 29.56 23.55 -36.59 29.86 21.42 coo 27.73 89.90 76.08 29.24 91.46 75.95 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 33.83 91.15 88.62 31.07 91.06 83.02 -48.64 32.02 26.16 -47.11 28.29 30.57 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 11 3 # 11 A 44 THR D 69 THR.? 36.92 N6 ADP C1001 A 45 THR D 89 THR.? 41.56 N6 ADP C1001 A 161 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 27.73 89.90 76.08 29.24 91.46 75.95 -8.88 62.80 15.73 -9.19 64.25 17.31 coo 33.83 91.15 88.62 31.07 91.06 83.02 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 12 3 # 12 A 44 THR D 89 THR.? 41.56 N6 ADP C1001 A 45 THR D 69 THR.? 36.92 N6 ADP C1001 A 161 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 26.16 88.25 79.16 25.22 89.47 80.71 -8.88 62.80 15.73 -9.19 64.25 17.31 coo 27.73 89.90 76.08 29.24 91.46 75.95 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 33.83 91.15 88.62 31.07 91.06 83.02 1.94 54.62 12.82 6.05 51.27 9.45 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 12 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 69 THR.? 44.69 N6 ADP C1001 B 45 THR A 89 THR.? 50.21 N6 ADP C1001 B 161 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 5.75 129.25 91.25 4.29 128.16 90.07 -3.01 -7.90 5.97 -2.57 -9.33 4.41 coo -0.17 119.75 99.65 2.51 123.83 95.70 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 89 THR.? 50.21 N6 ADP C1001 B 45 THR A 69 THR.? 44.69 N6 ADP C1001 B 161 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -3.01 -7.90 5.97 -2.57 -9.33 4.41 coo 5.75 129.25 91.25 4.29 128.16 90.07 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo -0.17 119.75 99.65 2.51 123.83 95.70 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR B 69 THR.? 8.02 N6 ADP C1001 B 45 THR B 89 THR.? -3.20 N6 ADP C1001s B 161 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 5.75 129.25 91.25 4.29 128.16 90.07 -30.78 27.78 11.26 -32.72 28.03 12.28 coo -0.17 119.75 99.65 2.51 123.83 95.70 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR B 69 THR.? 8.02 N6 ADP C1001 B 45 THR B 89 THR.? -3.20 N6 ADP C1001s B 161 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 5.75 129.25 91.25 4.29 128.16 90.07 -30.78 27.78 11.26 -32.72 28.03 12.28 coo -0.17 119.75 99.65 2.51 123.83 95.70 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR B 89 THR.? -3.20 N6 ADP C1001s B 45 THR B 69 THR.? 8.02 N6 ADP C1001 B 161 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -30.78 27.78 11.26 -32.72 28.03 12.28 coo 5.75 129.25 91.25 4.29 128.16 90.07 -28.27 23.67 9.92 -29.81 23.02 11.35 coo -0.17 119.75 99.65 2.51 123.83 95.70 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR B 89 THR.? -3.20 N6 ADP C1001s B 45 THR B 69 THR.? 8.02 N6 ADP C1001 B 161 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -30.78 27.78 11.26 -32.72 28.03 12.28 coo 5.75 129.25 91.25 4.29 128.16 90.07 -28.27 23.67 9.92 -29.81 23.02 11.35 coo -0.17 119.75 99.65 2.51 123.83 95.70 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 B 44 THR C 69 THR.? 8.25 C2 ADP C1001 B 45 THR C 89 THR.? 3.96 N3 ADP C1001 B 161 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 5.75 129.25 91.25 4.29 128.16 90.07 -36.03 29.56 23.55 -36.59 29.86 21.42 coo -0.17 119.75 99.65 2.51 123.83 95.70 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 B 44 THR C 69 THR.? 8.25 C2 ADP C1001 B 45 THR C 89 THR.? 3.96 N3 ADP C1001 B 161 LYS C 116 LYS.? 13.74 O3' ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 5.75 129.25 91.25 4.29 128.16 90.07 -36.03 29.56 23.55 -36.59 29.86 21.42 coo -0.17 119.75 99.65 2.51 123.83 95.70 -48.64 32.02 26.16 -47.11 28.29 30.57 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 B 44 THR C 89 THR.? 3.96 N3 ADP C1001 B 45 THR C 69 THR.? 8.25 C2 ADP C1001 B 161 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -36.03 29.56 23.55 -36.59 29.86 21.42 coo 5.75 129.25 91.25 4.29 128.16 90.07 -34.19 32.67 26.93 -33.84 33.77 25.09 coo -0.17 119.75 99.65 2.51 123.83 95.70 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 B 44 THR C 89 THR.? 3.96 N3 ADP C1001 B 45 THR C 69 THR.? 8.25 C2 ADP C1001 B 161 LYS C 116 LYS.? 13.74 O3' ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -36.03 29.56 23.55 -36.59 29.86 21.42 coo 5.75 129.25 91.25 4.29 128.16 90.07 -34.19 32.67 26.93 -33.84 33.77 25.09 coo -0.17 119.75 99.65 2.51 123.83 95.70 -48.64 32.02 26.16 -47.11 28.29 30.57 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 11 3 # 11 B 44 THR D 69 THR.? 36.92 N6 ADP C1001 B 45 THR D 89 THR.? 41.56 N6 ADP C1001 B 161 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 5.75 129.25 91.25 4.29 128.16 90.07 -8.88 62.80 15.73 -9.19 64.25 17.31 coo -0.17 119.75 99.65 2.51 123.83 95.70 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 12 3 # 12 B 44 THR D 89 THR.? 41.56 N6 ADP C1001 B 45 THR D 69 THR.? 36.92 N6 ADP C1001 B 161 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 7.39 128.28 94.56 8.34 126.36 94.79 -8.88 62.80 15.73 -9.19 64.25 17.31 coo 5.75 129.25 91.25 4.29 128.16 90.07 -11.97 60.08 12.90 -13.39 61.48 13.64 coo -0.17 119.75 99.65 2.51 123.83 95.70 1.94 54.62 12.82 6.05 51.27 9.45 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 12 hits 1dhp_c03 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 183 LYS B 114 LYS.? -3.14 O1A ADP C1001s A 278 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 19.43 18.53 42.32 17.66 18.80 40.15 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 21.92 15.80 36.19 17.64 19.44 36.35 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 15.46 19.03 31.40 15.01 18.25 33.31 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 183 LYS B 116 LYS.? 13.79 O2B ADP C1001 A 278 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 19.43 18.53 42.32 17.66 18.80 40.15 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 21.92 15.80 36.19 17.64 19.44 36.35 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 15.46 19.03 31.40 15.01 18.25 33.31 -35.67 34.06 2.87 -37.59 34.07 2.20 1do8_c00 source 1do8 MALIC ENZYME : 2 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR B 70 TYR.? 11.71 N6 ADP C1001 B 183 LYS B 114 LYS.? -3.14 O1A ADP C1001s B 278 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 58.62 15.99 58.34 60.98 14.60 58.93 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 60.11 10.60 53.63 62.59 10.74 58.67 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 66.50 7.32 58.45 66.26 9.42 58.23 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR B 70 TYR.? 11.71 N6 ADP C1001 B 183 LYS B 116 LYS.? 13.79 O2B ADP C1001 B 278 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 58.62 15.99 58.34 60.98 14.60 58.93 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 60.11 10.60 53.63 62.59 10.74 58.67 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 66.50 7.32 58.45 66.26 9.42 58.23 -35.67 34.06 2.87 -37.59 34.07 2.20 1do8_c01 source 1do8 MALIC ENZYME : 2 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR B 70 TYR.? 11.71 N6 ADP C1001 C 183 LYS B 114 LYS.? -3.14 O1A ADP C1001s C 278 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR B 70 TYR.? 11.71 N6 ADP C1001 C 183 LYS B 116 LYS.? 13.79 O2B ADP C1001 C 278 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -35.67 34.06 2.87 -37.59 34.07 2.20 1do8_c02 source 1do8 MALIC ENZYME : 2 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR B 70 TYR.? 11.71 N6 ADP C1001 D 183 LYS B 114 LYS.? -3.14 O1A ADP C1001s D 278 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR B 70 TYR.? 11.71 N6 ADP C1001 D 183 LYS B 116 LYS.? 13.79 O2B ADP C1001 D 278 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR D 70 TYR.? 43.17 N6 ADP C1001 D 183 LYS D 114 LYS.? 50.69 N6 ADP C1001 D 278 ASP D 112 ASP.? 52.73 N6 ADP C1001 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -10.19 64.81 9.49 -8.66 67.08 8.77 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -9.33 71.95 14.33 -7.85 74.07 18.29 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -3.02 71.97 12.29 -1.27 72.40 13.41 1do8_c03 source 1do8 MALIC ENZYME : 3 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 62 HIS~? 32.10 N6 ADP C1001 E 102 ASP A 61 ASP~? 37.71 N6 ADP C1001 E 193 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 11.39 26.86 25.95 9.85 26.64 27.36 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 10.90 32.83 25.96 10.83 30.68 25.98 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 4.57 20.60 30.29 4.74 21.36 30.66 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS B 62 HIS~? 22.43 N1 ADP C1001 E 102 ASP B 61 ASP~? 21.98 C2 ADP C1001 E 193 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo 11.39 26.86 25.95 9.85 26.64 27.36 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 10.90 32.83 25.96 10.83 30.68 25.98 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 4.57 20.60 30.29 4.74 21.36 30.66 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS C 50 HIS.? 17.04 O2' ADP C1001 E 102 ASP C 54 ASP~? 20.12 N1 ADP C1001 E 193 GLY C 73 GLY~? 7.38 O2' ADP C1001 coo 11.39 26.86 25.95 9.85 26.64 27.36 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 10.90 32.83 25.96 10.83 30.68 25.98 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 4.57 20.60 30.29 4.74 21.36 30.66 -38.52 37.92 18.83 -37.81 37.51 18.99 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 3 hits 1ds2_c02 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 14 LYS~? 28.69 N1 ADP C1001 A 215 LYS A 100 LYS~? 39.84 N1 ADP C1001 A 277 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -12.97 3.35 18.51 -15.05 7.51 22.75 coo 13.06 30.79 51.73 11.40 35.76 53.48 -1.03 5.78 15.30 1.15 8.50 19.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 19 LYS.? 46.12 N1 ADP C1001 A 215 LYS A 108 LYS.? 49.24 N1 ADP C1001 A 277 LYS A 100 LYS~? 39.84 N1 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 13.06 30.79 51.73 11.40 35.76 53.48 1.67 -4.82 14.87 3.65 -3.69 19.86 coo 13.04 31.88 60.72 10.57 35.34 57.49 -1.03 5.78 15.30 1.15 8.50 19.55 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 38 LYS^? 31.29 N6 ADP C1001 A 215 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 277 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 13.06 30.79 51.73 11.40 35.76 53.48 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 13.04 31.88 60.72 10.57 35.34 57.49 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS A 100 LYS~? 39.84 N1 ADP C1001 A 215 LYS A 38 LYS^? 31.29 N6 ADP C1001 A 277 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -1.03 5.78 15.30 1.15 8.50 19.55 coo 13.06 30.79 51.73 11.40 35.76 53.48 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 13.04 31.88 60.72 10.57 35.34 57.49 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS A 108 LYS.? 49.24 N1 ADP C1001 A 215 LYS A 19 LYS.? 46.12 N1 ADP C1001 A 277 LYS A 114 LYS.? 56.27 N6 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 1.67 -4.82 14.87 3.65 -3.69 19.86 coo 13.06 30.79 51.73 11.40 35.76 53.48 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 13.04 31.88 60.72 10.57 35.34 57.49 -4.38 -17.33 7.81 -3.33 -16.78 2.19 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS B 14 LYS~? 27.17 N6 ADP C1001 A 215 LYS A 38 LYS^? 31.29 N6 ADP C1001 A 277 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 13.06 30.79 51.73 11.40 35.76 53.48 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 13.04 31.88 60.72 10.57 35.34 57.49 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 A 131 LYS B 14 LYS~? 27.17 N6 ADP C1001 A 215 LYS B 100 LYS~? 23.96 N6 ADP C1001 A 277 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 13.06 30.79 51.73 11.40 35.76 53.48 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 13.04 31.88 60.72 10.57 35.34 57.49 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 A 131 LYS B 38 LYS.? 29.47 N6 ADP C1001 A 215 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 277 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 13.06 30.79 51.73 11.40 35.76 53.48 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 A 131 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 215 LYS C 100 LYS~? 22.69 C2 ADP C1001 A 277 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 13.06 30.79 51.73 11.40 35.76 53.48 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 13.04 31.88 60.72 10.57 35.34 57.49 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 A 131 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 215 LYS C 106 LYS.? 22.18 C2 ADP C1001 A 277 LYS C 100 LYS~? 22.69 C2 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 13.06 30.79 51.73 11.40 35.76 53.48 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 13.04 31.88 60.72 10.57 35.34 57.49 -28.01 22.62 36.30 -24.43 24.45 38.49 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 A 131 LYS B 100 LYS~? 23.96 N6 ADP C1001 A 215 LYS B 38 LYS.? 29.47 N6 ADP C1001 A 277 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 13.06 30.79 51.73 11.40 35.76 53.48 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 13.04 31.88 60.72 10.57 35.34 57.49 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 A 131 LYS B 100 LYS~? 23.96 N6 ADP C1001 A 215 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 277 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 13.06 30.79 51.73 11.40 35.76 53.48 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 13.04 31.88 60.72 10.57 35.34 57.49 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 A 131 LYS B 108 LYS.? 17.61 N6 ADP C1001 A 215 LYS B 19 LYS.? 15.59 N6 ADP C1001 A 277 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 0.50 24.09 51.68 1.51 29.34 52.35 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 13.06 30.79 51.73 11.40 35.76 53.48 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 13.04 31.88 60.72 10.57 35.34 57.49 -38.05 28.30 5.66 -42.50 28.99 10.13 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 A 131 LYS B 108 LYS.? 17.61 N6 ADP C1001 A 215 LYS B 19 LYS.? 15.59 N6 ADP C1001 A 277 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 13.06 30.79 51.73 11.40 35.76 53.48 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 13.04 31.88 60.72 10.57 35.34 57.49 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 A 131 LYS C 14 LYS.? 27.01 C2 ADP C1001 A 215 LYS C 100 LYS~? 22.69 C2 ADP C1001 A 277 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -31.38 33.30 42.44 -27.73 35.10 43.96 coo 13.06 30.79 51.73 11.40 35.76 53.48 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 13.04 31.88 60.72 10.57 35.34 57.49 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 A 131 LYS C 19 LYS.? 18.77 O3' ADP C1001 A 215 LYS C 108 LYS.? 14.57 N3 ADP C1001 A 277 LYS C 100 LYS~? 22.69 C2 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 13.06 30.79 51.73 11.40 35.76 53.48 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 13.04 31.88 60.72 10.57 35.34 57.49 -28.01 22.62 36.30 -24.43 24.45 38.49 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 A 131 LYS C 38 LYS^? 29.32 C2 ADP C1001 A 215 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 277 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -16.18 28.34 36.63 -11.47 27.59 37.59 coo 13.06 30.79 51.73 11.40 35.76 53.48 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 13.04 31.88 60.72 10.57 35.34 57.49 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 A 131 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 215 LYS B 100 LYS~? 23.96 N6 ADP C1001 A 277 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 13.06 30.79 51.73 11.40 35.76 53.48 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 13.04 31.88 60.72 10.57 35.34 57.49 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 A 131 LYS C 100 LYS~? 22.69 C2 ADP C1001 A 215 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 277 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 13.06 30.79 51.73 11.40 35.76 53.48 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 A 131 LYS C 108 LYS.? 14.57 N3 ADP C1001 A 215 LYS C 19 LYS.? 18.77 O3' ADP C1001 A 277 LYS C 116 LYS.? 13.74 O3' ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 13.06 30.79 51.73 11.40 35.76 53.48 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 13.04 31.88 60.72 10.57 35.34 57.49 -48.64 32.02 26.16 -47.11 28.29 30.57 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 21 3 # 21 A 131 LYS D 38 LYS^? 26.03 N6 ADP C1001 A 215 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 277 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -10.44 39.35 12.00 -7.01 36.04 14.36 coo 13.06 30.79 51.73 11.40 35.76 53.48 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 13.04 31.88 60.72 10.57 35.34 57.49 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 22 3 # 22 A 131 LYS D 38 LYS^? 26.03 N6 ADP C1001 A 215 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 277 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -10.44 39.35 12.00 -7.01 36.04 14.36 coo 13.06 30.79 51.73 11.40 35.76 53.48 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 13.04 31.88 60.72 10.57 35.34 57.49 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 23 3 # 23 A 131 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 215 LYS D 38 LYS^? 26.03 N6 ADP C1001 A 277 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 0.50 24.09 51.68 1.51 29.34 52.35 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 13.06 30.79 51.73 11.40 35.76 53.48 -10.44 39.35 12.00 -7.01 36.04 14.36 coo 13.04 31.88 60.72 10.57 35.34 57.49 -19.68 36.01 11.35 -19.41 40.72 7.99 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 23 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 14 LYS~? 28.69 N1 ADP C1001 B 215 LYS A 100 LYS~? 39.84 N1 ADP C1001 B 277 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -12.97 3.35 18.51 -15.05 7.51 22.75 coo 17.88 38.77 19.81 16.38 34.23 17.24 -1.03 5.78 15.30 1.15 8.50 19.55 coo 20.33 37.78 11.20 16.77 34.53 13.47 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 100 LYS~? 39.84 N1 ADP C1001 B 215 LYS A 38 LYS^? 31.29 N6 ADP C1001 B 277 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -1.03 5.78 15.30 1.15 8.50 19.55 coo 17.88 38.77 19.81 16.38 34.23 17.24 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 20.33 37.78 11.20 16.77 34.53 13.47 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 108 LYS.? 49.24 N1 ADP C1001 B 215 LYS A 19 LYS.? 46.12 N1 ADP C1001 B 277 LYS A 114 LYS.? 56.27 N6 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 1.67 -4.82 14.87 3.65 -3.69 19.86 coo 17.88 38.77 19.81 16.38 34.23 17.24 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 20.33 37.78 11.20 16.77 34.53 13.47 -4.38 -17.33 7.81 -3.33 -16.78 2.19 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS B 14 LYS~? 27.17 N6 ADP C1001 B 215 LYS A 38 LYS^? 31.29 N6 ADP C1001 B 277 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 17.88 38.77 19.81 16.38 34.23 17.24 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 20.33 37.78 11.20 16.77 34.53 13.47 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS B 14 LYS~? 27.17 N6 ADP C1001 B 215 LYS B 100 LYS~? 23.96 N6 ADP C1001 B 277 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 17.88 38.77 19.81 16.38 34.23 17.24 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 20.33 37.78 11.20 16.77 34.53 13.47 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 215 LYS C 100 LYS~? 22.69 C2 ADP C1001 B 277 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 17.88 38.77 19.81 16.38 34.23 17.24 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 20.33 37.78 11.20 16.77 34.53 13.47 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 B 131 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 215 LYS C 106 LYS.? 22.18 C2 ADP C1001 B 277 LYS C 100 LYS~? 22.69 C2 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 17.88 38.77 19.81 16.38 34.23 17.24 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 20.33 37.78 11.20 16.77 34.53 13.47 -28.01 22.62 36.30 -24.43 24.45 38.49 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 B 131 LYS B 100 LYS~? 23.96 N6 ADP C1001 B 215 LYS B 38 LYS.? 29.47 N6 ADP C1001 B 277 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 17.88 38.77 19.81 16.38 34.23 17.24 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 20.33 37.78 11.20 16.77 34.53 13.47 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 B 131 LYS B 100 LYS~? 23.96 N6 ADP C1001 B 215 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 277 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 17.88 38.77 19.81 16.38 34.23 17.24 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 20.33 37.78 11.20 16.77 34.53 13.47 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 B 131 LYS B 108 LYS.? 17.61 N6 ADP C1001 B 215 LYS B 19 LYS.? 15.59 N6 ADP C1001 B 277 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 6.78 45.91 16.15 7.82 40.81 15.84 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 17.88 38.77 19.81 16.38 34.23 17.24 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 20.33 37.78 11.20 16.77 34.53 13.47 -38.05 28.30 5.66 -42.50 28.99 10.13 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 B 131 LYS B 108 LYS.? 17.61 N6 ADP C1001 B 215 LYS B 19 LYS.? 15.59 N6 ADP C1001 B 277 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 17.88 38.77 19.81 16.38 34.23 17.24 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 20.33 37.78 11.20 16.77 34.53 13.47 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 B 131 LYS B 108 LYS.? 17.61 N6 ADP C1001 B 215 LYS B 114 LYS.? -3.14 O1A ADP C1001s B 277 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 17.88 38.77 19.81 16.38 34.23 17.24 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 20.33 37.78 11.20 16.77 34.53 13.47 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 B 131 LYS C 14 LYS.? 27.01 C2 ADP C1001 B 215 LYS C 100 LYS~? 22.69 C2 ADP C1001 B 277 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -31.38 33.30 42.44 -27.73 35.10 43.96 coo 17.88 38.77 19.81 16.38 34.23 17.24 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 20.33 37.78 11.20 16.77 34.53 13.47 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 B 131 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 215 LYS B 100 LYS~? 23.96 N6 ADP C1001 B 277 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 17.88 38.77 19.81 16.38 34.23 17.24 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 20.33 37.78 11.20 16.77 34.53 13.47 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 B 131 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 215 LYS B 106 LYS.? 18.25 N6 ADP C1001 B 277 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 17.88 38.77 19.81 16.38 34.23 17.24 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 20.33 37.78 11.20 16.77 34.53 13.47 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 B 131 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 215 LYS B 106 LYS.? 18.25 N6 ADP C1001 B 277 LYS D 38 LYS^? 26.03 N6 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 17.88 38.77 19.81 16.38 34.23 17.24 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 20.33 37.78 11.20 16.77 34.53 13.47 -10.44 39.35 12.00 -7.01 36.04 14.36 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 B 131 LYS C 100 LYS~? 22.69 C2 ADP C1001 B 215 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 277 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 17.88 38.77 19.81 16.38 34.23 17.24 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 20.33 37.78 11.20 16.77 34.53 13.47 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 B 131 LYS C 108 LYS.? 14.57 N3 ADP C1001 B 215 LYS C 19 LYS.? 18.77 O3' ADP C1001 B 277 LYS C 114 LYS.? -2.76 O3B ADP C1001s coo 6.78 45.91 16.15 7.82 40.81 15.84 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 17.88 38.77 19.81 16.38 34.23 17.24 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 20.33 37.78 11.20 16.77 34.53 13.47 -44.82 31.28 21.50 -43.38 31.47 16.20 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 B 131 LYS C 108 LYS.? 14.57 N3 ADP C1001 B 215 LYS C 19 LYS.? 18.77 O3' ADP C1001 B 277 LYS C 116 LYS.? 13.74 O3' ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 17.88 38.77 19.81 16.38 34.23 17.24 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 20.33 37.78 11.20 16.77 34.53 13.47 -48.64 32.02 26.16 -47.11 28.29 30.57 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 B 131 LYS D 38 LYS^? 26.03 N6 ADP C1001 B 215 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 277 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 6.78 45.91 16.15 7.82 40.81 15.84 -10.44 39.35 12.00 -7.01 36.04 14.36 coo 17.88 38.77 19.81 16.38 34.23 17.24 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 20.33 37.78 11.20 16.77 34.53 13.47 -21.73 32.18 22.71 -16.79 33.08 21.29 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 20 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR C 79 TYR~? 13.12 N6 ADP C1001 B 40 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 103 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -29.26 47.42 21.46 -29.58 49.13 20.24 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 1 hits 1e3v_c03 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 9 ASP.? 35.63 N1 ADP C1001 A 35 SER A 15 SER~? 35.42 N1 ADP C1001 A 218 ASP A 10 ASP.? 29.48 N1 ADP C1001 coo 47.22 22.34 8.57 45.16 22.02 9.13 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 43.58 20.85 5.15 44.62 23.01 5.76 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo 44.05 16.99 12.67 44.05 18.89 11.74 -21.48 2.08 13.35 -22.87 1.76 14.94 1eag_c04 source 1eag PEPTIDE INHIBITOR : 1 hits 1eag_c04 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 108 LYS.? 49.24 N1 ADP C1001 A 207 LYS A 106 LYS.? 50.79 N6 ADP C1001 A 366 ASP A 97 ASP~? 39.49 N1 ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 1.67 -4.82 14.87 3.65 -3.69 19.86 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 5.53 0.28 13.93 10.17 1.85 15.47 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -4.20 1.28 18.72 -4.75 1.76 20.72 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS B 108 LYS.? 17.61 N6 ADP C1001 A 207 LYS B 106 LYS.? 18.25 N6 ADP C1001 A 366 ASP B 97 ASP~? 21.13 N6 ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -23.61 33.84 6.26 -20.57 37.69 4.41 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -19.68 36.01 11.35 -19.41 40.72 7.99 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -17.01 28.05 3.64 -15.70 27.74 1.96 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS B 114 LYS.? -3.14 O1A ADP C1001s A 207 LYS B 116 LYS.? 13.79 O2B ADP C1001 A 366 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -38.05 28.30 5.66 -42.50 28.99 10.13 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -38.53 26.18 0.73 -35.66 28.79 0.03 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS B 114 LYS.? -3.14 O1A ADP C1001s A 207 LYS B 116 LYS.? 13.79 O2B ADP C1001 A 366 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -38.05 28.30 5.66 -42.50 28.99 10.13 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -38.53 26.18 0.73 -35.66 28.79 0.03 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 5 3 # 5 A 205 LYS C 100 LYS~? 22.69 C2 ADP C1001 A 207 LYS C 106 LYS.? 22.18 C2 ADP C1001 A 366 ASP C 97 ASP~? 22.56 C2 ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -28.01 22.62 36.30 -24.43 24.45 38.49 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -32.20 18.25 30.35 -29.71 15.02 34.83 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -33.31 25.31 38.38 -33.83 25.06 40.38 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 6 3 # 6 A 205 LYS C 108 LYS.? 14.57 N3 ADP C1001 A 207 LYS C 106 LYS.? 22.18 C2 ADP C1001 A 366 ASP C 97 ASP~? 22.56 C2 ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -37.26 21.98 30.89 -34.43 24.41 31.94 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -32.20 18.25 30.35 -29.71 15.02 34.83 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -33.31 25.31 38.38 -33.83 25.06 40.38 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 7 3 # 7 A 205 LYS C 114 LYS.? -2.76 O3B ADP C1001s A 207 LYS C 116 LYS.? 13.74 O3' ADP C1001 A 366 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -44.82 31.28 21.50 -43.38 31.47 16.20 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -48.64 32.02 26.16 -47.11 28.29 30.57 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 8 3 # 8 A 205 LYS C 116 LYS.? 13.74 O3' ADP C1001 A 207 LYS C 114 LYS.? -2.76 O3B ADP C1001s A 366 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -48.64 32.02 26.16 -47.11 28.29 30.57 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -44.82 31.28 21.50 -43.38 31.47 16.20 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 9 3 # 9 A 205 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 207 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 366 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -21.35 51.92 21.59 -25.15 52.63 26.23 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -14.21 50.71 21.89 -14.80 46.21 24.73 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 10 3 # 10 A 205 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 207 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 366 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -14.21 50.71 21.89 -14.80 46.21 24.73 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -21.35 51.92 21.59 -25.15 52.63 26.23 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 11 3 # 11 A 205 LYS D 108 LYS.? 47.30 N6 ADP C1001 A 207 LYS D 106 LYS.? 44.27 N6 ADP C1001 A 366 ASP D 97 ASP~? 39.15 N6 ADP C1001 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -0.82 59.67 9.89 3.99 59.45 8.43 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 1.94 54.62 12.82 6.05 51.27 9.45 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -4.34 53.74 3.65 -4.01 53.36 1.58 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 11 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 108 LYS.? 49.24 N1 ADP C1001 B 207 LYS A 106 LYS.? 50.79 N6 ADP C1001 B 366 ASP A 97 ASP~? 39.49 N1 ADP C1001 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 1.67 -4.82 14.87 3.65 -3.69 19.86 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 5.53 0.28 13.93 10.17 1.85 15.47 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -4.20 1.28 18.72 -4.75 1.76 20.72 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS B 108 LYS.? 17.61 N6 ADP C1001 B 207 LYS B 106 LYS.? 18.25 N6 ADP C1001 B 366 ASP B 97 ASP~? 21.13 N6 ADP C1001 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -23.61 33.84 6.26 -20.57 37.69 4.41 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -19.68 36.01 11.35 -19.41 40.72 7.99 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -17.01 28.05 3.64 -15.70 27.74 1.96 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS B 114 LYS.? -3.14 O1A ADP C1001s B 207 LYS B 116 LYS.? 13.79 O2B ADP C1001 B 366 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -38.05 28.30 5.66 -42.50 28.99 10.13 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -38.53 26.18 0.73 -35.66 28.79 0.03 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS B 114 LYS.? -3.14 O1A ADP C1001s B 207 LYS B 116 LYS.? 13.79 O2B ADP C1001 B 366 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -38.05 28.30 5.66 -42.50 28.99 10.13 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -38.53 26.18 0.73 -35.66 28.79 0.03 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 5 3 # 5 B 205 LYS C 100 LYS~? 22.69 C2 ADP C1001 B 207 LYS C 106 LYS.? 22.18 C2 ADP C1001 B 366 ASP C 97 ASP~? 22.56 C2 ADP C1001 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -28.01 22.62 36.30 -24.43 24.45 38.49 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -32.20 18.25 30.35 -29.71 15.02 34.83 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -33.31 25.31 38.38 -33.83 25.06 40.38 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 6 3 # 6 B 205 LYS C 108 LYS.? 14.57 N3 ADP C1001 B 207 LYS C 106 LYS.? 22.18 C2 ADP C1001 B 366 ASP C 97 ASP~? 22.56 C2 ADP C1001 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -37.26 21.98 30.89 -34.43 24.41 31.94 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -32.20 18.25 30.35 -29.71 15.02 34.83 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -33.31 25.31 38.38 -33.83 25.06 40.38 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 7 3 # 7 B 205 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 207 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 366 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -21.35 51.92 21.59 -25.15 52.63 26.23 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -14.21 50.71 21.89 -14.80 46.21 24.73 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 8 3 # 8 B 205 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 207 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 366 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -14.21 50.71 21.89 -14.80 46.21 24.73 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -21.35 51.92 21.59 -25.15 52.63 26.23 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 9 3 # 9 B 205 LYS D 108 LYS.? 47.30 N6 ADP C1001 B 207 LYS D 106 LYS.? 44.27 N6 ADP C1001 B 366 ASP D 97 ASP~? 39.15 N6 ADP C1001 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -0.82 59.67 9.89 3.99 59.45 8.43 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 1.94 54.62 12.82 6.05 51.27 9.45 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -4.34 53.74 3.65 -4.01 53.36 1.58 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 9 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 108 LYS.? 49.24 N1 ADP C1001 C 207 LYS A 106 LYS.? 50.79 N6 ADP C1001 C 366 ASP A 97 ASP~? 39.49 N1 ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 1.67 -4.82 14.87 3.65 -3.69 19.86 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 5.53 0.28 13.93 10.17 1.85 15.47 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -4.20 1.28 18.72 -4.75 1.76 20.72 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS B 108 LYS.? 17.61 N6 ADP C1001 C 207 LYS B 106 LYS.? 18.25 N6 ADP C1001 C 366 ASP B 97 ASP~? 21.13 N6 ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -17.01 28.05 3.64 -15.70 27.74 1.96 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS B 114 LYS.? -3.14 O1A ADP C1001s C 207 LYS B 116 LYS.? 13.79 O2B ADP C1001 C 366 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 4 3 # 4 C 205 LYS B 114 LYS.? -3.14 O1A ADP C1001s C 207 LYS B 116 LYS.? 13.79 O2B ADP C1001 C 366 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 5 3 # 5 C 205 LYS C 100 LYS~? 22.69 C2 ADP C1001 C 207 LYS C 106 LYS.? 22.18 C2 ADP C1001 C 366 ASP C 97 ASP~? 22.56 C2 ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -33.31 25.31 38.38 -33.83 25.06 40.38 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 6 3 # 6 C 205 LYS C 108 LYS.? 14.57 N3 ADP C1001 C 207 LYS C 106 LYS.? 22.18 C2 ADP C1001 C 366 ASP C 97 ASP~? 22.56 C2 ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -33.31 25.31 38.38 -33.83 25.06 40.38 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 7 3 # 7 C 205 LYS C 114 LYS.? -2.76 O3B ADP C1001s C 207 LYS C 116 LYS.? 13.74 O3' ADP C1001 C 366 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 8 3 # 8 C 205 LYS C 116 LYS.? 13.74 O3' ADP C1001 C 207 LYS C 114 LYS.? -2.76 O3B ADP C1001s C 366 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 9 3 # 9 C 205 LYS D 60 LYS~? 25.96 N1 ADP C1001 C 207 LYS D 65 LYS.? 25.59 N1 ADP C1001 C 366 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 10 3 # 10 C 205 LYS D 65 LYS.? 25.59 N1 ADP C1001 C 207 LYS D 60 LYS~? 25.96 N1 ADP C1001 C 366 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 11 3 # 11 C 205 LYS D 108 LYS.? 47.30 N6 ADP C1001 C 207 LYS D 106 LYS.? 44.27 N6 ADP C1001 C 366 ASP D 97 ASP~? 39.15 N6 ADP C1001 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -0.82 59.67 9.89 3.99 59.45 8.43 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 1.94 54.62 12.82 6.05 51.27 9.45 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -4.34 53.74 3.65 -4.01 53.36 1.58 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 11 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 108 LYS.? 49.24 N1 ADP C1001 D 207 LYS A 106 LYS.? 50.79 N6 ADP C1001 D 366 ASP A 97 ASP~? 39.49 N1 ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 1.67 -4.82 14.87 3.65 -3.69 19.86 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 5.53 0.28 13.93 10.17 1.85 15.47 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -4.20 1.28 18.72 -4.75 1.76 20.72 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS B 108 LYS.? 17.61 N6 ADP C1001 D 207 LYS B 106 LYS.? 18.25 N6 ADP C1001 D 366 ASP B 97 ASP~? 21.13 N6 ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -17.01 28.05 3.64 -15.70 27.74 1.96 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS B 114 LYS.? -3.14 O1A ADP C1001s D 207 LYS B 116 LYS.? 13.79 O2B ADP C1001 D 366 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS B 114 LYS.? -3.14 O1A ADP C1001s D 207 LYS B 116 LYS.? 13.79 O2B ADP C1001 D 366 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 5 3 # 5 D 205 LYS C 100 LYS~? 22.69 C2 ADP C1001 D 207 LYS C 106 LYS.? 22.18 C2 ADP C1001 D 366 ASP C 97 ASP~? 22.56 C2 ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -33.31 25.31 38.38 -33.83 25.06 40.38 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 6 3 # 6 D 205 LYS C 108 LYS.? 14.57 N3 ADP C1001 D 207 LYS C 106 LYS.? 22.18 C2 ADP C1001 D 366 ASP C 97 ASP~? 22.56 C2 ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -33.31 25.31 38.38 -33.83 25.06 40.38 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 7 3 # 7 D 205 LYS C 114 LYS.? -2.76 O3B ADP C1001s D 207 LYS C 116 LYS.? 13.74 O3' ADP C1001 D 366 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 8 3 # 8 D 205 LYS C 116 LYS.? 13.74 O3' ADP C1001 D 207 LYS C 114 LYS.? -2.76 O3B ADP C1001s D 366 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 9 3 # 9 D 205 LYS D 60 LYS~? 25.96 N1 ADP C1001 D 207 LYS D 65 LYS.? 25.59 N1 ADP C1001 D 366 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 10 3 # 10 D 205 LYS D 65 LYS.? 25.59 N1 ADP C1001 D 207 LYS D 60 LYS~? 25.96 N1 ADP C1001 D 366 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 11 3 # 11 D 205 LYS D 108 LYS.? 47.30 N6 ADP C1001 D 207 LYS D 106 LYS.? 44.27 N6 ADP C1001 D 366 ASP D 97 ASP~? 39.15 N6 ADP C1001 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -0.82 59.67 9.89 3.99 59.45 8.43 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 1.94 54.62 12.82 6.05 51.27 9.45 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -4.34 53.74 3.65 -4.01 53.36 1.58 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 11 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 177 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 203 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 8.74 45.76 47.19 9.33 46.93 45.56 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 11.68 42.31 52.96 12.05 43.92 51.65 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 18.07 52.81 49.62 14.17 49.99 48.07 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 177 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 203 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 8.74 45.76 47.19 9.33 46.93 45.56 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 11.68 42.31 52.96 12.05 43.92 51.65 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 18.07 52.81 49.62 14.17 49.99 48.07 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 177 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 203 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 8.74 45.76 47.19 9.33 46.93 45.56 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 11.68 42.31 52.96 12.05 43.92 51.65 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 18.07 52.81 49.62 14.17 49.99 48.07 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 177 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 203 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 8.74 45.76 47.19 9.33 46.93 45.56 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 11.68 42.31 52.96 12.05 43.92 51.65 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 18.07 52.81 49.62 14.17 49.99 48.07 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 5 3 # 5 A 99 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 177 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 203 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 8.74 45.76 47.19 9.33 46.93 45.56 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 11.68 42.31 52.96 12.05 43.92 51.65 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 18.07 52.81 49.62 14.17 49.99 48.07 -14.21 50.71 21.89 -14.80 46.21 24.73 1ecx_c02 source 1ecx AMINOTRANSFERASE : 5 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 177 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 203 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 14.87 88.04 21.51 13.64 87.90 19.81 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 15.87 92.46 27.37 14.46 91.76 25.94 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 3.60 91.42 23.52 8.20 89.55 22.63 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 177 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 203 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 14.87 88.04 21.51 13.64 87.90 19.81 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 15.87 92.46 27.37 14.46 91.76 25.94 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 3.60 91.42 23.52 8.20 89.55 22.63 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 177 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 203 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 14.87 88.04 21.51 13.64 87.90 19.81 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 15.87 92.46 27.37 14.46 91.76 25.94 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 3.60 91.42 23.52 8.20 89.55 22.63 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 177 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 203 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 14.87 88.04 21.51 13.64 87.90 19.81 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 15.87 92.46 27.37 14.46 91.76 25.94 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 3.60 91.42 23.52 8.20 89.55 22.63 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 5 3 # 5 B 99 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 177 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 203 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 14.87 88.04 21.51 13.64 87.90 19.81 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 15.87 92.46 27.37 14.46 91.76 25.94 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 3.60 91.42 23.52 8.20 89.55 22.63 -14.21 50.71 21.89 -14.80 46.21 24.73 1ecx_c03 source 1ecx AMINOTRANSFERASE : 5 hits 1ecx_c03 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 246 ASP A 31 ASP^? 31.30 N6 ADP C1001 B 275 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 34.84 56.77 81.62 34.95 54.74 82.03 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 43.18 49.30 68.39 44.75 49.87 69.78 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 38.73 55.10 77.62 36.80 55.01 78.46 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 246 ASP A 54 ASP~? 42.89 N6 ADP C1001 B 275 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 34.84 56.77 81.62 34.95 54.74 82.03 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 43.18 49.30 68.39 44.75 49.87 69.78 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 38.73 55.10 77.62 36.80 55.01 78.46 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 246 ASP B 31 ASP^? 22.05 N1 ADP C1001 B 275 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 34.84 56.77 81.62 34.95 54.74 82.03 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 43.18 49.30 68.39 44.75 49.87 69.78 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 38.73 55.10 77.62 36.80 55.01 78.46 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 246 ASP C 31 ASP^? 21.62 C2 ADP C1001 B 275 HIS C 62 HIS~? 21.13 N1 ADP C1001 coo 34.84 56.77 81.62 34.95 54.74 82.03 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 43.18 49.30 68.39 44.75 49.87 69.78 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 38.73 55.10 77.62 36.80 55.01 78.46 -20.79 41.45 28.58 -20.89 43.35 29.47 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 B 107 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 246 ASP D 31 ASP^? 21.52 N6 ADP C1001 B 275 HIS D 62 HIS.? 20.37 N6 ADP C1001 coo 34.84 56.77 81.62 34.95 54.74 82.03 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 43.18 49.30 68.39 44.75 49.87 69.78 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 38.73 55.10 77.62 36.80 55.01 78.46 -23.21 48.47 15.79 -25.03 48.41 14.73 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 5 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 246 ASP A 54 ASP~? 42.89 N6 ADP C1001 C 275 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 1.90 35.26 72.76 3.20 35.74 71.18 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 12.03 20.33 71.56 10.48 19.25 70.56 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 3.92 29.96 71.75 4.22 31.96 72.31 -15.84 6.06 -0.29 -17.94 5.95 -0.14 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 1 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 61 ASP~? 37.71 N6 ADP C1001 D 246 ASP A 31 ASP^? 31.30 N6 ADP C1001 D 275 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 37.41 19.89 81.58 37.64 21.98 81.53 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 23.50 26.43 88.52 24.76 26.47 90.29 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 33.16 21.44 85.29 34.07 21.53 83.40 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP B 10 ASP.? 28.32 N6 ADP C1001 D 246 ASP A 54 ASP~? 42.89 N6 ADP C1001 D 275 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 37.41 19.89 81.58 37.64 21.98 81.53 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 23.50 26.43 88.52 24.76 26.47 90.29 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 33.16 21.44 85.29 34.07 21.53 83.40 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP B 61 ASP~? 21.98 C2 ADP C1001 D 246 ASP B 31 ASP^? 22.05 N1 ADP C1001 D 275 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 37.41 19.89 81.58 37.64 21.98 81.53 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 23.50 26.43 88.52 24.76 26.47 90.29 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 33.16 21.44 85.29 34.07 21.53 83.40 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 246 ASP C 31 ASP^? 21.62 C2 ADP C1001 D 275 HIS C 62 HIS~? 21.13 N1 ADP C1001 coo 37.41 19.89 81.58 37.64 21.98 81.53 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 23.50 26.43 88.52 24.76 26.47 90.29 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 33.16 21.44 85.29 34.07 21.53 83.40 -20.79 41.45 28.58 -20.89 43.35 29.47 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 D 107 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 246 ASP D 31 ASP^? 21.52 N6 ADP C1001 D 275 HIS D 62 HIS.? 20.37 N6 ADP C1001 coo 37.41 19.89 81.58 37.64 21.98 81.53 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 23.50 26.43 88.52 24.76 26.47 90.29 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 33.16 21.44 85.29 34.07 21.53 83.40 -23.21 48.47 15.79 -25.03 48.41 14.73 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 5 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 197 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 223 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 197 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 223 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 197 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 223 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 197 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 223 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 A 114 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 197 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 223 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -14.21 50.71 21.89 -14.80 46.21 24.73 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 5 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 197 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 223 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 197 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 223 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 197 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 223 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -14.21 50.71 21.89 -14.80 46.21 24.73 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 3 hits 1elq_c03 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP B 10 ASP.? 28.32 N6 ADP C1001 153 ARG B 11 ARG~? 27.94 N6 ADP C1001 177 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 6.83 2.75 19.17 7.40 0.75 19.11 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -15.84 6.06 -0.29 -17.94 5.95 -0.14 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 1 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 4 ALA^? 37.50 N6 ADP C1001 A 257 ALA A 64 ALA.? 37.27 N6 ADP C1001 A 328 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.47 2.58 4.42 -9.97 2.04 3.08 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 4 ALA^? 37.50 N6 ADP C1001 A 257 ALA A 64 ALA.? 37.27 N6 ADP C1001 A 328 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.47 2.58 4.42 -9.97 2.04 3.08 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 64 ALA.? 37.27 N6 ADP C1001 A 257 ALA A 4 ALA^? 37.50 N6 ADP C1001 A 328 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 39.84 24.12 8.44 38.50 24.23 9.11 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo 43.22 26.73 5.37 41.81 27.09 5.79 -9.47 2.58 4.42 -9.97 2.04 3.08 coo 38.17 34.10 6.67 37.72 32.06 6.84 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA B 4 ALA^? 14.54 N6 ADP C1001 A 257 ALA B 64 ALA.? 15.41 N1 ADP C1001 A 328 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 39.84 24.12 8.44 38.50 24.23 9.11 -22.49 19.03 14.42 -23.52 18.15 15.03 coo 43.22 26.73 5.37 41.81 27.09 5.79 -22.22 17.81 20.01 -22.67 17.81 18.54 coo 38.17 34.10 6.67 37.72 32.06 6.84 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA B 64 ALA.? 15.41 N1 ADP C1001 A 257 ALA B 4 ALA^? 14.54 N6 ADP C1001 A 328 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 39.84 24.12 8.44 38.50 24.23 9.11 -22.22 17.81 20.01 -22.67 17.81 18.54 coo 43.22 26.73 5.37 41.81 27.09 5.79 -22.49 19.03 14.42 -23.52 18.15 15.03 coo 38.17 34.10 6.67 37.72 32.06 6.84 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA C 4 ALA^? 13.75 C2 ADP C1001 A 257 ALA C 64 ALA.? 14.62 N1 ADP C1001 A 328 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 39.84 24.12 8.44 38.50 24.23 9.11 -25.90 34.40 28.80 -25.82 35.52 27.80 coo 43.22 26.73 5.37 41.81 27.09 5.79 -21.29 34.81 25.43 -22.58 35.15 26.14 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA C 4 ALA^? 13.75 C2 ADP C1001 A 257 ALA C 64 ALA.? 14.62 N1 ADP C1001 A 328 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 39.84 24.12 8.44 38.50 24.23 9.11 -25.90 34.40 28.80 -25.82 35.52 27.80 coo 43.22 26.73 5.37 41.81 27.09 5.79 -21.29 34.81 25.43 -22.58 35.15 26.14 coo 38.17 34.10 6.67 37.72 32.06 6.84 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA C 64 ALA.? 14.62 N1 ADP C1001 A 257 ALA C 4 ALA^? 13.75 C2 ADP C1001 A 328 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 39.84 24.12 8.44 38.50 24.23 9.11 -21.29 34.81 25.43 -22.58 35.15 26.14 coo 43.22 26.73 5.37 41.81 27.09 5.79 -25.90 34.40 28.80 -25.82 35.52 27.80 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA D 4 ALA^? 27.82 N6 ADP C1001 A 257 ALA D 64 ALA.? 26.15 N6 ADP C1001 A 328 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 39.84 24.12 8.44 38.50 24.23 9.11 -15.17 52.28 14.24 -16.54 52.72 14.92 coo 43.22 26.73 5.37 41.81 27.09 5.79 -16.76 49.68 19.26 -17.00 50.74 18.25 coo 38.17 34.10 6.67 37.72 32.06 6.84 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA D 64 ALA.? 26.15 N6 ADP C1001 A 257 ALA D 4 ALA^? 27.82 N6 ADP C1001 A 328 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 39.84 24.12 8.44 38.50 24.23 9.11 -16.76 49.68 19.26 -17.00 50.74 18.25 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.17 52.28 14.24 -16.54 52.72 14.92 coo 38.17 34.10 6.67 37.72 32.06 6.84 -13.15 42.40 14.58 -15.11 42.76 15.19 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 10 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER B 82 SER~? 11.53 O4' ADP C1001 A 140 TYR C 111 TYR.? 9.78 O3' ADP C1001 A 144 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 34.67 35.79 48.83 33.57 37.88 49.47 -34.46 19.85 25.71 -36.11 18.63 24.45 coo 29.60 38.99 53.89 30.10 37.88 51.36 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 32.73 32.94 54.42 29.29 32.83 50.35 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER C 82 SER~? 10.86 N6 ADP C1001 A 140 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 144 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 34.67 35.79 48.83 33.57 37.88 49.47 -25.49 36.24 12.26 -26.11 38.47 12.83 coo 29.60 38.99 53.89 30.10 37.88 51.36 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 32.73 32.94 54.42 29.29 32.83 50.35 -23.61 33.84 6.26 -20.57 37.69 4.41 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER B 82 SER~? 11.53 O4' ADP C1001 B 140 TYR C 111 TYR.? 9.78 O3' ADP C1001 B 144 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 30.90 35.65 89.60 29.85 37.72 88.83 -34.46 19.85 25.71 -36.11 18.63 24.45 coo 24.43 38.83 86.53 27.07 38.03 86.12 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 25.13 32.62 89.49 27.74 32.61 84.91 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER C 82 SER~? 10.86 N6 ADP C1001 B 140 TYR B 111 TYR.? 10.00 N6 ADP C1001 B 144 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 30.90 35.65 89.60 29.85 37.72 88.83 -25.49 36.24 12.26 -26.11 38.47 12.83 coo 24.43 38.83 86.53 27.07 38.03 86.12 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 25.13 32.62 89.49 27.74 32.61 84.91 -23.61 33.84 6.26 -20.57 37.69 4.41 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER B 82 SER~? 11.53 O4' ADP C1001 C 140 TYR C 111 TYR.? 9.78 O3' ADP C1001 C 144 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -34.46 19.85 25.71 -36.11 18.63 24.45 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -42.34 21.68 23.98 -40.45 19.79 24.70 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER C 82 SER~? 10.86 N6 ADP C1001 C 140 TYR B 111 TYR.? 10.00 N6 ADP C1001 C 144 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -25.49 36.24 12.26 -26.11 38.47 12.83 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -31.63 36.54 7.53 -29.30 37.35 8.87 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -23.61 33.84 6.26 -20.57 37.69 4.41 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER B 82 SER~? 11.53 O4' ADP C1001 D 140 TYR C 111 TYR.? 9.78 O3' ADP C1001 D 144 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -34.46 19.85 25.71 -36.11 18.63 24.45 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -42.34 21.68 23.98 -40.45 19.79 24.70 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER C 82 SER~? 10.86 N6 ADP C1001 D 140 TYR B 111 TYR.? 10.00 N6 ADP C1001 D 144 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -25.49 36.24 12.26 -26.11 38.47 12.83 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -31.63 36.54 7.53 -29.30 37.35 8.87 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -23.61 33.84 6.26 -20.57 37.69 4.41 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER B 82 SER~? 11.53 O4' ADP C1001 E 140 TYR C 111 TYR.? 9.78 O3' ADP C1001 E 144 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -34.46 19.85 25.71 -36.11 18.63 24.45 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER C 82 SER~? 10.86 N6 ADP C1001 E 140 TYR B 111 TYR.? 10.00 N6 ADP C1001 E 144 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -25.49 36.24 12.26 -26.11 38.47 12.83 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -23.61 33.84 6.26 -20.57 37.69 4.41 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER B 82 SER~? 11.53 O4' ADP C1001 F 140 TYR C 111 TYR.? 9.78 O3' ADP C1001 F 144 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 55.30 92.46 56.72 55.15 90.39 55.38 -34.46 19.85 25.71 -36.11 18.63 24.45 coo 54.49 89.31 49.65 53.35 90.16 52.06 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 56.78 95.62 51.15 51.59 95.31 52.37 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER C 82 SER~? 10.86 N6 ADP C1001 F 140 TYR B 111 TYR.? 10.00 N6 ADP C1001 F 144 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 55.30 92.46 56.72 55.15 90.39 55.38 -25.49 36.24 12.26 -26.11 38.47 12.83 coo 54.49 89.31 49.65 53.35 90.16 52.06 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 56.78 95.62 51.15 51.59 95.31 52.37 -23.61 33.84 6.26 -20.57 37.69 4.41 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER B 82 SER~? 11.53 O4' ADP C1001 G 140 TYR C 111 TYR.? 9.78 O3' ADP C1001 G 144 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 76.25 95.63 21.56 75.29 93.40 21.36 -34.46 19.85 25.71 -36.11 18.63 24.45 coo 69.78 91.62 20.06 71.51 92.68 22.02 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 71.19 98.21 18.32 70.69 97.75 23.67 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER C 82 SER~? 10.86 N6 ADP C1001 G 140 TYR B 111 TYR.? 10.00 N6 ADP C1001 G 144 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 76.25 95.63 21.56 75.29 93.40 21.36 -25.49 36.24 12.26 -26.11 38.47 12.83 coo 69.78 91.62 20.06 71.51 92.68 22.02 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 71.19 98.21 18.32 70.69 97.75 23.67 -23.61 33.84 6.26 -20.57 37.69 4.41 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER B 82 SER~? 11.53 O4' ADP C1001 H 140 TYR C 111 TYR.? 9.78 O3' ADP C1001 H 144 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 15.45 90.62 47.70 16.55 88.57 46.97 -34.46 19.85 25.71 -36.11 18.63 24.45 coo 21.92 87.58 44.67 19.30 88.41 44.23 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 21.26 93.70 47.67 18.47 93.68 43.08 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER C 82 SER~? 10.86 N6 ADP C1001 H 140 TYR B 111 TYR.? 10.00 N6 ADP C1001 H 144 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 15.45 90.62 47.70 16.55 88.57 46.97 -25.49 36.24 12.26 -26.11 38.47 12.83 coo 21.92 87.58 44.67 19.30 88.41 44.23 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 21.26 93.70 47.67 18.47 93.68 43.08 -23.61 33.84 6.26 -20.57 37.69 4.41 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER B 82 SER~? 11.53 O4' ADP C1001 I 140 TYR C 111 TYR.? 9.78 O3' ADP C1001 I 144 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 11.78 90.82 7.18 12.84 88.72 7.93 -34.46 19.85 25.71 -36.11 18.63 24.45 coo 16.78 87.76 12.19 16.39 88.69 9.59 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 13.67 93.83 12.65 17.08 93.94 8.58 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER C 82 SER~? 10.86 N6 ADP C1001 I 140 TYR B 111 TYR.? 10.00 N6 ADP C1001 I 144 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 11.78 90.82 7.18 12.84 88.72 7.93 -25.49 36.24 12.26 -26.11 38.47 12.83 coo 16.78 87.76 12.19 16.39 88.69 9.59 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 13.67 93.83 12.65 17.08 93.94 8.58 -23.61 33.84 6.26 -20.57 37.69 4.41 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER B 82 SER~? 11.53 O4' ADP C1001 J 140 TYR C 111 TYR.? 9.78 O3' ADP C1001 J 144 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -34.46 19.85 25.71 -36.11 18.63 24.45 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER C 82 SER~? 10.86 N6 ADP C1001 J 140 TYR B 111 TYR.? 10.00 N6 ADP C1001 J 144 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -25.49 36.24 12.26 -26.11 38.47 12.83 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -23.61 33.84 6.26 -20.57 37.69 4.41 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 38 LYS^? 31.29 N6 ADP C1001 A 193 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 217 VAL A 30 VAL^? 33.13 N6 ADP C1001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -6.79 15.32 9.19 -4.05 19.39 6.22 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -8.68 8.21 7.44 -7.83 7.56 9.36 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS A 38 LYS^? 31.29 N6 ADP C1001 A 193 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 217 VAL A 40 VAL^? 28.74 N6 ADP C1001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -6.79 15.32 9.19 -4.05 19.39 6.22 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -12.04 10.51 9.85 -11.74 9.36 11.65 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS A 38 LYS^? 31.29 N6 ADP C1001 A 193 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 217 VAL A 40 VAL^? 28.74 N6 ADP C1001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -6.79 15.32 9.19 -4.05 19.39 6.22 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -12.04 10.51 9.85 -11.74 9.36 11.65 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS A 38 LYS^? 31.29 N6 ADP C1001 A 193 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 217 VAL B 40 VAL.? 23.36 N6 ADP C1001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -6.79 15.32 9.19 -4.05 19.39 6.22 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -13.02 16.51 12.14 -12.89 17.77 10.38 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS B 38 LYS.? 29.47 N6 ADP C1001 A 193 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 217 VAL B 30 VAL^? 19.12 N6 ADP C1001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -9.30 19.94 15.62 -4.67 19.41 15.25 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -15.85 19.10 14.67 -16.13 20.48 12.91 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS B 38 LYS.? 29.47 N6 ADP C1001 A 193 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 217 VAL B 40 VAL.? 23.36 N6 ADP C1001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -9.30 19.94 15.62 -4.67 19.41 15.25 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -13.02 16.51 12.14 -12.89 17.77 10.38 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 159 LYS C 38 LYS^? 29.32 C2 ADP C1001 A 193 GLU C 41 GLU^? 24.05 C2 ADP C1001 A 217 VAL C 30 VAL^? 18.40 C2 ADP C1001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -16.18 28.34 36.63 -11.47 27.59 37.59 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -21.92 31.89 33.13 -23.87 30.87 33.18 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 159 LYS C 38 LYS^? 29.32 C2 ADP C1001 A 193 GLU C 41 GLU^? 24.05 C2 ADP C1001 A 217 VAL C 40 VAL^? 23.42 C2 ADP C1001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -16.18 28.34 36.63 -11.47 27.59 37.59 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -20.93 33.88 37.25 -22.12 32.63 38.71 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 159 LYS D 38 LYS^? 26.03 N6 ADP C1001 A 193 GLU D 41 GLU^? 18.65 N6 ADP C1001 A 217 VAL D 30 VAL^? 26.73 N6 ADP C1001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -10.44 39.35 12.00 -7.01 36.04 14.36 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -12.90 46.59 12.22 -11.32 47.46 11.02 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 159 LYS D 38 LYS^? 26.03 N6 ADP C1001 A 193 GLU D 41 GLU^? 18.65 N6 ADP C1001 A 217 VAL D 40 VAL^? 24.34 N6 ADP C1001 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -10.44 39.35 12.00 -7.01 36.04 14.36 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -14.64 43.98 8.50 -13.88 44.76 6.52 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 10 hits 1et0_c00 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 10 ASP.? 29.48 N1 ADP C1001 260 GLU A 41 GLU^? 26.55 N6 ADP C1001 370 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -23.26 11.23 5.07 -23.26 9.04 3.31 1euu_c00 source 1euu SIALIDASE : 1 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 260 ARG A 2 ARG^? 31.43 N6 ADP C1001 A 270 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 50.99 29.43 12.86 52.11 29.45 14.65 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 39.80 27.50 22.98 42.20 26.56 21.34 -10.05 8.79 1.44 -11.10 11.55 0.50 coo 48.83 21.70 19.50 47.44 24.99 15.25 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU B 78 GLU~? 5.47 O3' ADP C1001 A 260 ARG C 74 ARG~? 5.25 O1B ADP C1001 A 270 LYS C 114 LYS.? -2.76 O3B ADP C1001s coo 50.99 29.43 12.86 52.11 29.45 14.65 -39.37 23.43 20.35 -41.49 23.57 20.23 coo 39.80 27.50 22.98 42.20 26.56 21.34 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 48.83 21.70 19.50 47.44 24.99 15.25 -44.82 31.28 21.50 -43.38 31.47 16.20 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU C 49 GLU.? 21.81 N1 ADP C1001 A 260 ARG D 2 ARG^? 19.52 N6 ADP C1001 A 270 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 50.99 29.43 12.86 52.11 29.45 14.65 -30.22 47.91 25.82 -28.66 49.28 25.41 coo 39.80 27.50 22.98 42.20 26.56 21.34 -16.51 45.11 16.54 -19.16 44.24 15.23 coo 48.83 21.70 19.50 47.44 24.99 15.25 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU C 78 GLU~? 9.17 N6 ADP C1001 A 260 ARG B 74 ARG~? -6.26 O2A ADP C1001s A 270 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 50.99 29.43 12.86 52.11 29.45 14.65 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 39.80 27.50 22.98 42.20 26.56 21.34 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 48.83 21.70 19.50 47.44 24.99 15.25 -38.05 28.30 5.66 -42.50 28.99 10.13 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU D 35 GLU.? 34.89 N6 ADP C1001 A 260 ARG D 2 ARG^? 19.52 N6 ADP C1001 A 270 LYS D 38 LYS^? 26.03 N6 ADP C1001 coo 50.99 29.43 12.86 52.11 29.45 14.65 -1.41 44.17 17.18 -1.59 46.26 17.19 coo 39.80 27.50 22.98 42.20 26.56 21.34 -16.51 45.11 16.54 -19.16 44.24 15.23 coo 48.83 21.70 19.50 47.44 24.99 15.25 -10.44 39.35 12.00 -7.01 36.04 14.36 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 5 hits 1euy_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP A 36 ASP^? 33.81 N6 ADP C1001 A 74 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 98 GLU A 33 GLU^? 35.51 N6 ADP C1001 coo 17.19 9.05 25.28 15.77 9.98 26.53 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 15.99 8.54 17.36 14.96 7.80 19.05 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 16.31 12.85 18.11 16.71 11.79 19.90 -2.83 15.49 5.14 -2.18 15.03 3.15 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 2 3 # 2 A 68 ASP C 36 ASP^? 27.15 C2 ADP C1001 A 74 ASP C 31 ASP^? 21.62 C2 ADP C1001 A 98 GLU C 33 GLU^? 22.62 N1 ADP C1001 coo 17.19 9.05 25.28 15.77 9.98 26.53 -16.89 23.06 36.75 -16.41 21.35 37.85 coo 15.99 8.54 17.36 14.96 7.80 19.05 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 16.31 12.85 18.11 16.71 11.79 19.90 -14.30 26.31 31.75 -13.99 26.91 29.72 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 3 3 # 3 A 68 ASP D 36 ASP^? 31.16 N6 ADP C1001 A 74 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 98 GLU D 33 GLU^? 24.81 N6 ADP C1001 coo 17.19 9.05 25.28 15.77 9.98 26.53 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 15.99 8.54 17.36 14.96 7.80 19.05 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 16.31 12.85 18.11 16.71 11.79 19.90 -9.58 39.62 17.74 -10.11 39.83 19.83 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 3 hits 1eyi_c00 naa= 3 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 1 3 # 1 A 233 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 254 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 301 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 1ez2_c00 PHOSPHOTRIESTERASE user 2 3 # 2 A 233 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 254 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 301 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo 54.85 -0.50 33.94 53.35 -1.92 34.23 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 49.60 -2.04 34.84 49.44 -3.48 33.35 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 45.28 -3.05 33.32 45.60 -4.40 31.72 -16.08 4.88 -5.43 -16.33 3.76 -7.24 1ez2_c00 source 1ez2 PHOSPHOTRIESTERASE : 2 hits 1ez2_c00 naa= 3 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 1 3 # 1 B 233 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 254 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 301 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 1ez2_c01 PHOSPHOTRIESTERASE user 2 3 # 2 B 233 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 254 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 301 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo 56.25 -34.15 2.23 54.65 -32.85 1.82 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 50.90 -32.78 1.00 50.77 -31.41 2.56 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 46.50 -31.79 2.21 46.79 -30.43 3.83 -16.08 4.88 -5.43 -16.33 3.76 -7.24 1ez2_c01 source 1ez2 PHOSPHOTRIESTERASE : 2 hits 1ez2_c01 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 36 ASP^? 33.81 N6 ADP C1001 C 117 GLU A 35 GLU.? 41.16 N6 ADP C1001 C 131 GLU A 33 GLU^? 35.51 N6 ADP C1001 coo 68.01 56.37 72.57 68.42 56.10 70.51 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 66.59 62.50 67.44 67.57 60.64 67.12 4.51 12.95 12.26 5.81 14.21 13.42 coo 69.24 52.27 71.96 69.91 50.26 71.89 -2.83 15.49 5.14 -2.18 15.03 3.15 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP B 9 ASP.? 24.63 N6 ADP C1001 C 117 GLU A 41 GLU^? 26.55 N6 ADP C1001 C 131 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 68.01 56.37 72.57 68.42 56.10 70.51 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 66.59 62.50 67.44 67.57 60.64 67.12 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 69.24 52.27 71.96 69.91 50.26 71.89 -24.54 18.07 0.49 -24.62 18.94 -1.46 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 3 # 3 C 95 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 117 GLU A 44 GLU^? 29.72 N6 ADP C1001 C 131 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 68.01 56.37 72.57 68.42 56.10 70.51 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 66.59 62.50 67.44 67.57 60.64 67.12 -23.95 2.54 6.45 -25.82 1.78 7.26 coo 69.24 52.27 71.96 69.91 50.26 71.89 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 4 3 # 4 C 95 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 117 GLU B 8 GLU.? 21.08 N6 ADP C1001 C 131 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 68.01 56.37 72.57 68.42 56.10 70.51 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 66.59 62.50 67.44 67.57 60.64 67.12 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 69.24 52.27 71.96 69.91 50.26 71.89 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 5 3 # 5 C 95 ASP B 36 ASP^? 26.54 N6 ADP C1001 C 117 GLU B 35 GLU.? 24.64 N6 ADP C1001 C 131 GLU B 33 GLU^? 22.82 N1 ADP C1001 coo 68.01 56.37 72.57 68.42 56.10 70.51 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 66.59 62.50 67.44 67.57 60.64 67.12 -8.42 31.70 14.79 -7.88 32.87 13.09 coo 69.24 52.27 71.96 69.91 50.26 71.89 -10.19 23.43 20.85 -11.43 22.93 22.49 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 6 3 # 6 C 95 ASP B 112 ASP.? 11.36 O1B ADP C1001 C 117 GLU C 78 GLU~? 9.17 N6 ADP C1001 C 131 GLU B 115 GLU.? 12.48 O1B ADP C1001 coo 68.01 56.37 72.57 68.42 56.10 70.51 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 66.59 62.50 67.44 67.57 60.64 67.12 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 69.24 52.27 71.96 69.91 50.26 71.89 -39.49 31.51 1.54 -40.33 32.66 0.02 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 7 3 # 7 C 95 ASP C 9 ASP.? 24.62 C2 ADP C1001 C 117 GLU C 44 GLU^? 27.03 C2 ADP C1001 C 131 GLU C 8 GLU.? 21.29 O3' ADP C1001 coo 68.01 56.37 72.57 68.42 56.10 70.51 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 66.59 62.50 67.44 67.57 60.64 67.12 -28.75 47.24 35.01 -29.12 48.55 36.63 coo 69.24 52.27 71.96 69.91 50.26 71.89 -38.22 39.03 36.55 -39.65 38.08 37.81 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 8 3 # 8 C 95 ASP D 31 ASP^? 21.52 N6 ADP C1001 C 117 GLU D 41 GLU^? 18.65 N6 ADP C1001 C 131 GLU D 33 GLU^? 24.81 N6 ADP C1001 coo 68.01 56.37 72.57 68.42 56.10 70.51 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 66.59 62.50 67.44 67.57 60.64 67.12 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 69.24 52.27 71.96 69.91 50.26 71.89 -9.58 39.62 17.74 -10.11 39.83 19.83 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 8 hits 1f6d_c02 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 21 PHE.? 42.86 N6 ADP C1001 A 210 ASP A 54 ASP~? 42.89 N6 ADP C1001 A 244 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 10.51 37.86 19.71 9.07 39.38 20.04 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo -1.20 42.34 17.67 3.19 45.13 19.06 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 27 PHE^? 37.41 N6 ADP C1001 A 210 ASP A 9 ASP.? 35.63 N1 ADP C1001 A 244 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo -1.20 42.34 17.67 3.19 45.13 19.06 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 27 PHE^? 37.41 N6 ADP C1001 A 210 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 244 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 210 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 244 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 10.51 37.86 19.71 9.07 39.38 20.04 -7.60 12.44 5.41 -8.89 12.13 3.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE A 102 PHE~? 42.29 N6 ADP C1001 A 210 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 244 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -0.48 3.09 8.71 -0.12 3.21 5.93 coo 10.51 37.86 19.71 9.07 39.38 20.04 -7.60 12.44 5.41 -8.89 12.13 3.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE B 21 PHE.? 12.47 N7 ADP C1001 A 210 ASP B 54 ASP~? 20.52 O4' ADP C1001 A 244 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.61 18.24 11.10 -30.96 16.75 13.38 coo 10.51 37.86 19.71 9.07 39.38 20.04 -33.59 8.19 15.94 -35.17 6.84 16.43 coo -1.20 42.34 17.67 3.19 45.13 19.06 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE B 27 PHE^? 16.30 N6 ADP C1001 A 210 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 244 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 10.51 37.86 19.71 9.07 39.38 20.04 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 27 PHE^? 16.30 N6 ADP C1001 A 210 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 244 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 10.51 37.86 19.71 9.07 39.38 20.04 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -1.20 42.34 17.67 3.19 45.13 19.06 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 210 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 244 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 -13.40 19.33 18.81 -14.28 17.40 18.97 coo -1.20 42.34 17.67 3.19 45.13 19.06 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 210 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 244 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -1.20 42.34 17.67 3.19 45.13 19.06 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE B 80 PHE~? 11.23 C2 ADP C1001 A 210 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 244 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.32 19.21 18.41 -30.35 17.46 16.44 coo 10.51 37.86 19.71 9.07 39.38 20.04 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -1.20 42.34 17.67 3.19 45.13 19.06 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE C 21 PHE.? 11.41 C2 ADP C1001 A 210 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 244 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 210 ASP C 9 ASP.? 24.62 C2 ADP C1001 A 244 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 -34.52 40.90 40.15 -34.60 38.85 40.85 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 112 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 210 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 244 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -1.20 42.34 17.67 3.19 45.13 19.06 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 112 PHE D 21 PHE.? 33.63 N6 ADP C1001 A 210 ASP D 54 ASP~? 30.93 N6 ADP C1001 A 244 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.33 59.98 17.64 -30.29 60.47 18.21 coo -1.20 42.34 17.67 3.19 45.13 19.06 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 112 PHE D 27 PHE^? 29.27 N6 ADP C1001 A 210 ASP D 9 ASP.? 34.87 N6 ADP C1001 A 244 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -19.87 54.80 11.53 -19.94 57.47 12.38 coo 10.51 37.86 19.71 9.07 39.38 20.04 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo -1.20 42.34 17.67 3.19 45.13 19.06 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 112 PHE D 27 PHE^? 29.27 N6 ADP C1001 A 210 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 244 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -19.87 54.80 11.53 -19.94 57.47 12.38 coo 10.51 37.86 19.71 9.07 39.38 20.04 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -1.20 42.34 17.67 3.19 45.13 19.06 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 A 112 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 210 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 244 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 9.23 46.77 25.11 11.48 48.39 24.76 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 10.51 37.86 19.71 9.07 39.38 20.04 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -1.20 42.34 17.67 3.19 45.13 19.06 -21.36 39.39 22.00 -17.64 41.95 19.02 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 18 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 21 PHE.? 42.86 N6 ADP C1001 B 210 ASP A 54 ASP~? 42.89 N6 ADP C1001 B 244 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 9.06 56.85 40.30 7.71 55.27 39.90 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo -2.38 51.82 41.62 2.07 49.19 40.42 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 27 PHE^? 37.41 N6 ADP C1001 B 210 ASP A 9 ASP.? 35.63 N1 ADP C1001 B 244 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo -2.38 51.82 41.62 2.07 49.19 40.42 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 27 PHE^? 37.41 N6 ADP C1001 B 210 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 244 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 29 PHE^? 33.27 N6 ADP C1001 B 210 ASP A 31 ASP^? 31.30 N6 ADP C1001 B 244 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 9.06 56.85 40.30 7.71 55.27 39.90 -7.60 12.44 5.41 -8.89 12.13 3.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE A 102 PHE~? 42.29 N6 ADP C1001 B 210 ASP A 31 ASP^? 31.30 N6 ADP C1001 B 244 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -0.48 3.09 8.71 -0.12 3.21 5.93 coo 9.06 56.85 40.30 7.71 55.27 39.90 -7.60 12.44 5.41 -8.89 12.13 3.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE B 21 PHE.? 12.47 N7 ADP C1001 B 210 ASP B 54 ASP~? 20.52 O4' ADP C1001 B 244 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.61 18.24 11.10 -30.96 16.75 13.38 coo 9.06 56.85 40.30 7.71 55.27 39.90 -33.59 8.19 15.94 -35.17 6.84 16.43 coo -2.38 51.82 41.62 2.07 49.19 40.42 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE B 27 PHE^? 16.30 N6 ADP C1001 B 210 ASP B 9 ASP.? 24.63 N6 ADP C1001 B 244 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 9.06 56.85 40.30 7.71 55.27 39.90 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 27 PHE^? 16.30 N6 ADP C1001 B 210 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 244 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 9.06 56.85 40.30 7.71 55.27 39.90 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -2.38 51.82 41.62 2.07 49.19 40.42 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE B 29 PHE^? 19.13 N6 ADP C1001 B 210 ASP B 31 ASP^? 22.05 N1 ADP C1001 B 244 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.40 19.33 18.81 -14.28 17.40 18.97 coo -2.38 51.82 41.62 2.07 49.19 40.42 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE B 29 PHE^? 19.13 N6 ADP C1001 B 210 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 244 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -2.38 51.82 41.62 2.07 49.19 40.42 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE C 21 PHE.? 11.41 C2 ADP C1001 B 210 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 244 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE C 27 PHE^? 15.44 C2 ADP C1001 B 210 ASP C 9 ASP.? 24.62 C2 ADP C1001 B 244 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 -34.52 40.90 40.15 -34.60 38.85 40.85 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE C 27 PHE^? 15.44 C2 ADP C1001 B 210 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 244 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -2.38 51.82 41.62 2.07 49.19 40.42 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 112 PHE D 21 PHE.? 33.63 N6 ADP C1001 B 210 ASP D 54 ASP~? 30.93 N6 ADP C1001 B 244 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 -28.33 59.98 17.64 -30.29 60.47 18.21 coo -2.38 51.82 41.62 2.07 49.19 40.42 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 112 PHE D 27 PHE^? 29.27 N6 ADP C1001 B 210 ASP D 9 ASP.? 34.87 N6 ADP C1001 B 244 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -19.87 54.80 11.53 -19.94 57.47 12.38 coo 9.06 56.85 40.30 7.71 55.27 39.90 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 112 PHE D 27 PHE^? 29.27 N6 ADP C1001 B 210 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 244 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -19.87 54.80 11.53 -19.94 57.47 12.38 coo 9.06 56.85 40.30 7.71 55.27 39.90 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -2.38 51.82 41.62 2.07 49.19 40.42 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 B 112 PHE D 29 PHE^? 23.81 N6 ADP C1001 B 210 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 244 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 8.76 47.85 34.91 11.08 46.36 35.41 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 9.06 56.85 40.30 7.71 55.27 39.90 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -2.38 51.82 41.62 2.07 49.19 40.42 -21.36 39.39 22.00 -17.64 41.95 19.02 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 17 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 210 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 244 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 11.28 44.53 18.60 9.91 46.00 19.20 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 10.51 37.86 19.71 9.07 39.38 20.04 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 210 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 244 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 11.28 44.53 18.60 9.91 46.00 19.20 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 10.51 37.86 19.71 9.07 39.38 20.04 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -1.20 42.34 17.67 3.19 45.13 19.06 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 210 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 244 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 11.28 44.53 18.60 9.91 46.00 19.20 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 10.51 37.86 19.71 9.07 39.38 20.04 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -1.20 42.34 17.67 3.19 45.13 19.06 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 210 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 244 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 11.28 44.53 18.60 9.91 46.00 19.20 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 10.51 37.86 19.71 9.07 39.38 20.04 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -1.20 42.34 17.67 3.19 45.13 19.06 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 136 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 210 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 244 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 11.28 44.53 18.60 9.91 46.00 19.20 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 136 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 210 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 244 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 11.28 44.53 18.60 9.91 46.00 19.20 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -1.20 42.34 17.67 3.19 45.13 19.06 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 136 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 210 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 244 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 11.28 44.53 18.60 9.91 46.00 19.20 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -1.20 42.34 17.67 3.19 45.13 19.06 -14.21 50.71 21.89 -14.80 46.21 24.73 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 7 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 210 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 244 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 10.08 50.18 41.78 8.91 48.61 41.04 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 9.06 56.85 40.30 7.71 55.27 39.90 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 210 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 244 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 10.08 50.18 41.78 8.91 48.61 41.04 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 9.06 56.85 40.30 7.71 55.27 39.90 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -2.38 51.82 41.62 2.07 49.19 40.42 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 210 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 244 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 10.08 50.18 41.78 8.91 48.61 41.04 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 9.06 56.85 40.30 7.71 55.27 39.90 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -2.38 51.82 41.62 2.07 49.19 40.42 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS C 62 HIS~? 21.13 N1 ADP C1001 B 210 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 244 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 10.08 50.18 41.78 8.91 48.61 41.04 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 9.06 56.85 40.30 7.71 55.27 39.90 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -2.38 51.82 41.62 2.07 49.19 40.42 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 210 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 244 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 10.08 50.18 41.78 8.91 48.61 41.04 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 210 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 244 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 10.08 50.18 41.78 8.91 48.61 41.04 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -2.38 51.82 41.62 2.07 49.19 40.42 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 136 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 210 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 244 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 10.08 50.18 41.78 8.91 48.61 41.04 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -2.38 51.82 41.62 2.07 49.19 40.42 -14.21 50.71 21.89 -14.80 46.21 24.73 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 7 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 70 TYR.? 48.30 N6 ADP C1001 A 142 LEU A 68 LEU^? 41.88 N6 ADP C1001 A 165 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -5.16 -1.18 7.49 -3.42 0.19 7.46 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 142 LEU B 68 LEU^? 9.99 N6 ADP C1001 A 165 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -30.56 25.72 4.57 -31.82 27.56 2.83 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -24.17 24.82 12.03 -22.94 26.13 13.15 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR B 92 TYR.? 14.20 N6 ADP C1001 A 142 LEU B 68 LEU^? 9.99 N6 ADP C1001 A 165 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -24.17 24.82 12.03 -22.94 26.13 13.15 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR C 70 TYR.? 10.33 O3' ADP C1001 A 142 LEU C 68 LEU^? 10.60 C2 ADP C1001 A 165 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -40.11 31.99 28.67 -42.64 30.90 28.52 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -30.63 29.87 28.30 -29.34 28.10 28.18 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR D 70 TYR.? 43.17 N6 ADP C1001 A 142 LEU D 68 LEU^? 34.10 N6 ADP C1001 A 165 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -10.19 64.81 9.49 -8.66 67.08 8.77 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -10.17 55.90 13.54 -8.92 54.46 14.54 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR D 92 TYR.? 44.20 N6 ADP C1001 A 142 LEU D 68 LEU^? 34.10 N6 ADP C1001 A 165 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -10.17 55.90 13.54 -8.92 54.46 14.54 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -0.82 59.67 9.89 3.99 59.45 8.43 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 70 TYR.? 48.30 N6 ADP C1001 B 142 LEU A 68 LEU^? 41.88 N6 ADP C1001 B 165 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -5.16 -1.18 7.49 -3.42 0.19 7.46 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR B 70 TYR.? 11.71 N6 ADP C1001 B 142 LEU B 68 LEU^? 9.99 N6 ADP C1001 B 165 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -30.56 25.72 4.57 -31.82 27.56 2.83 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -24.17 24.82 12.03 -22.94 26.13 13.15 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR C 70 TYR.? 10.33 O3' ADP C1001 B 142 LEU C 68 LEU^? 10.60 C2 ADP C1001 B 165 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -40.11 31.99 28.67 -42.64 30.90 28.52 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -30.63 29.87 28.30 -29.34 28.10 28.18 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR D 70 TYR.? 43.17 N6 ADP C1001 B 142 LEU D 68 LEU^? 34.10 N6 ADP C1001 B 165 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -10.19 64.81 9.49 -8.66 67.08 8.77 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -10.17 55.90 13.54 -8.92 54.46 14.54 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -14.01 64.85 7.32 -9.19 66.73 4.57 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 70 TYR.? 48.30 N6 ADP C1001 C 142 LEU A 68 LEU^? 41.88 N6 ADP C1001 C 165 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -5.16 -1.18 7.49 -3.42 0.19 7.46 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR B 70 TYR.? 11.71 N6 ADP C1001 C 142 LEU B 68 LEU^? 9.99 N6 ADP C1001 C 165 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -30.56 25.72 4.57 -31.82 27.56 2.83 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -24.17 24.82 12.03 -22.94 26.13 13.15 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR C 70 TYR.? 10.33 O3' ADP C1001 C 142 LEU C 68 LEU^? 10.60 C2 ADP C1001 C 165 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -40.11 31.99 28.67 -42.64 30.90 28.52 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -30.63 29.87 28.30 -29.34 28.10 28.18 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR D 70 TYR.? 43.17 N6 ADP C1001 C 142 LEU D 68 LEU^? 34.10 N6 ADP C1001 C 165 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -10.19 64.81 9.49 -8.66 67.08 8.77 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -10.17 55.90 13.54 -8.92 54.46 14.54 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -14.01 64.85 7.32 -9.19 66.73 4.57 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 70 TYR.? 48.30 N6 ADP C1001 D 142 LEU A 68 LEU^? 41.88 N6 ADP C1001 D 165 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -5.16 -1.18 7.49 -3.42 0.19 7.46 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR B 70 TYR.? 11.71 N6 ADP C1001 D 142 LEU B 68 LEU^? 9.99 N6 ADP C1001 D 165 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -30.56 25.72 4.57 -31.82 27.56 2.83 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -24.17 24.82 12.03 -22.94 26.13 13.15 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR C 70 TYR.? 10.33 O3' ADP C1001 D 142 LEU C 68 LEU^? 10.60 C2 ADP C1001 D 165 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -40.11 31.99 28.67 -42.64 30.90 28.52 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -30.63 29.87 28.30 -29.34 28.10 28.18 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR D 70 TYR.? 43.17 N6 ADP C1001 D 142 LEU D 68 LEU^? 34.10 N6 ADP C1001 D 165 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -10.19 64.81 9.49 -8.66 67.08 8.77 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -10.17 55.90 13.54 -8.92 54.46 14.54 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -14.01 64.85 7.32 -9.19 66.73 4.57 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c03 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 281 ARG A 94 ARG~? 34.60 N1 ADP C1001 A 289 TYR A 92 TYR.? 47.39 N1 ADP C1001 coo 54.86 40.00 47.23 55.57 38.60 48.67 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 52.08 40.18 50.14 50.83 38.93 47.73 -9.32 1.83 20.70 -11.98 2.20 22.31 coo 57.82 31.70 50.73 57.94 34.00 49.17 -4.46 -7.57 15.71 -2.05 -7.82 17.04 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP B 97 ASP~? 21.13 N6 ADP C1001 A 281 ARG B 94 ARG~? 24.19 N6 ADP C1001 A 289 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 54.86 40.00 47.23 55.57 38.60 48.67 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 52.08 40.18 50.14 50.83 38.93 47.73 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo 57.82 31.70 50.73 57.94 34.00 49.17 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 3 3 # 3 A 54 ASP D 97 ASP~? 39.15 N6 ADP C1001 A 281 ARG D 94 ARG~? 36.27 N6 ADP C1001 A 289 TYR D 92 TYR.? 44.20 N6 ADP C1001 coo 54.86 40.00 47.23 55.57 38.60 48.67 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 52.08 40.18 50.14 50.83 38.93 47.73 -8.09 53.40 -0.40 -7.97 50.74 -1.98 coo 57.82 31.70 50.73 57.94 34.00 49.17 -5.36 62.57 6.57 -2.60 62.73 6.26 1foh_c00 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 97 ASP~? 39.49 N1 ADP C1001 B 281 ARG A 94 ARG~? 34.60 N1 ADP C1001 B 289 TYR A 92 TYR.? 47.39 N1 ADP C1001 coo 90.56 80.24 98.04 90.36 81.53 96.34 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 86.62 80.67 97.51 87.37 82.00 100.10 -9.32 1.83 20.70 -11.98 2.20 22.31 coo 91.83 88.28 92.88 92.60 85.93 94.14 -4.46 -7.57 15.71 -2.05 -7.82 17.04 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP B 97 ASP~? 21.13 N6 ADP C1001 B 281 ARG B 94 ARG~? 24.19 N6 ADP C1001 B 289 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 90.56 80.24 98.04 90.36 81.53 96.34 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 86.62 80.67 97.51 87.37 82.00 100.10 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo 91.83 88.28 92.88 92.60 85.93 94.14 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 3 3 # 3 B 54 ASP D 97 ASP~? 39.15 N6 ADP C1001 B 281 ARG D 94 ARG~? 36.27 N6 ADP C1001 B 289 TYR D 92 TYR.? 44.20 N6 ADP C1001 coo 90.56 80.24 98.04 90.36 81.53 96.34 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 86.62 80.67 97.51 87.37 82.00 100.10 -8.09 53.40 -0.40 -7.97 50.74 -1.98 coo 91.83 88.28 92.88 92.60 85.93 94.14 -5.36 62.57 6.57 -2.60 62.73 6.26 1foh_c01 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 97 ASP~? 39.49 N1 ADP C1001 C 281 ARG A 94 ARG~? 34.60 N1 ADP C1001 C 289 TYR A 92 TYR.? 47.39 N1 ADP C1001 coo 42.34 76.83 49.10 43.06 78.59 50.01 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 46.12 77.15 48.13 44.44 77.61 45.70 -9.32 1.83 20.70 -11.98 2.20 22.31 coo 42.69 86.18 51.69 41.59 83.63 51.54 -4.46 -7.57 15.71 -2.05 -7.82 17.04 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP B 97 ASP~? 21.13 N6 ADP C1001 C 281 ARG B 94 ARG~? 24.19 N6 ADP C1001 C 289 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 42.34 76.83 49.10 43.06 78.59 50.01 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 46.12 77.15 48.13 44.44 77.61 45.70 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo 42.69 86.18 51.69 41.59 83.63 51.54 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 3 3 # 3 C 54 ASP D 97 ASP~? 39.15 N6 ADP C1001 C 281 ARG D 94 ARG~? 36.27 N6 ADP C1001 C 289 TYR D 92 TYR.? 44.20 N6 ADP C1001 coo 42.34 76.83 49.10 43.06 78.59 50.01 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 46.12 77.15 48.13 44.44 77.61 45.70 -8.09 53.40 -0.40 -7.97 50.74 -1.98 coo 42.69 86.18 51.69 41.59 83.63 51.54 -5.36 62.57 6.57 -2.60 62.73 6.26 1foh_c02 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 97 ASP~? 39.49 N1 ADP C1001 D 281 ARG A 94 ARG~? 34.60 N1 ADP C1001 D 289 TYR A 92 TYR.? 47.39 N1 ADP C1001 coo 75.05 45.80 106.18 74.73 43.88 105.51 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 78.52 44.93 104.78 78.72 44.49 107.76 -9.32 1.83 20.70 -11.98 2.20 22.31 coo 72.35 36.51 104.82 72.00 39.20 105.46 -4.46 -7.57 15.71 -2.05 -7.82 17.04 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP B 97 ASP~? 21.13 N6 ADP C1001 D 281 ARG B 94 ARG~? 24.19 N6 ADP C1001 D 289 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 75.05 45.80 106.18 74.73 43.88 105.51 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 78.52 44.93 104.78 78.72 44.49 107.76 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo 72.35 36.51 104.82 72.00 39.20 105.46 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 3 3 # 3 D 54 ASP D 97 ASP~? 39.15 N6 ADP C1001 D 281 ARG D 94 ARG~? 36.27 N6 ADP C1001 D 289 TYR D 92 TYR.? 44.20 N6 ADP C1001 coo 75.05 45.80 106.18 74.73 43.88 105.51 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 78.52 44.93 104.78 78.72 44.49 107.76 -8.09 53.40 -0.40 -7.97 50.74 -1.98 coo 72.35 36.51 104.82 72.00 39.20 105.46 -5.36 62.57 6.57 -2.60 62.73 6.26 1foh_c03 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c03 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 44 GLU^? 29.72 N6 ADP C1001 B 319 ASP A 10 ASP.? 29.48 N1 ADP C1001 B 359 ARG A 11 ARG~? 32.97 N1 ADP C1001 coo 10.77 13.13 40.94 11.03 14.73 39.51 -23.95 2.54 6.45 -25.82 1.78 7.26 coo 3.77 12.64 38.21 3.35 14.53 37.39 -21.48 2.08 13.35 -22.87 1.76 14.94 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -18.24 1.32 19.87 -15.89 1.49 21.96 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU B 44 GLU^? 27.54 N6 ADP C1001 B 319 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 359 ARG B 11 ARG~? 27.94 N6 ADP C1001 coo 10.77 13.13 40.94 11.03 14.73 39.51 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 3.77 12.64 38.21 3.35 14.53 37.39 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -18.01 15.98 -2.43 -14.90 16.29 -2.31 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU D 44 GLU^? 25.61 N6 ADP C1001 B 319 ASP D 10 ASP.? 31.49 N6 ADP C1001 B 359 ARG D 11 ARG~? 37.61 N6 ADP C1001 coo 10.77 13.13 40.94 11.03 14.73 39.51 -26.92 53.16 5.77 -28.08 52.58 4.08 coo 3.77 12.64 38.21 3.35 14.53 37.39 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -15.91 54.83 -3.29 -13.93 57.19 -3.15 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 3 hits 1fr8_c01 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 331 GLU A 41 GLU^? 26.55 N6 ADP C1001 B 188 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 130.22 155.23 83.49 125.21 153.71 84.04 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 120.90 152.23 75.28 120.94 153.09 77.19 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 122.04 152.80 81.06 120.71 154.37 81.46 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 331 GLU C 41 GLU^? 24.05 C2 ADP C1001 B 188 HIS C 62 HIS~? 21.13 N1 ADP C1001 coo 130.22 155.23 83.49 125.21 153.71 84.04 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 120.90 152.23 75.28 120.94 153.09 77.19 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 122.04 152.80 81.06 120.71 154.37 81.46 -20.79 41.45 28.58 -20.89 43.35 29.47 ULMN 3 1fuq_c00 FUMARASE C user 3 3 # 3 A 324 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 331 GLU D 41 GLU^? 18.65 N6 ADP C1001 B 188 HIS D 62 HIS.? 20.37 N6 ADP C1001 coo 130.22 155.23 83.49 125.21 153.71 84.04 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 120.90 152.23 75.28 120.94 153.09 77.19 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 122.04 152.80 81.06 120.71 154.37 81.46 -23.21 48.47 15.79 -25.03 48.41 14.73 1fuq_c00 source 1fuq FUMARASE C : 3 hits 1fuq_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP B 113 TRP.? 6.23 N7 ADP C1001 A 317 GLU C 78 GLU~? 9.17 N6 ADP C1001 A 365 ARG B 74 ARG~? -6.26 O2A ADP C1001s coo 79.91 26.87 38.77 78.95 23.18 37.81 -33.53 30.14 7.96 -35.79 27.09 9.08 coo 85.55 26.30 41.25 85.59 24.97 39.65 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 83.47 25.30 27.10 83.44 27.82 25.29 -43.21 24.74 16.58 -45.29 23.99 18.72 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP C 113 TRP.? -4.31 O3' ADP C1001s A 317 GLU B 78 GLU~? 5.47 O3' ADP C1001 A 365 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 79.91 26.87 38.77 78.95 23.18 37.81 -41.02 28.74 23.55 -40.73 32.19 21.60 coo 85.55 26.30 41.25 85.59 24.97 39.65 -39.37 23.43 20.35 -41.49 23.57 20.23 coo 83.47 25.30 27.10 83.44 27.82 25.29 -39.58 36.65 12.40 -39.71 35.25 9.68 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 2 hits 1g8o_c01 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 47 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 161 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 37.12 18.35 73.76 37.09 16.69 72.44 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 29.81 8.06 73.13 30.21 10.11 72.95 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 37.29 15.56 67.90 37.37 13.79 70.08 -23.26 11.23 5.07 -23.26 9.04 3.31 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 41 GLU^? 26.55 N6 ADP C1001 B 47 ASP A 10 ASP.? 29.48 N1 ADP C1001 B 161 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 53.87 35.49 53.22 55.44 35.72 54.61 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 63.47 43.65 53.95 61.45 43.07 54.06 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 56.38 35.81 59.19 58.25 35.77 57.10 -23.26 11.23 5.07 -23.26 9.04 3.31 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 64 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 155 ASN A 39 ASN^? 26.27 N6 ADP C1001 coo 3.12 38.70 24.20 3.24 38.59 26.33 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 1.90 38.00 29.77 3.91 38.35 29.95 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 9.89 36.55 37.38 9.27 37.99 36.08 -10.50 14.02 7.34 -12.57 14.30 7.00 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 64 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 155 ASN A 57 ASN~? 43.07 N6 ADP C1001 coo 3.12 38.70 24.20 3.24 38.59 26.33 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 1.90 38.00 29.77 3.91 38.35 29.95 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 9.89 36.55 37.38 9.27 37.99 36.08 -15.73 -0.75 -7.31 -14.92 -1.39 -9.21 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 64 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 155 ASN B 39 ASN.? 27.14 N6 ADP C1001 coo 3.12 38.70 24.20 3.24 38.59 26.33 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 1.90 38.00 29.77 3.91 38.35 29.95 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 9.89 36.55 37.38 9.27 37.99 36.08 -11.13 15.65 16.64 -9.36 15.49 17.83 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 64 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 155 ASN C 39 ASN^? 25.44 C2 ADP C1001 coo 3.12 38.70 24.20 3.24 38.59 26.33 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 1.90 38.00 29.77 3.91 38.35 29.95 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 9.89 36.55 37.38 9.27 37.99 36.08 -16.77 32.66 36.54 -17.11 34.71 36.97 1gns_c00 source 1gns SUBTILISIN BPN' : 4 hits 1gns_c00 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN C 57 ASN~? 16.68 N6 ADP C1001 A 108 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 144 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 51.28 61.14 17.85 51.16 61.61 19.96 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 52.62 57.63 23.12 50.77 57.51 22.26 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 46.65 56.95 20.09 48.42 58.17 20.01 -29.26 47.42 21.46 -29.58 49.13 20.24 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN C 57 ASN~? 16.68 N6 ADP C1001 A 108 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 144 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 51.28 61.14 17.85 51.16 61.61 19.96 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 52.62 57.63 23.12 50.77 57.51 22.26 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 46.65 56.95 20.09 48.42 58.17 20.01 -25.68 50.03 20.54 -26.38 51.13 22.17 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 2 hits 1grc_c02 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN C 57 ASN~? 16.68 N6 ADP C1001 B 108 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 144 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 36.64 101.02 13.15 38.55 101.84 12.78 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 41.00 107.18 12.86 42.70 107.82 11.96 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 31.60 110.69 6.14 29.69 109.74 5.94 -13.15 42.40 14.58 -15.11 42.76 15.19 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 1 hits 1grc_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 19 LYS.? 46.12 N1 ADP C1001 210 ARG A 75 ARG~? 52.31 N6 ADP C1001 225 ARG A 74 ARG~? 58.75 N6 ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 24.74 11.56 73.05 25.29 14.32 71.80 -9.93 -13.21 -7.89 -9.68 -10.57 -9.55 coo 27.81 15.44 77.10 25.66 16.50 75.19 -4.24 -15.34 -4.72 -4.23 -18.33 -3.84 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 60 LYS~? 43.57 N6 ADP C1001 210 ARG A 74 ARG~? 58.75 N6 ADP C1001 225 ARG A 75 ARG~? 52.31 N6 ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 24.74 11.56 73.05 25.29 14.32 71.80 -4.24 -15.34 -4.72 -4.23 -18.33 -3.84 coo 27.81 15.44 77.10 25.66 16.50 75.19 -9.93 -13.21 -7.89 -9.68 -10.57 -9.55 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS B 19 LYS.? 15.59 N6 ADP C1001 210 ARG B 74 ARG~? -6.26 O2A ADP C1001s 225 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 24.74 11.56 73.05 25.29 14.32 71.80 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 27.81 15.44 77.10 25.66 16.50 75.19 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS B 19 LYS.? 15.59 N6 ADP C1001 210 ARG B 75 ARG~? 7.41 O2A ADP C1001 225 ARG B 74 ARG~? -6.26 O2A ADP C1001s coo 17.51 28.50 73.42 17.24 23.02 75.86 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 24.74 11.56 73.05 25.29 14.32 71.80 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 27.81 15.44 77.10 25.66 16.50 75.19 -43.21 24.74 16.58 -45.29 23.99 18.72 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS B 108 LYS.? 17.61 N6 ADP C1001 210 ARG C 74 ARG~? 5.25 O1B ADP C1001 225 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 24.74 11.56 73.05 25.29 14.32 71.80 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 27.81 15.44 77.10 25.66 16.50 75.19 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 6 3 # 6 160 LYS B 108 LYS.? 17.61 N6 ADP C1001 210 ARG C 75 ARG~? 8.05 O3B ADP C1001 225 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 24.74 11.56 73.05 25.29 14.32 71.80 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 27.81 15.44 77.10 25.66 16.50 75.19 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 7 3 # 7 160 LYS B 116 LYS.? 13.79 O2B ADP C1001 210 ARG B 74 ARG~? -6.26 O2A ADP C1001s 225 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 24.74 11.56 73.05 25.29 14.32 71.80 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 27.81 15.44 77.10 25.66 16.50 75.19 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 8 3 # 8 160 LYS B 116 LYS.? 13.79 O2B ADP C1001 210 ARG B 75 ARG~? 7.41 O2A ADP C1001 225 ARG B 74 ARG~? -6.26 O2A ADP C1001s coo 17.51 28.50 73.42 17.24 23.02 75.86 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 24.74 11.56 73.05 25.29 14.32 71.80 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 27.81 15.44 77.10 25.66 16.50 75.19 -43.21 24.74 16.58 -45.29 23.99 18.72 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 9 3 # 9 160 LYS C 19 LYS.? 18.77 O3' ADP C1001 210 ARG C 74 ARG~? 5.25 O1B ADP C1001 225 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 24.74 11.56 73.05 25.29 14.32 71.80 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 27.81 15.44 77.10 25.66 16.50 75.19 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 10 3 # 10 160 LYS C 106 LYS.? 22.18 C2 ADP C1001 210 ARG B 74 ARG~? -6.26 O2A ADP C1001s 225 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 24.74 11.56 73.05 25.29 14.32 71.80 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 27.81 15.44 77.10 25.66 16.50 75.19 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 11 3 # 11 160 LYS C 106 LYS.? 22.18 C2 ADP C1001 210 ARG B 75 ARG~? 7.41 O2A ADP C1001 225 ARG B 74 ARG~? -6.26 O2A ADP C1001s coo 17.51 28.50 73.42 17.24 23.02 75.86 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 24.74 11.56 73.05 25.29 14.32 71.80 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 27.81 15.44 77.10 25.66 16.50 75.19 -43.21 24.74 16.58 -45.29 23.99 18.72 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 12 3 # 12 160 LYS C 116 LYS.? 13.74 O3' ADP C1001 210 ARG C 74 ARG~? 5.25 O1B ADP C1001 225 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 24.74 11.56 73.05 25.29 14.32 71.80 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 27.81 15.44 77.10 25.66 16.50 75.19 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 13 3 # 13 160 LYS C 116 LYS.? 13.74 O3' ADP C1001 210 ARG C 75 ARG~? 8.05 O3B ADP C1001 225 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 24.74 11.56 73.05 25.29 14.32 71.80 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 27.81 15.44 77.10 25.66 16.50 75.19 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 14 3 # 14 160 LYS D 19 LYS.? 44.78 N6 ADP C1001 210 ARG D 75 ARG~? 42.87 N1 ADP C1001 225 ARG D 74 ARG~? 47.97 N6 ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -14.01 64.85 7.32 -9.19 66.73 4.57 coo 24.74 11.56 73.05 25.29 14.32 71.80 -22.47 67.51 24.43 -22.92 70.53 24.84 coo 27.81 15.44 77.10 25.66 16.50 75.19 -14.99 70.93 23.88 -12.45 72.65 23.28 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 15 3 # 15 160 LYS D 60 LYS~? 25.96 N1 ADP C1001 210 ARG D 74 ARG~? 47.97 N6 ADP C1001 225 ARG D 75 ARG~? 42.87 N1 ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 24.74 11.56 73.05 25.29 14.32 71.80 -14.99 70.93 23.88 -12.45 72.65 23.28 coo 27.81 15.44 77.10 25.66 16.50 75.19 -22.47 67.51 24.43 -22.92 70.53 24.84 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 16 3 # 16 160 LYS D 65 LYS.? 25.59 N1 ADP C1001 210 ARG D 74 ARG~? 47.97 N6 ADP C1001 225 ARG D 75 ARG~? 42.87 N1 ADP C1001 coo 17.51 28.50 73.42 17.24 23.02 75.86 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 24.74 11.56 73.05 25.29 14.32 71.80 -14.99 70.93 23.88 -12.45 72.65 23.28 coo 27.81 15.44 77.10 25.66 16.50 75.19 -22.47 67.51 24.43 -22.92 70.53 24.84 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 16 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 21 PHE.? 42.86 N6 ADP C1001 A 298 ASP A 54 ASP~? 42.89 N6 ADP C1001 A 329 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 2.59 0.29 25.55 4.65 0.18 25.07 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 12.42 6.10 23.27 9.95 1.57 20.16 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 298 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 329 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 2.59 0.29 25.55 4.65 0.18 25.07 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 12.42 6.10 23.27 9.95 1.57 20.16 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 298 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 329 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 2.59 0.29 25.55 4.65 0.18 25.07 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 12.42 6.10 23.27 9.95 1.57 20.16 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 298 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 329 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 2.59 0.29 25.55 4.65 0.18 25.07 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 12.42 6.10 23.27 9.95 1.57 20.16 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE C 21 PHE.? 11.41 C2 ADP C1001 A 298 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 2.59 0.29 25.55 4.65 0.18 25.07 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 12.42 6.10 23.27 9.95 1.57 20.16 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 298 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 329 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 2.59 0.29 25.55 4.65 0.18 25.07 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 12.42 6.10 23.27 9.95 1.57 20.16 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE C 58 PHE~? 19.35 C2 ADP C1001 A 298 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 329 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 2.59 0.29 25.55 4.65 0.18 25.07 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 12.42 6.10 23.27 9.95 1.57 20.16 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE D 21 PHE.? 33.63 N6 ADP C1001 A 298 ASP D 54 ASP~? 30.93 N6 ADP C1001 A 329 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 2.59 0.29 25.55 4.65 0.18 25.07 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 12.42 6.10 23.27 9.95 1.57 20.16 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 298 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 329 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 12.42 6.10 23.27 9.95 1.57 20.16 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 A 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 298 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 12.42 6.10 23.27 9.95 1.57 20.16 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 A 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 298 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 12.42 6.10 23.27 9.95 1.57 20.16 -21.36 39.39 22.00 -17.64 41.95 19.02 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 11 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 21 PHE.? 42.86 N6 ADP C1001 B 298 ASP A 54 ASP~? 42.89 N6 ADP C1001 B 329 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 29 PHE^? 33.27 N6 ADP C1001 B 298 ASP A 31 ASP^? 31.30 N6 ADP C1001 B 329 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 29 PHE^? 33.27 N6 ADP C1001 B 298 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 329 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE B 29 PHE^? 19.13 N6 ADP C1001 B 298 ASP B 31 ASP^? 22.05 N1 ADP C1001 B 329 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE C 21 PHE.? 11.41 C2 ADP C1001 B 298 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE C 27 PHE^? 15.44 C2 ADP C1001 B 298 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 329 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE C 58 PHE~? 19.35 C2 ADP C1001 B 298 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 329 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE D 21 PHE.? 33.63 N6 ADP C1001 B 298 ASP D 54 ASP~? 30.93 N6 ADP C1001 B 329 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 B 298 ASP D 31 ASP^? 21.52 N6 ADP C1001 B 329 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 B 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 B 298 ASP D 31 ASP^? 21.52 N6 ADP C1001 B 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 B 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 B 298 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -21.36 39.39 22.00 -17.64 41.95 19.02 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 11 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 21 PHE.? 42.86 N6 ADP C1001 C 298 ASP A 54 ASP~? 42.89 N6 ADP C1001 C 329 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 24.10 66.43 63.33 24.18 64.30 63.40 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 27.64 56.61 58.17 22.18 57.92 60.36 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 29 PHE^? 33.27 N6 ADP C1001 C 298 ASP A 31 ASP^? 31.30 N6 ADP C1001 C 329 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 24.10 66.43 63.33 24.18 64.30 63.40 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 27.64 56.61 58.17 22.18 57.92 60.36 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 29 PHE^? 33.27 N6 ADP C1001 C 298 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 329 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 24.10 66.43 63.33 24.18 64.30 63.40 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 27.64 56.61 58.17 22.18 57.92 60.36 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE B 29 PHE^? 19.13 N6 ADP C1001 C 298 ASP B 31 ASP^? 22.05 N1 ADP C1001 C 329 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 24.10 66.43 63.33 24.18 64.30 63.40 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 27.64 56.61 58.17 22.18 57.92 60.36 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE C 21 PHE.? 11.41 C2 ADP C1001 C 298 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 24.10 66.43 63.33 24.18 64.30 63.40 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 27.64 56.61 58.17 22.18 57.92 60.36 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE C 27 PHE^? 15.44 C2 ADP C1001 C 298 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 329 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 24.10 66.43 63.33 24.18 64.30 63.40 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 27.64 56.61 58.17 22.18 57.92 60.36 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE C 58 PHE~? 19.35 C2 ADP C1001 C 298 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 329 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 24.10 66.43 63.33 24.18 64.30 63.40 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 27.64 56.61 58.17 22.18 57.92 60.36 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE D 21 PHE.? 33.63 N6 ADP C1001 C 298 ASP D 54 ASP~? 30.93 N6 ADP C1001 C 329 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 24.10 66.43 63.33 24.18 64.30 63.40 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 27.64 56.61 58.17 22.18 57.92 60.36 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 C 298 ASP D 31 ASP^? 21.52 N6 ADP C1001 C 329 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 27.64 56.61 58.17 22.18 57.92 60.36 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 C 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 C 298 ASP D 31 ASP^? 21.52 N6 ADP C1001 C 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 27.64 56.61 58.17 22.18 57.92 60.36 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 C 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 C 298 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 17.41 60.57 64.39 18.40 58.12 65.34 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 27.64 56.61 58.17 22.18 57.92 60.36 -21.36 39.39 22.00 -17.64 41.95 19.02 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 11 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 21 PHE.? 42.86 N6 ADP C1001 D 298 ASP A 54 ASP~? 42.89 N6 ADP C1001 D 329 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 29.72 46.46 83.60 30.79 47.36 81.99 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 36.89 44.91 74.55 37.33 48.94 79.01 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 29 PHE^? 33.27 N6 ADP C1001 D 298 ASP A 31 ASP^? 31.30 N6 ADP C1001 D 329 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 29.72 46.46 83.60 30.79 47.36 81.99 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 36.89 44.91 74.55 37.33 48.94 79.01 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 29 PHE^? 33.27 N6 ADP C1001 D 298 ASP B 10 ASP.? 28.32 N6 ADP C1001 D 329 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 29.72 46.46 83.60 30.79 47.36 81.99 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 36.89 44.91 74.55 37.33 48.94 79.01 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE B 29 PHE^? 19.13 N6 ADP C1001 D 298 ASP B 31 ASP^? 22.05 N1 ADP C1001 D 329 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 29.72 46.46 83.60 30.79 47.36 81.99 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 36.89 44.91 74.55 37.33 48.94 79.01 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE C 21 PHE.? 11.41 C2 ADP C1001 D 298 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 29.72 46.46 83.60 30.79 47.36 81.99 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 36.89 44.91 74.55 37.33 48.94 79.01 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE C 27 PHE^? 15.44 C2 ADP C1001 D 298 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 329 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 29.72 46.46 83.60 30.79 47.36 81.99 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 36.89 44.91 74.55 37.33 48.94 79.01 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE C 58 PHE~? 19.35 C2 ADP C1001 D 298 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 329 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 29.72 46.46 83.60 30.79 47.36 81.99 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 36.89 44.91 74.55 37.33 48.94 79.01 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE D 21 PHE.? 33.63 N6 ADP C1001 D 298 ASP D 54 ASP~? 30.93 N6 ADP C1001 D 329 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 29.72 46.46 83.60 30.79 47.36 81.99 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 36.89 44.91 74.55 37.33 48.94 79.01 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 D 298 ASP D 31 ASP^? 21.52 N6 ADP C1001 D 329 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 36.89 44.91 74.55 37.33 48.94 79.01 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 D 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 D 298 ASP D 31 ASP^? 21.52 N6 ADP C1001 D 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 36.89 44.91 74.55 37.33 48.94 79.01 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 D 189 PHE D 29 PHE^? 23.81 N6 ADP C1001 D 298 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 35.44 53.35 83.81 35.65 54.53 81.28 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 36.89 44.91 74.55 37.33 48.94 79.01 -21.36 39.39 22.00 -17.64 41.95 19.02 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 11 hits 1gtx_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 9 ASP.? 35.63 N1 ADP C1001 A 327 GLU D 41 GLU^? 18.65 N6 ADP C1001 A 339 ARG D 2 ARG^? 19.52 N6 ADP C1001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 75.11 41.01 160.30 76.65 40.06 161.41 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 82.23 40.35 159.87 85.09 40.67 161.01 -16.51 45.11 16.54 -19.16 44.24 15.23 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 327 GLU D 41 GLU^? 18.65 N6 ADP C1001 A 339 ARG D 2 ARG^? 19.52 N6 ADP C1001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 75.11 41.01 160.30 76.65 40.06 161.41 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 82.23 40.35 159.87 85.09 40.67 161.01 -16.51 45.11 16.54 -19.16 44.24 15.23 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 327 GLU D 78 GLU~? 42.25 N1 ADP C1001 A 339 ARG D 75 ARG~? 42.87 N1 ADP C1001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.63 66.44 26.22 -18.72 68.28 26.46 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.47 67.51 24.43 -22.92 70.53 24.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP C 9 ASP.? 24.62 C2 ADP C1001 A 327 GLU B 44 GLU^? 27.54 N6 ADP C1001 A 339 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 75.11 41.01 160.30 76.65 40.06 161.41 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 82.23 40.35 159.87 85.09 40.67 161.01 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 327 GLU D 78 GLU~? 42.25 N1 ADP C1001 A 339 ARG D 75 ARG~? 42.87 N1 ADP C1001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.63 66.44 26.22 -18.72 68.28 26.46 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.47 67.51 24.43 -22.92 70.53 24.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP C 112 ASP.? 10.30 O3' ADP C1001 A 327 GLU D 78 GLU~? 42.25 N1 ADP C1001 A 339 ARG D 75 ARG~? 42.87 N1 ADP C1001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.63 66.44 26.22 -18.72 68.28 26.46 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.47 67.51 24.43 -22.92 70.53 24.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP D 10 ASP.? 31.49 N6 ADP C1001 A 327 GLU B 44 GLU^? 27.54 N6 ADP C1001 A 339 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 75.11 41.01 160.30 76.65 40.06 161.41 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 82.23 40.35 159.87 85.09 40.67 161.01 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 327 GLU A 44 GLU^? 29.72 N6 ADP C1001 A 339 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 75.11 41.01 160.30 76.65 40.06 161.41 -23.95 2.54 6.45 -25.82 1.78 7.26 coo 82.23 40.35 159.87 85.09 40.67 161.01 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP D 112 ASP.? 52.73 N6 ADP C1001 A 327 GLU C 78 GLU~? 9.17 N6 ADP C1001 A 339 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 85.81 57.99 116.01 86.03 55.86 115.89 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 75.11 41.01 160.30 76.65 40.06 161.41 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 82.23 40.35 159.87 85.09 40.67 161.01 -38.47 40.65 15.33 -40.88 39.19 16.61 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 9 hits 1hto_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 37 VAL^? 32.56 N6 ADP C1001 A 200 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 226 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -4.85 12.62 11.07 -5.75 10.99 12.22 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 34.47 51.09 7.19 28.58 51.18 7.53 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 42 VAL^? 28.28 N6 ADP C1001 A 200 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 226 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -17.22 6.50 9.05 -17.23 6.12 11.14 coo 24.51 43.28 11.18 25.17 44.50 9.58 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 43 VAL^? 29.07 N6 ADP C1001 A 200 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 226 LYS A 100 LYS~? 39.84 N1 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -19.60 5.09 6.39 -18.76 6.07 4.66 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -1.03 5.78 15.30 1.15 8.50 19.55 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 43 VAL^? 29.07 N6 ADP C1001 A 200 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 226 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -19.60 5.09 6.39 -18.76 6.07 4.66 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 43 VAL^? 29.07 N6 ADP C1001 A 200 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 226 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -19.60 5.09 6.39 -18.76 6.07 4.66 coo 24.51 43.28 11.18 25.17 44.50 9.58 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL A 67 VAL^? 41.71 N6 ADP C1001 A 200 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 226 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -6.41 -0.65 2.86 -8.07 -1.66 1.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 3 VAL^? 14.14 N6 ADP C1001 A 200 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 226 LYS D 38 LYS^? 26.03 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -20.36 21.33 16.68 -20.22 23.45 16.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 -10.44 39.35 12.00 -7.01 36.04 14.36 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL B 3 VAL^? 14.14 N6 ADP C1001 A 200 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 226 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -20.36 21.33 16.68 -20.22 23.45 16.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 34.47 51.09 7.19 28.58 51.18 7.53 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL B 28 VAL^? 19.02 N6 ADP C1001 A 200 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 226 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -19.89 16.36 10.31 -18.76 17.41 8.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL B 28 VAL^? 19.02 N6 ADP C1001 A 200 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 226 LYS A 100 LYS~? 39.84 N1 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -19.89 16.36 10.31 -18.76 17.41 8.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -1.03 5.78 15.30 1.15 8.50 19.55 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL B 28 VAL^? 19.02 N6 ADP C1001 A 200 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 226 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -19.89 16.36 10.31 -18.76 17.41 8.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 34.47 51.09 7.19 28.58 51.18 7.53 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL B 28 VAL^? 19.02 N6 ADP C1001 A 200 ASP B 97 ASP~? 21.13 N6 ADP C1001 A 226 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -19.89 16.36 10.31 -18.76 17.41 8.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 34.47 51.09 7.19 28.58 51.18 7.53 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL B 30 VAL^? 19.12 N6 ADP C1001 A 200 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 226 LYS A 100 LYS~? 39.84 N1 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -15.85 19.10 14.67 -16.13 20.48 12.91 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -1.03 5.78 15.30 1.15 8.50 19.55 ULMN 3 1i29_c03 CSDB user 14 3 # 14 A 128 VAL B 30 VAL^? 19.12 N6 ADP C1001 A 200 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 226 LYS D 38 LYS^? 26.03 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -15.85 19.10 14.67 -16.13 20.48 12.91 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 -10.44 39.35 12.00 -7.01 36.04 14.36 ULMN 3 1i29_c03 CSDB user 15 3 # 15 A 128 VAL B 37 VAL^? 22.32 N6 ADP C1001 A 200 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 226 LYS A 100 LYS~? 39.84 N1 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -10.74 23.15 14.22 -11.39 22.86 12.12 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -1.03 5.78 15.30 1.15 8.50 19.55 ULMN 3 1i29_c03 CSDB user 16 3 # 16 A 128 VAL B 40 VAL.? 23.36 N6 ADP C1001 A 200 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 226 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -13.02 16.51 12.14 -12.89 17.77 10.38 coo 24.51 43.28 11.18 25.17 44.50 9.58 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 34.47 51.09 7.19 28.58 51.18 7.53 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1i29_c03 CSDB user 17 3 # 17 A 128 VAL B 42 VAL^? 23.32 N6 ADP C1001 A 200 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 226 LYS A 100 LYS~? 39.84 N1 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -17.95 12.57 9.46 -17.80 12.68 7.30 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -1.03 5.78 15.30 1.15 8.50 19.55 ULMN 3 1i29_c03 CSDB user 18 3 # 18 A 128 VAL B 43 VAL^? 23.70 N6 ADP C1001 A 200 ASP A 9 ASP.? 35.63 N1 ADP C1001 A 226 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -20.38 9.81 10.42 -20.34 9.32 12.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 34.47 51.09 7.19 28.58 51.18 7.53 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1i29_c03 CSDB user 19 3 # 19 A 128 VAL B 43 VAL^? 23.70 N6 ADP C1001 A 200 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 226 LYS A 100 LYS~? 39.84 N1 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -20.38 9.81 10.42 -20.34 9.32 12.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -1.03 5.78 15.30 1.15 8.50 19.55 ULMN 3 1i29_c03 CSDB user 20 3 # 20 A 128 VAL B 45 VAL.? 22.45 N6 ADP C1001 A 200 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 226 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -26.29 7.76 10.45 -27.74 9.22 9.62 coo 24.51 43.28 11.18 25.17 44.50 9.58 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 34.47 51.09 7.19 28.58 51.18 7.53 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1i29_c03 CSDB user 21 3 # 21 A 128 VAL B 67 VAL^? 10.26 N6 ADP C1001 A 200 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 226 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -25.94 22.13 15.60 -27.27 20.33 15.42 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 34.47 51.09 7.19 28.58 51.18 7.53 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1i29_c03 CSDB user 22 3 # 22 A 128 VAL C 30 VAL^? 18.40 C2 ADP C1001 A 200 ASP C 97 ASP~? 22.56 C2 ADP C1001 A 226 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -21.92 31.89 33.13 -23.87 30.87 33.18 coo 24.51 43.28 11.18 25.17 44.50 9.58 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1i29_c03 CSDB user 23 3 # 23 A 128 VAL C 43 VAL^? 22.36 C2 ADP C1001 A 200 ASP C 31 ASP^? 21.62 C2 ADP C1001 A 226 LYS C 100 LYS~? 22.69 C2 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -24.59 42.75 34.36 -23.69 42.87 32.38 coo 24.51 43.28 11.18 25.17 44.50 9.58 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -28.01 22.62 36.30 -24.43 24.45 38.49 ULMN 3 1i29_c03 CSDB user 24 3 # 24 A 128 VAL D 3 VAL^? 29.18 N6 ADP C1001 A 200 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 226 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -12.67 50.02 16.10 -10.57 50.71 15.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 34.47 51.09 7.19 28.58 51.18 7.53 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1i29_c03 CSDB user 25 3 # 25 A 128 VAL D 3 VAL^? 29.18 N6 ADP C1001 A 200 ASP D 36 ASP^? 31.16 N6 ADP C1001 A 226 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -12.67 50.02 16.10 -10.57 50.71 15.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 34.47 51.09 7.19 28.58 51.18 7.53 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1i29_c03 CSDB user 26 3 # 26 A 128 VAL D 28 VAL^? 27.26 N6 ADP C1001 A 200 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 226 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -16.76 50.64 9.02 -15.30 50.60 7.46 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 34.47 51.09 7.19 28.58 51.18 7.53 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1i29_c03 CSDB user 27 3 # 27 A 128 VAL D 30 VAL^? 26.73 N6 ADP C1001 A 200 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 226 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -12.90 46.59 12.22 -11.32 47.46 11.02 coo 24.51 43.28 11.18 25.17 44.50 9.58 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 34.47 51.09 7.19 28.58 51.18 7.53 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1i29_c03 CSDB user 28 3 # 28 A 128 VAL D 30 VAL^? 26.73 N6 ADP C1001 A 200 ASP D 97 ASP~? 39.15 N6 ADP C1001 A 226 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -12.90 46.59 12.22 -11.32 47.46 11.02 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 34.47 51.09 7.19 28.58 51.18 7.53 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1i29_c03 CSDB user 29 3 # 29 A 128 VAL D 42 VAL^? 24.34 N6 ADP C1001 A 200 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 226 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -19.91 48.50 7.10 -20.30 49.35 5.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 34.47 51.09 7.19 28.58 51.18 7.53 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1i29_c03 CSDB user 30 3 # 30 A 128 VAL D 43 VAL^? 22.13 N6 ADP C1001 A 200 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 226 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -23.17 49.47 8.72 -22.77 48.89 10.83 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 34.47 51.09 7.19 28.58 51.18 7.53 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1i29_c03 CSDB user 31 3 # 31 A 128 VAL D 43 VAL^? 22.13 N6 ADP C1001 A 200 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 226 LYS D 100 LYS~? 39.55 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -23.17 49.47 8.72 -22.77 48.89 10.83 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.04 48.91 8.43 1.31 48.12 4.91 ULMN 3 1i29_c03 CSDB user 32 3 # 32 A 128 VAL D 45 VAL.? 26.95 N6 ADP C1001 A 200 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 226 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -26.52 54.77 10.29 -25.43 56.49 11.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 34.47 51.09 7.19 28.58 51.18 7.53 -21.36 39.39 22.00 -17.64 41.95 19.02 1i29_c03 source 1i29 CSDB : 32 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 74 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 165 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 165 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 165 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 A 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 165 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 A 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 A 14 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 74 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 A 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 A 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -17.63 66.44 26.22 -18.72 68.28 26.46 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 16 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 60 LYS~? 43.57 N6 ADP C1001 B 74 LYS A 65 LYS.? 41.76 N6 ADP C1001 B 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 B 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 B 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -26.04 13.89 21.83 -25.92 10.67 25.77 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -23.42 20.96 21.77 -22.73 18.61 26.55 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 165 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -26.04 13.89 21.83 -25.92 10.67 25.77 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -23.42 20.96 21.77 -22.73 18.61 26.55 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -23.42 20.96 21.77 -22.73 18.61 26.55 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -26.04 13.89 21.83 -25.92 10.67 25.77 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -23.42 20.96 21.77 -22.73 18.61 26.55 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -26.04 13.89 21.83 -25.92 10.67 25.77 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -21.36 39.39 22.00 -17.64 41.95 19.02 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -21.73 32.18 22.71 -16.79 33.08 21.29 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -21.36 39.39 22.00 -17.64 41.95 19.02 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -21.73 32.18 22.71 -16.79 33.08 21.29 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -21.73 32.18 22.71 -16.79 33.08 21.29 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -21.36 39.39 22.00 -17.64 41.95 19.02 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 B 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 165 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -21.73 32.18 22.71 -16.79 33.08 21.29 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -21.36 39.39 22.00 -17.64 41.95 19.02 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 B 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -21.73 32.18 22.71 -16.79 33.08 21.29 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -21.36 39.39 22.00 -17.64 41.95 19.02 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 B 14 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 74 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -21.35 51.92 21.59 -25.15 52.63 26.23 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -14.21 50.71 21.89 -14.80 46.21 24.73 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -17.63 66.44 26.22 -18.72 68.28 26.46 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 B 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -14.21 50.71 21.89 -14.80 46.21 24.73 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -21.35 51.92 21.59 -25.15 52.63 26.23 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 B 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -14.21 50.71 21.89 -14.80 46.21 24.73 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -21.35 51.92 21.59 -25.15 52.63 26.23 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -17.63 66.44 26.22 -18.72 68.28 26.46 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 14 hits 1idt_c01 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 110 ASP.? 52.32 N6 ADP C1001 158 THR A 69 THR.? 44.69 N6 ADP C1001 317 ASP A 97 ASP~? 39.49 N1 ADP C1001 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -4.20 1.28 18.72 -4.75 1.76 20.72 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP B 110 ASP.? 12.77 N6 ADP C1001 158 THR B 69 THR.? 8.02 N6 ADP C1001 317 ASP B 97 ASP~? 21.13 N6 ADP C1001 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -30.45 31.51 3.79 -31.95 31.85 2.33 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -28.27 23.67 9.92 -29.81 23.02 11.35 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -17.01 28.05 3.64 -15.70 27.74 1.96 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP C 110 ASP.? 10.54 O3' ADP C1001 158 THR C 69 THR.? 8.25 C2 ADP C1001 317 ASP C 97 ASP~? 22.56 C2 ADP C1001 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -42.40 26.72 28.14 -44.45 27.16 28.23 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -34.19 32.67 26.93 -33.84 33.77 25.09 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -33.31 25.31 38.38 -33.83 25.06 40.38 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 3 hits 1inp_c02 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 9 ASP.? 35.63 N1 ADP C1001 A1134 ALA A 7 ALA^? 34.93 N6 ADP C1001 A1137 ASN A 16 ASN.? 39.53 N1 ADP C1001 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -14.67 -1.89 11.08 -15.25 -0.53 11.40 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -11.80 -4.14 16.79 -11.72 -4.01 18.95 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP B 9 ASP.? 24.63 N6 ADP C1001 A1134 ALA B 7 ALA^? 19.02 N6 ADP C1001 A1137 ASN B 16 ASN.? 20.20 N6 ADP C1001 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -23.95 17.01 5.35 -22.53 16.46 5.45 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -23.35 21.88 0.52 -22.21 22.66 -1.09 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 2 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 204 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 279 TYR A 26 TYR^? 32.13 N6 ADP C1001 coo 5.85 5.60 30.32 5.00 7.49 29.88 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 7.79 1.83 27.81 9.08 3.25 26.92 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 8.22 7.77 18.64 7.58 8.47 21.28 -20.23 -0.15 10.23 -22.87 -0.31 11.21 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 1 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 61 GLU B 44 GLU^? 27.54 N6 ADP C1001 A 162 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -15.90 11.43 13.39 -16.60 10.91 15.33 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -24.18 6.66 6.64 -23.83 5.58 4.84 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU C 41 GLU^? 24.05 C2 ADP C1001 A 61 GLU C 44 GLU^? 27.03 C2 ADP C1001 A 162 HIS C 62 HIS~? 21.13 N1 ADP C1001 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -20.29 38.32 35.00 -18.64 39.42 34.23 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -28.75 47.24 35.01 -29.12 48.55 36.63 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -20.79 41.45 28.58 -20.89 43.35 29.47 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU D 41 GLU^? 18.65 N6 ADP C1001 A 61 GLU D 44 GLU^? 25.61 N6 ADP C1001 A 162 HIS D 62 HIS.? 20.37 N6 ADP C1001 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -19.13 44.82 10.40 -20.77 44.03 11.36 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -26.92 53.16 5.77 -28.08 52.58 4.08 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -23.21 48.47 15.79 -25.03 48.41 14.73 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 3 hits 1j53_c00 naa= 3 ULMN 3 1joa_c00 NADH PEROXIDASE user 1 3 # 1 10 HIS A 20 HIS.? 47.81 N6 ADP C1001 41 SER A 18 SER.? 40.87 N6 ADP C1001 303 ARG A 23 ARG.? 47.94 N6 ADP C1001 coo 62.94 54.74 73.45 64.13 56.17 74.27 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 65.67 62.51 70.93 64.56 61.94 68.74 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo 63.38 52.38 77.01 66.48 52.75 76.49 -17.87 -12.22 3.83 -15.16 -13.38 2.91 1joa_c00 source 1joa NADH PEROXIDASE : 1 hits 1joa_c00 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 58 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 424 GLU B 44 GLU^? 27.54 N6 ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 58.59 41.80 18.81 58.94 43.89 18.94 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 52.85 46.34 13.34 54.09 44.97 14.42 -24.18 6.66 6.64 -23.83 5.58 4.84 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 58 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 424 GLU B 44 GLU^? 27.54 N6 ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 58.59 41.80 18.81 58.94 43.89 18.94 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 52.85 46.34 13.34 54.09 44.97 14.42 -24.18 6.66 6.64 -23.83 5.58 4.84 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 58 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 424 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 58.59 41.80 18.81 58.94 43.89 18.94 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 52.85 46.34 13.34 54.09 44.97 14.42 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 58 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 424 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 58.59 41.80 18.81 58.94 43.89 18.94 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 52.85 46.34 13.34 54.09 44.97 14.42 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP C 9 ASP.? 24.62 C2 ADP C1001 A 58 ASP C 10 ASP.? 28.10 C2 ADP C1001 A 424 GLU C 44 GLU^? 27.03 C2 ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 58.59 41.80 18.81 58.94 43.89 18.94 -29.82 42.88 40.75 -30.96 43.09 42.54 coo 52.85 46.34 13.34 54.09 44.97 14.42 -28.75 47.24 35.01 -29.12 48.55 36.63 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 58 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 424 GLU C 48 GLU.? 22.51 O2' ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 58.59 41.80 18.81 58.94 43.89 18.94 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 52.85 46.34 13.34 54.09 44.97 14.42 -33.52 53.52 23.97 -33.48 52.09 22.33 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 7 3 # 7 A 55 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 58 ASP C 112 ASP.? 10.30 O3' ADP C1001 A 424 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 58.59 41.80 18.81 58.94 43.89 18.94 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 52.85 46.34 13.34 54.09 44.97 14.42 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 8 3 # 8 A 55 ASP C 112 ASP.? 10.30 O3' ADP C1001 A 58 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 424 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 58.59 41.80 18.81 58.94 43.89 18.94 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 52.85 46.34 13.34 54.09 44.97 14.42 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 9 3 # 9 A 55 ASP D 9 ASP.? 34.87 N6 ADP C1001 A 58 ASP D 10 ASP.? 31.49 N6 ADP C1001 A 424 GLU D 44 GLU^? 25.61 N6 ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 58.59 41.80 18.81 58.94 43.89 18.94 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 52.85 46.34 13.34 54.09 44.97 14.42 -26.92 53.16 5.77 -28.08 52.58 4.08 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 10 3 # 10 A 55 ASP D 10 ASP.? 31.49 N6 ADP C1001 A 58 ASP D 9 ASP.? 34.87 N6 ADP C1001 A 424 GLU D 44 GLU^? 25.61 N6 ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 58.59 41.80 18.81 58.94 43.89 18.94 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 52.85 46.34 13.34 54.09 44.97 14.42 -26.92 53.16 5.77 -28.08 52.58 4.08 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 11 3 # 11 A 55 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 58 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 424 GLU C 48 GLU.? 22.51 O2' ADP C1001 coo 58.42 47.76 20.67 58.01 49.10 19.12 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 58.59 41.80 18.81 58.94 43.89 18.94 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 52.85 46.34 13.34 54.09 44.97 14.42 -33.52 53.52 23.97 -33.48 52.09 22.33 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 11 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP B 110 ASP.? 12.77 N6 ADP C1001 B 58 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 424 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 117.85 63.62 21.08 115.96 63.25 20.18 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 118.47 57.23 15.57 119.32 58.77 16.73 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 58 ASP B 110 ASP.? 12.77 N6 ADP C1001 B 424 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 117.85 63.62 21.08 115.96 63.25 20.18 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 118.47 57.23 15.57 119.32 58.77 16.73 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP C 9 ASP.? 24.62 C2 ADP C1001 B 58 ASP C 10 ASP.? 28.10 C2 ADP C1001 B 424 GLU C 44 GLU^? 27.03 C2 ADP C1001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 117.85 63.62 21.08 115.96 63.25 20.18 -29.82 42.88 40.75 -30.96 43.09 42.54 coo 118.47 57.23 15.57 119.32 58.77 16.73 -28.75 47.24 35.01 -29.12 48.55 36.63 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP C 10 ASP.? 28.10 C2 ADP C1001 B 58 ASP C 9 ASP.? 24.62 C2 ADP C1001 B 424 GLU C 44 GLU^? 27.03 C2 ADP C1001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -29.82 42.88 40.75 -30.96 43.09 42.54 coo 117.85 63.62 21.08 115.96 63.25 20.18 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 118.47 57.23 15.57 119.32 58.77 16.73 -28.75 47.24 35.01 -29.12 48.55 36.63 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 58 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 424 GLU C 48 GLU.? 22.51 O2' ADP C1001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 117.85 63.62 21.08 115.96 63.25 20.18 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 118.47 57.23 15.57 119.32 58.77 16.73 -33.52 53.52 23.97 -33.48 52.09 22.33 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 6 3 # 6 B 55 ASP C 110 ASP.? 10.54 O3' ADP C1001 B 58 ASP C 112 ASP.? 10.30 O3' ADP C1001 B 424 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 117.85 63.62 21.08 115.96 63.25 20.18 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 118.47 57.23 15.57 119.32 58.77 16.73 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 7 3 # 7 B 55 ASP C 112 ASP.? 10.30 O3' ADP C1001 B 58 ASP C 110 ASP.? 10.54 O3' ADP C1001 B 424 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 117.85 63.62 21.08 115.96 63.25 20.18 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 118.47 57.23 15.57 119.32 58.77 16.73 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 8 3 # 8 B 55 ASP D 9 ASP.? 34.87 N6 ADP C1001 B 58 ASP D 10 ASP.? 31.49 N6 ADP C1001 B 424 GLU D 44 GLU^? 25.61 N6 ADP C1001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 117.85 63.62 21.08 115.96 63.25 20.18 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 118.47 57.23 15.57 119.32 58.77 16.73 -26.92 53.16 5.77 -28.08 52.58 4.08 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 9 3 # 9 B 55 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 58 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 424 GLU C 48 GLU.? 22.51 O2' ADP C1001 coo 112.10 61.46 19.99 111.82 60.65 18.07 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 117.85 63.62 21.08 115.96 63.25 20.18 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 118.47 57.23 15.57 119.32 58.77 16.73 -33.52 53.52 23.97 -33.48 52.09 22.33 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 9 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 8 GLU.? 40.05 N1 ADP C1001 A 56 LYS A 19 LYS.? 46.12 N1 ADP C1001 A 258 ARG A 11 ARG~? 32.97 N1 ADP C1001 coo 42.33 1.56 26.99 42.38 2.91 28.66 -16.47 -6.15 15.18 -15.55 -6.74 17.02 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -18.24 1.32 19.87 -15.89 1.49 21.96 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 8 GLU.? 40.05 N1 ADP C1001 A 56 LYS A 19 LYS.? 46.12 N1 ADP C1001 A 258 ARG A 94 ARG~? 34.60 N1 ADP C1001 coo 42.33 1.56 26.99 42.38 2.91 28.66 -16.47 -6.15 15.18 -15.55 -6.74 17.02 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -9.32 1.83 20.70 -11.98 2.20 22.31 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU B 8 GLU.? 21.08 N6 ADP C1001 A 56 LYS B 19 LYS.? 15.59 N6 ADP C1001 A 258 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo 42.33 1.56 26.99 42.38 2.91 28.66 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU B 8 GLU.? 21.08 N6 ADP C1001 A 56 LYS B 19 LYS.? 15.59 N6 ADP C1001 A 258 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo 42.33 1.56 26.99 42.38 2.91 28.66 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU C 8 GLU.? 21.29 O3' ADP C1001 A 56 LYS C 19 LYS.? 18.77 O3' ADP C1001 A 258 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo 42.33 1.56 26.99 42.38 2.91 28.66 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 A 2 GLU C 8 GLU.? 21.29 O3' ADP C1001 A 56 LYS C 19 LYS.? 18.77 O3' ADP C1001 A 258 ARG C 94 ARG~? 23.82 O3' ADP C1001 coo 42.33 1.56 26.99 42.38 2.91 28.66 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -33.86 30.07 42.29 -36.45 31.77 42.05 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 A 2 GLU D 8 GLU.? 38.64 N6 ADP C1001 A 56 LYS D 14 LYS~? 32.56 N6 ADP C1001 A 258 ARG D 25 ARG.? 35.20 N6 ADP C1001 coo 42.33 1.56 26.99 42.38 2.91 28.66 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -12.53 51.88 -0.15 -12.30 47.61 -3.60 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -26.42 60.33 5.19 -27.57 62.82 3.77 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 A 2 GLU D 8 GLU.? 38.64 N6 ADP C1001 A 56 LYS D 19 LYS.? 44.78 N6 ADP C1001 A 258 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo 42.33 1.56 26.99 42.38 2.91 28.66 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -14.01 64.85 7.32 -9.19 66.73 4.57 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -8.09 53.40 -0.40 -7.97 50.74 -1.98 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 8 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 8 GLU.? 40.05 N1 ADP C1001 B 56 LYS A 19 LYS.? 46.12 N1 ADP C1001 B 258 ARG A 94 ARG~? 34.60 N1 ADP C1001 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -16.47 -6.15 15.18 -15.55 -6.74 17.02 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 2.64 1.83 34.81 1.56 1.13 32.02 -9.32 1.83 20.70 -11.98 2.20 22.31 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 8 GLU.? 21.08 N6 ADP C1001 B 56 LYS B 19 LYS.? 15.59 N6 ADP C1001 B 258 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 2.64 1.83 34.81 1.56 1.13 32.02 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU B 8 GLU.? 21.08 N6 ADP C1001 B 56 LYS B 19 LYS.? 15.59 N6 ADP C1001 B 258 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 2.64 1.83 34.81 1.56 1.13 32.02 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU C 8 GLU.? 21.29 O3' ADP C1001 B 56 LYS C 19 LYS.? 18.77 O3' ADP C1001 B 258 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 2.64 1.83 34.81 1.56 1.13 32.02 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU C 8 GLU.? 21.29 O3' ADP C1001 B 56 LYS C 19 LYS.? 18.77 O3' ADP C1001 B 258 ARG C 94 ARG~? 23.82 O3' ADP C1001 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 2.64 1.83 34.81 1.56 1.13 32.02 -33.86 30.07 42.29 -36.45 31.77 42.05 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU D 8 GLU.? 38.64 N6 ADP C1001 B 56 LYS D 14 LYS~? 32.56 N6 ADP C1001 B 258 ARG D 25 ARG.? 35.20 N6 ADP C1001 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -12.53 51.88 -0.15 -12.30 47.61 -3.60 coo 2.64 1.83 34.81 1.56 1.13 32.02 -26.42 60.33 5.19 -27.57 62.82 3.77 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU D 8 GLU.? 38.64 N6 ADP C1001 B 56 LYS D 19 LYS.? 44.78 N6 ADP C1001 B 258 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -14.01 64.85 7.32 -9.19 66.73 4.57 coo 2.64 1.83 34.81 1.56 1.13 32.02 -8.09 53.40 -0.40 -7.97 50.74 -1.98 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 7 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 8 GLU.? 40.05 N1 ADP C1001 C 56 LYS A 19 LYS.? 46.12 N1 ADP C1001 C 258 ARG A 94 ARG~? 34.60 N1 ADP C1001 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -16.47 -6.15 15.18 -15.55 -6.74 17.02 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -9.32 1.83 20.70 -11.98 2.20 22.31 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 8 GLU.? 21.08 N6 ADP C1001 C 56 LYS B 19 LYS.? 15.59 N6 ADP C1001 C 258 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU B 8 GLU.? 21.08 N6 ADP C1001 C 56 LYS B 19 LYS.? 15.59 N6 ADP C1001 C 258 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU C 8 GLU.? 21.29 O3' ADP C1001 C 56 LYS C 19 LYS.? 18.77 O3' ADP C1001 C 258 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU C 8 GLU.? 21.29 O3' ADP C1001 C 56 LYS C 19 LYS.? 18.77 O3' ADP C1001 C 258 ARG C 94 ARG~? 23.82 O3' ADP C1001 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -33.86 30.07 42.29 -36.45 31.77 42.05 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU D 8 GLU.? 38.64 N6 ADP C1001 C 56 LYS D 14 LYS~? 32.56 N6 ADP C1001 C 258 ARG D 25 ARG.? 35.20 N6 ADP C1001 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -12.53 51.88 -0.15 -12.30 47.61 -3.60 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -26.42 60.33 5.19 -27.57 62.82 3.77 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU D 8 GLU.? 38.64 N6 ADP C1001 C 56 LYS D 19 LYS.? 44.78 N6 ADP C1001 C 258 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -14.01 64.85 7.32 -9.19 66.73 4.57 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -8.09 53.40 -0.40 -7.97 50.74 -1.98 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 7 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 8 GLU.? 40.05 N1 ADP C1001 D 56 LYS A 19 LYS.? 46.12 N1 ADP C1001 D 258 ARG A 94 ARG~? 34.60 N1 ADP C1001 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -16.47 -6.15 15.18 -15.55 -6.74 17.02 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -9.32 1.83 20.70 -11.98 2.20 22.31 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 8 GLU.? 21.08 N6 ADP C1001 D 56 LYS B 19 LYS.? 15.59 N6 ADP C1001 D 258 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU B 8 GLU.? 21.08 N6 ADP C1001 D 56 LYS B 19 LYS.? 15.59 N6 ADP C1001 D 258 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU C 8 GLU.? 21.29 O3' ADP C1001 D 56 LYS C 19 LYS.? 18.77 O3' ADP C1001 D 258 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU C 8 GLU.? 21.29 O3' ADP C1001 D 56 LYS C 19 LYS.? 18.77 O3' ADP C1001 D 258 ARG C 94 ARG~? 23.82 O3' ADP C1001 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -33.86 30.07 42.29 -36.45 31.77 42.05 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU D 8 GLU.? 38.64 N6 ADP C1001 D 56 LYS D 14 LYS~? 32.56 N6 ADP C1001 D 258 ARG D 25 ARG.? 35.20 N6 ADP C1001 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -12.53 51.88 -0.15 -12.30 47.61 -3.60 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -26.42 60.33 5.19 -27.57 62.82 3.77 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU D 8 GLU.? 38.64 N6 ADP C1001 D 56 LYS D 19 LYS.? 44.78 N6 ADP C1001 D 258 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -14.01 64.85 7.32 -9.19 66.73 4.57 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -8.09 53.40 -0.40 -7.97 50.74 -1.98 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 7 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU D 78 GLU~? 42.25 N1 ADP C1001 A 163 ARG D 74 ARG~? 47.97 N6 ADP C1001 A 222 ARG D 75 ARG~? 42.87 N1 ADP C1001 coo 51.27 81.34 48.31 51.67 80.79 50.28 -17.63 66.44 26.22 -18.72 68.28 26.46 coo 48.06 78.22 50.94 48.51 78.27 53.98 -14.99 70.93 23.88 -12.45 72.65 23.28 coo 54.85 84.16 52.60 54.26 81.23 53.34 -22.47 67.51 24.43 -22.92 70.53 24.84 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU D 78 GLU~? 42.25 N1 ADP C1001 A 163 ARG D 75 ARG~? 42.87 N1 ADP C1001 A 222 ARG D 74 ARG~? 47.97 N6 ADP C1001 coo 51.27 81.34 48.31 51.67 80.79 50.28 -17.63 66.44 26.22 -18.72 68.28 26.46 coo 48.06 78.22 50.94 48.51 78.27 53.98 -22.47 67.51 24.43 -22.92 70.53 24.84 coo 54.85 84.16 52.60 54.26 81.23 53.34 -14.99 70.93 23.88 -12.45 72.65 23.28 1kim_c00 source 1kim THYMIDINE KINASE : 2 hits 1kim_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 74 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 19.46 3.44 61.93 23.95 1.12 60.13 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 19.46 3.44 61.93 23.95 1.12 60.13 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 19.46 3.44 61.93 23.95 1.12 60.13 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 165 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 19.46 3.44 61.93 23.95 1.12 60.13 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 19.46 3.44 61.93 23.95 1.12 60.13 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 19.46 3.44 61.93 23.95 1.12 60.13 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 19.46 3.44 61.93 23.95 1.12 60.13 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 19.46 3.44 61.93 23.95 1.12 60.13 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 19.46 3.44 61.93 23.95 1.12 60.13 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 165 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 19.46 3.44 61.93 23.95 1.12 60.13 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 19.46 3.44 61.93 23.95 1.12 60.13 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 74 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 19.46 3.44 61.93 23.95 1.12 60.13 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -17.63 66.44 26.22 -18.72 68.28 26.46 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 19.46 3.44 61.93 23.95 1.12 60.13 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo 24.97 5.82 58.78 26.79 1.97 55.46 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 19.46 3.44 61.93 23.95 1.12 60.13 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -17.63 66.44 26.22 -18.72 68.28 26.46 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 14 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 60 LYS~? 43.57 N6 ADP C1001 B 74 LYS A 65 LYS.? 41.76 N6 ADP C1001 B 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 10.43 2.88 20.75 5.72 0.41 23.95 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 B 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 B 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 10.43 2.88 20.75 5.72 0.41 23.95 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 10.43 2.88 20.75 5.72 0.41 23.95 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 10.43 2.88 20.75 5.72 0.41 23.95 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 165 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 10.43 2.88 20.75 5.72 0.41 23.95 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 10.43 2.88 20.75 5.72 0.41 23.95 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 10.43 2.88 20.75 5.72 0.41 23.95 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 10.43 2.88 20.75 5.72 0.41 23.95 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 10.43 2.88 20.75 5.72 0.41 23.95 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 10.43 2.88 20.75 5.72 0.41 23.95 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 165 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 10.43 2.88 20.75 5.72 0.41 23.95 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 10.43 2.88 20.75 5.72 0.41 23.95 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 74 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 10.43 2.88 20.75 5.72 0.41 23.95 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 74 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 10.43 2.88 20.75 5.72 0.41 23.95 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -17.63 66.44 26.22 -18.72 68.28 26.46 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 10.43 2.88 20.75 5.72 0.41 23.95 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo 4.84 5.09 23.75 3.30 1.39 27.48 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 10.43 2.88 20.75 5.72 0.41 23.95 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -17.63 66.44 26.22 -18.72 68.28 26.46 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 16 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 60 LYS~? 43.57 N6 ADP C1001 C 74 LYS A 65 LYS.? 41.76 N6 ADP C1001 C 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 12.29 34.52 28.11 16.84 32.47 25.43 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 12.06 27.10 15.56 13.23 27.02 13.80 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 C 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 C 165 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 12.29 34.52 28.11 16.84 32.47 25.43 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 12.06 27.10 15.56 13.23 27.02 13.80 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 C 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 C 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 12.29 34.52 28.11 16.84 32.47 25.43 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 12.06 27.10 15.56 13.23 27.02 13.80 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 C 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 C 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 12.29 34.52 28.11 16.84 32.47 25.43 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 C 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 C 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 12.29 34.52 28.11 16.84 32.47 25.43 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 C 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 C 165 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 12.29 34.52 28.11 16.84 32.47 25.43 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 C 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 C 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 12.29 34.52 28.11 16.84 32.47 25.43 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 12.06 27.10 15.56 13.23 27.02 13.80 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 C 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 C 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 12.29 34.52 28.11 16.84 32.47 25.43 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 12.06 27.10 15.56 13.23 27.02 13.80 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 C 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 C 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 C 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 12.29 34.52 28.11 16.84 32.47 25.43 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 12.06 27.10 15.56 13.23 27.02 13.80 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 C 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 C 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 C 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 12.29 34.52 28.11 16.84 32.47 25.43 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 12.06 27.10 15.56 13.23 27.02 13.80 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 C 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 C 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 C 165 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 12.29 34.52 28.11 16.84 32.47 25.43 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 12.06 27.10 15.56 13.23 27.02 13.80 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 C 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 C 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 C 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 12.29 34.52 28.11 16.84 32.47 25.43 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 12.06 27.10 15.56 13.23 27.02 13.80 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 C 14 LYS D 60 LYS~? 25.96 N1 ADP C1001 C 74 LYS D 65 LYS.? 25.59 N1 ADP C1001 C 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 12.29 34.52 28.11 16.84 32.47 25.43 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 12.06 27.10 15.56 13.23 27.02 13.80 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 C 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 C 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 C 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 12.29 34.52 28.11 16.84 32.47 25.43 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 12.06 27.10 15.56 13.23 27.02 13.80 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 C 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 C 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 C 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo 17.59 37.25 25.80 19.64 34.15 21.60 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 12.29 34.52 28.11 16.84 32.47 25.43 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 12.06 27.10 15.56 13.23 27.02 13.80 -17.63 66.44 26.22 -18.72 68.28 26.46 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 15 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 60 LYS~? 43.57 N6 ADP C1001 D 74 LYS A 65 LYS.? 41.76 N6 ADP C1001 D 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 D 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 D 165 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 D 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 D 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 D 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 D 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 D 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 D 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 D 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 D 165 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 D 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 D 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 D 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 D 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 D 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 D 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 D 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 D 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 D 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 D 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 D 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 D 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 D 165 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 D 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 D 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 D 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 D 14 LYS D 60 LYS~? 25.96 N1 ADP C1001 D 74 LYS D 65 LYS.? 25.59 N1 ADP C1001 D 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 D 14 LYS D 60 LYS~? 25.96 N1 ADP C1001 D 74 LYS D 65 LYS.? 25.59 N1 ADP C1001 D 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -17.63 66.44 26.22 -18.72 68.28 26.46 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 D 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 D 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 D 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 D 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 D 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 D 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -17.63 66.44 26.22 -18.72 68.28 26.46 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 17 hits 1kqc_c03 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 197 HIS A 20 HIS.? 47.81 N6 ADP C1001 A 446 ARG A 23 ARG.? 47.94 N6 ADP C1001 coo 3.26 62.02 109.14 4.83 57.73 107.38 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 9.48 43.28 113.60 10.05 44.21 111.80 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 12.14 46.28 115.16 13.57 43.60 115.68 -17.87 -12.22 3.83 -15.16 -13.38 2.91 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 2 3 # 2 A 94 LYS B 14 LYS~? 27.17 N6 ADP C1001 A 197 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 446 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 3.26 62.02 109.14 4.83 57.73 107.38 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 9.48 43.28 113.60 10.05 44.21 111.80 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 12.14 46.28 115.16 13.57 43.60 115.68 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 3 3 # 3 A 94 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 197 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 446 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 3.26 62.02 109.14 4.83 57.73 107.38 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 9.48 43.28 113.60 10.05 44.21 111.80 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 12.14 46.28 115.16 13.57 43.60 115.68 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 4 3 # 4 A 94 LYS C 14 LYS.? 27.01 C2 ADP C1001 A 197 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 446 ARG C 23 ARG.? 19.01 O2' ADP C1001 coo 3.26 62.02 109.14 4.83 57.73 107.38 -31.38 33.30 42.44 -27.73 35.10 43.96 coo 9.48 43.28 113.60 10.05 44.21 111.80 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 12.14 46.28 115.16 13.57 43.60 115.68 -41.38 43.66 27.78 -43.67 44.44 29.75 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 5 3 # 5 A 94 LYS D 14 LYS~? 32.56 N6 ADP C1001 A 197 HIS D 20 HIS.? 42.10 N6 ADP C1001 A 446 ARG D 23 ARG.? 42.28 N6 ADP C1001 coo 3.26 62.02 109.14 4.83 57.73 107.38 -12.53 51.88 -0.15 -12.30 47.61 -3.60 coo 9.48 43.28 113.60 10.05 44.21 111.80 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 12.14 46.28 115.16 13.57 43.60 115.68 -21.76 67.41 8.31 -21.73 70.32 9.28 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 6 3 # 6 A 94 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 197 HIS D 20 HIS.? 42.10 N6 ADP C1001 A 446 ARG D 23 ARG.? 42.28 N6 ADP C1001 coo 3.26 62.02 109.14 4.83 57.73 107.38 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 9.48 43.28 113.60 10.05 44.21 111.80 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 12.14 46.28 115.16 13.57 43.60 115.68 -21.76 67.41 8.31 -21.73 70.32 9.28 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 6 hits 1kqf_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP B 9 ASP.? 24.63 N6 ADP C1001 262 LYS B 14 LYS~? 27.17 N6 ADP C1001 336 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo 61.88 50.78 12.96 63.84 50.60 13.71 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 63.59 44.40 18.32 63.20 49.74 17.95 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 72.60 57.42 15.86 71.61 56.68 18.70 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP B 110 ASP.? 12.77 N6 ADP C1001 262 LYS B 108 LYS.? 17.61 N6 ADP C1001 336 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 61.88 50.78 12.96 63.84 50.60 13.71 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 63.59 44.40 18.32 63.20 49.74 17.95 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 72.60 57.42 15.86 71.61 56.68 18.70 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP B 110 ASP.? 12.77 N6 ADP C1001 262 LYS B 116 LYS.? 13.79 O2B ADP C1001 336 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 61.88 50.78 12.96 63.84 50.60 13.71 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 63.59 44.40 18.32 63.20 49.74 17.95 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 72.60 57.42 15.86 71.61 56.68 18.70 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 112 ASP.? 11.36 O1B ADP C1001 262 LYS B 114 LYS.? -3.14 O1A ADP C1001s 336 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 61.88 50.78 12.96 63.84 50.60 13.71 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 63.59 44.40 18.32 63.20 49.74 17.95 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 72.60 57.42 15.86 71.61 56.68 18.70 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP C 54 ASP~? 20.12 N1 ADP C1001 262 LYS D 60 LYS~? 25.96 N1 ADP C1001 336 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo 61.88 50.78 12.96 63.84 50.60 13.71 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 63.59 44.40 18.32 63.20 49.74 17.95 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 72.60 57.42 15.86 71.61 56.68 18.70 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP C 110 ASP.? 10.54 O3' ADP C1001 262 LYS C 19 LYS.? 18.77 O3' ADP C1001 336 ARG B 74 ARG~? -6.26 O2A ADP C1001s coo 61.88 50.78 12.96 63.84 50.60 13.71 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 63.59 44.40 18.32 63.20 49.74 17.95 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 72.60 57.42 15.86 71.61 56.68 18.70 -43.21 24.74 16.58 -45.29 23.99 18.72 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 7 3 # 7 255 ASP C 110 ASP.? 10.54 O3' ADP C1001 262 LYS C 108 LYS.? 14.57 N3 ADP C1001 336 ARG B 74 ARG~? -6.26 O2A ADP C1001s coo 61.88 50.78 12.96 63.84 50.60 13.71 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 63.59 44.40 18.32 63.20 49.74 17.95 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 72.60 57.42 15.86 71.61 56.68 18.70 -43.21 24.74 16.58 -45.29 23.99 18.72 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 8 3 # 8 255 ASP C 110 ASP.? 10.54 O3' ADP C1001 262 LYS C 108 LYS.? 14.57 N3 ADP C1001 336 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 61.88 50.78 12.96 63.84 50.60 13.71 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 63.59 44.40 18.32 63.20 49.74 17.95 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 72.60 57.42 15.86 71.61 56.68 18.70 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 9 3 # 9 255 ASP C 110 ASP.? 10.54 O3' ADP C1001 262 LYS C 116 LYS.? 13.74 O3' ADP C1001 336 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 61.88 50.78 12.96 63.84 50.60 13.71 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 63.59 44.40 18.32 63.20 49.74 17.95 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 72.60 57.42 15.86 71.61 56.68 18.70 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 10 3 # 10 255 ASP D 36 ASP^? 31.16 N6 ADP C1001 262 LYS D 100 LYS~? 39.55 N6 ADP C1001 336 ARG D 2 ARG^? 19.52 N6 ADP C1001 coo 61.88 50.78 12.96 63.84 50.60 13.71 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 63.59 44.40 18.32 63.20 49.74 17.95 -3.04 48.91 8.43 1.31 48.12 4.91 coo 72.60 57.42 15.86 71.61 56.68 18.70 -16.51 45.11 16.54 -19.16 44.24 15.23 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 10 hits 1lam_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP B 10 ASP.? 28.32 N6 ADP C1001 169 ARG B 11 ARG~? 27.94 N6 ADP C1001 193 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 20.88 15.91 3.60 20.25 17.72 4.50 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 18.81 19.85 7.63 17.55 19.89 5.97 -15.84 6.06 -0.29 -17.94 5.95 -0.14 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 1 hits 1ldm_c01 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 295 GLU A 33 GLU^? 35.51 N6 ADP C1001 A 369 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 16.11 33.72 80.99 14.10 33.54 81.63 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP C 31 ASP^? 21.62 C2 ADP C1001 A 295 GLU C 33 GLU^? 22.62 N1 ADP C1001 A 369 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 16.11 33.72 80.99 14.10 33.54 81.63 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 295 GLU D 33 GLU^? 24.81 N6 ADP C1001 A 369 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 16.11 33.72 80.99 14.10 33.54 81.63 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.58 39.61 12.64 -2.59 38.96 12.51 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 3 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 265 GLU A 33 GLU^? 35.51 N6 ADP C1001 A 369 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 17.36 23.57 72.04 18.68 21.92 71.98 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 265 GLU A 33 GLU^? 35.51 N6 ADP C1001 A 369 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 17.36 23.57 72.04 18.68 21.92 71.98 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP C 31 ASP^? 21.62 C2 ADP C1001 A 265 GLU B 33 GLU^? 22.82 N1 ADP C1001 A 369 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 12.19 31.08 87.29 11.13 32.66 86.38 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 265 GLU C 78 GLU~? 9.17 N6 ADP C1001 A 369 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 17.36 23.57 72.04 18.68 21.92 71.98 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 12.19 31.08 87.29 11.13 32.66 86.38 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 265 GLU C 78 GLU~? 9.17 N6 ADP C1001 A 369 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 17.36 23.57 72.04 18.68 21.92 71.98 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 12.19 31.08 87.29 11.13 32.66 86.38 -20.25 43.54 24.10 -19.06 45.03 24.94 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 5 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 279 GLU A 44 GLU^? 29.72 N6 ADP C1001 A 369 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 16.54 46.37 63.94 14.77 45.79 62.95 -23.95 2.54 6.45 -25.82 1.78 7.26 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 279 GLU A 33 GLU^? 35.51 N6 ADP C1001 A 369 ASP A 54 ASP~? 42.89 N6 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 16.54 46.37 63.94 14.77 45.79 62.95 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 279 GLU A 78 GLU~? 55.68 N6 ADP C1001 A 369 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 16.54 46.37 63.94 14.77 45.79 62.95 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 coo 12.19 31.08 87.29 11.13 32.66 86.38 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 279 GLU B 44 GLU^? 27.54 N6 ADP C1001 A 369 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 16.54 46.37 63.94 14.77 45.79 62.95 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 12.19 31.08 87.29 11.13 32.66 86.38 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 279 GLU D 35 GLU.? 34.89 N6 ADP C1001 A 369 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 16.54 46.37 63.94 14.77 45.79 62.95 -1.41 44.17 17.18 -1.59 46.26 17.19 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 279 GLU B 33 GLU^? 22.82 N1 ADP C1001 A 369 ASP B 54 ASP~? 20.52 O4' ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 16.54 46.37 63.94 14.77 45.79 62.95 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 12.19 31.08 87.29 11.13 32.66 86.38 -33.59 8.19 15.94 -35.17 6.84 16.43 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 279 GLU B 78 GLU~? 5.47 O3' ADP C1001 A 369 ASP A 10 ASP.? 29.48 N1 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 16.54 46.37 63.94 14.77 45.79 62.95 -39.37 23.43 20.35 -41.49 23.57 20.23 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.48 2.08 13.35 -22.87 1.76 14.94 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP C 31 ASP^? 21.62 C2 ADP C1001 A 279 GLU C 44 GLU^? 27.03 C2 ADP C1001 A 369 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 16.54 46.37 63.94 14.77 45.79 62.95 -28.75 47.24 35.01 -29.12 48.55 36.63 coo 12.19 31.08 87.29 11.13 32.66 86.38 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP C 31 ASP^? 21.62 C2 ADP C1001 A 279 GLU D 33 GLU^? 24.81 N6 ADP C1001 A 369 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 16.54 46.37 63.94 14.77 45.79 62.95 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 279 GLU B 35 GLU.? 24.64 N6 ADP C1001 A 369 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 16.54 46.37 63.94 14.77 45.79 62.95 -8.42 31.70 14.79 -7.88 32.87 13.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.26 47.42 21.46 -29.58 49.13 20.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 279 GLU C 33 GLU^? 22.62 N1 ADP C1001 A 369 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 16.54 46.37 63.94 14.77 45.79 62.95 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.26 47.42 21.46 -29.58 49.13 20.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 279 GLU C 33 GLU^? 22.62 N1 ADP C1001 A 369 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 16.54 46.37 63.94 14.77 45.79 62.95 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 279 GLU D 35 GLU.? 34.89 N6 ADP C1001 A 369 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 16.54 46.37 63.94 14.77 45.79 62.95 -1.41 44.17 17.18 -1.59 46.26 17.19 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.26 47.42 21.46 -29.58 49.13 20.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 279 GLU D 44 GLU^? 25.61 N6 ADP C1001 A 369 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 16.54 46.37 63.94 14.77 45.79 62.95 -26.92 53.16 5.77 -28.08 52.58 4.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 279 GLU C 41 GLU^? 24.05 C2 ADP C1001 A 369 ASP D 54 ASP~? 30.93 N6 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 16.54 46.37 63.94 14.77 45.79 62.95 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.33 59.98 17.64 -30.29 60.47 18.21 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 279 GLU D 33 GLU^? 24.81 N6 ADP C1001 A 369 ASP D 54 ASP~? 30.93 N6 ADP C1001 coo 11.74 38.14 80.19 10.63 36.40 80.65 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 16.54 46.37 63.94 14.77 45.79 62.95 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.33 59.98 17.64 -30.29 60.47 18.21 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 16 hits 1m53_c06 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 38 LYS^? 31.29 N6 ADP C1001 166 LYS B 38 LYS.? 29.47 N6 ADP C1001 324 SER B 18 SER.? 16.80 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 27.27 1.43 25.09 29.18 5.25 22.89 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 46.32 14.55 19.93 45.95 12.72 21.27 -27.97 19.58 3.98 -27.31 17.40 4.71 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 38 LYS^? 31.29 N6 ADP C1001 166 LYS B 38 LYS.? 29.47 N6 ADP C1001 324 SER B 24 SER.? 17.25 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 27.27 1.43 25.09 29.18 5.25 22.89 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 46.32 14.55 19.93 45.95 12.72 21.27 -29.56 14.13 6.20 -27.58 15.07 7.20 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 60 LYS~? 43.57 N6 ADP C1001 166 LYS A 65 LYS.? 41.76 N6 ADP C1001 324 SER B 96 SER~? 21.70 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 27.27 1.43 25.09 29.18 5.25 22.89 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 46.32 14.55 19.93 45.95 12.72 21.27 -15.47 24.08 5.71 -14.65 24.49 3.41 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS A 65 LYS.? 41.76 N6 ADP C1001 166 LYS A 60 LYS~? 43.57 N6 ADP C1001 324 SER A 15 SER~? 35.42 N1 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 27.27 1.43 25.09 29.18 5.25 22.89 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 46.32 14.55 19.93 45.95 12.72 21.27 -14.03 0.17 16.67 -15.21 -1.29 15.12 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS A 65 LYS.? 41.76 N6 ADP C1001 166 LYS A 60 LYS~? 43.57 N6 ADP C1001 324 SER B 96 SER~? 21.70 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 27.27 1.43 25.09 29.18 5.25 22.89 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 46.32 14.55 19.93 45.95 12.72 21.27 -15.47 24.08 5.71 -14.65 24.49 3.41 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS A 100 LYS~? 39.84 N1 ADP C1001 166 LYS A 106 LYS.? 50.79 N6 ADP C1001 324 SER A 24 SER.? 39.01 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -1.03 5.78 15.30 1.15 8.50 19.55 coo 27.27 1.43 25.09 29.18 5.25 22.89 5.53 0.28 13.93 10.17 1.85 15.47 coo 46.32 14.55 19.93 45.95 12.72 21.27 -17.71 -6.23 7.18 -16.21 -4.71 6.28 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS A 108 LYS.? 49.24 N1 ADP C1001 166 LYS A 106 LYS.? 50.79 N6 ADP C1001 324 SER A 24 SER.? 39.01 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 1.67 -4.82 14.87 3.65 -3.69 19.86 coo 27.27 1.43 25.09 29.18 5.25 22.89 5.53 0.28 13.93 10.17 1.85 15.47 coo 46.32 14.55 19.93 45.95 12.72 21.27 -17.71 -6.23 7.18 -16.21 -4.71 6.28 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS B 38 LYS.? 29.47 N6 ADP C1001 166 LYS A 38 LYS^? 31.29 N6 ADP C1001 324 SER B 18 SER.? 16.80 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 27.27 1.43 25.09 29.18 5.25 22.89 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 46.32 14.55 19.93 45.95 12.72 21.27 -27.97 19.58 3.98 -27.31 17.40 4.71 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS B 38 LYS.? 29.47 N6 ADP C1001 166 LYS A 38 LYS^? 31.29 N6 ADP C1001 324 SER B 24 SER.? 17.25 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 27.27 1.43 25.09 29.18 5.25 22.89 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 46.32 14.55 19.93 45.95 12.72 21.27 -29.56 14.13 6.20 -27.58 15.07 7.20 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS B 60 LYS~? 21.40 C2 ADP C1001 166 LYS B 65 LYS.? 17.22 C2 ADP C1001 324 SER A 96 SER~? 35.53 N1 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 27.27 1.43 25.09 29.18 5.25 22.89 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 46.32 14.55 19.93 45.95 12.72 21.27 -7.24 4.52 16.66 -7.72 4.23 19.06 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS B 65 LYS.? 17.22 C2 ADP C1001 166 LYS B 60 LYS~? 21.40 C2 ADP C1001 324 SER B 15 SER~? 20.97 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 27.27 1.43 25.09 29.18 5.25 22.89 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 46.32 14.55 19.93 45.95 12.72 21.27 -19.71 18.90 1.41 -21.68 17.51 1.61 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS B 100 LYS~? 23.96 N6 ADP C1001 166 LYS B 106 LYS.? 18.25 N6 ADP C1001 324 SER B 24 SER.? 17.25 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 27.27 1.43 25.09 29.18 5.25 22.89 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 46.32 14.55 19.93 45.95 12.72 21.27 -29.56 14.13 6.20 -27.58 15.07 7.20 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 13 3 # 13 164 LYS B 106 LYS.? 18.25 N6 ADP C1001 166 LYS B 108 LYS.? 17.61 N6 ADP C1001 324 SER D 15 SER~? 33.93 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 27.27 1.43 25.09 29.18 5.25 22.89 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 46.32 14.55 19.93 45.95 12.72 21.27 -14.05 55.07 1.32 -15.85 56.53 2.06 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 14 3 # 14 164 LYS B 108 LYS.? 17.61 N6 ADP C1001 166 LYS B 106 LYS.? 18.25 N6 ADP C1001 324 SER B 24 SER.? 17.25 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 27.27 1.43 25.09 29.18 5.25 22.89 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 46.32 14.55 19.93 45.95 12.72 21.27 -29.56 14.13 6.20 -27.58 15.07 7.20 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 15 3 # 15 164 LYS B 108 LYS.? 17.61 N6 ADP C1001 166 LYS B 106 LYS.? 18.25 N6 ADP C1001 324 SER D 15 SER~? 33.93 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 27.27 1.43 25.09 29.18 5.25 22.89 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 46.32 14.55 19.93 45.95 12.72 21.27 -14.05 55.07 1.32 -15.85 56.53 2.06 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 16 3 # 16 164 LYS B 114 LYS.? -3.14 O1A ADP C1001s 166 LYS B 116 LYS.? 13.79 O2B ADP C1001 324 SER B 96 SER~? 21.70 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 27.27 1.43 25.09 29.18 5.25 22.89 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 46.32 14.55 19.93 45.95 12.72 21.27 -15.47 24.08 5.71 -14.65 24.49 3.41 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 17 3 # 17 164 LYS B 116 LYS.? 13.79 O2B ADP C1001 166 LYS B 114 LYS.? -3.14 O1A ADP C1001s 324 SER B 96 SER~? 21.70 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 27.27 1.43 25.09 29.18 5.25 22.89 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 46.32 14.55 19.93 45.95 12.72 21.27 -15.47 24.08 5.71 -14.65 24.49 3.41 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 18 3 # 18 164 LYS C 65 LYS.? 16.76 N1 ADP C1001 166 LYS C 60 LYS~? 19.47 N6 ADP C1001 324 SER C 15 SER.? 21.32 C2 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 27.27 1.43 25.09 29.18 5.25 22.89 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 46.32 14.55 19.93 45.95 12.72 21.27 -33.57 35.15 39.94 -32.12 36.31 38.28 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 19 3 # 19 164 LYS C 100 LYS~? 22.69 C2 ADP C1001 166 LYS C 106 LYS.? 22.18 C2 ADP C1001 324 SER C 24 SER.? 15.73 O2' ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 27.27 1.43 25.09 29.18 5.25 22.89 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 46.32 14.55 19.93 45.95 12.72 21.27 -34.60 42.57 30.36 -34.63 40.35 29.52 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 20 3 # 20 164 LYS C 108 LYS.? 14.57 N3 ADP C1001 166 LYS C 106 LYS.? 22.18 C2 ADP C1001 324 SER C 24 SER.? 15.73 O2' ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 27.27 1.43 25.09 29.18 5.25 22.89 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 46.32 14.55 19.93 45.95 12.72 21.27 -34.60 42.57 30.36 -34.63 40.35 29.52 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 21 3 # 21 164 LYS C 114 LYS.? -2.76 O3B ADP C1001s 166 LYS C 116 LYS.? 13.74 O3' ADP C1001 324 SER C 96 SER~? 23.21 C2 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 27.27 1.43 25.09 29.18 5.25 22.89 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 46.32 14.55 19.93 45.95 12.72 21.27 -29.63 28.34 39.20 -30.85 27.83 41.24 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 22 3 # 22 164 LYS C 116 LYS.? 13.74 O3' ADP C1001 166 LYS C 114 LYS.? -2.76 O3B ADP C1001s 324 SER C 15 SER.? 21.32 C2 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 27.27 1.43 25.09 29.18 5.25 22.89 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 46.32 14.55 19.93 45.95 12.72 21.27 -33.57 35.15 39.94 -32.12 36.31 38.28 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 23 3 # 23 164 LYS C 116 LYS.? 13.74 O3' ADP C1001 166 LYS C 114 LYS.? -2.76 O3B ADP C1001s 324 SER C 96 SER~? 23.21 C2 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 27.27 1.43 25.09 29.18 5.25 22.89 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 46.32 14.55 19.93 45.95 12.72 21.27 -29.63 28.34 39.20 -30.85 27.83 41.24 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 24 3 # 24 164 LYS D 60 LYS~? 25.96 N1 ADP C1001 166 LYS D 65 LYS.? 25.59 N1 ADP C1001 324 SER C 86 SER^? 7.39 N1 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 27.27 1.43 25.09 29.18 5.25 22.89 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 46.32 14.55 19.93 45.95 12.72 21.27 -26.83 30.24 19.36 -25.45 28.48 18.57 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 25 3 # 25 164 LYS D 65 LYS.? 25.59 N1 ADP C1001 166 LYS D 60 LYS~? 25.96 N1 ADP C1001 324 SER D 15 SER~? 33.93 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 27.27 1.43 25.09 29.18 5.25 22.89 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 46.32 14.55 19.93 45.95 12.72 21.27 -14.05 55.07 1.32 -15.85 56.53 2.06 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 26 3 # 26 164 LYS D 100 LYS~? 39.55 N6 ADP C1001 166 LYS D 106 LYS.? 44.27 N6 ADP C1001 324 SER D 24 SER.? 31.80 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -3.04 48.91 8.43 1.31 48.12 4.91 coo 27.27 1.43 25.09 29.18 5.25 22.89 1.94 54.62 12.82 6.05 51.27 9.45 coo 46.32 14.55 19.93 45.95 12.72 21.27 -21.41 60.30 8.38 -19.94 58.41 8.67 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 27 3 # 27 164 LYS D 108 LYS.? 47.30 N6 ADP C1001 166 LYS D 106 LYS.? 44.27 N6 ADP C1001 324 SER D 24 SER.? 31.80 N6 ADP C1001 coo 25.93 8.11 25.51 26.40 7.80 19.66 -0.82 59.67 9.89 3.99 59.45 8.43 coo 27.27 1.43 25.09 29.18 5.25 22.89 1.94 54.62 12.82 6.05 51.27 9.45 coo 46.32 14.55 19.93 45.95 12.72 21.27 -21.41 60.30 8.38 -19.94 58.41 8.67 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 27 hits 1mdr_c01 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 12 GLY~? 30.18 N6 ADP C1001 A 501 ASP A 54 ASP~? 42.89 N6 ADP C1001 B 367 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -15.34 4.79 13.98 -15.18 4.16 14.49 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 63 GLY.? 35.61 N6 ADP C1001 A 501 ASP A 97 ASP~? 39.49 N1 ADP C1001 B 367 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -10.41 7.85 -2.69 -10.52 7.16 -2.28 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 93 GLY.? 42.20 N1 ADP C1001 A 501 ASP B 31 ASP^? 22.05 N1 ADP C1001 B 367 TYR A 79 TYR~? 47.68 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -7.00 -4.03 17.29 -7.39 -3.85 16.59 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 93 GLY.? 42.20 N1 ADP C1001 A 501 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 367 TYR A 79 TYR~? 47.68 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -7.00 -4.03 17.29 -7.39 -3.85 16.59 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY B 12 GLY~? 22.61 N6 ADP C1001 A 501 ASP B 54 ASP~? 20.52 O4' ADP C1001 B 367 TYR A 79 TYR~? 47.68 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -17.91 15.52 4.82 -17.88 16.00 4.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY B 22 GLY.? 14.86 O1A ADP C1001 A 501 ASP B 97 ASP~? 21.13 N6 ADP C1001 B 367 TYR C 92 TYR.? 13.82 O3' ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -33.99 15.05 9.19 -33.34 14.99 8.60 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -39.98 27.63 32.25 -40.82 24.99 32.44 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY B 63 GLY.? 19.32 N1 ADP C1001 A 501 ASP A 31 ASP^? 31.30 N6 ADP C1001 B 367 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY B 63 GLY.? 19.32 N1 ADP C1001 A 501 ASP A 36 ASP^? 33.81 N6 ADP C1001 B 367 TYR B 111 TYR.? 10.00 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -31.63 36.54 7.53 -29.30 37.35 8.87 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 63 GLY.? 19.32 N1 ADP C1001 A 501 ASP A 36 ASP^? 33.81 N6 ADP C1001 B 367 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY B 63 GLY.? 19.32 N1 ADP C1001 A 501 ASP B 9 ASP.? 24.63 N6 ADP C1001 B 367 TYR C 70 TYR.? 10.33 O3' ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -40.11 31.99 28.67 -42.64 30.90 28.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY B 63 GLY.? 19.32 N1 ADP C1001 A 501 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 367 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY B 90 GLY.? 7.42 N6 ADP C1001 A 501 ASP B 31 ASP^? 22.05 N1 ADP C1001 B 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -30.30 29.32 7.79 -29.71 28.87 8.11 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY B 90 GLY.? 7.42 N6 ADP C1001 A 501 ASP D 31 ASP^? 21.52 N6 ADP C1001 B 367 TYR C 92 TYR.? 13.82 O3' ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -30.30 29.32 7.79 -29.71 28.87 8.11 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -39.98 27.63 32.25 -40.82 24.99 32.44 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY B 93 GLY.? 16.72 N6 ADP C1001 A 501 ASP B 31 ASP^? 22.05 N1 ADP C1001 B 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -22.84 26.20 1.59 -22.97 25.70 2.25 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY B 93 GLY.? 16.72 N6 ADP C1001 A 501 ASP D 31 ASP^? 21.52 N6 ADP C1001 B 367 TYR B 79 TYR~? 13.34 O4' ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -22.84 26.20 1.59 -22.97 25.70 2.25 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -36.09 15.89 20.59 -36.23 13.43 21.88 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY B 104 GLY~? 17.92 N6 ADP C1001 A 501 ASP A 36 ASP^? 33.81 N6 ADP C1001 B 367 TYR B 79 TYR~? 13.34 O4' ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -14.96 34.23 13.50 -15.73 33.92 13.69 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -36.09 15.89 20.59 -36.23 13.43 21.88 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY B 105 GLY.? 14.83 N6 ADP C1001 A 501 ASP D 10 ASP.? 31.49 N6 ADP C1001 B 367 TYR C 26 TYR^? 24.03 C2 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -18.36 34.95 14.87 -18.15 34.98 14.15 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -30.56 43.06 36.03 -31.04 45.27 37.68 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY C 22 GLY.? 14.12 O2' ADP C1001 A 501 ASP C 31 ASP^? 21.62 C2 ADP C1001 B 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -35.88 42.47 25.00 -35.89 42.36 25.87 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY C 22 GLY.? 14.12 O2' ADP C1001 A 501 ASP C 97 ASP~? 22.56 C2 ADP C1001 B 367 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -35.88 42.47 25.00 -35.89 42.36 25.87 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY C 22 GLY.? 14.12 O2' ADP C1001 A 501 ASP D 54 ASP~? 30.93 N6 ADP C1001 B 367 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -35.88 42.47 25.00 -35.89 42.36 25.87 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY C 63 GLY.? 18.10 N1 ADP C1001 A 501 ASP C 9 ASP.? 24.62 C2 ADP C1001 B 367 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -18.24 37.08 25.10 -19.00 37.10 25.28 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY C 73 GLY~? 7.38 O2' ADP C1001 A 501 ASP C 10 ASP.? 28.10 C2 ADP C1001 B 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -38.52 37.92 18.83 -37.81 37.51 18.99 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -29.82 42.88 40.75 -30.96 43.09 42.54 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 23 3 # 23 A 465 GLY C 105 GLY.? 16.33 C2 ADP C1001 A 501 ASP A 10 ASP.? 29.48 N1 ADP C1001 B 367 TYR B 111 TYR.? 10.00 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -28.59 18.07 29.12 -28.98 18.05 29.83 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -31.63 36.54 7.53 -29.30 37.35 8.87 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 24 3 # 24 A 465 GLY D 12 GLY~? 28.94 N6 ADP C1001 A 501 ASP B 110 ASP.? 12.77 N6 ADP C1001 B 367 TYR D 79 TYR~? 36.26 N1 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -16.72 51.02 2.91 -16.29 51.55 2.48 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.76 62.70 24.87 -24.61 64.61 25.82 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 25 3 # 25 A 465 GLY D 12 GLY~? 28.94 N6 ADP C1001 A 501 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 367 TYR D 111 TYR.? 48.44 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -16.72 51.02 2.91 -16.29 51.55 2.48 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -0.39 66.61 15.04 1.31 64.37 15.18 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 26 3 # 26 A 465 GLY D 12 GLY~? 28.94 N6 ADP C1001 A 501 ASP D 54 ASP~? 30.93 N6 ADP C1001 B 367 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -16.72 51.02 2.91 -16.29 51.55 2.48 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 27 3 # 27 A 465 GLY D 34 GLY.? 30.79 N6 ADP C1001 A 501 ASP B 31 ASP^? 22.05 N1 ADP C1001 B 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 28 3 # 28 A 465 GLY D 34 GLY.? 30.79 N6 ADP C1001 A 501 ASP B 97 ASP~? 21.13 N6 ADP C1001 B 367 TYR D 70 TYR.? 43.17 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -10.19 64.81 9.49 -8.66 67.08 8.77 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 29 3 # 29 A 465 GLY D 34 GLY.? 30.79 N6 ADP C1001 A 501 ASP C 31 ASP^? 21.62 C2 ADP C1001 B 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 30 3 # 30 A 465 GLY D 51 GLY.? 34.90 O2' ADP C1001 A 501 ASP D 10 ASP.? 31.49 N6 ADP C1001 B 367 TYR C 26 TYR^? 24.03 C2 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -29.93 64.41 19.47 -29.53 63.99 18.88 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -30.56 43.06 36.03 -31.04 45.27 37.68 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 31 3 # 31 A 465 GLY D 63 GLY.? 22.25 N6 ADP C1001 A 501 ASP D 97 ASP~? 39.15 N6 ADP C1001 B 367 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -19.39 47.07 20.40 -19.28 47.74 19.95 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -30.56 25.72 4.57 -31.82 27.56 2.83 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 31 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 12 GLY~? 30.18 N6 ADP C1001 D 501 ASP A 54 ASP~? 42.89 N6 ADP C1001 E 367 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -15.34 4.79 13.98 -15.18 4.16 14.49 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 63 GLY.? 35.61 N6 ADP C1001 D 501 ASP A 97 ASP~? 39.49 N1 ADP C1001 E 367 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -10.41 7.85 -2.69 -10.52 7.16 -2.28 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 93 GLY.? 42.20 N1 ADP C1001 D 501 ASP B 31 ASP^? 22.05 N1 ADP C1001 E 367 TYR A 79 TYR~? 47.68 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -7.00 -4.03 17.29 -7.39 -3.85 16.59 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 93 GLY.? 42.20 N1 ADP C1001 D 501 ASP B 61 ASP~? 21.98 C2 ADP C1001 E 367 TYR A 79 TYR~? 47.68 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -7.00 -4.03 17.29 -7.39 -3.85 16.59 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY B 12 GLY~? 22.61 N6 ADP C1001 D 501 ASP B 54 ASP~? 20.52 O4' ADP C1001 E 367 TYR A 79 TYR~? 47.68 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -17.91 15.52 4.82 -17.88 16.00 4.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY B 22 GLY.? 14.86 O1A ADP C1001 D 501 ASP B 97 ASP~? 21.13 N6 ADP C1001 E 367 TYR C 92 TYR.? 13.82 O3' ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -33.99 15.05 9.19 -33.34 14.99 8.60 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -39.98 27.63 32.25 -40.82 24.99 32.44 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY B 63 GLY.? 19.32 N1 ADP C1001 D 501 ASP A 31 ASP^? 31.30 N6 ADP C1001 E 367 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY B 63 GLY.? 19.32 N1 ADP C1001 D 501 ASP A 36 ASP^? 33.81 N6 ADP C1001 E 367 TYR B 111 TYR.? 10.00 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -31.63 36.54 7.53 -29.30 37.35 8.87 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY B 63 GLY.? 19.32 N1 ADP C1001 D 501 ASP A 36 ASP^? 33.81 N6 ADP C1001 E 367 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY B 63 GLY.? 19.32 N1 ADP C1001 D 501 ASP B 9 ASP.? 24.63 N6 ADP C1001 E 367 TYR C 70 TYR.? 10.33 O3' ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -40.11 31.99 28.67 -42.64 30.90 28.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY B 63 GLY.? 19.32 N1 ADP C1001 D 501 ASP B 10 ASP.? 28.32 N6 ADP C1001 E 367 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.09 14.83 22.17 -21.52 14.99 21.54 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY B 90 GLY.? 7.42 N6 ADP C1001 D 501 ASP B 31 ASP^? 22.05 N1 ADP C1001 E 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -30.30 29.32 7.79 -29.71 28.87 8.11 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY B 90 GLY.? 7.42 N6 ADP C1001 D 501 ASP D 31 ASP^? 21.52 N6 ADP C1001 E 367 TYR C 92 TYR.? 13.82 O3' ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -30.30 29.32 7.79 -29.71 28.87 8.11 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -39.98 27.63 32.25 -40.82 24.99 32.44 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY B 93 GLY.? 16.72 N6 ADP C1001 D 501 ASP B 31 ASP^? 22.05 N1 ADP C1001 E 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -22.84 26.20 1.59 -22.97 25.70 2.25 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY B 93 GLY.? 16.72 N6 ADP C1001 D 501 ASP D 31 ASP^? 21.52 N6 ADP C1001 E 367 TYR B 79 TYR~? 13.34 O4' ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -22.84 26.20 1.59 -22.97 25.70 2.25 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -36.09 15.89 20.59 -36.23 13.43 21.88 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY B 104 GLY~? 17.92 N6 ADP C1001 D 501 ASP A 36 ASP^? 33.81 N6 ADP C1001 E 367 TYR B 79 TYR~? 13.34 O4' ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -14.96 34.23 13.50 -15.73 33.92 13.69 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -36.09 15.89 20.59 -36.23 13.43 21.88 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY B 105 GLY.? 14.83 N6 ADP C1001 D 501 ASP D 10 ASP.? 31.49 N6 ADP C1001 E 367 TYR C 26 TYR^? 24.03 C2 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -18.36 34.95 14.87 -18.15 34.98 14.15 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -30.56 43.06 36.03 -31.04 45.27 37.68 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY C 22 GLY.? 14.12 O2' ADP C1001 D 501 ASP C 31 ASP^? 21.62 C2 ADP C1001 E 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -35.88 42.47 25.00 -35.89 42.36 25.87 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY C 22 GLY.? 14.12 O2' ADP C1001 D 501 ASP C 97 ASP~? 22.56 C2 ADP C1001 E 367 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -35.88 42.47 25.00 -35.89 42.36 25.87 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY C 22 GLY.? 14.12 O2' ADP C1001 D 501 ASP D 54 ASP~? 30.93 N6 ADP C1001 E 367 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -35.88 42.47 25.00 -35.89 42.36 25.87 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY C 63 GLY.? 18.10 N1 ADP C1001 D 501 ASP C 97 ASP~? 22.56 C2 ADP C1001 E 367 TYR B 92 TYR.? 14.20 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -18.24 37.08 25.10 -19.00 37.10 25.28 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -26.28 29.17 2.52 -25.72 31.84 1.90 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY C 73 GLY~? 7.38 O2' ADP C1001 D 501 ASP C 10 ASP.? 28.10 C2 ADP C1001 E 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -38.52 37.92 18.83 -37.81 37.51 18.99 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -29.82 42.88 40.75 -30.96 43.09 42.54 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY C 105 GLY.? 16.33 C2 ADP C1001 D 501 ASP A 10 ASP.? 29.48 N1 ADP C1001 E 367 TYR B 111 TYR.? 10.00 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -28.59 18.07 29.12 -28.98 18.05 29.83 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -31.63 36.54 7.53 -29.30 37.35 8.87 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY D 12 GLY~? 28.94 N6 ADP C1001 D 501 ASP B 110 ASP.? 12.77 N6 ADP C1001 E 367 TYR D 79 TYR~? 36.26 N1 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -16.72 51.02 2.91 -16.29 51.55 2.48 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.76 62.70 24.87 -24.61 64.61 25.82 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 25 3 # 25 D 465 GLY D 12 GLY~? 28.94 N6 ADP C1001 D 501 ASP C 54 ASP~? 20.12 N1 ADP C1001 E 367 TYR D 111 TYR.? 48.44 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -16.72 51.02 2.91 -16.29 51.55 2.48 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -0.39 66.61 15.04 1.31 64.37 15.18 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 26 3 # 26 D 465 GLY D 12 GLY~? 28.94 N6 ADP C1001 D 501 ASP D 54 ASP~? 30.93 N6 ADP C1001 E 367 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -16.72 51.02 2.91 -16.29 51.55 2.48 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 27 3 # 27 D 465 GLY D 34 GLY.? 30.79 N6 ADP C1001 D 501 ASP B 31 ASP^? 22.05 N1 ADP C1001 E 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 28 3 # 28 D 465 GLY D 34 GLY.? 30.79 N6 ADP C1001 D 501 ASP B 97 ASP~? 21.13 N6 ADP C1001 E 367 TYR D 70 TYR.? 43.17 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -10.19 64.81 9.49 -8.66 67.08 8.77 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 29 3 # 29 D 465 GLY D 34 GLY.? 30.79 N6 ADP C1001 D 501 ASP B 97 ASP~? 21.13 N6 ADP C1001 E 367 TYR D 92 TYR.? 44.20 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -5.36 62.57 6.57 -2.60 62.73 6.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 30 3 # 30 D 465 GLY D 34 GLY.? 30.79 N6 ADP C1001 D 501 ASP C 31 ASP^? 21.62 C2 ADP C1001 E 367 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.44 40.17 17.98 -3.83 40.71 17.51 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -22.48 54.16 4.72 -24.58 53.78 2.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 31 3 # 31 D 465 GLY D 51 GLY.? 34.90 O2' ADP C1001 D 501 ASP D 10 ASP.? 31.49 N6 ADP C1001 E 367 TYR C 26 TYR^? 24.03 C2 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -29.93 64.41 19.47 -29.53 63.99 18.88 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -30.56 43.06 36.03 -31.04 45.27 37.68 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 32 3 # 32 D 465 GLY D 63 GLY.? 22.25 N6 ADP C1001 D 501 ASP D 97 ASP~? 39.15 N6 ADP C1001 E 367 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -19.39 47.07 20.40 -19.28 47.74 19.95 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -30.56 25.72 4.57 -31.82 27.56 2.83 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 32 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 55 TYR A 92 TYR.? 47.39 N1 ADP C1001 A 84 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 4.60 40.33 20.42 7.25 39.50 20.05 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 9.71 44.83 15.47 10.13 41.43 19.93 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP A 110 ASP.? 52.32 N6 ADP C1001 A 55 TYR A 111 TYR.? 55.51 N6 ADP C1001 A 84 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 4.60 40.33 20.42 7.25 39.50 20.05 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 9.71 44.83 15.47 10.13 41.43 19.93 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP B 54 ASP~? 20.52 O4' ADP C1001 A 55 TYR B 79 TYR~? 13.34 O4' ADP C1001 A 84 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 4.60 40.33 20.42 7.25 39.50 20.05 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 9.71 44.83 15.47 10.13 41.43 19.93 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP B 97 ASP~? 21.13 N6 ADP C1001 A 55 TYR B 92 TYR.? 14.20 N6 ADP C1001 A 84 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 4.60 40.33 20.42 7.25 39.50 20.05 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 9.71 44.83 15.47 10.13 41.43 19.93 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 55 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 84 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 4.60 40.33 20.42 7.25 39.50 20.05 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 9.71 44.83 15.47 10.13 41.43 19.93 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 55 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 84 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 4.60 40.33 20.42 7.25 39.50 20.05 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 9.71 44.83 15.47 10.13 41.43 19.93 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 7 3 # 7 A 50 ASP C 97 ASP~? 22.56 C2 ADP C1001 A 55 TYR C 92 TYR.? 13.82 O3' ADP C1001 A 84 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 4.60 40.33 20.42 7.25 39.50 20.05 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 9.71 44.83 15.47 10.13 41.43 19.93 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 8 3 # 8 A 50 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 55 TYR C 111 TYR.? 9.78 O3' ADP C1001 A 84 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 4.60 40.33 20.42 7.25 39.50 20.05 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 9.71 44.83 15.47 10.13 41.43 19.93 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 9 3 # 9 A 50 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 55 TYR C 111 TYR.? 9.78 O3' ADP C1001 A 84 LYS C 114 LYS.? -2.76 O3B ADP C1001s coo 11.09 42.89 24.44 11.32 42.06 22.49 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 4.60 40.33 20.42 7.25 39.50 20.05 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 9.71 44.83 15.47 10.13 41.43 19.93 -44.82 31.28 21.50 -43.38 31.47 16.20 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 10 3 # 10 A 50 ASP D 110 ASP.? 48.95 N6 ADP C1001 A 55 TYR D 70 TYR.? 43.17 N6 ADP C1001 A 84 LYS D 114 LYS.? 50.69 N6 ADP C1001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 4.60 40.33 20.42 7.25 39.50 20.05 -10.19 64.81 9.49 -8.66 67.08 8.77 coo 9.71 44.83 15.47 10.13 41.43 19.93 -9.33 71.95 14.33 -7.85 74.07 18.29 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 11 3 # 11 A 50 ASP D 110 ASP.? 48.95 N6 ADP C1001 A 55 TYR D 111 TYR.? 48.44 N6 ADP C1001 A 84 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo 11.09 42.89 24.44 11.32 42.06 22.49 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 4.60 40.33 20.42 7.25 39.50 20.05 -0.39 66.61 15.04 1.31 64.37 15.18 coo 9.71 44.83 15.47 10.13 41.43 19.93 -0.82 59.67 9.89 3.99 59.45 8.43 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 11 hits 1mrq_c02 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS B 106 LYS.? 18.25 N6 ADP C1001 A 169 LYS B 108 LYS.? 17.61 N6 ADP C1001 A 327 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 20.73 15.53 25.54 22.09 15.64 19.40 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 24.31 10.25 23.71 29.02 12.05 20.75 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 21.86 20.40 18.59 22.12 18.33 18.33 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS C 100 LYS~? 22.69 C2 ADP C1001 A 169 LYS C 106 LYS.? 22.18 C2 ADP C1001 A 327 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 20.73 15.53 25.54 22.09 15.64 19.40 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 24.31 10.25 23.71 29.02 12.05 20.75 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 21.86 20.40 18.59 22.12 18.33 18.33 -21.26 18.31 34.64 -21.49 16.34 35.41 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 2 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 38 LYS^? 31.29 N6 ADP C1001 B 169 LYS B 38 LYS.? 29.47 N6 ADP C1001 B 327 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS B 106 LYS.? 18.25 N6 ADP C1001 B 169 LYS B 108 LYS.? 17.61 N6 ADP C1001 B 327 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -23.61 33.84 6.26 -20.57 37.69 4.41 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS C 100 LYS~? 22.69 C2 ADP C1001 B 169 LYS C 106 LYS.? 22.18 C2 ADP C1001 B 327 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -21.26 18.31 34.64 -21.49 16.34 35.41 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 3 hits 1muc_c01 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 290 LYS C 114 LYS.? -2.76 O3B ADP C1001s A 405 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 41.33 25.99 28.05 41.95 26.95 29.80 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 37.11 33.75 31.82 38.72 27.95 29.90 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 42.28 27.98 41.30 43.16 28.14 38.35 -38.47 40.65 15.33 -40.88 39.19 16.61 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 1 hits 1nhx_c00 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS B 38 LYS.? 29.47 N6 ADP C1001 631 LYS C 38 LYS^? 29.32 C2 ADP C1001 708 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -9.30 19.94 15.62 -4.67 19.41 15.25 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -16.18 28.34 36.63 -11.47 27.59 37.59 coo 18.16 32.86 9.85 16.06 28.20 13.56 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS B 38 LYS.? 29.47 N6 ADP C1001 631 LYS C 60 LYS~? 19.47 N6 ADP C1001 708 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -9.30 19.94 15.62 -4.67 19.41 15.25 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 18.16 32.86 9.85 16.06 28.20 13.56 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS B 60 LYS~? 21.40 C2 ADP C1001 631 LYS A 38 LYS^? 31.29 N6 ADP C1001 708 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -26.04 13.89 21.83 -25.92 10.67 25.77 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 18.16 32.86 9.85 16.06 28.20 13.56 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS B 60 LYS~? 21.40 C2 ADP C1001 631 LYS B 14 LYS~? 27.17 N6 ADP C1001 708 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -26.04 13.89 21.83 -25.92 10.67 25.77 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 18.16 32.86 9.85 16.06 28.20 13.56 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS B 65 LYS.? 17.22 C2 ADP C1001 631 LYS A 14 LYS~? 28.69 N1 ADP C1001 708 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -23.42 20.96 21.77 -22.73 18.61 26.55 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -12.97 3.35 18.51 -15.05 7.51 22.75 coo 18.16 32.86 9.85 16.06 28.20 13.56 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS B 100 LYS~? 23.96 N6 ADP C1001 631 LYS B 60 LYS~? 21.40 C2 ADP C1001 708 LYS D 38 LYS^? 26.03 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -14.49 29.22 9.50 -10.36 30.43 5.24 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 18.16 32.86 9.85 16.06 28.20 13.56 -10.44 39.35 12.00 -7.01 36.04 14.36 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 7 3 # 7 549 LYS B 100 LYS~? 23.96 N6 ADP C1001 631 LYS B 114 LYS.? -3.14 O1A ADP C1001s 708 LYS D 38 LYS^? 26.03 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -14.49 29.22 9.50 -10.36 30.43 5.24 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 18.16 32.86 9.85 16.06 28.20 13.56 -10.44 39.35 12.00 -7.01 36.04 14.36 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 8 3 # 8 549 LYS B 106 LYS.? 18.25 N6 ADP C1001 631 LYS B 114 LYS.? -3.14 O1A ADP C1001s 708 LYS D 38 LYS^? 26.03 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -19.68 36.01 11.35 -19.41 40.72 7.99 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 18.16 32.86 9.85 16.06 28.20 13.56 -10.44 39.35 12.00 -7.01 36.04 14.36 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 9 3 # 9 549 LYS B 106 LYS.? 18.25 N6 ADP C1001 631 LYS B 116 LYS.? 13.79 O2B ADP C1001 708 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -19.68 36.01 11.35 -19.41 40.72 7.99 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 18.16 32.86 9.85 16.06 28.20 13.56 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 10 3 # 10 549 LYS B 106 LYS.? 18.25 N6 ADP C1001 631 LYS B 116 LYS.? 13.79 O2B ADP C1001 708 LYS D 38 LYS^? 26.03 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -19.68 36.01 11.35 -19.41 40.72 7.99 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 18.16 32.86 9.85 16.06 28.20 13.56 -10.44 39.35 12.00 -7.01 36.04 14.36 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 11 3 # 11 549 LYS B 114 LYS.? -3.14 O1A ADP C1001s 631 LYS C 116 LYS.? 13.74 O3' ADP C1001 708 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -38.05 28.30 5.66 -42.50 28.99 10.13 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 18.16 32.86 9.85 16.06 28.20 13.56 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 12 3 # 12 549 LYS C 60 LYS~? 19.47 N6 ADP C1001 631 LYS C 14 LYS.? 27.01 C2 ADP C1001 708 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -21.36 39.39 22.00 -17.64 41.95 19.02 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -31.38 33.30 42.44 -27.73 35.10 43.96 coo 18.16 32.86 9.85 16.06 28.20 13.56 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 13 3 # 13 549 LYS C 60 LYS~? 19.47 N6 ADP C1001 631 LYS C 100 LYS~? 22.69 C2 ADP C1001 708 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -21.36 39.39 22.00 -17.64 41.95 19.02 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 18.16 32.86 9.85 16.06 28.20 13.56 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 14 3 # 14 549 LYS C 114 LYS.? -2.76 O3B ADP C1001s 631 LYS B 116 LYS.? 13.79 O2B ADP C1001 708 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -44.82 31.28 21.50 -43.38 31.47 16.20 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -38.53 26.18 0.73 -35.66 28.79 0.03 coo 18.16 32.86 9.85 16.06 28.20 13.56 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 15 3 # 15 549 LYS D 38 LYS^? 26.03 N6 ADP C1001 631 LYS D 108 LYS.? 47.30 N6 ADP C1001 708 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -10.44 39.35 12.00 -7.01 36.04 14.36 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -0.82 59.67 9.89 3.99 59.45 8.43 coo 18.16 32.86 9.85 16.06 28.20 13.56 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 16 3 # 16 549 LYS D 38 LYS^? 26.03 N6 ADP C1001 631 LYS D 108 LYS.? 47.30 N6 ADP C1001 708 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -10.44 39.35 12.00 -7.01 36.04 14.36 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -0.82 59.67 9.89 3.99 59.45 8.43 coo 18.16 32.86 9.85 16.06 28.20 13.56 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 17 3 # 17 549 LYS D 100 LYS~? 39.55 N6 ADP C1001 631 LYS B 100 LYS~? 23.96 N6 ADP C1001 708 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -3.04 48.91 8.43 1.31 48.12 4.91 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 18.16 32.86 9.85 16.06 28.20 13.56 1.94 54.62 12.82 6.05 51.27 9.45 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 18 3 # 18 549 LYS D 100 LYS~? 39.55 N6 ADP C1001 631 LYS B 100 LYS~? 23.96 N6 ADP C1001 708 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -3.04 48.91 8.43 1.31 48.12 4.91 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 18.16 32.86 9.85 16.06 28.20 13.56 -0.82 59.67 9.89 3.99 59.45 8.43 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 19 3 # 19 549 LYS D 100 LYS~? 39.55 N6 ADP C1001 631 LYS B 106 LYS.? 18.25 N6 ADP C1001 708 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo 8.61 33.06 11.15 10.12 29.19 8.82 -3.04 48.91 8.43 1.31 48.12 4.91 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 18.16 32.86 9.85 16.06 28.20 13.56 -0.82 59.67 9.89 3.99 59.45 8.43 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 19 hits 1nsf_c00 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 24 SER.? 39.01 N6 ADP C1001 A 154 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 261 ARG A 25 ARG.? 39.86 N6 ADP C1001 coo 16.10 74.10 3.11 17.18 73.52 5.20 -17.71 -6.23 7.18 -16.21 -4.71 6.28 coo 16.07 84.71 8.14 15.20 82.81 8.14 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 10.59 77.85 4.81 13.09 76.36 5.76 -23.17 -5.31 5.72 -21.44 -6.89 3.60 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 24 SER.? 39.01 N6 ADP C1001 A 154 ASP A 54 ASP~? 42.89 N6 ADP C1001 A 261 ARG A 25 ARG.? 39.86 N6 ADP C1001 coo 16.10 74.10 3.11 17.18 73.52 5.20 -17.71 -6.23 7.18 -16.21 -4.71 6.28 coo 16.07 84.71 8.14 15.20 82.81 8.14 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 10.59 77.85 4.81 13.09 76.36 5.76 -23.17 -5.31 5.72 -21.44 -6.89 3.60 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER A 96 SER~? 35.53 N1 ADP C1001 A 154 ASP A 9 ASP.? 35.63 N1 ADP C1001 A 261 ARG A 94 ARG~? 34.60 N1 ADP C1001 coo 16.10 74.10 3.11 17.18 73.52 5.20 -7.24 4.52 16.66 -7.72 4.23 19.06 coo 16.07 84.71 8.14 15.20 82.81 8.14 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 10.59 77.85 4.81 13.09 76.36 5.76 -9.32 1.83 20.70 -11.98 2.20 22.31 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER B 24 SER.? 17.25 N6 ADP C1001 A 154 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 261 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo 16.10 74.10 3.11 17.18 73.52 5.20 -29.56 14.13 6.20 -27.58 15.07 7.20 coo 16.07 84.71 8.14 15.20 82.81 8.14 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 10.59 77.85 4.81 13.09 76.36 5.76 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER B 24 SER.? 17.25 N6 ADP C1001 A 154 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 261 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo 16.10 74.10 3.11 17.18 73.52 5.20 -29.56 14.13 6.20 -27.58 15.07 7.20 coo 16.07 84.71 8.14 15.20 82.81 8.14 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 10.59 77.85 4.81 13.09 76.36 5.76 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 6 3 # 6 A 62 SER B 96 SER~? 21.70 N6 ADP C1001 A 154 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 261 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo 16.10 74.10 3.11 17.18 73.52 5.20 -15.47 24.08 5.71 -14.65 24.49 3.41 coo 16.07 84.71 8.14 15.20 82.81 8.14 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 10.59 77.85 4.81 13.09 76.36 5.76 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 7 3 # 7 A 62 SER C 24 SER.? 15.73 O2' ADP C1001 A 154 ASP C 9 ASP.? 24.62 C2 ADP C1001 A 261 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo 16.10 74.10 3.11 17.18 73.52 5.20 -34.60 42.57 30.36 -34.63 40.35 29.52 coo 16.07 84.71 8.14 15.20 82.81 8.14 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 10.59 77.85 4.81 13.09 76.36 5.76 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 8 3 # 8 A 62 SER C 24 SER.? 15.73 O2' ADP C1001 A 154 ASP C 10 ASP.? 28.10 C2 ADP C1001 A 261 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo 16.10 74.10 3.11 17.18 73.52 5.20 -34.60 42.57 30.36 -34.63 40.35 29.52 coo 16.07 84.71 8.14 15.20 82.81 8.14 -29.82 42.88 40.75 -30.96 43.09 42.54 coo 10.59 77.85 4.81 13.09 76.36 5.76 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 9 3 # 9 A 62 SER C 96 SER~? 23.21 C2 ADP C1001 A 154 ASP C 9 ASP.? 24.62 C2 ADP C1001 A 261 ARG C 94 ARG~? 23.82 O3' ADP C1001 coo 16.10 74.10 3.11 17.18 73.52 5.20 -29.63 28.34 39.20 -30.85 27.83 41.24 coo 16.07 84.71 8.14 15.20 82.81 8.14 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 10.59 77.85 4.81 13.09 76.36 5.76 -33.86 30.07 42.29 -36.45 31.77 42.05 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 10 3 # 10 A 62 SER D 24 SER.? 31.80 N6 ADP C1001 A 154 ASP D 10 ASP.? 31.49 N6 ADP C1001 A 261 ARG D 25 ARG.? 35.20 N6 ADP C1001 coo 16.10 74.10 3.11 17.18 73.52 5.20 -21.41 60.30 8.38 -19.94 58.41 8.67 coo 16.07 84.71 8.14 15.20 82.81 8.14 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 10.59 77.85 4.81 13.09 76.36 5.76 -26.42 60.33 5.19 -27.57 62.82 3.77 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 10 hits 1o98_c00 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 A 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 A 177 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 1.87 119.38 16.45 1.41 122.11 16.84 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 A 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 A 177 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 1.87 119.38 16.45 1.41 122.11 16.84 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -2.59 124.07 12.67 -0.91 126.17 18.42 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 A 177 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 1.87 119.38 16.45 1.41 122.11 16.84 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 A 177 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 1.87 119.38 16.45 1.41 122.11 16.84 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 A 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 A 177 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 1.87 119.38 16.45 1.41 122.11 16.84 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 A 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 A 177 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 1.87 119.38 16.45 1.41 122.11 16.84 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 A 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 A 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 A 177 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 1.87 119.38 16.45 1.41 122.11 16.84 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 A 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 A 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 A 177 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 1.87 119.38 16.45 1.41 122.11 16.84 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -0.82 59.67 9.89 3.99 59.45 8.43 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 B 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 B 177 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 B 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 B 177 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -4.18 120.17 46.85 -4.02 115.31 51.00 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 B 177 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 B 177 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 B 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 B 177 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 B 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 B 177 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -47.22 26.04 24.41 -47.86 24.10 23.79 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 B 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 B 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 B 177 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 B 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 B 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 B 177 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -3.02 71.97 12.29 -1.27 72.40 13.41 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -0.82 59.67 9.89 3.99 59.45 8.43 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 C 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 C 177 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 C 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 C 177 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -11.22 87.18 53.49 -10.94 81.64 50.31 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 C 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 C 177 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 C 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 C 177 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 C 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 C 177 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 C 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 C 177 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 C 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 C 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 C 177 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 C 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 C 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 C 177 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -0.82 59.67 9.89 3.99 59.45 8.43 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 D 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 D 177 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 D 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 D 177 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -14.24 70.61 23.48 -12.55 71.73 17.42 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 D 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 D 177 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 D 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 D 177 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 D 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 D 177 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 D 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 D 177 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 D 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 D 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 D 177 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 D 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 D 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 D 177 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -0.82 59.67 9.89 3.99 59.45 8.43 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 E 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 E 177 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 E 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 E 177 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 E 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 E 177 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 E 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 E 177 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 E 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 E 177 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 E 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 E 177 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 E 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 E 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 E 177 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 E 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 E 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 E 177 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -0.82 59.67 9.89 3.99 59.45 8.43 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 F 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 F 177 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 F 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 F 177 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -44.10 135.86 19.99 -45.67 134.21 14.07 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 F 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 F 177 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 F 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 F 177 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 F 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 F 177 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 F 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 F 177 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 F 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 F 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 F 177 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 F 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 F 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 F 177 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -0.82 59.67 9.89 3.99 59.45 8.43 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 G 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 G 177 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 G 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 G 177 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -47.30 122.24 51.49 -47.46 127.44 47.81 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 G 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 G 177 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 G 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 G 177 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 G 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 G 177 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 G 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 G 177 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 G 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 G 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 G 177 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 G 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 G 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 G 177 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -0.82 59.67 9.89 3.99 59.45 8.43 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 H 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 H 177 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 H 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 H 177 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -54.32 88.79 48.13 -54.61 94.04 51.74 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 H 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 H 177 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 H 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 H 177 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 H 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 H 177 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 H 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 H 177 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 H 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 H 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 H 177 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 H 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 H 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 H 177 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -0.82 59.67 9.89 3.99 59.45 8.43 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 I 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 I 177 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 I 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 I 177 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -55.38 81.61 14.50 -57.11 80.05 20.41 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 I 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 I 177 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 I 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 I 177 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 I 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 I 177 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 I 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 I 177 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 I 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 I 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 I 177 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 I 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 I 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 I 177 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -0.82 59.67 9.89 3.99 59.45 8.43 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 J 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 J 177 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 112 ASP.? 58.40 N6 ADP C1001 J 146 TYR A 92 TYR.? 47.39 N1 ADP C1001 J 177 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 J 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 J 177 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP B 112 ASP.? 11.36 O1B ADP C1001 J 146 TYR B 92 TYR.? 14.20 N6 ADP C1001 J 177 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -35.67 34.06 2.87 -37.59 34.07 2.20 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -26.28 29.17 2.52 -25.72 31.84 1.90 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 J 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 J 177 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP C 112 ASP.? 10.30 O3' ADP C1001 J 146 TYR C 92 TYR.? 13.82 O3' ADP C1001 J 177 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -47.22 26.04 24.41 -47.86 24.10 23.79 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -39.98 27.63 32.25 -40.82 24.99 32.44 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 J 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 J 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 J 177 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 J 24 ASP D 112 ASP.? 52.73 N6 ADP C1001 J 146 TYR D 92 TYR.? 44.20 N6 ADP C1001 J 177 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -3.02 71.97 12.29 -1.27 72.40 13.41 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -5.36 62.57 6.57 -2.60 62.73 6.26 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -0.82 59.67 9.89 3.99 59.45 8.43 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 8 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 96 GLU D 33 GLU^? 24.81 N6 ADP C1001 A 132 LYS D 38 LYS^? 26.03 N6 ADP C1001 coo 31.23 12.29 16.44 30.82 11.56 18.39 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 26.82 3.20 24.36 27.99 4.86 24.98 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 29.99 0.62 22.18 30.38 6.69 20.81 -10.44 39.35 12.00 -7.01 36.04 14.36 1onr_c00 source 1onr TRANSALDOLASE B : 1 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP B 36 ASP^? 26.54 N6 ADP C1001 B 96 GLU D 33 GLU^? 24.81 N6 ADP C1001 B 132 LYS D 38 LYS^? 26.03 N6 ADP C1001 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 26.69 48.45 7.18 27.85 50.13 7.74 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 29.82 45.80 5.07 30.26 51.81 3.56 -10.44 39.35 12.00 -7.01 36.04 14.36 1onr_c01 source 1onr TRANSALDOLASE B : 1 hits 1onr_c01 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 15 SER~? 35.42 N1 ADP C1001 A 239 VAL A 17 VAL.? 40.72 N6 ADP C1001 A 413 ASN A 16 ASN.? 39.53 N1 ADP C1001 coo 80.14 40.76 52.28 77.73 40.59 51.94 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo 75.67 35.37 52.30 76.00 35.96 50.23 -10.52 -3.92 12.63 -8.53 -3.88 11.57 coo 81.75 35.21 52.13 80.92 37.12 51.69 -11.80 -4.14 16.79 -11.72 -4.01 18.95 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER B 15 SER~? 20.97 N6 ADP C1001 A 239 VAL B 17 VAL.? 14.01 N6 ADP C1001 A 413 ASN B 16 ASN.? 20.20 N6 ADP C1001 coo 80.14 40.76 52.28 77.73 40.59 51.94 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 75.67 35.37 52.30 76.00 35.96 50.23 -24.96 21.86 4.55 -25.07 23.45 6.01 coo 81.75 35.21 52.13 80.92 37.12 51.69 -23.35 21.88 0.52 -22.21 22.66 -1.09 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER B 86 SER^? 6.21 N1 ADP C1001 A 239 VAL C 88 VAL^? 5.84 C2 ADP C1001 A 413 ASN B 81 ASN~? 5.38 N3 ADP C1001 coo 80.14 40.76 52.28 77.73 40.59 51.94 -28.54 24.76 20.78 -28.08 27.14 20.69 coo 75.67 35.37 52.30 76.00 35.96 50.23 -32.41 28.41 23.16 -31.73 26.52 24.08 coo 81.75 35.21 52.13 80.92 37.12 51.69 -34.12 23.31 22.91 -33.74 24.78 21.37 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 4 3 # 4 A 170 SER C 15 SER.? 21.32 C2 ADP C1001 A 239 VAL C 17 VAL.? 15.05 C2 ADP C1001 A 413 ASN C 16 ASN.? 20.87 O3' ADP C1001 coo 80.14 40.76 52.28 77.73 40.59 51.94 -33.57 35.15 39.94 -32.12 36.31 38.28 coo 75.67 35.37 52.30 76.00 35.96 50.23 -35.30 33.77 33.44 -35.04 32.26 31.91 coo 81.75 35.21 52.13 80.92 37.12 51.69 -37.30 33.94 37.34 -37.96 32.85 39.06 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 5 3 # 5 A 170 SER C 86 SER^? 7.39 N1 ADP C1001 A 239 VAL B 88 VAL^? 4.85 N6 ADP C1001 A 413 ASN C 81 ASN~? -3.50 N6 ADP C1001s coo 80.14 40.76 52.28 77.73 40.59 51.94 -26.83 30.24 19.36 -25.45 28.48 18.57 coo 75.67 35.37 52.30 76.00 35.96 50.23 -28.56 27.62 14.44 -26.80 28.90 14.42 coo 81.75 35.21 52.13 80.92 37.12 51.69 -28.27 33.11 13.90 -29.33 31.68 15.09 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 6 3 # 6 A 170 SER D 15 SER~? 33.93 N6 ADP C1001 A 239 VAL D 17 VAL.? 36.25 N6 ADP C1001 A 413 ASN D 16 ASN.? 38.61 N6 ADP C1001 coo 80.14 40.76 52.28 77.73 40.59 51.94 -14.05 55.07 1.32 -15.85 56.53 2.06 coo 75.67 35.37 52.30 76.00 35.96 50.23 -12.38 58.83 6.66 -11.07 58.60 8.38 coo 81.75 35.21 52.13 80.92 37.12 51.69 -11.62 59.03 2.34 -10.83 58.47 0.52 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 6 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 15 SER~? 35.42 N1 ADP C1001 B 239 VAL A 17 VAL.? 40.72 N6 ADP C1001 B 413 ASN A 16 ASN.? 39.53 N1 ADP C1001 coo 25.22 6.41 2.90 27.67 6.33 3.11 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo 29.71 1.00 2.66 29.43 1.57 4.74 -10.52 -3.92 12.63 -8.53 -3.88 11.57 coo 23.72 0.88 2.95 24.56 2.79 3.34 -11.80 -4.14 16.79 -11.72 -4.01 18.95 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER B 15 SER~? 20.97 N6 ADP C1001 B 239 VAL B 17 VAL.? 14.01 N6 ADP C1001 B 413 ASN B 16 ASN.? 20.20 N6 ADP C1001 coo 25.22 6.41 2.90 27.67 6.33 3.11 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 29.71 1.00 2.66 29.43 1.57 4.74 -24.96 21.86 4.55 -25.07 23.45 6.01 coo 23.72 0.88 2.95 24.56 2.79 3.34 -23.35 21.88 0.52 -22.21 22.66 -1.09 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER B 86 SER^? 6.21 N1 ADP C1001 B 239 VAL C 88 VAL^? 5.84 C2 ADP C1001 B 413 ASN B 81 ASN~? 5.38 N3 ADP C1001 coo 25.22 6.41 2.90 27.67 6.33 3.11 -28.54 24.76 20.78 -28.08 27.14 20.69 coo 29.71 1.00 2.66 29.43 1.57 4.74 -32.41 28.41 23.16 -31.73 26.52 24.08 coo 23.72 0.88 2.95 24.56 2.79 3.34 -34.12 23.31 22.91 -33.74 24.78 21.37 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 4 3 # 4 B 170 SER C 15 SER.? 21.32 C2 ADP C1001 B 239 VAL C 17 VAL.? 15.05 C2 ADP C1001 B 413 ASN C 16 ASN.? 20.87 O3' ADP C1001 coo 25.22 6.41 2.90 27.67 6.33 3.11 -33.57 35.15 39.94 -32.12 36.31 38.28 coo 29.71 1.00 2.66 29.43 1.57 4.74 -35.30 33.77 33.44 -35.04 32.26 31.91 coo 23.72 0.88 2.95 24.56 2.79 3.34 -37.30 33.94 37.34 -37.96 32.85 39.06 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 5 3 # 5 B 170 SER C 86 SER^? 7.39 N1 ADP C1001 B 239 VAL B 88 VAL^? 4.85 N6 ADP C1001 B 413 ASN C 81 ASN~? -3.50 N6 ADP C1001s coo 25.22 6.41 2.90 27.67 6.33 3.11 -26.83 30.24 19.36 -25.45 28.48 18.57 coo 29.71 1.00 2.66 29.43 1.57 4.74 -28.56 27.62 14.44 -26.80 28.90 14.42 coo 23.72 0.88 2.95 24.56 2.79 3.34 -28.27 33.11 13.90 -29.33 31.68 15.09 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 6 3 # 6 B 170 SER D 15 SER~? 33.93 N6 ADP C1001 B 239 VAL D 17 VAL.? 36.25 N6 ADP C1001 B 413 ASN D 16 ASN.? 38.61 N6 ADP C1001 coo 25.22 6.41 2.90 27.67 6.33 3.11 -14.05 55.07 1.32 -15.85 56.53 2.06 coo 29.71 1.00 2.66 29.43 1.57 4.74 -12.38 58.83 6.66 -11.07 58.60 8.38 coo 23.72 0.88 2.95 24.56 2.79 3.34 -11.62 59.03 2.34 -10.83 58.47 0.52 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 6 hits 1oqz_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 247 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 342 GLU C 49 GLU.? 21.81 N1 ADP C1001 coo 44.36 35.68 9.71 43.29 36.20 11.51 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 41.40 28.81 12.91 40.82 30.90 12.97 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 40.37 33.11 18.06 39.99 34.93 17.06 -30.22 47.91 25.82 -28.66 49.28 25.41 1oyg_c00 source 1oyg LEVANSUCRASE : 1 hits 1oyg_c00 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 167 LYS A 108 LYS.? 49.24 N1 ADP C1001 A 201 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 26.53 8.31 20.37 28.45 8.41 19.40 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 24.92 6.08 13.38 27.75 4.33 18.83 1.67 -4.82 14.87 3.65 -3.69 19.86 coo 29.08 5.53 11.69 30.46 5.61 17.93 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 A 102 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 167 LYS B 114 LYS.? -3.14 O1A ADP C1001s A 201 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 26.53 8.31 20.37 28.45 8.41 19.40 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 24.92 6.08 13.38 27.75 4.33 18.83 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 29.08 5.53 11.69 30.46 5.61 17.93 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 A 102 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 167 LYS B 114 LYS.? -3.14 O1A ADP C1001s A 201 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 26.53 8.31 20.37 28.45 8.41 19.40 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 24.92 6.08 13.38 27.75 4.33 18.83 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 29.08 5.53 11.69 30.46 5.61 17.93 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 A 102 ASP C 97 ASP~? 22.56 C2 ADP C1001 A 167 LYS C 108 LYS.? 14.57 N3 ADP C1001 A 201 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 26.53 8.31 20.37 28.45 8.41 19.40 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 24.92 6.08 13.38 27.75 4.33 18.83 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 29.08 5.53 11.69 30.46 5.61 17.93 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 A 102 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 167 LYS C 114 LYS.? -2.76 O3B ADP C1001s A 201 LYS C 116 LYS.? 13.74 O3' ADP C1001 coo 26.53 8.31 20.37 28.45 8.41 19.40 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 24.92 6.08 13.38 27.75 4.33 18.83 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 29.08 5.53 11.69 30.46 5.61 17.93 -48.64 32.02 26.16 -47.11 28.29 30.57 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 6 3 # 6 A 102 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 167 LYS C 116 LYS.? 13.74 O3' ADP C1001 A 201 LYS C 114 LYS.? -2.76 O3B ADP C1001s coo 26.53 8.31 20.37 28.45 8.41 19.40 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 24.92 6.08 13.38 27.75 4.33 18.83 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 29.08 5.53 11.69 30.46 5.61 17.93 -44.82 31.28 21.50 -43.38 31.47 16.20 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 7 3 # 7 A 102 ASP D 97 ASP~? 39.15 N6 ADP C1001 A 167 LYS D 108 LYS.? 47.30 N6 ADP C1001 A 201 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 26.53 8.31 20.37 28.45 8.41 19.40 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 24.92 6.08 13.38 27.75 4.33 18.83 -0.82 59.67 9.89 3.99 59.45 8.43 coo 29.08 5.53 11.69 30.46 5.61 17.93 1.94 54.62 12.82 6.05 51.27 9.45 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 7 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 97 ASP~? 39.49 N1 ADP C1001 B1167 LYS A 108 LYS.? 49.24 N1 ADP C1001 B1201 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 26.10 12.11 49.61 24.19 12.48 50.51 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 27.70 11.69 56.92 24.82 8.55 52.12 1.67 -4.82 14.87 3.65 -3.69 19.86 coo 23.50 11.64 58.67 22.19 10.19 52.59 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP B 110 ASP.? 12.77 N6 ADP C1001 B1167 LYS B 114 LYS.? -3.14 O1A ADP C1001s B1201 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 26.10 12.11 49.61 24.19 12.48 50.51 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 27.70 11.69 56.92 24.82 8.55 52.12 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 23.50 11.64 58.67 22.19 10.19 52.59 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 B1102 ASP B 112 ASP.? 11.36 O1B ADP C1001 B1167 LYS B 114 LYS.? -3.14 O1A ADP C1001s B1201 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 26.10 12.11 49.61 24.19 12.48 50.51 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 27.70 11.69 56.92 24.82 8.55 52.12 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 23.50 11.64 58.67 22.19 10.19 52.59 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 B1102 ASP C 97 ASP~? 22.56 C2 ADP C1001 B1167 LYS C 108 LYS.? 14.57 N3 ADP C1001 B1201 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 26.10 12.11 49.61 24.19 12.48 50.51 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 27.70 11.69 56.92 24.82 8.55 52.12 -37.26 21.98 30.89 -34.43 24.41 31.94 coo 23.50 11.64 58.67 22.19 10.19 52.59 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 B1102 ASP C 110 ASP.? 10.54 O3' ADP C1001 B1167 LYS C 114 LYS.? -2.76 O3B ADP C1001s B1201 LYS C 116 LYS.? 13.74 O3' ADP C1001 coo 26.10 12.11 49.61 24.19 12.48 50.51 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 27.70 11.69 56.92 24.82 8.55 52.12 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 23.50 11.64 58.67 22.19 10.19 52.59 -48.64 32.02 26.16 -47.11 28.29 30.57 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 6 3 # 6 B1102 ASP C 110 ASP.? 10.54 O3' ADP C1001 B1167 LYS C 116 LYS.? 13.74 O3' ADP C1001 B1201 LYS C 114 LYS.? -2.76 O3B ADP C1001s coo 26.10 12.11 49.61 24.19 12.48 50.51 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 27.70 11.69 56.92 24.82 8.55 52.12 -48.64 32.02 26.16 -47.11 28.29 30.57 coo 23.50 11.64 58.67 22.19 10.19 52.59 -44.82 31.28 21.50 -43.38 31.47 16.20 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 7 3 # 7 B1102 ASP D 97 ASP~? 39.15 N6 ADP C1001 B1167 LYS D 108 LYS.? 47.30 N6 ADP C1001 B1201 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 26.10 12.11 49.61 24.19 12.48 50.51 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 27.70 11.69 56.92 24.82 8.55 52.12 -0.82 59.67 9.89 3.99 59.45 8.43 coo 23.50 11.64 58.67 22.19 10.19 52.59 1.94 54.62 12.82 6.05 51.27 9.45 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 7 hits 1p1x_c01 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR A 70 TYR.? 48.30 N6 ADP C1001 A 38 GLU A 115 GLU.? 59.12 N6 ADP C1001 A 46 TRP A 113 TRP.? 51.98 N6 ADP C1001 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -2.13 -20.10 11.70 -1.63 -20.78 13.69 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -2.27 -12.30 8.14 -4.73 -13.16 5.16 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 2 3 # 2 A 16 TYR A 111 TYR.? 55.51 N6 ADP C1001 A 38 GLU A 115 GLU.? 59.12 N6 ADP C1001 A 46 TRP A 113 TRP.? 51.98 N6 ADP C1001 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -2.13 -20.10 11.70 -1.63 -20.78 13.69 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -2.27 -12.30 8.14 -4.73 -13.16 5.16 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 3 3 # 3 A 16 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 38 GLU B 115 GLU.? 12.48 O1B ADP C1001 A 46 TRP B 113 TRP.? 6.23 N7 ADP C1001 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -39.49 31.51 1.54 -40.33 32.66 0.02 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -33.53 30.14 7.96 -35.79 27.09 9.08 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 4 3 # 4 A 16 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 38 GLU B 115 GLU.? 12.48 O1B ADP C1001 A 46 TRP B 113 TRP.? 6.23 N7 ADP C1001 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -39.49 31.51 1.54 -40.33 32.66 0.02 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -33.53 30.14 7.96 -35.79 27.09 9.08 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 5 3 # 5 A 16 TYR C 70 TYR.? 10.33 O3' ADP C1001 A 38 GLU C 115 GLU.? 11.76 O3B ADP C1001 A 46 TRP C 113 TRP.? -4.31 O3' ADP C1001s coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -40.11 31.99 28.67 -42.64 30.90 28.52 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -50.58 33.44 21.57 -49.74 35.49 21.49 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -41.02 28.74 23.55 -40.73 32.19 21.60 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 5 hits 1p7m_c00 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 20 HIS.? 47.81 N6 ADP C1001 A 259 TYR A 70 TYR.? 48.30 N6 ADP C1001 A 552 ASP B 97 ASP~? 21.13 N6 ADP C1001 coo 11.34 95.90 25.54 12.13 96.42 23.67 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 14.91 97.39 18.63 13.39 95.60 20.20 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 46.37 82.54 38.83 45.97 84.66 38.77 -17.01 28.05 3.64 -15.70 27.74 1.96 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 259 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 552 ASP A 97 ASP~? 39.49 N1 ADP C1001 coo 11.34 95.90 25.54 12.13 96.42 23.67 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 14.91 97.39 18.63 13.39 95.60 20.20 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 46.37 82.54 38.83 45.97 84.66 38.77 -4.20 1.28 18.72 -4.75 1.76 20.72 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 259 TYR C 70 TYR.? 10.33 O3' ADP C1001 A 552 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 11.34 95.90 25.54 12.13 96.42 23.67 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 14.91 97.39 18.63 13.39 95.60 20.20 -40.11 31.99 28.67 -42.64 30.90 28.52 coo 46.37 82.54 38.83 45.97 84.66 38.77 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS D 20 HIS.? 42.10 N6 ADP C1001 A 259 TYR D 70 TYR.? 43.17 N6 ADP C1001 A 552 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 11.34 95.90 25.54 12.13 96.42 23.67 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.19 64.81 9.49 -8.66 67.08 8.77 coo 46.37 82.54 38.83 45.97 84.66 38.77 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS D 20 HIS.? 42.10 N6 ADP C1001 A 259 TYR D 70 TYR.? 43.17 N6 ADP C1001 A 552 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 11.34 95.90 25.54 12.13 96.42 23.67 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.19 64.81 9.49 -8.66 67.08 8.77 coo 46.37 82.54 38.83 45.97 84.66 38.77 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 6 3 # 6 A 225 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 259 TYR C 79 TYR~? 13.12 N6 ADP C1001 A 552 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 11.34 95.90 25.54 12.13 96.42 23.67 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 14.91 97.39 18.63 13.39 95.60 20.20 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 46.37 82.54 38.83 45.97 84.66 38.77 -1.45 15.76 11.21 -1.10 16.77 13.16 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 6 hits 1pj5_c00 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 270 LYS B 14 LYS~? 27.17 N6 ADP C1001 A 382 MET A 1 MET.? 39.26 N6 ADP C1001 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -15.99 19.51 1.82 -10.82 19.61 1.70 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -3.11 10.06 1.84 -1.61 7.96 3.68 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 1 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP B 36 ASP^? 26.54 N6 ADP C1001 B 270 LYS B 38 LYS.? 29.47 N6 ADP C1001 B 382 MET C 1 MET.? 15.55 C2 ADP C1001 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -7.49 25.66 16.69 -6.44 23.85 16.43 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -9.30 19.94 15.62 -4.67 19.41 15.25 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -18.24 28.03 27.17 -21.35 25.33 27.23 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 1 hits 1pjq_c03 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 15 SER~? 35.42 N1 ADP C1001 B 69 ALA A 7 ALA^? 34.93 N6 ADP C1001 B 241 ASN A 16 ASN.? 39.53 N1 ADP C1001 coo 13.24 41.94 33.13 13.08 39.54 33.17 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo 9.15 37.89 36.69 10.55 37.76 37.22 -14.67 -1.89 11.08 -15.25 -0.53 11.40 coo 10.91 43.03 38.47 11.81 41.82 36.93 -11.80 -4.14 16.79 -11.72 -4.01 18.95 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER B 15 SER~? 20.97 N6 ADP C1001 B 69 ALA B 7 ALA^? 19.02 N6 ADP C1001 B 241 ASN B 16 ASN.? 20.20 N6 ADP C1001 coo 13.24 41.94 33.13 13.08 39.54 33.17 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 9.15 37.89 36.69 10.55 37.76 37.22 -23.95 17.01 5.35 -22.53 16.46 5.45 coo 10.91 43.03 38.47 11.81 41.82 36.93 -23.35 21.88 0.52 -22.21 22.66 -1.09 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER B 18 SER.? 16.80 N6 ADP C1001 B 69 ALA B 7 ALA^? 19.02 N6 ADP C1001 B 241 ASN B 16 ASN.? 20.20 N6 ADP C1001 coo 13.24 41.94 33.13 13.08 39.54 33.17 -27.97 19.58 3.98 -27.31 17.40 4.71 coo 9.15 37.89 36.69 10.55 37.76 37.22 -23.95 17.01 5.35 -22.53 16.46 5.45 coo 10.91 43.03 38.47 11.81 41.82 36.93 -23.35 21.88 0.52 -22.21 22.66 -1.09 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER C 15 SER.? 21.32 C2 ADP C1001 B 69 ALA C 7 ALA^? 19.38 C2 ADP C1001 B 241 ASN C 16 ASN.? 20.87 O3' ADP C1001 coo 13.24 41.94 33.13 13.08 39.54 33.17 -33.57 35.15 39.94 -32.12 36.31 38.28 coo 9.15 37.89 36.69 10.55 37.76 37.22 -32.65 37.85 34.38 -31.51 37.98 35.41 coo 10.91 43.03 38.47 11.81 41.82 36.93 -37.30 33.94 37.34 -37.96 32.85 39.06 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 5 3 # 5 B 1 SER C 18 SER.? 15.10 O2' ADP C1001 B 69 ALA C 7 ALA^? 19.38 C2 ADP C1001 B 241 ASN C 16 ASN.? 20.87 O3' ADP C1001 coo 13.24 41.94 33.13 13.08 39.54 33.17 -36.98 36.98 32.18 -36.06 38.40 30.49 coo 9.15 37.89 36.69 10.55 37.76 37.22 -32.65 37.85 34.38 -31.51 37.98 35.41 coo 10.91 43.03 38.47 11.81 41.82 36.93 -37.30 33.94 37.34 -37.96 32.85 39.06 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 6 3 # 6 B 1 SER D 15 SER~? 33.93 N6 ADP C1001 B 69 ALA D 7 ALA^? 31.06 N6 ADP C1001 B 241 ASN D 16 ASN.? 38.61 N6 ADP C1001 coo 13.24 41.94 33.13 13.08 39.54 33.17 -14.05 55.07 1.32 -15.85 56.53 2.06 coo 9.15 37.89 36.69 10.55 37.76 37.22 -16.88 56.61 6.05 -17.27 55.26 5.42 coo 10.91 43.03 38.47 11.81 41.82 36.93 -11.62 59.03 2.34 -10.83 58.47 0.52 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 7 3 # 7 B 1 SER D 18 SER.? 35.50 N6 ADP C1001 B 69 ALA D 7 ALA^? 31.06 N6 ADP C1001 B 241 ASN D 16 ASN.? 38.61 N6 ADP C1001 coo 13.24 41.94 33.13 13.08 39.54 33.17 -15.27 61.31 6.78 -16.76 61.07 8.60 coo 9.15 37.89 36.69 10.55 37.76 37.22 -16.88 56.61 6.05 -17.27 55.26 5.42 coo 10.91 43.03 38.47 11.81 41.82 36.93 -11.62 59.03 2.34 -10.83 58.47 0.52 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 7 hits 1pnl_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 2 ARG^? 31.43 N6 ADP C1001 A 479 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 483 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 17.33 52.29 2.24 18.71 54.03 0.18 -10.05 8.79 1.44 -11.10 11.55 0.50 coo 20.06 57.44 1.28 18.39 56.19 3.12 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG B 2 ARG^? 22.13 N1 ADP C1001 A 479 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 483 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 17.33 52.29 2.24 18.71 54.03 0.18 -18.09 16.69 18.57 -16.32 14.84 20.16 coo 20.06 57.44 1.28 18.39 56.19 3.12 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG B 25 ARG.? 26.72 N7 ADP C1001 A 479 PHE B 47 PHE.? 28.85 O4' ADP C1001 A 483 GLU A 44 GLU^? 29.72 N6 ADP C1001 coo 17.33 52.29 2.24 18.71 54.03 0.18 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 20.06 57.44 1.28 18.39 56.19 3.12 -29.91 1.80 9.18 -28.86 -0.57 10.37 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -23.95 2.54 6.45 -25.82 1.78 7.26 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG C 2 ARG^? 21.46 C2 ADP C1001 A 479 PHE C 29 PHE^? 17.94 C2 ADP C1001 A 483 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 17.33 52.29 2.24 18.71 54.03 0.18 -18.93 34.99 28.58 -17.63 35.83 31.18 coo 20.06 57.44 1.28 18.39 56.19 3.12 -22.69 37.33 30.80 -23.71 39.19 28.97 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 A 264 ARG D 2 ARG^? 19.52 N6 ADP C1001 A 479 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 483 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 17.33 52.29 2.24 18.71 54.03 0.18 -16.51 45.11 16.54 -19.16 44.24 15.23 coo 20.06 57.44 1.28 18.39 56.19 3.12 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -19.13 44.82 10.40 -20.77 44.03 11.36 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 5 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 2 ARG^? 31.43 N6 ADP C1001 B 479 PHE A 29 PHE^? 33.27 N6 ADP C1001 B 483 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -10.05 8.79 1.44 -11.10 11.55 0.50 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -12.99 5.90 3.87 -14.20 3.90 2.32 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG B 2 ARG^? 22.13 N1 ADP C1001 B 479 PHE B 29 PHE^? 19.13 N6 ADP C1001 B 483 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -18.09 16.69 18.57 -16.32 14.84 20.16 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -19.97 14.78 14.91 -22.45 13.54 15.08 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG B 25 ARG.? 26.72 N7 ADP C1001 B 479 PHE B 47 PHE.? 28.85 O4' ADP C1001 B 483 GLU A 44 GLU^? 29.72 N6 ADP C1001 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -29.04 7.60 4.48 -27.73 5.04 5.73 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -29.91 1.80 9.18 -28.86 -0.57 10.37 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -23.95 2.54 6.45 -25.82 1.78 7.26 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG C 2 ARG^? 21.46 C2 ADP C1001 B 479 PHE C 29 PHE^? 17.94 C2 ADP C1001 B 483 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -18.93 34.99 28.58 -17.63 35.83 31.18 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -22.69 37.33 30.80 -23.71 39.19 28.97 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 B 264 ARG D 2 ARG^? 19.52 N6 ADP C1001 B 479 PHE D 29 PHE^? 23.81 N6 ADP C1001 B 483 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -16.51 45.11 16.54 -19.16 44.24 15.23 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -18.44 48.91 13.36 -20.46 50.71 14.19 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -19.13 44.82 10.40 -20.77 44.03 11.36 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 5 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 39 ASN^? 26.27 N6 ADP C1001 A 192 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 195 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -10.50 14.02 7.34 -12.57 14.30 7.00 coo 2.03 47.14 19.75 1.72 46.26 21.64 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN A 57 ASN~? 43.07 N6 ADP C1001 A 192 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 195 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -15.73 -0.75 -7.31 -14.92 -1.39 -9.21 coo 2.03 47.14 19.75 1.72 46.26 21.64 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -15.84 6.06 -0.29 -17.94 5.95 -0.14 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 2 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 39 ASN^? 26.27 N6 ADP C1001 B 192 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 195 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo -1.08 51.41 10.34 0.65 52.62 10.17 -10.50 14.02 7.34 -12.57 14.30 7.00 coo 11.36 52.33 5.59 10.18 53.87 6.47 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 7.99 56.74 7.55 6.88 55.39 8.70 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN A 57 ASN~? 43.07 N6 ADP C1001 B 192 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 195 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo -1.08 51.41 10.34 0.65 52.62 10.17 -15.73 -0.75 -7.31 -14.92 -1.39 -9.21 coo 11.36 52.33 5.59 10.18 53.87 6.47 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 7.99 56.74 7.55 6.88 55.39 8.70 -15.84 6.06 -0.29 -17.94 5.95 -0.14 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 2 hits 1pp4_c03 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU C 55 LEU~? 15.31 C2 ADP C1001 A 58 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 120 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 34.02 69.29 75.26 34.82 67.82 76.74 -30.41 42.77 23.50 -31.26 43.18 25.42 coo 34.46 72.45 78.57 32.82 72.75 77.28 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 28.96 77.64 81.19 29.05 74.53 77.51 -21.35 51.92 21.59 -25.15 52.63 26.23 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 1 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU C 55 LEU~? 15.31 C2 ADP C1001 B 58 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 120 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 54.50 104.32 58.69 55.83 105.69 59.81 -30.41 42.77 23.50 -31.26 43.18 25.42 coo 57.63 101.19 59.83 56.60 100.89 57.99 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 61.58 95.88 55.22 58.18 99.30 54.71 -21.35 51.92 21.59 -25.15 52.63 26.23 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 1 hits 1pym_c01 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 81 ASN~? 50.50 N6 ADP C1001 A 239 ARG A 75 ARG~? 52.31 N6 ADP C1001 A 246 TYR A 79 TYR~? 47.68 N6 ADP C1001 coo 2.50 7.27 18.06 0.76 7.28 16.81 -3.09 -5.47 -6.59 -2.17 -5.74 -4.66 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -9.93 -13.21 -7.89 -9.68 -10.57 -9.55 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 1 hits 1qaz_c00 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 143 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 170 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 1.36 26.79 49.43 3.17 26.89 50.50 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 7.24 31.80 48.14 6.27 25.92 49.70 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 A 86 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 143 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 170 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 1.36 26.79 49.43 3.17 26.89 50.50 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 7.24 31.80 48.14 6.27 25.92 49.70 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 A 86 GLU C 41 GLU^? 24.05 C2 ADP C1001 A 143 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 170 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 1.36 26.79 49.43 3.17 26.89 50.50 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 7.24 31.80 48.14 6.27 25.92 49.70 -21.36 39.39 22.00 -17.64 41.95 19.02 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 3 hits 1qfe_c00 naa= 3 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 B 86 GLU A 41 GLU^? 26.55 N6 ADP C1001 B 143 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 170 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 13.90 37.16 5.96 12.00 36.26 6.12 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 13.52 33.69 9.79 13.20 31.83 8.88 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 7.52 28.83 11.02 13.59 28.74 9.95 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 B 86 GLU B 41 GLU^? 24.52 N6 ADP C1001 B 143 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 170 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 13.90 37.16 5.96 12.00 36.26 6.12 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 13.52 33.69 9.79 13.20 31.83 8.88 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 7.52 28.83 11.02 13.59 28.74 9.95 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 B 86 GLU C 41 GLU^? 24.05 C2 ADP C1001 B 143 HIS C 62 HIS~? 21.13 N1 ADP C1001 B 170 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 13.90 37.16 5.96 12.00 36.26 6.12 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 13.52 33.69 9.79 13.20 31.83 8.88 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 7.52 28.83 11.02 13.59 28.74 9.95 -21.36 39.39 22.00 -17.64 41.95 19.02 1qfe_c01 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 3 hits 1qfe_c01 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 236 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 55.45 46.76 42.08 57.34 46.16 42.75 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 48.87 29.19 44.63 49.10 27.34 43.63 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 47.58 17.35 41.83 51.40 20.85 40.83 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 55.45 46.76 42.08 57.34 46.16 42.75 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 48.87 29.19 44.63 49.10 27.34 43.63 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 47.58 17.35 41.83 51.40 20.85 40.83 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 155 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 236 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 261 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 55.45 46.76 42.08 57.34 46.16 42.75 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 48.87 29.19 44.63 49.10 27.34 43.63 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 47.58 17.35 41.83 51.40 20.85 40.83 -14.21 50.71 21.89 -14.80 46.21 24.73 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS B 20 HIS.? 13.19 O1A ADP C1001 B 236 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 B 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 155 HIS C 20 HIS.? 13.76 O2' ADP C1001 B 236 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 261 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -14.21 50.71 21.89 -14.80 46.21 24.73 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS B 20 HIS.? 13.19 O1A ADP C1001 C 236 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 55.11 47.10 12.61 53.44 47.85 11.58 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 45.78 31.11 9.51 44.25 30.06 10.53 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 37.54 22.37 12.10 37.83 27.55 13.24 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS B 62 HIS~? 22.43 N1 ADP C1001 C 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 C 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 55.11 47.10 12.61 53.44 47.85 11.58 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 45.78 31.11 9.51 44.25 30.06 10.53 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 37.54 22.37 12.10 37.83 27.55 13.24 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 155 HIS C 20 HIS.? 13.76 O2' ADP C1001 C 236 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 261 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 55.11 47.10 12.61 53.44 47.85 11.58 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 45.78 31.11 9.51 44.25 30.06 10.53 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 37.54 22.37 12.10 37.83 27.55 13.24 -14.21 50.71 21.89 -14.80 46.21 24.73 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS B 20 HIS.? 13.19 O1A ADP C1001 D 236 ASP B 10 ASP.? 28.32 N6 ADP C1001 D 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS B 62 HIS~? 22.43 N1 ADP C1001 D 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 D 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 155 HIS C 20 HIS.? 13.76 O2' ADP C1001 D 236 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 261 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -14.21 50.71 21.89 -14.80 46.21 24.73 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS B 20 HIS.? 13.19 O1A ADP C1001 E 236 ASP B 10 ASP.? 28.32 N6 ADP C1001 E 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS B 62 HIS~? 22.43 N1 ADP C1001 E 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 E 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 155 HIS C 20 HIS.? 13.76 O2' ADP C1001 E 236 ASP D 61 ASP~? 23.08 N1 ADP C1001 E 261 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -14.21 50.71 21.89 -14.80 46.21 24.73 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS B 20 HIS.? 13.19 O1A ADP C1001 F 236 ASP B 10 ASP.? 28.32 N6 ADP C1001 F 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS B 62 HIS~? 22.43 N1 ADP C1001 F 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 F 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 155 HIS C 20 HIS.? 13.76 O2' ADP C1001 F 236 ASP D 61 ASP~? 23.08 N1 ADP C1001 F 261 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -14.21 50.71 21.89 -14.80 46.21 24.73 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS B 20 HIS.? 13.19 O1A ADP C1001 G 236 ASP B 10 ASP.? 28.32 N6 ADP C1001 G 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS B 62 HIS~? 22.43 N1 ADP C1001 G 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 G 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 155 HIS C 20 HIS.? 13.76 O2' ADP C1001 G 236 ASP D 61 ASP~? 23.08 N1 ADP C1001 G 261 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -14.21 50.71 21.89 -14.80 46.21 24.73 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS B 20 HIS.? 13.19 O1A ADP C1001 H 236 ASP B 10 ASP.? 28.32 N6 ADP C1001 H 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS B 62 HIS~? 22.43 N1 ADP C1001 H 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 H 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 155 HIS C 20 HIS.? 13.76 O2' ADP C1001 H 236 ASP D 61 ASP~? 23.08 N1 ADP C1001 H 261 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -14.21 50.71 21.89 -14.80 46.21 24.73 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 26 TYR^? 32.13 N6 ADP C1001 A 236 ASP A 9 ASP.? 35.63 N1 ADP C1001 A 261 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 48.87 29.19 44.63 49.10 27.34 43.63 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 47.58 17.35 41.83 51.40 20.85 40.83 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 70 TYR.? 48.30 N6 ADP C1001 A 236 ASP A 112 ASP.? 58.40 N6 ADP C1001 A 261 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 48.87 29.19 44.63 49.10 27.34 43.63 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 47.58 17.35 41.83 51.40 20.85 40.83 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 79 TYR~? 47.68 N6 ADP C1001 A 236 ASP A 54 ASP~? 42.89 N6 ADP C1001 A 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 48.87 29.19 44.63 49.10 27.34 43.63 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 47.58 17.35 41.83 51.40 20.85 40.83 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR A 92 TYR.? 47.39 N1 ADP C1001 A 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 48.87 29.19 44.63 49.10 27.34 43.63 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 47.58 17.35 41.83 51.40 20.85 40.83 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR A 111 TYR.? 55.51 N6 ADP C1001 A 236 ASP A 110 ASP.? 52.32 N6 ADP C1001 A 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 48.87 29.19 44.63 49.10 27.34 43.63 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 47.58 17.35 41.83 51.40 20.85 40.83 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR B 26 TYR^? 24.12 N6 ADP C1001 A 236 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 261 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 48.87 29.19 44.63 49.10 27.34 43.63 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 47.58 17.35 41.83 51.40 20.85 40.83 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 A 261 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 48.87 29.19 44.63 49.10 27.34 43.63 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 47.58 17.35 41.83 51.40 20.85 40.83 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 A 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 A 261 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 47.58 17.35 41.83 51.40 20.85 40.83 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR B 92 TYR.? 14.20 N6 ADP C1001 A 236 ASP B 97 ASP~? 21.13 N6 ADP C1001 A 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 48.87 29.19 44.63 49.10 27.34 43.63 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 47.58 17.35 41.83 51.40 20.85 40.83 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 48.87 29.19 44.63 49.10 27.34 43.63 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 47.58 17.35 41.83 51.40 20.85 40.83 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 A 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 261 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 48.87 29.19 44.63 49.10 27.34 43.63 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 47.58 17.35 41.83 51.40 20.85 40.83 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 163 TYR C 92 TYR.? 13.82 O3' ADP C1001 A 236 ASP C 97 ASP~? 22.56 C2 ADP C1001 A 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 47.58 17.35 41.83 51.40 20.85 40.83 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 A 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 48.87 29.19 44.63 49.10 27.34 43.63 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 47.58 17.35 41.83 51.40 20.85 40.83 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 A 163 TYR D 26 TYR^? 28.03 N6 ADP C1001 A 236 ASP D 9 ASP.? 34.87 N6 ADP C1001 A 261 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 48.87 29.19 44.63 49.10 27.34 43.63 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 47.58 17.35 41.83 51.40 20.85 40.83 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 A 163 TYR D 79 TYR~? 36.26 N1 ADP C1001 A 236 ASP D 54 ASP~? 30.93 N6 ADP C1001 A 261 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 48.87 29.19 44.63 49.10 27.34 43.63 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 47.58 17.35 41.83 51.40 20.85 40.83 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 A 163 TYR D 92 TYR.? 44.20 N6 ADP C1001 A 236 ASP D 97 ASP~? 39.15 N6 ADP C1001 A 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 48.87 29.19 44.63 49.10 27.34 43.63 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 47.58 17.35 41.83 51.40 20.85 40.83 1.94 54.62 12.82 6.05 51.27 9.45 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 26 TYR^? 32.13 N6 ADP C1001 B 236 ASP A 9 ASP.? 35.63 N1 ADP C1001 B 261 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 70 TYR.? 48.30 N6 ADP C1001 B 236 ASP A 112 ASP.? 58.40 N6 ADP C1001 B 261 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR A 79 TYR~? 47.68 N6 ADP C1001 B 236 ASP A 54 ASP~? 42.89 N6 ADP C1001 B 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR A 92 TYR.? 47.39 N1 ADP C1001 B 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 B 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR A 111 TYR.? 55.51 N6 ADP C1001 B 236 ASP A 110 ASP.? 52.32 N6 ADP C1001 B 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR B 26 TYR^? 24.12 N6 ADP C1001 B 236 ASP B 9 ASP.? 24.63 N6 ADP C1001 B 261 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR B 70 TYR.? 11.71 N6 ADP C1001 B 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 B 261 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 B 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 B 261 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 163 TYR B 92 TYR.? 14.20 N6 ADP C1001 B 236 ASP B 97 ASP~? 21.13 N6 ADP C1001 B 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 B 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 B 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 163 TYR C 26 TYR^? 24.03 C2 ADP C1001 B 236 ASP C 9 ASP.? 24.62 C2 ADP C1001 B 261 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -30.56 43.06 36.03 -31.04 45.27 37.68 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 B 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 261 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 163 TYR C 92 TYR.? 13.82 O3' ADP C1001 B 236 ASP C 97 ASP~? 22.56 C2 ADP C1001 B 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 B 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 B 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 B 163 TYR D 26 TYR^? 28.03 N6 ADP C1001 B 236 ASP D 9 ASP.? 34.87 N6 ADP C1001 B 261 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 B 163 TYR D 79 TYR~? 36.26 N1 ADP C1001 B 236 ASP D 54 ASP~? 30.93 N6 ADP C1001 B 261 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 B 163 TYR D 92 TYR.? 44.20 N6 ADP C1001 B 236 ASP D 97 ASP~? 39.15 N6 ADP C1001 B 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 1.94 54.62 12.82 6.05 51.27 9.45 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 B 163 TYR D 111 TYR.? 48.44 N6 ADP C1001 B 236 ASP D 110 ASP.? 48.95 N6 ADP C1001 B 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -0.39 66.61 15.04 1.31 64.37 15.18 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 1.94 54.62 12.82 6.05 51.27 9.45 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 26 TYR^? 32.13 N6 ADP C1001 C 236 ASP A 9 ASP.? 35.63 N1 ADP C1001 C 261 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 45.78 31.11 9.51 44.25 30.06 10.53 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 37.54 22.37 12.10 37.83 27.55 13.24 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR A 70 TYR.? 48.30 N6 ADP C1001 C 236 ASP A 112 ASP.? 58.40 N6 ADP C1001 C 261 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 45.78 31.11 9.51 44.25 30.06 10.53 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 37.54 22.37 12.10 37.83 27.55 13.24 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR A 79 TYR~? 47.68 N6 ADP C1001 C 236 ASP A 54 ASP~? 42.89 N6 ADP C1001 C 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 45.78 31.11 9.51 44.25 30.06 10.53 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 37.54 22.37 12.10 37.83 27.55 13.24 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR A 92 TYR.? 47.39 N1 ADP C1001 C 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 C 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 45.78 31.11 9.51 44.25 30.06 10.53 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 37.54 22.37 12.10 37.83 27.55 13.24 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 163 TYR A 111 TYR.? 55.51 N6 ADP C1001 C 236 ASP A 110 ASP.? 52.32 N6 ADP C1001 C 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 45.78 31.11 9.51 44.25 30.06 10.53 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 37.54 22.37 12.10 37.83 27.55 13.24 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 163 TYR B 26 TYR^? 24.12 N6 ADP C1001 C 236 ASP B 9 ASP.? 24.63 N6 ADP C1001 C 261 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 45.78 31.11 9.51 44.25 30.06 10.53 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 37.54 22.37 12.10 37.83 27.55 13.24 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 163 TYR B 70 TYR.? 11.71 N6 ADP C1001 C 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 C 261 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 45.78 31.11 9.51 44.25 30.06 10.53 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 37.54 22.37 12.10 37.83 27.55 13.24 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 C 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 C 261 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 37.54 22.37 12.10 37.83 27.55 13.24 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 163 TYR B 92 TYR.? 14.20 N6 ADP C1001 C 236 ASP B 97 ASP~? 21.13 N6 ADP C1001 C 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 45.78 31.11 9.51 44.25 30.06 10.53 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 37.54 22.37 12.10 37.83 27.55 13.24 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 C 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 C 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 C 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 45.78 31.11 9.51 44.25 30.06 10.53 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 37.54 22.37 12.10 37.83 27.55 13.24 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 C 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 C 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 261 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 45.78 31.11 9.51 44.25 30.06 10.53 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 37.54 22.37 12.10 37.83 27.55 13.24 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 C 163 TYR C 92 TYR.? 13.82 O3' ADP C1001 C 236 ASP C 97 ASP~? 22.56 C2 ADP C1001 C 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 37.54 22.37 12.10 37.83 27.55 13.24 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 C 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 C 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 C 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 45.78 31.11 9.51 44.25 30.06 10.53 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 37.54 22.37 12.10 37.83 27.55 13.24 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 C 163 TYR D 26 TYR^? 28.03 N6 ADP C1001 C 236 ASP D 9 ASP.? 34.87 N6 ADP C1001 C 261 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 45.78 31.11 9.51 44.25 30.06 10.53 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 37.54 22.37 12.10 37.83 27.55 13.24 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 C 163 TYR D 79 TYR~? 36.26 N1 ADP C1001 C 236 ASP D 54 ASP~? 30.93 N6 ADP C1001 C 261 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 45.78 31.11 9.51 44.25 30.06 10.53 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 37.54 22.37 12.10 37.83 27.55 13.24 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 C 163 TYR D 92 TYR.? 44.20 N6 ADP C1001 C 236 ASP D 97 ASP~? 39.15 N6 ADP C1001 C 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 39.51 34.34 13.63 37.63 32.61 14.79 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 45.78 31.11 9.51 44.25 30.06 10.53 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 37.54 22.37 12.10 37.83 27.55 13.24 1.94 54.62 12.82 6.05 51.27 9.45 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 26 TYR^? 32.13 N6 ADP C1001 D 236 ASP A 9 ASP.? 35.63 N1 ADP C1001 D 261 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR A 70 TYR.? 48.30 N6 ADP C1001 D 236 ASP A 112 ASP.? 58.40 N6 ADP C1001 D 261 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR A 79 TYR~? 47.68 N6 ADP C1001 D 236 ASP A 54 ASP~? 42.89 N6 ADP C1001 D 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR A 92 TYR.? 47.39 N1 ADP C1001 D 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 D 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 163 TYR A 111 TYR.? 55.51 N6 ADP C1001 D 236 ASP A 110 ASP.? 52.32 N6 ADP C1001 D 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 163 TYR B 26 TYR^? 24.12 N6 ADP C1001 D 236 ASP B 9 ASP.? 24.63 N6 ADP C1001 D 261 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 163 TYR B 70 TYR.? 11.71 N6 ADP C1001 D 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 D 261 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 D 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 D 261 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 163 TYR B 92 TYR.? 14.20 N6 ADP C1001 D 236 ASP B 97 ASP~? 21.13 N6 ADP C1001 D 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 D 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 D 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 D 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 D 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 D 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 261 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 D 163 TYR C 92 TYR.? 13.82 O3' ADP C1001 D 236 ASP C 97 ASP~? 22.56 C2 ADP C1001 D 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 D 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 D 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 D 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 D 163 TYR D 26 TYR^? 28.03 N6 ADP C1001 D 236 ASP D 9 ASP.? 34.87 N6 ADP C1001 D 261 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 D 163 TYR D 79 TYR~? 36.26 N1 ADP C1001 D 236 ASP D 54 ASP~? 30.93 N6 ADP C1001 D 261 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 D 163 TYR D 92 TYR.? 44.20 N6 ADP C1001 D 236 ASP D 97 ASP~? 39.15 N6 ADP C1001 D 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 1.94 54.62 12.82 6.05 51.27 9.45 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 26 TYR^? 32.13 N6 ADP C1001 E 236 ASP A 9 ASP.? 35.63 N1 ADP C1001 E 261 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 70 TYR.? 48.30 N6 ADP C1001 E 236 ASP A 112 ASP.? 58.40 N6 ADP C1001 E 261 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 79 TYR~? 47.68 N6 ADP C1001 E 236 ASP A 54 ASP~? 42.89 N6 ADP C1001 E 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR A 92 TYR.? 47.39 N1 ADP C1001 E 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 E 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR A 111 TYR.? 55.51 N6 ADP C1001 E 236 ASP A 110 ASP.? 52.32 N6 ADP C1001 E 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR B 26 TYR^? 24.12 N6 ADP C1001 E 236 ASP B 9 ASP.? 24.63 N6 ADP C1001 E 261 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR B 70 TYR.? 11.71 N6 ADP C1001 E 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 E 261 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 E 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 E 261 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR B 92 TYR.? 14.20 N6 ADP C1001 E 236 ASP B 97 ASP~? 21.13 N6 ADP C1001 E 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 E 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 E 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 163 TYR C 26 TYR^? 24.03 C2 ADP C1001 E 236 ASP C 9 ASP.? 24.62 C2 ADP C1001 E 261 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -30.56 43.06 36.03 -31.04 45.27 37.68 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 E 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 E 261 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 E 163 TYR C 92 TYR.? 13.82 O3' ADP C1001 E 236 ASP C 97 ASP~? 22.56 C2 ADP C1001 E 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 E 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 E 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 E 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 E 163 TYR D 26 TYR^? 28.03 N6 ADP C1001 E 236 ASP D 9 ASP.? 34.87 N6 ADP C1001 E 261 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 E 163 TYR D 79 TYR~? 36.26 N1 ADP C1001 E 236 ASP D 54 ASP~? 30.93 N6 ADP C1001 E 261 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 E 163 TYR D 92 TYR.? 44.20 N6 ADP C1001 E 236 ASP D 97 ASP~? 39.15 N6 ADP C1001 E 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 1.94 54.62 12.82 6.05 51.27 9.45 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 E 163 TYR D 111 TYR.? 48.44 N6 ADP C1001 E 236 ASP D 110 ASP.? 48.95 N6 ADP C1001 E 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -0.39 66.61 15.04 1.31 64.37 15.18 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 1.94 54.62 12.82 6.05 51.27 9.45 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 26 TYR^? 32.13 N6 ADP C1001 F 236 ASP A 9 ASP.? 35.63 N1 ADP C1001 F 261 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 70 TYR.? 48.30 N6 ADP C1001 F 236 ASP A 112 ASP.? 58.40 N6 ADP C1001 F 261 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 79 TYR~? 47.68 N6 ADP C1001 F 236 ASP A 54 ASP~? 42.89 N6 ADP C1001 F 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR A 92 TYR.? 47.39 N1 ADP C1001 F 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 F 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR A 111 TYR.? 55.51 N6 ADP C1001 F 236 ASP A 110 ASP.? 52.32 N6 ADP C1001 F 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR B 26 TYR^? 24.12 N6 ADP C1001 F 236 ASP B 9 ASP.? 24.63 N6 ADP C1001 F 261 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR B 70 TYR.? 11.71 N6 ADP C1001 F 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 F 261 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 F 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 F 261 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR B 92 TYR.? 14.20 N6 ADP C1001 F 236 ASP B 97 ASP~? 21.13 N6 ADP C1001 F 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 F 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 F 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 F 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 F 261 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 163 TYR C 92 TYR.? 13.82 O3' ADP C1001 F 236 ASP C 97 ASP~? 22.56 C2 ADP C1001 F 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 F 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 F 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 F 163 TYR D 26 TYR^? 28.03 N6 ADP C1001 F 236 ASP D 9 ASP.? 34.87 N6 ADP C1001 F 261 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 F 163 TYR D 79 TYR~? 36.26 N1 ADP C1001 F 236 ASP D 54 ASP~? 30.93 N6 ADP C1001 F 261 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 F 163 TYR D 92 TYR.? 44.20 N6 ADP C1001 F 236 ASP D 97 ASP~? 39.15 N6 ADP C1001 F 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 1.94 54.62 12.82 6.05 51.27 9.45 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 26 TYR^? 32.13 N6 ADP C1001 G 236 ASP A 9 ASP.? 35.63 N1 ADP C1001 G 261 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR A 70 TYR.? 48.30 N6 ADP C1001 G 236 ASP A 112 ASP.? 58.40 N6 ADP C1001 G 261 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR A 79 TYR~? 47.68 N6 ADP C1001 G 236 ASP A 54 ASP~? 42.89 N6 ADP C1001 G 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR A 92 TYR.? 47.39 N1 ADP C1001 G 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 G 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 163 TYR A 111 TYR.? 55.51 N6 ADP C1001 G 236 ASP A 110 ASP.? 52.32 N6 ADP C1001 G 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 163 TYR B 26 TYR^? 24.12 N6 ADP C1001 G 236 ASP B 9 ASP.? 24.63 N6 ADP C1001 G 261 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 163 TYR B 70 TYR.? 11.71 N6 ADP C1001 G 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 G 261 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 G 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 G 261 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 163 TYR B 92 TYR.? 14.20 N6 ADP C1001 G 236 ASP B 97 ASP~? 21.13 N6 ADP C1001 G 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 G 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 G 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 G 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 G 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 G 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 G 261 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 G 163 TYR C 92 TYR.? 13.82 O3' ADP C1001 G 236 ASP C 97 ASP~? 22.56 C2 ADP C1001 G 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 G 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 G 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 G 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 G 163 TYR D 26 TYR^? 28.03 N6 ADP C1001 G 236 ASP D 9 ASP.? 34.87 N6 ADP C1001 G 261 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 G 163 TYR D 79 TYR~? 36.26 N1 ADP C1001 G 236 ASP D 54 ASP~? 30.93 N6 ADP C1001 G 261 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 G 163 TYR D 92 TYR.? 44.20 N6 ADP C1001 G 236 ASP D 97 ASP~? 39.15 N6 ADP C1001 G 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 1.94 54.62 12.82 6.05 51.27 9.45 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 26 TYR^? 32.13 N6 ADP C1001 H 236 ASP A 9 ASP.? 35.63 N1 ADP C1001 H 261 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR A 70 TYR.? 48.30 N6 ADP C1001 H 236 ASP A 112 ASP.? 58.40 N6 ADP C1001 H 261 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -0.40 -16.97 12.76 1.53 -17.82 13.03 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR A 79 TYR~? 47.68 N6 ADP C1001 H 236 ASP A 54 ASP~? 42.89 N6 ADP C1001 H 261 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR A 92 TYR.? 47.39 N1 ADP C1001 H 236 ASP A 97 ASP~? 39.49 N1 ADP C1001 H 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 163 TYR A 111 TYR.? 55.51 N6 ADP C1001 H 236 ASP A 110 ASP.? 52.32 N6 ADP C1001 H 261 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 4.09 -12.42 11.59 5.78 -10.22 12.07 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 163 TYR B 26 TYR^? 24.12 N6 ADP C1001 H 236 ASP B 9 ASP.? 24.63 N6 ADP C1001 H 261 LYS B 19 LYS.? 15.59 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -31.10 21.58 3.18 -29.68 25.32 0.22 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 163 TYR B 70 TYR.? 11.71 N6 ADP C1001 H 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 H 261 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 H 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 H 261 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 163 TYR B 92 TYR.? 14.20 N6 ADP C1001 H 236 ASP B 97 ASP~? 21.13 N6 ADP C1001 H 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 H 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 H 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 H 261 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 H 163 TYR C 26 TYR^? 24.03 C2 ADP C1001 H 236 ASP C 9 ASP.? 24.62 C2 ADP C1001 H 261 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -30.56 43.06 36.03 -31.04 45.27 37.68 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -40.14 36.21 30.10 -44.63 37.95 34.40 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 H 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 H 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 H 261 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 H 163 TYR C 92 TYR.? 13.82 O3' ADP C1001 H 236 ASP C 97 ASP~? 22.56 C2 ADP C1001 H 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.31 25.31 38.38 -33.83 25.06 40.38 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 H 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 H 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 H 261 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 H 163 TYR D 26 TYR^? 28.03 N6 ADP C1001 H 236 ASP D 9 ASP.? 34.87 N6 ADP C1001 H 261 LYS D 19 LYS.? 44.78 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -14.01 64.85 7.32 -9.19 66.73 4.57 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 H 163 TYR D 79 TYR~? 36.26 N1 ADP C1001 H 236 ASP D 54 ASP~? 30.93 N6 ADP C1001 H 261 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 H 163 TYR D 92 TYR.? 44.20 N6 ADP C1001 H 236 ASP D 97 ASP~? 39.15 N6 ADP C1001 H 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 1.94 54.62 12.82 6.05 51.27 9.45 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 H 163 TYR D 111 TYR.? 48.44 N6 ADP C1001 H 236 ASP D 110 ASP.? 48.95 N6 ADP C1001 H 261 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -0.39 66.61 15.04 1.31 64.37 15.18 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 1.94 54.62 12.82 6.05 51.27 9.45 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 18 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 C 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 C 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 coo 39.01 29.77 22.02 37.48 31.30 19.84 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 39.51 34.34 13.63 37.63 32.61 14.79 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 45.78 31.11 9.51 44.25 30.06 10.53 -33.59 8.19 15.94 -35.17 6.84 16.43 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 C 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 C 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 39.01 29.77 22.02 37.48 31.30 19.84 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 39.51 34.34 13.63 37.63 32.61 14.79 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 45.78 31.11 9.51 44.25 30.06 10.53 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG C 74 ARG~? 5.25 O1B ADP C1001 C 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 C 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 39.01 29.77 22.02 37.48 31.30 19.84 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 39.51 34.34 13.63 37.63 32.61 14.79 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 45.78 31.11 9.51 44.25 30.06 10.53 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 C 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 C 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 39.01 29.77 22.02 37.48 31.30 19.84 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 39.51 34.34 13.63 37.63 32.61 14.79 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 45.78 31.11 9.51 44.25 30.06 10.53 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 C 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 C 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 39.01 29.77 22.02 37.48 31.30 19.84 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 45.78 31.11 9.51 44.25 30.06 10.53 -29.26 47.42 21.46 -29.58 49.13 20.24 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 D 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 D 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -33.59 8.19 15.94 -35.17 6.84 16.43 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 D 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 D 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG C 74 ARG~? 5.25 O1B ADP C1001 D 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 D 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 D 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 D 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 D 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 D 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -29.26 47.42 21.46 -29.58 49.13 20.24 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 A 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 C 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 48.87 29.19 44.63 49.10 27.34 43.63 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 52.39 23.42 32.10 54.51 23.27 34.29 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 C 110 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 48.87 29.19 44.63 49.10 27.34 43.63 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 52.39 23.42 32.10 54.51 23.27 34.29 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 C 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 48.87 29.19 44.63 49.10 27.34 43.63 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 52.39 23.42 32.10 54.51 23.27 34.29 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 A 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 48.87 29.19 44.63 49.10 27.34 43.63 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 52.39 23.42 32.10 54.51 23.27 34.29 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 A 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 C 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 55.48 26.51 40.65 55.39 23.99 39.43 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 48.87 29.19 44.63 49.10 27.34 43.63 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 52.39 23.42 32.10 54.51 23.27 34.29 -43.83 18.61 16.41 -46.11 20.56 15.85 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 B 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 D 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 B 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 D 110 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 B 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 D 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 B 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 B 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 D 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -43.83 18.61 16.41 -46.11 20.56 15.85 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 G 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 G 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -33.59 8.19 15.94 -35.17 6.84 16.43 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 G 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 G 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG C 74 ARG~? 5.25 O1B ADP C1001 G 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 G 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 G 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 G 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 G 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 G 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -29.26 47.42 21.46 -29.58 49.13 20.24 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 H 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 H 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -33.59 8.19 15.94 -35.17 6.84 16.43 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 H 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 H 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG C 74 ARG~? 5.25 O1B ADP C1001 H 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 H 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 H 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 H 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -35.67 34.06 2.87 -37.59 34.07 2.20 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 H 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 H 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -29.26 47.42 21.46 -29.58 49.13 20.24 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 E 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 G 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 E 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 G 110 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 E 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 G 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 E 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 G 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 E 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 G 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -43.83 18.61 16.41 -46.11 20.56 15.85 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR B 79 TYR~? 13.34 O4' ADP C1001 F 236 ASP B 54 ASP~? 20.52 O4' ADP C1001 H 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 F 236 ASP B 110 ASP.? 12.77 N6 ADP C1001 H 110 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 111 TYR.? 10.00 N6 ADP C1001 F 236 ASP B 112 ASP.? 11.36 O1B ADP C1001 H 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -35.67 34.06 2.87 -37.59 34.07 2.20 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR C 79 TYR~? 13.12 N6 ADP C1001 F 236 ASP C 54 ASP~? 20.12 N1 ADP C1001 H 110 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR C 111 TYR.? 9.78 O3' ADP C1001 F 236 ASP C 110 ASP.? 10.54 O3' ADP C1001 H 110 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -43.83 18.61 16.41 -46.11 20.56 15.85 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 256 GLU A 33 GLU^? 35.51 N6 ADP C1001 A 329 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 30.54 71.65 32.58 31.73 72.26 30.92 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 36 ASP^? 33.81 N6 ADP C1001 A 256 GLU A 33 GLU^? 35.51 N6 ADP C1001 A 329 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 30.54 71.65 32.58 31.73 72.26 30.92 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 256 GLU B 33 GLU^? 22.82 N1 ADP C1001 A 329 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 30.54 71.65 32.58 31.73 72.26 30.92 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 256 GLU D 33 GLU^? 24.81 N6 ADP C1001 A 329 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 30.54 71.65 32.58 31.73 72.26 30.92 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 1qho_c04 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP D 36 ASP^? 31.16 N6 ADP C1001 A 256 GLU D 33 GLU^? 24.81 N6 ADP C1001 A 329 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 30.54 71.65 32.58 31.73 72.26 30.92 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 37.87 70.12 31.80 36.61 69.74 30.15 -13.15 42.40 14.58 -15.11 42.76 15.19 1qho_c04 source 1qho ALPHA-AMYLASE : 5 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 261 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 329 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 37.87 70.12 31.80 36.61 69.74 30.15 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 261 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 329 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 34.02 79.89 42.60 34.73 78.01 41.86 -4.20 1.28 18.72 -4.75 1.76 20.72 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 261 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 329 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 34.02 79.89 42.60 34.73 78.01 41.86 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 261 ASP B 97 ASP~? 21.13 N6 ADP C1001 A 329 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 34.02 79.89 42.60 34.73 78.01 41.86 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 54 ASP~? 20.52 O4' ADP C1001 A 261 ASP A 9 ASP.? 35.63 N1 ADP C1001 A 329 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 34.02 79.89 42.60 34.73 78.01 41.86 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 37.87 70.12 31.80 36.61 69.74 30.15 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 261 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 329 ASP A 10 ASP.? 29.48 N1 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 34.02 79.89 42.60 34.73 78.01 41.86 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 37.87 70.12 31.80 36.61 69.74 30.15 -21.48 2.08 13.35 -22.87 1.76 14.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 261 ASP D 54 ASP~? 30.93 N6 ADP C1001 A 329 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 37.87 70.12 31.80 36.61 69.74 30.15 -29.26 47.42 21.46 -29.58 49.13 20.24 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 261 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 329 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 34.02 79.89 42.60 34.73 78.01 41.86 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 261 ASP D 97 ASP~? 39.15 N6 ADP C1001 A 329 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 34.02 79.89 42.60 34.73 78.01 41.86 -4.34 53.74 3.65 -4.01 53.36 1.58 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.58 39.61 12.64 -2.59 38.96 12.51 1qho_c05 source 1qho ALPHA-AMYLASE : 9 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 260 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 329 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 30.73 81.29 37.61 31.23 82.07 35.69 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 260 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 329 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 36 ASP^? 33.81 N6 ADP C1001 A 260 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 329 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 30.73 81.29 37.61 31.23 82.07 35.69 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 260 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 329 ASP B 9 ASP.? 24.63 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 -21.79 14.69 -0.26 -22.78 14.66 -2.05 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 260 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 329 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 260 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 329 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 260 ASP A 36 ASP^? 33.81 N6 ADP C1001 A 329 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 30.73 81.29 37.61 31.23 82.07 35.69 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 260 ASP B 97 ASP~? 21.13 N6 ADP C1001 A 329 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 30.73 81.29 37.61 31.23 82.07 35.69 -17.01 28.05 3.64 -15.70 27.74 1.96 coo 37.87 70.12 31.80 36.61 69.74 30.15 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 260 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 329 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 260 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 329 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 30.73 81.29 37.61 31.23 82.07 35.69 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.58 39.61 12.64 -2.59 38.96 12.51 1qho_c07 source 1qho ALPHA-AMYLASE : 10 hits 1qho_c07 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA B 64 ALA.? 15.41 N1 ADP C1001 A 148 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 163 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 1.42 19.18 21.84 1.11 19.57 23.28 -22.22 17.81 20.01 -22.67 17.81 18.54 coo 0.71 19.67 27.92 2.43 19.16 26.83 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 7.15 16.22 27.50 6.15 18.00 27.94 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA D 64 ALA.? 26.15 N6 ADP C1001 A 148 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 163 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 1.42 19.18 21.84 1.11 19.57 23.28 -16.76 49.68 19.26 -17.00 50.74 18.25 coo 0.71 19.67 27.92 2.43 19.16 26.83 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 7.15 16.22 27.50 6.15 18.00 27.94 -25.68 50.03 20.54 -26.38 51.13 22.17 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA D 64 ALA.? 26.15 N6 ADP C1001 B 148 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 163 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -16.76 49.68 19.26 -17.00 50.74 18.25 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -25.68 50.03 20.54 -26.38 51.13 22.17 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 64 ALA.? 37.27 N6 ADP C1001 C 148 HIS A 62 HIS~? 32.10 N6 ADP C1001 C 163 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA B 64 ALA.? 15.41 N1 ADP C1001 C 148 HIS B 62 HIS~? 22.43 N1 ADP C1001 C 163 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -22.22 17.81 20.01 -22.67 17.81 18.54 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA D 64 ALA.? 26.15 N6 ADP C1001 C 148 HIS D 62 HIS.? 20.37 N6 ADP C1001 C 163 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -16.76 49.68 19.26 -17.00 50.74 18.25 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -25.68 50.03 20.54 -26.38 51.13 22.17 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 64 ALA.? 37.27 N6 ADP C1001 D 148 HIS A 62 HIS~? 32.10 N6 ADP C1001 D 163 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA B 64 ALA.? 15.41 N1 ADP C1001 D 148 HIS B 62 HIS~? 22.43 N1 ADP C1001 D 163 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -22.22 17.81 20.01 -22.67 17.81 18.54 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA D 64 ALA.? 26.15 N6 ADP C1001 D 148 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 163 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -16.76 49.68 19.26 -17.00 50.74 18.25 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -25.68 50.03 20.54 -26.38 51.13 22.17 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 64 ALA.? 37.27 N6 ADP C1001 E 148 HIS A 62 HIS~? 32.10 N6 ADP C1001 E 163 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA B 64 ALA.? 15.41 N1 ADP C1001 E 148 HIS B 62 HIS~? 22.43 N1 ADP C1001 E 163 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -22.22 17.81 20.01 -22.67 17.81 18.54 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 E 51 ALA D 64 ALA.? 26.15 N6 ADP C1001 E 148 HIS D 62 HIS.? 20.37 N6 ADP C1001 E 163 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -16.76 49.68 19.26 -17.00 50.74 18.25 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -25.68 50.03 20.54 -26.38 51.13 22.17 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA B 64 ALA.? 15.41 N1 ADP C1001 F 148 HIS B 62 HIS~? 22.43 N1 ADP C1001 F 163 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -22.22 17.81 20.01 -22.67 17.81 18.54 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA D 64 ALA.? 26.15 N6 ADP C1001 F 148 HIS D 62 HIS.? 20.37 N6 ADP C1001 F 163 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -16.76 49.68 19.26 -17.00 50.74 18.25 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -25.68 50.03 20.54 -26.38 51.13 22.17 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 64 ALA.? 37.27 N6 ADP C1001 G 148 HIS A 62 HIS~? 32.10 N6 ADP C1001 G 163 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA B 64 ALA.? 15.41 N1 ADP C1001 G 148 HIS B 62 HIS~? 22.43 N1 ADP C1001 G 163 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -22.22 17.81 20.01 -22.67 17.81 18.54 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA D 64 ALA.? 26.15 N6 ADP C1001 G 148 HIS D 62 HIS.? 20.37 N6 ADP C1001 G 163 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -16.76 49.68 19.26 -17.00 50.74 18.25 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -25.68 50.03 20.54 -26.38 51.13 22.17 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA B 64 ALA.? 15.41 N1 ADP C1001 H 148 HIS B 62 HIS~? 22.43 N1 ADP C1001 H 163 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -22.22 17.81 20.01 -22.67 17.81 18.54 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA D 64 ALA.? 26.15 N6 ADP C1001 H 148 HIS D 62 HIS.? 20.37 N6 ADP C1001 H 163 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -16.76 49.68 19.26 -17.00 50.74 18.25 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -25.68 50.03 20.54 -26.38 51.13 22.17 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 69 THR.? 44.69 N6 ADP C1001 A 182 TYR A 92 TYR.? 47.39 N1 ADP C1001 A 186 LYS A 19 LYS.? 46.12 N1 ADP C1001 coo 69.38 87.38 24.64 71.11 88.47 25.40 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 73.61 90.42 31.12 71.36 89.66 29.64 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 73.54 84.00 28.64 69.01 86.68 29.71 -11.55 -9.81 11.23 -8.77 -9.92 15.05 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR C 69 THR.? 8.25 C2 ADP C1001 A 182 TYR C 92 TYR.? 13.82 O3' ADP C1001 A 186 LYS C 19 LYS.? 18.77 O3' ADP C1001 coo 69.38 87.38 24.64 71.11 88.47 25.40 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 73.61 90.42 31.12 71.36 89.66 29.64 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 73.54 84.00 28.64 69.01 86.68 29.71 -40.14 36.21 30.10 -44.63 37.95 34.40 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 2 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 646 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 739 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -21.48 2.08 13.35 -22.87 1.76 14.94 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 646 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 739 GLY B 53 GLY~? 15.89 O4' ADP C1001 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -21.48 2.08 13.35 -22.87 1.76 14.94 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -36.20 11.44 18.47 -35.68 11.67 17.90 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS C 50 HIS.? 17.04 O2' ADP C1001 A 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 739 GLY C 71 GLY.? 8.01 O2' ADP C1001 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -36.38 48.00 21.35 -37.79 46.44 21.40 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -39.43 34.32 24.82 -38.66 34.55 25.11 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 739 GLY B 105 GLY.? 14.83 N6 ADP C1001 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -18.36 34.95 14.87 -18.15 34.98 14.15 ULMN 3 1qrz_c20 PLASMINOGEN user 5 3 # 5 A 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 739 GLY C 84 GLY.? 10.47 N6 ADP C1001 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -22.35 33.13 15.48 -22.85 33.59 15.97 ULMN 3 1qrz_c20 PLASMINOGEN user 6 3 # 6 A 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 739 GLY D 84 GLY.? 31.79 N1 ADP C1001 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -16.24 54.50 27.95 -16.49 54.77 27.19 1qrz_c20 source 1qrz PLASMINOGEN : 6 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 646 ASP A 10 ASP.? 29.48 N1 ADP C1001 B 739 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -21.48 2.08 13.35 -22.87 1.76 14.94 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS C 50 HIS.? 17.04 O2' ADP C1001 B 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 739 GLY C 71 GLY.? 8.01 O2' ADP C1001 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -36.38 48.00 21.35 -37.79 46.44 21.40 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -39.43 34.32 24.82 -38.66 34.55 25.11 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 739 GLY B 105 GLY.? 14.83 N6 ADP C1001 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -18.36 34.95 14.87 -18.15 34.98 14.15 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 739 GLY C 63 GLY.? 18.10 N1 ADP C1001 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -18.24 37.08 25.10 -19.00 37.10 25.28 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 739 GLY C 84 GLY.? 10.47 N6 ADP C1001 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -22.35 33.13 15.48 -22.85 33.59 15.97 ULMN 3 1qrz_c21 PLASMINOGEN user 6 3 # 6 B 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 739 GLY D 84 GLY.? 31.79 N1 ADP C1001 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -16.24 54.50 27.95 -16.49 54.77 27.19 1qrz_c21 source 1qrz PLASMINOGEN : 6 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 C 646 ASP A 10 ASP.? 29.48 N1 ADP C1001 C 739 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 7.82 1.25 3.03 7.30 1.31 3.65 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 C 646 ASP A 10 ASP.? 29.48 N1 ADP C1001 C 739 GLY B 53 GLY~? 15.89 O4' ADP C1001 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 7.82 1.25 3.03 7.30 1.31 3.65 -36.20 11.44 18.47 -35.68 11.67 17.90 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS C 50 HIS.? 17.04 O2' ADP C1001 C 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 739 GLY C 71 GLY.? 8.01 O2' ADP C1001 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 7.82 1.25 3.03 7.30 1.31 3.65 -39.43 34.32 24.82 -38.66 34.55 25.11 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 C 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 739 GLY B 105 GLY.? 14.83 N6 ADP C1001 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 7.82 1.25 3.03 7.30 1.31 3.65 -18.36 34.95 14.87 -18.15 34.98 14.15 ULMN 3 1qrz_c22 PLASMINOGEN user 5 3 # 5 C 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 C 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 739 GLY C 84 GLY.? 10.47 N6 ADP C1001 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 7.82 1.25 3.03 7.30 1.31 3.65 -22.35 33.13 15.48 -22.85 33.59 15.97 ULMN 3 1qrz_c22 PLASMINOGEN user 6 3 # 6 C 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 C 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 739 GLY D 84 GLY.? 31.79 N1 ADP C1001 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 7.82 1.25 3.03 7.30 1.31 3.65 -16.24 54.50 27.95 -16.49 54.77 27.19 1qrz_c22 source 1qrz PLASMINOGEN : 6 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 D 646 ASP A 10 ASP.? 29.48 N1 ADP C1001 D 739 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -21.48 2.08 13.35 -22.87 1.76 14.94 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS B 62 HIS~? 22.43 N1 ADP C1001 D 646 ASP A 10 ASP.? 29.48 N1 ADP C1001 D 739 GLY B 53 GLY~? 15.89 O4' ADP C1001 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -21.48 2.08 13.35 -22.87 1.76 14.94 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -36.20 11.44 18.47 -35.68 11.67 17.90 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS C 50 HIS.? 17.04 O2' ADP C1001 D 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 739 GLY C 71 GLY.? 8.01 O2' ADP C1001 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -36.38 48.00 21.35 -37.79 46.44 21.40 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -39.43 34.32 24.82 -38.66 34.55 25.11 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 739 GLY B 105 GLY.? 14.83 N6 ADP C1001 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -18.36 34.95 14.87 -18.15 34.98 14.15 ULMN 3 1qrz_c23 PLASMINOGEN user 5 3 # 5 D 603 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 646 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 739 GLY D 84 GLY.? 31.79 N1 ADP C1001 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -16.24 54.50 27.95 -16.49 54.77 27.19 1qrz_c23 source 1qrz PLASMINOGEN : 5 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 58 PHE~? 34.92 N6 ADP C1001 A 201 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 227 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 23.39 49.81 32.16 21.33 51.68 32.26 -17.56 0.82 -0.93 -18.36 2.22 1.34 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 12.68 46.83 36.69 18.26 48.67 34.51 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE B 58 PHE~? 21.02 N6 ADP C1001 A 201 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 227 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 23.39 49.81 32.16 21.33 51.68 32.26 -26.58 9.98 15.28 -24.37 9.78 13.51 coo 25.52 45.12 37.98 23.98 46.65 37.85 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 12.68 46.83 36.69 18.26 48.67 34.51 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE C 58 PHE~? 19.35 C2 ADP C1001 A 201 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 227 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 23.39 49.81 32.16 21.33 51.68 32.26 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 25.52 45.12 37.98 23.98 46.65 37.85 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 12.68 46.83 36.69 18.26 48.67 34.51 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 201 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 227 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 23.39 49.81 32.16 21.33 51.68 32.26 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 12.68 46.83 36.69 18.26 48.67 34.51 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE D 58 PHE~? 24.52 N6 ADP C1001 A 201 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 227 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 23.39 49.81 32.16 21.33 51.68 32.26 -24.99 53.85 15.24 -24.47 52.34 12.98 coo 25.52 45.12 37.98 23.98 46.65 37.85 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 12.68 46.83 36.69 18.26 48.67 34.51 -14.21 50.71 21.89 -14.80 46.21 24.73 1qz9_c02 source 1qz9 KYNURENINASE : 5 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 186 ASN C 57 ASN~? 16.68 N6 ADP C1001 A 260 ALA D 64 ALA.? 26.15 N6 ADP C1001 coo 11.81 33.10 11.71 13.07 31.45 11.40 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 11.43 26.53 7.41 13.01 27.56 8.43 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 21.53 26.33 6.96 20.26 25.69 7.52 -16.76 49.68 19.26 -17.00 50.74 18.25 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 186 ASN D 57 ASN~? 28.49 N1 ADP C1001 A 260 ALA D 64 ALA.? 26.15 N6 ADP C1001 coo 11.81 33.10 11.71 13.07 31.45 11.40 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 11.43 26.53 7.41 13.01 27.56 8.43 -26.50 55.76 21.71 -26.74 56.60 23.67 coo 21.53 26.33 6.96 20.26 25.69 7.52 -16.76 49.68 19.26 -17.00 50.74 18.25 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 2 hits 1r4f_c00 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 610 HIS C 50 HIS.? 17.04 O2' ADP C1001 A 661 HIS D 62 HIS.? 20.37 N6 ADP C1001 coo 75.99 81.56 1.86 73.91 81.34 2.28 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 71.04 78.84 0.46 71.54 76.90 1.02 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 75.40 81.38 12.06 74.88 79.42 12.63 -23.21 48.47 15.79 -25.03 48.41 14.73 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 610 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 661 HIS C 50 HIS.? 17.04 O2' ADP C1001 coo 75.99 81.56 1.86 73.91 81.34 2.28 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 71.04 78.84 0.46 71.54 76.90 1.02 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 75.40 81.38 12.06 74.88 79.42 12.63 -36.38 48.00 21.35 -37.79 46.44 21.40 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 2 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 610 HIS C 50 HIS.? 17.04 O2' ADP C1001 C 661 HIS D 62 HIS.? 20.37 N6 ADP C1001 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -36.38 48.00 21.35 -37.79 46.44 21.40 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -23.21 48.47 15.79 -25.03 48.41 14.73 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 610 HIS D 62 HIS.? 20.37 N6 ADP C1001 C 661 HIS C 50 HIS.? 17.04 O2' ADP C1001 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -36.38 48.00 21.35 -37.79 46.44 21.40 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 2 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 84 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 140 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS C 50 HIS.? 17.04 O2' ADP C1001 B 84 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 140 GLY C 73 GLY~? 7.38 O2' ADP C1001 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -38.52 37.92 18.83 -37.81 37.51 18.99 1rgq_c01 source 1rgq NS4A PEPTIDE : 2 hits 1rgq_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 9 ASP.? 35.63 N1 ADP C1001 35 SER A 15 SER~? 35.42 N1 ADP C1001 215 ASP A 10 ASP.? 29.48 N1 ADP C1001 coo 11.85 17.24 72.81 11.09 15.37 72.36 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 12.20 12.71 75.45 13.69 13.84 74.03 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo 5.22 15.03 71.43 7.19 14.88 70.83 -21.48 2.08 13.35 -22.87 1.76 14.94 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP B 9 ASP.? 24.63 N6 ADP C1001 35 SER B 15 SER~? 20.97 N6 ADP C1001 215 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 11.85 17.24 72.81 11.09 15.37 72.36 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 12.20 12.71 75.45 13.69 13.84 74.03 -19.71 18.90 1.41 -21.68 17.51 1.61 coo 5.22 15.03 71.43 7.19 14.88 70.83 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP C 9 ASP.? 24.62 C2 ADP C1001 35 SER C 15 SER.? 21.32 C2 ADP C1001 215 ASP C 10 ASP.? 28.10 C2 ADP C1001 coo 11.85 17.24 72.81 11.09 15.37 72.36 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 12.20 12.71 75.45 13.69 13.84 74.03 -33.57 35.15 39.94 -32.12 36.31 38.28 coo 5.22 15.03 71.43 7.19 14.88 70.83 -29.82 42.88 40.75 -30.96 43.09 42.54 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 3 hits 1rne_c04 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG A 23 ARG.? 47.94 N6 ADP C1001 D 156 TYR A 70 TYR.? 48.30 N6 ADP C1001 D 188 HIS A 20 HIS.? 47.81 N6 ADP C1001 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 -17.87 -12.22 3.83 -15.16 -13.38 2.91 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -13.99 -12.93 8.41 -13.37 -14.79 9.16 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 3 # 2 D 129 ARG D 2 ARG^? 19.52 N6 ADP C1001 D 156 TYR C 79 TYR~? 13.12 N6 ADP C1001 D 188 HIS D 62 HIS.? 20.37 N6 ADP C1001 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 -16.51 45.11 16.54 -19.16 44.24 15.23 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -29.67 41.42 14.91 -30.18 43.90 13.55 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -23.21 48.47 15.79 -25.03 48.41 14.73 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 2 hits 1ro7_c03 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 288 HIS A 20 HIS.? 47.81 N6 ADP C1001 A 329 LYS A 114 LYS.? 56.27 N6 ADP C1001 coo 29.27 18.78 14.99 27.16 18.62 14.76 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 49.52 10.06 10.36 50.99 9.65 8.92 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 57.80 12.92 13.83 53.77 8.42 12.15 -4.38 -17.33 7.81 -3.33 -16.78 2.19 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 288 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 329 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 29.27 18.78 14.99 27.16 18.62 14.76 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 49.52 10.06 10.36 50.99 9.65 8.92 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 57.80 12.92 13.83 53.77 8.42 12.15 -38.05 28.30 5.66 -42.50 28.99 10.13 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 288 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 329 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 29.27 18.78 14.99 27.16 18.62 14.76 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 49.52 10.06 10.36 50.99 9.65 8.92 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 57.80 12.92 13.83 53.77 8.42 12.15 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 288 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 329 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 29.27 18.78 14.99 27.16 18.62 14.76 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 49.52 10.06 10.36 50.99 9.65 8.92 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 57.80 12.92 13.83 53.77 8.42 12.15 -38.05 28.30 5.66 -42.50 28.99 10.13 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU B 41 GLU^? 24.52 N6 ADP C1001 A 288 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 329 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 29.27 18.78 14.99 27.16 18.62 14.76 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 49.52 10.06 10.36 50.99 9.65 8.92 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 57.80 12.92 13.83 53.77 8.42 12.15 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU C 41 GLU^? 24.05 C2 ADP C1001 A 288 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 329 LYS C 114 LYS.? -2.76 O3B ADP C1001s coo 29.27 18.78 14.99 27.16 18.62 14.76 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 49.52 10.06 10.36 50.99 9.65 8.92 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 57.80 12.92 13.83 53.77 8.42 12.15 -44.82 31.28 21.50 -43.38 31.47 16.20 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU C 41 GLU^? 24.05 C2 ADP C1001 A 288 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 329 LYS C 116 LYS.? 13.74 O3' ADP C1001 coo 29.27 18.78 14.99 27.16 18.62 14.76 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 49.52 10.06 10.36 50.99 9.65 8.92 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 57.80 12.92 13.83 53.77 8.42 12.15 -48.64 32.02 26.16 -47.11 28.29 30.57 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU D 41 GLU^? 18.65 N6 ADP C1001 A 288 HIS D 20 HIS.? 42.10 N6 ADP C1001 A 329 LYS D 114 LYS.? 50.69 N6 ADP C1001 coo 29.27 18.78 14.99 27.16 18.62 14.76 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 49.52 10.06 10.36 50.99 9.65 8.92 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 57.80 12.92 13.83 53.77 8.42 12.15 -9.33 71.95 14.33 -7.85 74.07 18.29 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 A 137 GLU D 78 GLU~? 42.25 N1 ADP C1001 A 288 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 29.27 18.78 14.99 27.16 18.62 14.76 -17.63 66.44 26.22 -18.72 68.28 26.46 coo 49.52 10.06 10.36 50.99 9.65 8.92 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 57.80 12.92 13.83 53.77 8.42 12.15 -21.36 39.39 22.00 -17.64 41.95 19.02 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 9 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 41 GLU^? 26.55 N6 ADP C1001 B 288 HIS A 20 HIS.? 47.81 N6 ADP C1001 B 329 LYS A 114 LYS.? 56.27 N6 ADP C1001 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -4.38 -17.33 7.81 -3.33 -16.78 2.19 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 41 GLU^? 26.55 N6 ADP C1001 B 288 HIS B 20 HIS.? 13.19 O1A ADP C1001 B 329 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -38.05 28.30 5.66 -42.50 28.99 10.13 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU A 41 GLU^? 26.55 N6 ADP C1001 B 288 HIS B 20 HIS.? 13.19 O1A ADP C1001 B 329 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU B 41 GLU^? 24.52 N6 ADP C1001 B 288 HIS B 20 HIS.? 13.19 O1A ADP C1001 B 329 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -38.05 28.30 5.66 -42.50 28.99 10.13 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU B 41 GLU^? 24.52 N6 ADP C1001 B 288 HIS B 20 HIS.? 13.19 O1A ADP C1001 B 329 LYS B 116 LYS.? 13.79 O2B ADP C1001 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -38.53 26.18 0.73 -35.66 28.79 0.03 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU B 44 GLU^? 27.54 N6 ADP C1001 B 288 HIS A 20 HIS.? 47.81 N6 ADP C1001 B 329 LYS A 114 LYS.? 56.27 N6 ADP C1001 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -4.38 -17.33 7.81 -3.33 -16.78 2.19 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU C 41 GLU^? 24.05 C2 ADP C1001 B 288 HIS C 20 HIS.? 13.76 O2' ADP C1001 B 329 LYS C 114 LYS.? -2.76 O3B ADP C1001s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -44.82 31.28 21.50 -43.38 31.47 16.20 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 B 137 GLU C 41 GLU^? 24.05 C2 ADP C1001 B 288 HIS C 20 HIS.? 13.76 O2' ADP C1001 B 329 LYS C 116 LYS.? 13.74 O3' ADP C1001 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -48.64 32.02 26.16 -47.11 28.29 30.57 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 B 137 GLU D 41 GLU^? 18.65 N6 ADP C1001 B 288 HIS D 20 HIS.? 42.10 N6 ADP C1001 B 329 LYS D 114 LYS.? 50.69 N6 ADP C1001 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -19.13 44.82 10.40 -20.77 44.03 11.36 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -17.65 67.63 8.70 -17.05 69.61 8.40 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -9.33 71.95 14.33 -7.85 74.07 18.29 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 B 137 GLU D 78 GLU~? 42.25 N1 ADP C1001 B 288 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 329 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -17.63 66.44 26.22 -18.72 68.28 26.46 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -21.36 39.39 22.00 -17.64 41.95 19.02 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 10 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 102 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 193 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 102 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 193 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS C 50 HIS.? 17.04 O2' ADP C1001 B 102 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 193 GLY C 73 GLY~? 7.38 O2' ADP C1001 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -36.38 48.00 21.35 -37.79 46.44 21.40 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -38.52 37.92 18.83 -37.81 37.51 18.99 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 3 hits 1rtf_c06 naa= 3 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 3 # 1 A 104 ILE A 59 ILE~? 38.52 N6 ADP C1001 A 106 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 142 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -12.06 0.61 -1.09 -12.03 0.96 0.31 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 3 # 2 A 104 ILE B 59 ILE~? 15.13 N1 ADP C1001 A 106 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 142 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -26.69 15.15 17.37 -26.90 15.90 16.49 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 3 3 # 3 A 104 ILE C 59 ILE~? 13.60 N1 ADP C1001 A 106 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 142 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -25.26 38.92 24.31 -26.26 38.42 24.64 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 4 3 # 4 A 104 ILE D 59 ILE~? 27.70 N6 ADP C1001 A 106 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 142 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -20.30 54.25 17.65 -19.56 54.69 16.84 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -25.68 50.03 20.54 -26.38 51.13 22.17 1s3i_c00 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 4 hits 1s3i_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 61 ASP~? 37.71 N6 ADP C1001 64 HIS A 62 HIS~? 32.10 N6 ADP C1001 155 ASN A 39 ASN^? 26.27 N6 ADP C1001 coo 80.16 73.25 62.48 80.01 71.25 61.82 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 78.27 67.69 61.83 79.58 67.76 60.19 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 80.34 61.88 52.75 81.25 63.19 54.35 -10.50 14.02 7.34 -12.57 14.30 7.00 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP B 10 ASP.? 28.32 N6 ADP C1001 64 HIS A 62 HIS~? 32.10 N6 ADP C1001 155 ASN A 57 ASN~? 43.07 N6 ADP C1001 coo 80.16 73.25 62.48 80.01 71.25 61.82 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 78.27 67.69 61.83 79.58 67.76 60.19 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 80.34 61.88 52.75 81.25 63.19 54.35 -15.73 -0.75 -7.31 -14.92 -1.39 -9.21 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP B 61 ASP~? 21.98 C2 ADP C1001 64 HIS B 62 HIS~? 22.43 N1 ADP C1001 155 ASN B 39 ASN.? 27.14 N6 ADP C1001 coo 80.16 73.25 62.48 80.01 71.25 61.82 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 78.27 67.69 61.83 79.58 67.76 60.19 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 80.34 61.88 52.75 81.25 63.19 54.35 -11.13 15.65 16.64 -9.36 15.49 17.83 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP C 61 ASP~? 22.05 N1 ADP C1001 64 HIS C 62 HIS~? 21.13 N1 ADP C1001 155 ASN C 39 ASN^? 25.44 C2 ADP C1001 coo 80.16 73.25 62.48 80.01 71.25 61.82 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 78.27 67.69 61.83 79.58 67.76 60.19 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 80.34 61.88 52.75 81.25 63.19 54.35 -16.77 32.66 36.54 -17.11 34.71 36.97 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 4 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 10 ASP.? 29.48 N1 ADP C1001 595 GLU A 41 GLU^? 26.55 N6 ADP C1001 713 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 5.64 2.82 38.49 4.59 4.19 37.25 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 4.35 13.73 37.63 3.39 12.18 36.55 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 3.76 10.25 31.38 3.16 9.87 34.10 -23.26 11.23 5.07 -23.26 9.04 3.31 1sll_c00 source 1sll SIALIDASE L : 1 hits 1sll_c00 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 102 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 193 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 15.02 29.17 19.44 15.63 29.96 17.60 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 19.67 30.58 22.61 18.30 29.87 21.17 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 14.52 29.10 10.01 15.08 29.66 10.19 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 102 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 193 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo 15.02 29.17 19.44 15.63 29.96 17.60 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 19.67 30.58 22.61 18.30 29.87 21.17 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 14.52 29.10 10.01 15.08 29.66 10.19 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS C 50 HIS.? 17.04 O2' ADP C1001 A 102 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 193 GLY C 73 GLY~? 7.38 O2' ADP C1001 coo 15.02 29.17 19.44 15.63 29.96 17.60 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 19.67 30.58 22.61 18.30 29.87 21.17 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 14.52 29.10 10.01 15.08 29.66 10.19 -38.52 37.92 18.83 -37.81 37.51 18.99 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 3 hits 1ssx_c02 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 110 ASP.? 52.32 N6 ADP C1001 E 168 LYS A 114 LYS.? 56.27 N6 ADP C1001 E 201 THR A 89 THR.? 50.21 N6 ADP C1001 coo 5.36 16.20 22.10 3.88 17.00 23.31 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 5.06 22.32 18.11 1.02 22.08 22.74 -4.38 -17.33 7.81 -3.33 -16.78 2.19 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -3.01 -7.90 5.97 -2.57 -9.33 4.41 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 110 ASP.? 12.77 N6 ADP C1001 E 168 LYS B 114 LYS.? -3.14 O1A ADP C1001s E 201 THR B 89 THR.? -3.20 N6 ADP C1001s coo 5.36 16.20 22.10 3.88 17.00 23.31 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 5.06 22.32 18.11 1.02 22.08 22.74 -38.05 28.30 5.66 -42.50 28.99 10.13 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -30.78 27.78 11.26 -32.72 28.03 12.28 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP C 110 ASP.? 10.54 O3' ADP C1001 E 168 LYS C 114 LYS.? -2.76 O3B ADP C1001s E 201 THR C 89 THR.? 3.96 N3 ADP C1001 coo 5.36 16.20 22.10 3.88 17.00 23.31 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 5.06 22.32 18.11 1.02 22.08 22.74 -44.82 31.28 21.50 -43.38 31.47 16.20 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -36.03 29.56 23.55 -36.59 29.86 21.42 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP D 110 ASP.? 48.95 N6 ADP C1001 E 168 LYS D 114 LYS.? 50.69 N6 ADP C1001 E 201 THR D 89 THR.? 41.56 N6 ADP C1001 coo 5.36 16.20 22.10 3.88 17.00 23.31 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 5.06 22.32 18.11 1.02 22.08 22.74 -9.33 71.95 14.33 -7.85 74.07 18.29 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -8.88 62.80 15.73 -9.19 64.25 17.31 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 4 hits 1stc_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 80 GLU B 41 GLU^? 24.52 N6 ADP C1001 B 223 ARG C 74 ARG~? 5.25 O1B ADP C1001 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -15.90 11.43 13.39 -16.60 10.91 15.33 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -39.58 36.65 12.40 -39.71 35.25 9.68 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS C 50 HIS.? 17.04 O2' ADP C1001 B 80 GLU C 48 GLU.? 22.51 O2' ADP C1001 B 223 ARG D 11 ARG~? 37.61 N6 ADP C1001 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -36.38 48.00 21.35 -37.79 46.44 21.40 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -33.52 53.52 23.97 -33.48 52.09 22.33 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -15.91 54.83 -3.29 -13.93 57.19 -3.15 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS C 62 HIS~? 21.13 N1 ADP C1001 B 80 GLU C 41 GLU^? 24.05 C2 ADP C1001 B 223 ARG B 74 ARG~? -6.26 O2A ADP C1001s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -20.29 38.32 35.00 -18.64 39.42 34.23 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -43.21 24.74 16.58 -45.29 23.99 18.72 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 3 hits 1t0u_c01 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER B 86 SER^? 6.21 N1 ADP C1001 A 90 SER C 86 SER^? 7.39 N1 ADP C1001 A 145 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -28.54 24.76 20.78 -28.08 27.14 20.69 coo 1.47 40.03 18.48 2.45 41.37 16.68 -26.83 30.24 19.36 -25.45 28.48 18.57 coo 7.35 44.71 16.29 4.71 40.98 14.52 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER C 86 SER^? 7.39 N1 ADP C1001 A 90 SER B 86 SER^? 6.21 N1 ADP C1001 A 145 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -26.83 30.24 19.36 -25.45 28.48 18.57 coo 1.47 40.03 18.48 2.45 41.37 16.68 -28.54 24.76 20.78 -28.08 27.14 20.69 coo 7.35 44.71 16.29 4.71 40.98 14.52 -23.42 20.96 21.77 -22.73 18.61 26.55 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 2 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER B 86 SER^? 6.21 N1 ADP C1001 B 90 SER C 86 SER^? 7.39 N1 ADP C1001 B 145 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 61.01 10.03 12.97 58.78 10.97 12.69 -28.54 24.76 20.78 -28.08 27.14 20.69 coo 56.85 12.22 16.37 55.62 11.34 14.45 -26.83 30.24 19.36 -25.45 28.48 18.57 coo 49.80 9.51 14.88 53.14 11.99 12.77 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER C 86 SER^? 7.39 N1 ADP C1001 B 90 SER B 86 SER^? 6.21 N1 ADP C1001 B 145 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 61.01 10.03 12.97 58.78 10.97 12.69 -26.83 30.24 19.36 -25.45 28.48 18.57 coo 56.85 12.22 16.37 55.62 11.34 14.45 -28.54 24.76 20.78 -28.08 27.14 20.69 coo 49.80 9.51 14.88 53.14 11.99 12.77 -23.42 20.96 21.77 -22.73 18.61 26.55 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 2 hits 1t7d_c01 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 174 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 404 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -29.67 41.42 14.91 -30.18 43.90 13.55 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS D 62 HIS.? 20.37 N6 ADP C1001 C 174 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 404 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -29.67 41.42 14.91 -30.18 43.90 13.55 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS D 62 HIS.? 20.37 N6 ADP C1001 E 174 ASP C 61 ASP~? 22.05 N1 ADP C1001 E 404 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -29.67 41.42 14.91 -30.18 43.90 13.55 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c08 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS B 14 LYS~? 27.17 N6 ADP C1001 138 ASN A 39 ASN^? 26.27 N6 ADP C1001 183 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -10.50 14.02 7.34 -12.57 14.30 7.00 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS B 106 LYS.? 18.25 N6 ADP C1001 138 ASN D 39 ASN^? 19.52 N6 ADP C1001 183 HIS D 62 HIS.? 20.37 N6 ADP C1001 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -14.81 40.52 11.20 -15.13 38.43 11.40 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -23.21 48.47 15.79 -25.03 48.41 14.73 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 3 3 # 3 115 LYS D 60 LYS~? 25.96 N1 ADP C1001 138 ASN C 57 ASN~? 16.68 N6 ADP C1001 183 HIS C 62 HIS~? 21.13 N1 ADP C1001 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -20.79 41.45 28.58 -20.89 43.35 29.47 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 3 hits 1uag_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 8 GLU.? 40.05 N1 ADP C1001 A 126 LYS A 19 LYS.? 46.12 N1 ADP C1001 A 171 ALA A 7 ALA^? 34.93 N6 ADP C1001 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -16.47 -6.15 15.18 -15.55 -6.74 17.02 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -14.67 -1.89 11.08 -15.25 -0.53 11.40 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU B 8 GLU.? 21.08 N6 ADP C1001 A 126 LYS B 14 LYS~? 27.17 N6 ADP C1001 A 171 ALA B 7 ALA^? 19.02 N6 ADP C1001 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -23.95 17.01 5.35 -22.53 16.46 5.45 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU B 8 GLU.? 21.08 N6 ADP C1001 A 126 LYS B 19 LYS.? 15.59 N6 ADP C1001 A 171 ALA B 7 ALA^? 19.02 N6 ADP C1001 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -23.95 17.01 5.35 -22.53 16.46 5.45 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU C 8 GLU.? 21.29 O3' ADP C1001 A 126 LYS C 19 LYS.? 18.77 O3' ADP C1001 A 171 ALA C 7 ALA^? 19.38 C2 ADP C1001 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -32.65 37.85 34.38 -31.51 37.98 35.41 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU D 8 GLU.? 38.64 N6 ADP C1001 A 126 LYS D 14 LYS~? 32.56 N6 ADP C1001 A 171 ALA D 7 ALA^? 31.06 N6 ADP C1001 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -12.53 51.88 -0.15 -12.30 47.61 -3.60 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -16.88 56.61 6.05 -17.27 55.26 5.42 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 A 46 GLU D 8 GLU.? 38.64 N6 ADP C1001 A 126 LYS D 19 LYS.? 44.78 N6 ADP C1001 A 171 ALA D 7 ALA^? 31.06 N6 ADP C1001 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -14.01 64.85 7.32 -9.19 66.73 4.57 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -16.88 56.61 6.05 -17.27 55.26 5.42 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 6 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 8 GLU.? 40.05 N1 ADP C1001 B 126 LYS A 19 LYS.? 46.12 N1 ADP C1001 B 171 ALA A 7 ALA^? 34.93 N6 ADP C1001 coo 20.47 87.42 16.54 20.16 87.17 14.45 -16.47 -6.15 15.18 -15.55 -6.74 17.02 coo 24.73 94.37 14.59 21.08 89.84 11.98 -11.55 -9.81 11.23 -8.77 -9.92 15.05 coo 24.38 86.32 12.71 22.88 86.54 12.71 -14.67 -1.89 11.08 -15.25 -0.53 11.40 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU B 8 GLU.? 21.08 N6 ADP C1001 B 126 LYS B 14 LYS~? 27.17 N6 ADP C1001 B 171 ALA B 7 ALA^? 19.02 N6 ADP C1001 coo 20.47 87.42 16.54 20.16 87.17 14.45 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 24.73 94.37 14.59 21.08 89.84 11.98 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 24.38 86.32 12.71 22.88 86.54 12.71 -23.95 17.01 5.35 -22.53 16.46 5.45 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU B 8 GLU.? 21.08 N6 ADP C1001 B 126 LYS B 19 LYS.? 15.59 N6 ADP C1001 B 171 ALA B 7 ALA^? 19.02 N6 ADP C1001 coo 20.47 87.42 16.54 20.16 87.17 14.45 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 24.73 94.37 14.59 21.08 89.84 11.98 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 24.38 86.32 12.71 22.88 86.54 12.71 -23.95 17.01 5.35 -22.53 16.46 5.45 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU C 8 GLU.? 21.29 O3' ADP C1001 B 126 LYS C 19 LYS.? 18.77 O3' ADP C1001 B 171 ALA C 7 ALA^? 19.38 C2 ADP C1001 coo 20.47 87.42 16.54 20.16 87.17 14.45 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 24.73 94.37 14.59 21.08 89.84 11.98 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 24.38 86.32 12.71 22.88 86.54 12.71 -32.65 37.85 34.38 -31.51 37.98 35.41 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU D 8 GLU.? 38.64 N6 ADP C1001 B 126 LYS D 14 LYS~? 32.56 N6 ADP C1001 B 171 ALA D 7 ALA^? 31.06 N6 ADP C1001 coo 20.47 87.42 16.54 20.16 87.17 14.45 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 24.73 94.37 14.59 21.08 89.84 11.98 -12.53 51.88 -0.15 -12.30 47.61 -3.60 coo 24.38 86.32 12.71 22.88 86.54 12.71 -16.88 56.61 6.05 -17.27 55.26 5.42 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 B 46 GLU D 8 GLU.? 38.64 N6 ADP C1001 B 126 LYS D 19 LYS.? 44.78 N6 ADP C1001 B 171 ALA D 7 ALA^? 31.06 N6 ADP C1001 coo 20.47 87.42 16.54 20.16 87.17 14.45 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 24.73 94.37 14.59 21.08 89.84 11.98 -14.01 64.85 7.32 -9.19 66.73 4.57 coo 24.38 86.32 12.71 22.88 86.54 12.71 -16.88 56.61 6.05 -17.27 55.26 5.42 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 6 hits 1uf7_c01 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 64 ALA.? 37.27 N6 ADP C1001 A 224 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 252 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA B 64 ALA.? 15.41 N1 ADP C1001 A 224 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 252 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -22.22 17.81 20.01 -22.67 17.81 18.54 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 3 1uk7_c00 3.07.01.0009 user 3 3 # 3 A 103 ALA C 64 ALA.? 14.62 N1 ADP C1001 A 224 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 252 HIS C 62 HIS~? 21.13 N1 ADP C1001 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -21.29 34.81 25.43 -22.58 35.15 26.14 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -20.79 41.45 28.58 -20.89 43.35 29.47 ULMN 3 1uk7_c00 3.07.01.0009 user 4 3 # 4 A 103 ALA D 64 ALA.? 26.15 N6 ADP C1001 A 224 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 252 HIS D 62 HIS.? 20.37 N6 ADP C1001 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -16.76 49.68 19.26 -17.00 50.74 18.25 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -23.21 48.47 15.79 -25.03 48.41 14.73 1uk7_c00 source 1uk7 3.07.01.0009 : 4 hits 1uk7_c00 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU B 33 GLU^? 22.82 N1 ADP C1001 A 87 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 89 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 A 85 GLU B 35 GLU.? 24.64 N6 ADP C1001 A 87 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 89 GLU B 33 GLU^? 22.82 N1 ADP C1001 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -8.42 31.70 14.79 -7.88 32.87 13.09 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -10.19 23.43 20.85 -11.43 22.93 22.49 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 2 hits 1un1_c00 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 31 ASP^? 31.30 N6 ADP C1001 255 GLU A 33 GLU^? 35.51 N6 ADP C1001 329 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 52.57 37.12 10.17 53.37 35.95 11.75 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 36 ASP^? 33.81 N6 ADP C1001 255 GLU A 33 GLU^? 35.51 N6 ADP C1001 329 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 52.57 37.12 10.17 53.37 35.95 11.75 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP C 31 ASP^? 21.62 C2 ADP C1001 255 GLU C 33 GLU^? 22.62 N1 ADP C1001 329 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 52.57 37.12 10.17 53.37 35.95 11.75 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP D 31 ASP^? 21.52 N6 ADP C1001 255 GLU D 33 GLU^? 24.81 N6 ADP C1001 329 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 52.57 37.12 10.17 53.37 35.95 11.75 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 -4.58 39.61 12.64 -2.59 38.96 12.51 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 4 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 10 ASP.? 29.48 N1 ADP C1001 218 GLU B 35 GLU.? 24.64 N6 ADP C1001 329 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 -8.42 31.70 14.79 -7.88 32.87 13.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 31 ASP^? 31.30 N6 ADP C1001 218 GLU C 35 GLU.? 24.58 C2 ADP C1001 329 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 -21.26 18.31 34.64 -21.49 16.34 35.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 61 ASP~? 37.71 N6 ADP C1001 218 GLU A 115 GLU.? 59.12 N6 ADP C1001 329 ASP A 54 ASP~? 42.89 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.13 -20.10 11.70 -1.63 -20.78 13.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 54 ASP~? 20.52 O4' ADP C1001 218 GLU A 33 GLU^? 35.51 N6 ADP C1001 329 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 61 ASP~? 21.98 C2 ADP C1001 218 GLU A 35 GLU.? 41.16 N6 ADP C1001 329 ASP A 10 ASP.? 29.48 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 70.09 11.71 8.46 70.56 12.89 6.77 4.51 12.95 12.26 5.81 14.21 13.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.48 2.08 13.35 -22.87 1.76 14.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 61 ASP~? 21.98 C2 ADP C1001 218 GLU B 115 GLU.? 12.48 O1B ADP C1001 329 ASP B 54 ASP~? 20.52 O4' ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 70.09 11.71 8.46 70.56 12.89 6.77 -39.49 31.51 1.54 -40.33 32.66 0.02 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.59 8.19 15.94 -35.17 6.84 16.43 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP C 36 ASP^? 27.15 C2 ADP C1001 218 GLU C 78 GLU~? 9.17 N6 ADP C1001 329 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -16.89 23.06 36.75 -16.41 21.35 37.85 coo 70.09 11.71 8.46 70.56 12.89 6.77 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP C 54 ASP~? 20.12 N1 ADP C1001 218 GLU C 35 GLU.? 24.58 C2 ADP C1001 329 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 70.09 11.71 8.46 70.56 12.89 6.77 -21.26 18.31 34.64 -21.49 16.34 35.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP C 61 ASP~? 22.05 N1 ADP C1001 218 GLU B 115 GLU.? 12.48 O1B ADP C1001 329 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 -39.49 31.51 1.54 -40.33 32.66 0.02 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.26 47.42 21.46 -29.58 49.13 20.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP C 61 ASP~? 22.05 N1 ADP C1001 218 GLU B 115 GLU.? 12.48 O1B ADP C1001 329 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 -39.49 31.51 1.54 -40.33 32.66 0.02 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP C 61 ASP~? 22.05 N1 ADP C1001 218 GLU C 115 GLU.? 11.76 O3B ADP C1001 329 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 70.09 11.71 8.46 70.56 12.89 6.77 -50.58 33.44 21.57 -49.74 35.49 21.49 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP D 31 ASP^? 21.52 N6 ADP C1001 218 GLU B 41 GLU^? 24.52 N6 ADP C1001 329 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 70.09 11.71 8.46 70.56 12.89 6.77 -15.90 11.43 13.39 -16.60 10.91 15.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP D 31 ASP^? 21.52 N6 ADP C1001 218 GLU B 78 GLU~? 5.47 O3' ADP C1001 329 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 70.09 11.71 8.46 70.56 12.89 6.77 -39.37 23.43 20.35 -41.49 23.57 20.23 coo 59.16 37.82 13.95 57.63 37.03 15.12 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP D 31 ASP^? 21.52 N6 ADP C1001 218 GLU C 35 GLU.? 24.58 C2 ADP C1001 329 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 70.09 11.71 8.46 70.56 12.89 6.77 -21.26 18.31 34.64 -21.49 16.34 35.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP D 36 ASP^? 31.16 N6 ADP C1001 218 GLU B 8 GLU.? 21.08 N6 ADP C1001 329 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 70.09 11.71 8.46 70.56 12.89 6.77 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP D 36 ASP^? 31.16 N6 ADP C1001 218 GLU D 78 GLU~? 42.25 N1 ADP C1001 329 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 70.09 11.71 8.46 70.56 12.89 6.77 -17.63 66.44 26.22 -18.72 68.28 26.46 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.15 42.40 14.58 -15.11 42.76 15.19 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 16 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 61 ASP~? 21.98 C2 ADP C1001 242 GLU B 33 GLU^? 22.82 N1 ADP C1001 329 ASP B 54 ASP~? 20.52 O4' ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.59 8.19 15.94 -35.17 6.84 16.43 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 61 ASP~? 21.98 C2 ADP C1001 242 GLU B 78 GLU~? 5.47 O3' ADP C1001 329 ASP A 10 ASP.? 29.48 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 -39.37 23.43 20.35 -41.49 23.57 20.23 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.48 2.08 13.35 -22.87 1.76 14.94 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 61 ASP~? 21.98 C2 ADP C1001 242 GLU C 33 GLU^? 22.62 N1 ADP C1001 329 ASP A 10 ASP.? 29.48 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.48 2.08 13.35 -22.87 1.76 14.94 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 61 ASP~? 21.98 C2 ADP C1001 242 GLU C 33 GLU^? 22.62 N1 ADP C1001 329 ASP B 54 ASP~? 20.52 O4' ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 -33.59 8.19 15.94 -35.17 6.84 16.43 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP C 31 ASP^? 21.62 C2 ADP C1001 242 GLU C 49 GLU.? 21.81 N1 ADP C1001 329 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 30.42 34.74 5.00 29.09 35.09 3.38 -30.22 47.91 25.82 -28.66 49.28 25.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP C 61 ASP~? 22.05 N1 ADP C1001 242 GLU B 33 GLU^? 22.82 N1 ADP C1001 329 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 30.42 34.74 5.00 29.09 35.09 3.38 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.26 47.42 21.46 -29.58 49.13 20.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP C 61 ASP~? 22.05 N1 ADP C1001 242 GLU B 33 GLU^? 22.82 N1 ADP C1001 329 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 30.42 34.74 5.00 29.09 35.09 3.38 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP C 61 ASP~? 22.05 N1 ADP C1001 242 GLU C 33 GLU^? 22.62 N1 ADP C1001 329 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 30.42 34.74 5.00 29.09 35.09 3.38 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP C 61 ASP~? 22.05 N1 ADP C1001 242 GLU D 35 GLU.? 34.89 N6 ADP C1001 329 ASP C 54 ASP~? 20.12 N1 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 30.42 34.74 5.00 29.09 35.09 3.38 -1.41 44.17 17.18 -1.59 46.26 17.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.26 47.42 21.46 -29.58 49.13 20.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP D 31 ASP^? 21.52 N6 ADP C1001 242 GLU C 49 GLU.? 21.81 N1 ADP C1001 329 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 30.42 34.74 5.00 29.09 35.09 3.38 -30.22 47.91 25.82 -28.66 49.28 25.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP D 31 ASP^? 21.52 N6 ADP C1001 242 GLU C 78 GLU~? 9.17 N6 ADP C1001 329 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 30.42 34.74 5.00 29.09 35.09 3.38 -33.42 36.31 11.72 -34.81 37.44 10.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP D 61 ASP~? 23.08 N1 ADP C1001 242 GLU C 8 GLU.? 21.29 O3' ADP C1001 329 ASP D 54 ASP~? 30.93 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 30.42 34.74 5.00 29.09 35.09 3.38 -38.22 39.03 36.55 -39.65 38.08 37.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.33 59.98 17.64 -30.29 60.47 18.21 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP D 61 ASP~? 23.08 N1 ADP C1001 242 GLU C 41 GLU^? 24.05 C2 ADP C1001 329 ASP D 54 ASP~? 30.93 N6 ADP C1001 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 30.42 34.74 5.00 29.09 35.09 3.38 -20.29 38.32 35.00 -18.64 39.42 34.23 coo 59.16 37.82 13.95 57.63 37.03 15.12 -28.33 59.98 17.64 -30.29 60.47 18.21 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 13 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU B 8 GLU.? 21.08 N6 ADP C1001 A 596 ARG B 11 ARG~? 27.94 N6 ADP C1001 A 647 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo 69.13 32.20 28.58 68.39 32.96 30.44 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 70.89 37.31 29.70 69.54 36.29 32.39 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 66.09 40.54 34.70 66.92 37.69 35.49 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU D 8 GLU.? 38.64 N6 ADP C1001 A 596 ARG D 11 ARG~? 37.61 N6 ADP C1001 A 647 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo 69.13 32.20 28.58 68.39 32.96 30.44 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 70.89 37.31 29.70 69.54 36.29 32.39 -15.91 54.83 -3.29 -13.93 57.19 -3.15 coo 66.09 40.54 34.70 66.92 37.69 35.49 -8.09 53.40 -0.40 -7.97 50.74 -1.98 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU B 8 GLU.? 21.08 N6 ADP C1001 B 596 ARG B 11 ARG~? 27.94 N6 ADP C1001 B 647 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo 38.22 57.83 70.36 36.82 56.74 69.18 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 34.24 60.89 68.08 33.31 57.93 67.63 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 31.43 57.38 61.97 31.90 55.58 64.41 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU D 8 GLU.? 38.64 N6 ADP C1001 B 596 ARG D 11 ARG~? 37.61 N6 ADP C1001 B 647 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo 38.22 57.83 70.36 36.82 56.74 69.18 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 34.24 60.89 68.08 33.31 57.93 67.63 -15.91 54.83 -3.29 -13.93 57.19 -3.15 coo 31.43 57.38 61.97 31.90 55.58 64.41 -8.09 53.40 -0.40 -7.97 50.74 -1.98 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU B 8 GLU.? 21.08 N6 ADP C1001 C 596 ARG B 11 ARG~? 27.94 N6 ADP C1001 C 647 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo 11.31 31.26 27.00 13.31 30.71 26.58 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 13.44 32.78 22.07 15.56 30.91 23.37 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 21.00 33.35 22.82 19.83 30.82 24.09 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU D 8 GLU.? 38.64 N6 ADP C1001 C 596 ARG D 11 ARG~? 37.61 N6 ADP C1001 C 647 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo 11.31 31.26 27.00 13.31 30.71 26.58 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 13.44 32.78 22.07 15.56 30.91 23.37 -15.91 54.83 -3.29 -13.93 57.19 -3.15 coo 21.00 33.35 22.82 19.83 30.82 24.09 -8.09 53.40 -0.40 -7.97 50.74 -1.98 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU B 8 GLU.? 21.08 N6 ADP C1001 D 596 ARG B 11 ARG~? 27.94 N6 ADP C1001 D 647 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU D 8 GLU.? 38.64 N6 ADP C1001 D 596 ARG D 11 ARG~? 37.61 N6 ADP C1001 D 647 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -15.71 59.79 2.00 -14.33 61.02 0.98 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -15.91 54.83 -3.29 -13.93 57.19 -3.15 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -8.09 53.40 -0.40 -7.97 50.74 -1.98 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU B 8 GLU.? 21.08 N6 ADP C1001 E 596 ARG B 11 ARG~? 27.94 N6 ADP C1001 E 647 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -24.54 18.07 0.49 -24.62 18.94 -1.46 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU D 8 GLU.? 38.64 N6 ADP C1001 E 596 ARG D 11 ARG~? 37.61 N6 ADP C1001 E 647 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -15.71 59.79 2.00 -14.33 61.02 0.98 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -15.91 54.83 -3.29 -13.93 57.19 -3.15 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -8.09 53.40 -0.40 -7.97 50.74 -1.98 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU D 8 GLU.? 38.64 N6 ADP C1001 F 596 ARG D 11 ARG~? 37.61 N6 ADP C1001 F 647 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -15.71 59.79 2.00 -14.33 61.02 0.98 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -15.91 54.83 -3.29 -13.93 57.19 -3.15 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -8.09 53.40 -0.40 -7.97 50.74 -1.98 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 39 ASN^? 26.27 N6 ADP C1001 457 GLY B 12 GLY~? 22.61 N6 ADP C1001 459 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -10.50 14.02 7.34 -12.57 14.30 7.00 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -17.91 15.52 4.82 -17.88 16.00 4.18 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -16.06 9.21 5.46 -17.05 10.76 4.34 1vom_c00 source 1vom MYOSIN : 1 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE B 58 PHE~? 21.02 N6 ADP C1001 A 197 ASN B 57 ASN~? 18.41 O4' ADP C1001 A 198 PRO B 56 PRO~? 13.92 O4' ADP C1001 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -26.58 9.98 15.28 -24.37 9.78 13.51 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -30.78 10.03 20.77 -32.50 10.37 22.02 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -33.40 15.05 17.76 -31.43 13.95 17.73 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE D 47 PHE.? 27.02 N6 ADP C1001 A 197 ASN D 57 ASN~? 28.49 N1 ADP C1001 A 198 PRO D 56 PRO~? 31.20 N6 ADP C1001 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -29.38 57.47 13.70 -28.51 55.69 15.67 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -26.50 55.76 21.71 -26.74 56.60 23.67 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -22.96 59.96 20.88 -22.69 58.09 19.62 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE B 58 PHE~? 21.02 N6 ADP C1001 B 197 ASN B 57 ASN~? 18.41 O4' ADP C1001 B 198 PRO B 56 PRO~? 13.92 O4' ADP C1001 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -26.58 9.98 15.28 -24.37 9.78 13.51 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -30.78 10.03 20.77 -32.50 10.37 22.02 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -33.40 15.05 17.76 -31.43 13.95 17.73 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE C 58 PHE~? 19.35 C2 ADP C1001 B 197 ASN C 57 ASN~? 16.68 N6 ADP C1001 B 198 PRO C 56 PRO~? 12.62 N1 ADP C1001 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -29.27 40.71 19.48 -27.80 41.34 20.99 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE D 47 PHE.? 27.02 N6 ADP C1001 B 197 ASN D 57 ASN~? 28.49 N1 ADP C1001 B 198 PRO D 56 PRO~? 31.20 N6 ADP C1001 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -29.38 57.47 13.70 -28.51 55.69 15.67 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -26.50 55.76 21.71 -26.74 56.60 23.67 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -22.96 59.96 20.88 -22.69 58.09 19.62 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 3 hits 1vq1_c01 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 26 TYR^? 32.13 N6 ADP C1001 A 317 GLU A 44 GLU^? 29.72 N6 ADP C1001 A 365 ARG A 23 ARG.? 47.94 N6 ADP C1001 coo 1.77 6.56 57.05 3.05 7.44 59.37 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 3.06 2.85 52.79 4.83 3.89 53.24 -23.95 2.54 6.45 -25.82 1.78 7.26 coo 3.82 17.09 49.56 4.09 14.32 50.84 -17.87 -12.22 3.83 -15.16 -13.38 2.91 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR B 26 TYR^? 24.12 N6 ADP C1001 A 317 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 365 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo 1.77 6.56 57.05 3.05 7.44 59.37 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 3.06 2.85 52.79 4.83 3.89 53.24 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 3.82 17.09 49.56 4.09 14.32 50.84 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR B 26 TYR^? 24.12 N6 ADP C1001 A 317 GLU B 44 GLU^? 27.54 N6 ADP C1001 A 365 ARG A 2 ARG^? 31.43 N6 ADP C1001 coo 1.77 6.56 57.05 3.05 7.44 59.37 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 3.06 2.85 52.79 4.83 3.89 53.24 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 3.82 17.09 49.56 4.09 14.32 50.84 -10.05 8.79 1.44 -11.10 11.55 0.50 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR B 26 TYR^? 24.12 N6 ADP C1001 A 317 GLU B 44 GLU^? 27.54 N6 ADP C1001 A 365 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 1.77 6.56 57.05 3.05 7.44 59.37 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 3.06 2.85 52.79 4.83 3.89 53.24 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 3.82 17.09 49.56 4.09 14.32 50.84 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR C 26 TYR^? 24.03 C2 ADP C1001 A 317 GLU C 44 GLU^? 27.03 C2 ADP C1001 A 365 ARG C 23 ARG.? 19.01 O2' ADP C1001 coo 1.77 6.56 57.05 3.05 7.44 59.37 -30.56 43.06 36.03 -31.04 45.27 37.68 coo 3.06 2.85 52.79 4.83 3.89 53.24 -28.75 47.24 35.01 -29.12 48.55 36.63 coo 3.82 17.09 49.56 4.09 14.32 50.84 -41.38 43.66 27.78 -43.67 44.44 29.75 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR D 26 TYR^? 28.03 N6 ADP C1001 A 317 GLU D 44 GLU^? 25.61 N6 ADP C1001 A 365 ARG D 23 ARG.? 42.28 N6 ADP C1001 coo 1.77 6.56 57.05 3.05 7.44 59.37 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 3.06 2.85 52.79 4.83 3.89 53.24 -26.92 53.16 5.77 -28.08 52.58 4.08 coo 3.82 17.09 49.56 4.09 14.32 50.84 -21.76 67.41 8.31 -21.73 70.32 9.28 1vzx_c02 source 1vzx 2.04.01.0087 : 6 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 26 TYR^? 32.13 N6 ADP C1001 B1317 GLU A 44 GLU^? 29.72 N6 ADP C1001 B1365 ARG A 23 ARG.? 47.94 N6 ADP C1001 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -23.95 2.54 6.45 -25.82 1.78 7.26 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -17.87 -12.22 3.83 -15.16 -13.38 2.91 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR B 26 TYR^? 24.12 N6 ADP C1001 B1317 GLU A 41 GLU^? 26.55 N6 ADP C1001 B1365 ARG B 94 ARG~? 24.19 N6 ADP C1001 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -16.51 23.41 0.38 -17.12 22.32 -2.40 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR B 26 TYR^? 24.12 N6 ADP C1001 B1317 GLU B 44 GLU^? 27.54 N6 ADP C1001 B1365 ARG A 2 ARG^? 31.43 N6 ADP C1001 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -10.05 8.79 1.44 -11.10 11.55 0.50 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR B 26 TYR^? 24.12 N6 ADP C1001 B1317 GLU B 44 GLU^? 27.54 N6 ADP C1001 B1365 ARG B 23 ARG.? 16.12 O1A ADP C1001 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -24.18 6.66 6.64 -23.83 5.58 4.84 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -35.24 15.53 3.08 -37.20 16.95 1.17 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR C 26 TYR^? 24.03 C2 ADP C1001 B1317 GLU C 44 GLU^? 27.03 C2 ADP C1001 B1365 ARG C 23 ARG.? 19.01 O2' ADP C1001 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -30.56 43.06 36.03 -31.04 45.27 37.68 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -28.75 47.24 35.01 -29.12 48.55 36.63 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -41.38 43.66 27.78 -43.67 44.44 29.75 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR D 26 TYR^? 28.03 N6 ADP C1001 B1317 GLU D 44 GLU^? 25.61 N6 ADP C1001 B1365 ARG D 23 ARG.? 42.28 N6 ADP C1001 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -26.92 53.16 5.77 -28.08 52.58 4.08 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -21.76 67.41 8.31 -21.73 70.32 9.28 1vzx_c03 source 1vzx 2.04.01.0087 : 6 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 79 TYR~? 47.68 N6 ADP C1001 A 40 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 103 LEU A 55 LEU~? 40.94 N6 ADP C1001 coo 12.09 16.13 10.57 11.28 18.80 10.73 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 7.55 25.51 14.34 9.65 25.73 14.24 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 11.83 18.73 16.99 10.99 19.71 15.26 -15.73 -4.74 -1.28 -16.63 -4.61 0.71 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 79 TYR~? 47.68 N6 ADP C1001 A 40 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 103 LEU A 83 LEU~? 45.09 N6 ADP C1001 coo 12.09 16.13 10.57 11.28 18.80 10.73 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 7.55 25.51 14.34 9.65 25.73 14.24 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 11.83 18.73 16.99 10.99 19.71 15.26 -8.30 -0.81 -8.26 -10.27 -1.25 -9.08 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 79 TYR~? 13.34 O4' ADP C1001 A 40 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 103 LEU B 83 LEU~? 14.46 C2 ADP C1001 coo 12.09 16.13 10.57 11.28 18.80 10.73 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 7.55 25.51 14.34 9.65 25.73 14.24 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 11.83 18.73 16.99 10.99 19.71 15.26 -30.91 17.01 24.26 -31.89 15.25 23.69 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR C 79 TYR~? 13.12 N6 ADP C1001 A 40 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 103 LEU C 55 LEU~? 15.31 C2 ADP C1001 coo 12.09 16.13 10.57 11.28 18.80 10.73 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 7.55 25.51 14.34 9.65 25.73 14.24 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 11.83 18.73 16.99 10.99 19.71 15.26 -30.41 42.77 23.50 -31.26 43.18 25.42 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 4 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR C 79 TYR~? 13.12 N6 ADP C1001 B 40 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 103 LEU C 55 LEU~? 15.31 C2 ADP C1001 coo 14.25 20.09 37.35 13.48 17.40 37.38 -29.67 41.42 14.91 -30.18 43.90 13.55 coo 9.39 10.77 34.53 11.50 10.63 34.41 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 12.89 17.60 31.13 12.34 16.51 32.90 -30.41 42.77 23.50 -31.26 43.18 25.42 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 1 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 169 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 288 GLU A 33 GLU^? 35.51 N6 ADP C1001 coo 67.72 35.99 30.87 69.77 36.13 31.33 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 73.17 30.66 22.56 72.87 30.30 20.46 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 74.06 28.51 15.92 73.77 29.56 17.73 -2.83 15.49 5.14 -2.18 15.03 3.15 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 169 ASP A 9 ASP.? 35.63 N1 ADP C1001 A 288 GLU A 8 GLU.? 40.05 N1 ADP C1001 coo 67.72 35.99 30.87 69.77 36.13 31.33 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 73.17 30.66 22.56 72.87 30.30 20.46 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 74.06 28.51 15.92 73.77 29.56 17.73 -16.47 -6.15 15.18 -15.55 -6.74 17.02 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 169 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 288 GLU B 33 GLU^? 22.82 N1 ADP C1001 coo 67.72 35.99 30.87 69.77 36.13 31.33 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 73.17 30.66 22.56 72.87 30.30 20.46 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 74.06 28.51 15.92 73.77 29.56 17.73 -10.19 23.43 20.85 -11.43 22.93 22.49 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 4 3 # 4 A 105 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 169 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 288 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 67.72 35.99 30.87 69.77 36.13 31.33 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 73.17 30.66 22.56 72.87 30.30 20.46 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 74.06 28.51 15.92 73.77 29.56 17.73 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 5 3 # 5 A 105 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 169 ASP C 31 ASP^? 21.62 C2 ADP C1001 A 288 GLU C 33 GLU^? 22.62 N1 ADP C1001 coo 67.72 35.99 30.87 69.77 36.13 31.33 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 73.17 30.66 22.56 72.87 30.30 20.46 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 74.06 28.51 15.92 73.77 29.56 17.73 -14.30 26.31 31.75 -13.99 26.91 29.72 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 6 3 # 6 A 105 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 169 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 288 GLU C 48 GLU.? 22.51 O2' ADP C1001 coo 67.72 35.99 30.87 69.77 36.13 31.33 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 73.17 30.66 22.56 72.87 30.30 20.46 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 74.06 28.51 15.92 73.77 29.56 17.73 -33.52 53.52 23.97 -33.48 52.09 22.33 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 7 3 # 7 A 105 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 169 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 288 GLU D 33 GLU^? 24.81 N6 ADP C1001 coo 67.72 35.99 30.87 69.77 36.13 31.33 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 73.17 30.66 22.56 72.87 30.30 20.46 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 74.06 28.51 15.92 73.77 29.56 17.73 -9.58 39.62 17.74 -10.11 39.83 19.83 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 7 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 105 GLY.? 47.26 N6 ADP C1001 B 419 GLY A 104 GLY~? 44.37 N6 ADP C1001 B 420 ALA A 101 ALA~? 43.65 N6 ADP C1001 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 6.33 2.76 11.10 5.97 2.70 11.78 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 5.00 5.74 13.11 4.74 5.24 12.62 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 1.08 2.64 14.69 0.71 1.16 14.96 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY B 105 GLY.? 14.83 N6 ADP C1001 B 419 GLY B 104 GLY~? 17.92 N6 ADP C1001 B 420 ALA B 101 ALA~? 15.29 N6 ADP C1001 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -18.36 34.95 14.87 -18.15 34.98 14.15 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -14.96 34.23 13.50 -15.73 33.92 13.69 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -17.44 31.72 9.56 -18.53 31.73 8.48 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY C 105 GLY.? 16.33 C2 ADP C1001 B 419 GLY C 104 GLY~? 19.40 C2 ADP C1001 B 420 ALA C 101 ALA~? 16.96 C2 ADP C1001 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -28.59 18.07 29.12 -28.98 18.05 29.83 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -26.97 17.89 32.56 -27.17 18.36 31.87 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -30.45 21.41 33.63 -31.85 21.94 33.44 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY D 105 GLY.? 39.91 N6 ADP C1001 B 419 GLY D 104 GLY~? 38.97 N6 ADP C1001 B 420 ALA D 101 ALA~? 39.20 N6 ADP C1001 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 1.03 51.79 15.18 0.84 51.88 14.37 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 1.45 49.17 12.44 0.89 49.55 12.90 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -1.43 52.13 9.74 -1.61 53.51 9.15 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 4 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA B 101 ALA~? 15.29 N6 ADP C1001 B 182 GLY C 84 GLY.? 10.47 N6 ADP C1001 B 183 GLY B 105 GLY.? 14.83 N6 ADP C1001 coo 38.36-101.47-135.52 39.62-101.29-136.35 -17.44 31.72 9.56 -18.53 31.73 8.48 coo 41.93-102.35-126.87 41.52-101.89-126.30 -22.35 33.13 15.48 -22.85 33.59 15.97 coo 38.37-101.99-128.11 38.63-102.24-127.37 -18.36 34.95 14.87 -18.15 34.98 14.15 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA C 101 ALA~? 16.96 C2 ADP C1001 B 182 GLY B 84 GLY.? 12.08 C2 ADP C1001 B 183 GLY C 105 GLY.? 16.33 C2 ADP C1001 coo 38.36-101.47-135.52 39.62-101.29-136.35 -30.45 21.41 33.63 -31.85 21.94 33.44 coo 41.93-102.35-126.87 41.52-101.89-126.30 -29.23 21.04 26.04 -29.32 20.71 25.30 coo 38.37-101.99-128.11 38.63-102.24-127.37 -28.59 18.07 29.12 -28.98 18.05 29.83 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA D 76 ALA~? 36.53 N6 ADP C1001 B 182 GLY D 51 GLY.? 34.90 O2' ADP C1001 B 183 GLY D 53 GLY~? 32.56 N1 ADP C1001 coo 38.36-101.47-135.52 39.62-101.29-136.35 -19.66 63.86 20.66 -19.53 63.75 19.22 coo 41.93-102.35-126.87 41.52-101.89-126.30 -29.93 64.41 19.47 -29.53 63.99 18.88 coo 38.37-101.99-128.11 38.63-102.24-127.37 -26.31 61.10 21.77 -26.62 61.15 20.99 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 3 hits 1xny_c01 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 64 ALA.? 37.27 N6 ADP C1001 A 244 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 271 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 15.05 3.71 6.93 14.58 4.88 7.78 -8.60 5.30 -0.48 -9.23 4.31 0.41 coo 9.85 8.15 0.76 10.61 7.04 2.39 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 10.61 7.65 6.01 12.39 6.55 6.23 -15.84 6.06 -0.29 -17.94 5.95 -0.14 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA B 64 ALA.? 15.41 N1 ADP C1001 A 244 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 271 HIS B 62 HIS~? 22.43 N1 ADP C1001 coo 15.05 3.71 6.93 14.58 4.88 7.78 -22.22 17.81 20.01 -22.67 17.81 18.54 coo 9.85 8.15 0.76 10.61 7.04 2.39 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 10.61 7.65 6.01 12.39 6.55 6.23 -21.68 10.95 17.44 -21.09 9.22 16.39 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 105 ALA C 64 ALA.? 14.62 N1 ADP C1001 A 244 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 271 HIS C 62 HIS~? 21.13 N1 ADP C1001 coo 15.05 3.71 6.93 14.58 4.88 7.78 -21.29 34.81 25.43 -22.58 35.15 26.14 coo 9.85 8.15 0.76 10.61 7.04 2.39 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 10.61 7.65 6.01 12.39 6.55 6.23 -20.79 41.45 28.58 -20.89 43.35 29.47 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 105 ALA D 64 ALA.? 26.15 N6 ADP C1001 A 244 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 271 HIS D 62 HIS.? 20.37 N6 ADP C1001 coo 15.05 3.71 6.93 14.58 4.88 7.78 -16.76 49.68 19.26 -17.00 50.74 18.25 coo 9.85 8.15 0.76 10.61 7.04 2.39 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 10.61 7.65 6.01 12.39 6.55 6.23 -23.21 48.47 15.79 -25.03 48.41 14.73 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 4 hits 1xqw_c00 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 22 GLY.? 43.32 N6 ADP C1001 B 175 ARG A 25 ARG.? 39.86 N6 ADP C1001 B 242 TYR A 26 TYR^? 32.13 N6 ADP C1001 coo 99.45 58.28 3.33 99.57 58.61 4.10 -15.86 -8.41 2.68 -16.06 -8.23 3.51 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -23.17 -5.31 5.72 -21.44 -6.89 3.60 coo 100.93 69.04 4.38 99.52 68.48 2.09 -20.23 -0.15 10.23 -22.87 -0.31 11.21 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 73 GLY~? 50.94 N6 ADP C1001 B 175 ARG A 75 ARG~? 52.31 N6 ADP C1001 B 242 TYR A 79 TYR~? 47.68 N6 ADP C1001 coo 99.45 58.28 3.33 99.57 58.61 4.10 -9.03 -13.13 0.27 -8.69 -12.39 0.23 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -9.93 -13.21 -7.89 -9.68 -10.57 -9.55 coo 100.93 69.04 4.38 99.52 68.48 2.09 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY B 22 GLY.? 14.86 O1A ADP C1001 B 175 ARG B 25 ARG.? 26.72 N7 ADP C1001 B 242 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 99.45 58.28 3.33 99.57 58.61 4.10 -33.99 15.05 9.19 -33.34 14.99 8.60 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 100.93 69.04 4.38 99.52 68.48 2.09 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 73 GLY~? 6.44 O1A ADP C1001 B 175 ARG B 74 ARG~? -6.26 O2A ADP C1001s B 242 TYR C 111 TYR.? 9.78 O3' ADP C1001 coo 99.45 58.28 3.33 99.57 58.61 4.10 -38.60 21.75 11.85 -37.95 21.79 12.31 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 100.93 69.04 4.38 99.52 68.48 2.09 -42.34 21.68 23.98 -40.45 19.79 24.70 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 73 GLY~? 6.44 O1A ADP C1001 B 175 ARG B 75 ARG~? 7.41 O2A ADP C1001 B 242 TYR B 79 TYR~? 13.34 O4' ADP C1001 coo 99.45 58.28 3.33 99.57 58.61 4.10 -38.60 21.75 11.85 -37.95 21.79 12.31 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 100.93 69.04 4.38 99.52 68.48 2.09 -36.09 15.89 20.59 -36.23 13.43 21.88 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY B 73 GLY~? 6.44 O1A ADP C1001 B 175 ARG B 75 ARG~? 7.41 O2A ADP C1001 B 242 TYR C 111 TYR.? 9.78 O3' ADP C1001 coo 99.45 58.28 3.33 99.57 58.61 4.10 -38.60 21.75 11.85 -37.95 21.79 12.31 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 100.93 69.04 4.38 99.52 68.48 2.09 -42.34 21.68 23.98 -40.45 19.79 24.70 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY C 22 GLY.? 14.12 O2' ADP C1001 B 175 ARG C 75 ARG~? 8.05 O3B ADP C1001 B 242 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 99.45 58.28 3.33 99.57 58.61 4.10 -35.88 42.47 25.00 -35.89 42.36 25.87 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 100.93 69.04 4.38 99.52 68.48 2.09 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY D 22 GLY.? 35.41 N6 ADP C1001 B 175 ARG D 25 ARG.? 35.20 N6 ADP C1001 B 242 TYR D 26 TYR^? 28.03 N6 ADP C1001 coo 99.45 58.28 3.33 99.57 58.61 4.10 -21.83 63.53 12.51 -21.57 63.23 11.74 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -26.42 60.33 5.19 -27.57 62.82 3.77 coo 100.93 69.04 4.38 99.52 68.48 2.09 -22.48 54.16 4.72 -24.58 53.78 2.92 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 8 hits 1xva_c03 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER B 82 SER~? 11.53 O4' ADP C1001 A 178 TYR C 111 TYR.? 9.78 O3' ADP C1001 A 182 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 81.46 10.53 21.66 82.20 10.82 19.39 -34.46 19.85 25.71 -36.11 18.63 24.45 coo 87.67 8.69 17.10 86.62 10.83 18.52 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 85.30 6.17 22.83 87.26 11.02 23.50 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER C 82 SER~? 10.86 N6 ADP C1001 A 178 TYR B 111 TYR.? 10.00 N6 ADP C1001 A 182 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 81.46 10.53 21.66 82.20 10.82 19.39 -25.49 36.24 12.26 -26.11 38.47 12.83 coo 87.67 8.69 17.10 86.62 10.83 18.52 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 85.30 6.17 22.83 87.26 11.02 23.50 -23.61 33.84 6.26 -20.57 37.69 4.41 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER B 82 SER~? 11.53 O4' ADP C1001 B 178 TYR C 111 TYR.? 9.78 O3' ADP C1001 B 182 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 61.22 3.61 34.51 60.46 1.86 35.98 -34.46 19.85 25.71 -36.11 18.63 24.45 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 57.40 2.23 30.19 55.43 5.44 33.87 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER C 82 SER~? 10.86 N6 ADP C1001 B 178 TYR B 111 TYR.? 10.00 N6 ADP C1001 B 182 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 61.22 3.61 34.51 60.46 1.86 35.98 -25.49 36.24 12.26 -26.11 38.47 12.83 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -31.63 36.54 7.53 -29.30 37.35 8.87 coo 57.40 2.23 30.19 55.43 5.44 33.87 -23.61 33.84 6.26 -20.57 37.69 4.41 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_c01 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 74 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 14.16 13.09 37.03 20.00 12.44 37.49 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 22.22 16.06 48.76 23.94 15.33 49.78 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 165 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 14.16 13.09 37.03 20.00 12.44 37.49 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 22.22 16.06 48.76 23.94 15.33 49.78 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 14.16 13.09 37.03 20.00 12.44 37.49 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 22.22 16.06 48.76 23.94 15.33 49.78 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 14.16 13.09 37.03 20.00 12.44 37.49 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 14.16 13.09 37.03 20.00 12.44 37.49 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 165 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 14.16 13.09 37.03 20.00 12.44 37.49 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 14.16 13.09 37.03 20.00 12.44 37.49 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 22.22 16.06 48.76 23.94 15.33 49.78 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 A 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 A 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 14.16 13.09 37.03 20.00 12.44 37.49 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 22.22 16.06 48.76 23.94 15.33 49.78 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 14.16 13.09 37.03 20.00 12.44 37.49 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 22.22 16.06 48.76 23.94 15.33 49.78 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 165 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 14.16 13.09 37.03 20.00 12.44 37.49 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 22.22 16.06 48.76 23.94 15.33 49.78 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 14.16 13.09 37.03 20.00 12.44 37.49 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 22.22 16.06 48.76 23.94 15.33 49.78 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 165 GLU D 33 GLU^? 24.81 N6 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 14.16 13.09 37.03 20.00 12.44 37.49 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 22.22 16.06 48.76 23.94 15.33 49.78 -9.58 39.62 17.74 -10.11 39.83 19.83 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 74 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 14.16 13.09 37.03 20.00 12.44 37.49 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 22.22 16.06 48.76 23.94 15.33 49.78 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 14.16 13.09 37.03 20.00 12.44 37.49 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 22.22 16.06 48.76 23.94 15.33 49.78 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo 18.28 7.83 36.39 22.82 8.75 39.52 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 14.16 13.09 37.03 20.00 12.44 37.49 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 22.22 16.06 48.76 23.94 15.33 49.78 -17.63 66.44 26.22 -18.72 68.28 26.46 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 15 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 60 LYS~? 43.57 N6 ADP C1001 B 74 LYS A 65 LYS.? 41.76 N6 ADP C1001 B 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 21.39 11.56 68.52 20.24 13.13 67.73 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 B 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 B 165 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 21.39 11.56 68.52 20.24 13.13 67.73 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 65 LYS.? 41.76 N6 ADP C1001 B 74 LYS A 60 LYS~? 43.57 N6 ADP C1001 B 165 GLU A 78 GLU~? 55.68 N6 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 21.39 11.56 68.52 20.24 13.13 67.73 -4.39 -11.15 -6.80 -4.73 -13.12 -7.49 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 74 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 165 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 165 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 21.39 11.56 68.52 20.24 13.13 67.73 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 165 GLU B 78 GLU~? 5.47 O3' ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 21.39 11.56 68.52 20.24 13.13 67.73 -39.37 23.43 20.35 -41.49 23.57 20.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS B 65 LYS.? 17.22 C2 ADP C1001 B 74 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 165 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 21.39 11.56 68.52 20.24 13.13 67.73 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 165 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 21.39 11.56 68.52 20.24 13.13 67.73 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 74 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 21.39 11.56 68.52 20.24 13.13 67.73 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 165 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 21.39 11.56 68.52 20.24 13.13 67.73 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS C 65 LYS.? 16.76 N1 ADP C1001 B 74 LYS C 60 LYS~? 19.47 N6 ADP C1001 B 165 GLU C 78 GLU~? 9.17 N6 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 21.39 11.56 68.52 20.24 13.13 67.73 -33.42 36.31 11.72 -34.81 37.44 10.59 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 74 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 21.39 11.56 68.52 20.24 13.13 67.73 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 165 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 21.39 11.56 68.52 20.24 13.13 67.73 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS D 65 LYS.? 25.59 N1 ADP C1001 B 74 LYS D 60 LYS~? 25.96 N1 ADP C1001 B 165 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo 13.51 0.92 76.10 12.98 6.13 74.68 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 21.39 11.56 68.52 20.24 13.13 67.73 -17.63 66.44 26.22 -18.72 68.28 26.46 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 16 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 371 LYS B 114 LYS.? -3.14 O1A ADP C1001s A 407 THR B 89 THR.? -3.20 N6 ADP C1001s coo -5.17 31.09 15.73 -7.07 31.12 16.73 -30.45 31.51 3.79 -31.95 31.85 2.33 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -38.05 28.30 5.66 -42.50 28.99 10.13 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -30.78 27.78 11.26 -32.72 28.03 12.28 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 371 LYS C 114 LYS.? -2.76 O3B ADP C1001s A 407 THR C 89 THR.? 3.96 N3 ADP C1001 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -42.40 26.72 28.14 -44.45 27.16 28.23 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -44.82 31.28 21.50 -43.38 31.47 16.20 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -36.03 29.56 23.55 -36.59 29.86 21.42 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c02 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 371 LYS B 38 LYS.? 29.47 N6 ADP C1001 A 374 ASN B 39 ASN.? 27.14 N6 ADP C1001 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -13.40 19.33 18.81 -14.28 17.40 18.97 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -9.30 19.94 15.62 -4.67 19.41 15.25 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -11.13 15.65 16.64 -9.36 15.49 17.83 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 1 hits 1zrz_c03 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 48 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 77 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 13.04 30.41 72.50 12.95 30.65 70.36 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 12.77 23.50 68.33 13.58 25.42 68.49 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 7.53 29.84 65.06 12.29 29.41 67.79 -21.35 51.92 21.59 -25.15 52.63 26.23 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 1 hits 2acu_c01 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN A 57 ASN~? 43.07 N6 ADP C1001 A 106 PRO A 56 PRO~? 43.38 N6 ADP C1001 A 108 TYR A 79 TYR~? 47.68 N6 ADP C1001 coo 34.91 38.94 20.48 33.53 38.20 19.00 -15.73 -0.75 -7.31 -14.92 -1.39 -9.21 coo 36.18 33.51 20.99 37.11 35.33 20.14 -12.45 -5.07 -4.36 -13.43 -3.13 -3.80 coo 33.01 33.46 15.68 31.96 34.97 17.80 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 A 105 ASN C 57 ASN~? 16.68 N6 ADP C1001 A 106 PRO C 56 PRO~? 12.62 N1 ADP C1001 A 108 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 34.91 38.94 20.48 33.53 38.20 19.00 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 36.18 33.51 20.99 37.11 35.33 20.14 -29.27 40.71 19.48 -27.80 41.34 20.99 coo 33.01 33.46 15.68 31.96 34.97 17.80 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 A 105 ASN D 57 ASN~? 28.49 N1 ADP C1001 A 106 PRO D 56 PRO~? 31.20 N6 ADP C1001 A 108 TYR D 79 TYR~? 36.26 N1 ADP C1001 coo 34.91 38.94 20.48 33.53 38.20 19.00 -26.50 55.76 21.71 -26.74 56.60 23.67 coo 36.18 33.51 20.99 37.11 35.33 20.14 -22.96 59.96 20.88 -22.69 58.09 19.62 coo 33.01 33.46 15.68 31.96 34.97 17.80 -22.76 62.70 24.87 -24.61 64.61 25.82 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 3 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN A 57 ASN~? 43.07 N6 ADP C1001 B 106 PRO A 56 PRO~? 43.38 N6 ADP C1001 B 108 TYR A 79 TYR~? 47.68 N6 ADP C1001 coo 5.98 38.14 46.94 7.30 38.92 45.46 -15.73 -0.75 -7.31 -14.92 -1.39 -9.21 coo 4.66 43.53 47.47 3.74 41.73 46.59 -12.45 -5.07 -4.36 -13.43 -3.13 -3.80 coo 7.86 43.80 42.15 8.87 42.26 44.27 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 B 105 ASN C 57 ASN~? 16.68 N6 ADP C1001 B 106 PRO C 56 PRO~? 12.62 N1 ADP C1001 B 108 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 5.98 38.14 46.94 7.30 38.92 45.46 -24.16 44.44 19.70 -24.30 44.19 17.59 coo 4.66 43.53 47.47 3.74 41.73 46.59 -29.27 40.71 19.48 -27.80 41.34 20.99 coo 7.86 43.80 42.15 8.87 42.26 44.27 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 B 105 ASN D 57 ASN~? 28.49 N1 ADP C1001 B 106 PRO D 56 PRO~? 31.20 N6 ADP C1001 B 108 TYR D 79 TYR~? 36.26 N1 ADP C1001 coo 5.98 38.14 46.94 7.30 38.92 45.46 -26.50 55.76 21.71 -26.74 56.60 23.67 coo 4.66 43.53 47.47 3.74 41.73 46.59 -22.96 59.96 20.88 -22.69 58.09 19.62 coo 7.86 43.80 42.15 8.87 42.26 44.27 -22.76 62.70 24.87 -24.61 64.61 25.82 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 3 hits 2adm_c01 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 31 ASP^? 31.30 N6 ADP C1001 219 GLU A 33 GLU^? 35.51 N6 ADP C1001 294 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 25.84 105.87 9.06 27.86 105.55 8.74 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 36 ASP^? 33.81 N6 ADP C1001 219 GLU A 33 GLU^? 35.51 N6 ADP C1001 294 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 25.84 105.87 9.06 27.86 105.55 8.74 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 33.16 106.80 7.72 33.34 104.87 6.92 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 36 ASP^? 26.54 N6 ADP C1001 219 GLU B 33 GLU^? 22.82 N1 ADP C1001 294 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 25.84 105.87 9.06 27.86 105.55 8.74 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 33.16 106.80 7.72 33.34 104.87 6.92 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP C 31 ASP^? 21.62 C2 ADP C1001 219 GLU C 33 GLU^? 22.62 N1 ADP C1001 294 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 25.84 105.87 9.06 27.86 105.55 8.74 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 33.16 106.80 7.72 33.34 104.87 6.92 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP D 31 ASP^? 21.52 N6 ADP C1001 219 GLU D 33 GLU^? 24.81 N6 ADP C1001 294 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 25.84 105.87 9.06 27.86 105.55 8.74 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP D 36 ASP^? 31.16 N6 ADP C1001 219 GLU D 33 GLU^? 24.81 N6 ADP C1001 294 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 25.84 105.87 9.06 27.86 105.55 8.74 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 33.16 106.80 7.72 33.34 104.87 6.92 -13.15 42.40 14.58 -15.11 42.76 15.19 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 6 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 10 ASP.? 29.48 N1 ADP C1001 231 ASP A 36 ASP^? 33.81 N6 ADP C1001 294 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 33.16 106.80 7.72 33.34 104.87 6.92 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 31 ASP^? 31.30 N6 ADP C1001 231 ASP B 61 ASP~? 21.98 C2 ADP C1001 294 ASP A 36 ASP^? 33.81 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 -1.45 15.76 11.21 -1.10 16.77 13.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 10 ASP.? 28.32 N6 ADP C1001 231 ASP A 36 ASP^? 33.81 N6 ADP C1001 294 ASP A 61 ASP~? 37.71 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 33.16 106.80 7.72 33.34 104.87 6.92 -16.08 4.88 -5.43 -16.33 3.76 -7.24 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 31 ASP^? 22.05 N1 ADP C1001 231 ASP B 9 ASP.? 24.63 N6 ADP C1001 294 ASP B 36 ASP^? 26.54 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 33.16 106.80 7.72 33.34 104.87 6.92 -7.49 25.66 16.69 -6.44 23.85 16.43 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 36 ASP^? 26.54 N6 ADP C1001 231 ASP C 61 ASP~? 22.05 N1 ADP C1001 294 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 33.16 106.80 7.72 33.34 104.87 6.92 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 54 ASP~? 20.52 O4' ADP C1001 231 ASP B 9 ASP.? 24.63 N6 ADP C1001 294 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 33.16 106.80 7.72 33.34 104.87 6.92 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP B 54 ASP~? 20.52 O4' ADP C1001 231 ASP C 110 ASP.? 10.54 O3' ADP C1001 294 ASP B 61 ASP~? 21.98 C2 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 33.16 106.80 7.72 33.34 104.87 6.92 -24.91 9.18 21.46 -26.77 8.69 22.33 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP C 31 ASP^? 21.62 C2 ADP C1001 231 ASP C 9 ASP.? 24.62 C2 ADP C1001 294 ASP C 36 ASP^? 27.15 C2 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 33.16 106.80 7.72 33.34 104.87 6.92 -16.89 23.06 36.75 -16.41 21.35 37.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP C 36 ASP^? 27.15 C2 ADP C1001 231 ASP B 61 ASP~? 21.98 C2 ADP C1001 294 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -16.89 23.06 36.75 -16.41 21.35 37.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 231 ASP B 110 ASP.? 12.77 N6 ADP C1001 294 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP C 54 ASP~? 20.12 N1 ADP C1001 231 ASP D 10 ASP.? 31.49 N6 ADP C1001 294 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 -20.25 43.54 24.10 -19.06 45.03 24.94 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP C 61 ASP~? 22.05 N1 ADP C1001 231 ASP C 9 ASP.? 24.62 C2 ADP C1001 294 ASP D 61 ASP~? 23.08 N1 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 33.16 106.80 7.72 33.34 104.87 6.92 -25.68 50.03 20.54 -26.38 51.13 22.17 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP D 31 ASP^? 21.52 N6 ADP C1001 231 ASP B 31 ASP^? 22.05 N1 ADP C1001 294 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 33.16 106.80 7.72 33.34 104.87 6.92 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP D 31 ASP^? 21.52 N6 ADP C1001 231 ASP C 31 ASP^? 21.62 C2 ADP C1001 294 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -17.30 30.71 32.69 -16.98 32.62 31.85 coo 33.16 106.80 7.72 33.34 104.87 6.92 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 15 3 # 15 193 ASP D 31 ASP^? 21.52 N6 ADP C1001 231 ASP D 9 ASP.? 34.87 N6 ADP C1001 294 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -19.16 57.73 -0.10 -17.18 57.13 -0.55 coo 33.16 106.80 7.72 33.34 104.87 6.92 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 16 3 # 16 193 ASP D 36 ASP^? 31.16 N6 ADP C1001 231 ASP B 31 ASP^? 22.05 N1 ADP C1001 294 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 33.16 106.80 7.72 33.34 104.87 6.92 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 17 3 # 17 193 ASP D 61 ASP~? 23.08 N1 ADP C1001 231 ASP D 10 ASP.? 31.49 N6 ADP C1001 294 ASP C 61 ASP~? 22.05 N1 ADP C1001 coo 27.89 102.52 14.98 29.35 101.92 13.57 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -22.28 53.80 0.05 -22.17 54.33 -2.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 -20.25 43.54 24.10 -19.06 45.03 24.94 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 17 hits 2amg_c06 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 23 ARG.? 47.94 N6 ADP C1001 A 161 ASP A 9 ASP.? 35.63 N1 ADP C1001 A 174 TYR A 26 TYR^? 32.13 N6 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -17.87 -12.22 3.83 -15.16 -13.38 2.91 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -20.23 -0.15 10.23 -22.87 -0.31 11.21 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 25 ARG.? 39.86 N6 ADP C1001 A 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -23.17 -5.31 5.72 -21.44 -6.89 3.60 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG A 94 ARG~? 34.60 N1 ADP C1001 A 161 ASP A 110 ASP.? 52.32 N6 ADP C1001 A 174 TYR A 70 TYR.? 48.30 N6 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -9.32 1.83 20.70 -11.98 2.20 22.31 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -7.30 -10.03 11.13 -6.31 -12.30 12.53 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG B 23 ARG.? 16.12 O1A ADP C1001 A 161 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -35.24 15.53 3.08 -37.20 16.95 1.17 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG B 23 ARG.? 16.12 O1A ADP C1001 A 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -35.24 15.53 3.08 -37.20 16.95 1.17 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG B 94 ARG~? 24.19 N6 ADP C1001 A 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 7 3 # 7 A 14 ARG B 94 ARG~? 24.19 N6 ADP C1001 A 161 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 174 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 8 3 # 8 A 14 ARG C 23 ARG.? 19.01 O2' ADP C1001 A 161 ASP C 9 ASP.? 24.62 C2 ADP C1001 A 174 TYR C 26 TYR^? 24.03 C2 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -41.38 43.66 27.78 -43.67 44.44 29.75 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -30.56 43.06 36.03 -31.04 45.27 37.68 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 9 3 # 9 A 14 ARG C 74 ARG~? 5.25 O1B ADP C1001 A 161 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 174 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 10 3 # 10 A 14 ARG C 94 ARG~? 23.82 O3' ADP C1001 A 161 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 174 TYR C 70 TYR.? 10.33 O3' ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -33.86 30.07 42.29 -36.45 31.77 42.05 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -40.11 31.99 28.67 -42.64 30.90 28.52 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 11 3 # 11 A 14 ARG D 2 ARG^? 19.52 N6 ADP C1001 A 161 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 174 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -16.51 45.11 16.54 -19.16 44.24 15.23 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 12 3 # 12 A 14 ARG D 94 ARG~? 36.27 N6 ADP C1001 A 161 ASP D 110 ASP.? 48.95 N6 ADP C1001 A 174 TYR D 70 TYR.? 43.17 N6 ADP C1001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -8.09 53.40 -0.40 -7.97 50.74 -1.98 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -10.19 64.81 9.49 -8.66 67.08 8.77 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 12 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 23 ARG.? 47.94 N6 ADP C1001 B 161 ASP A 9 ASP.? 35.63 N1 ADP C1001 B 174 TYR A 26 TYR^? 32.13 N6 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -17.87 -12.22 3.83 -15.16 -13.38 2.91 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -20.23 -0.15 10.23 -22.87 -0.31 11.21 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 25 ARG.? 39.86 N6 ADP C1001 B 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -23.17 -5.31 5.72 -21.44 -6.89 3.60 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG A 94 ARG~? 34.60 N1 ADP C1001 B 161 ASP A 110 ASP.? 52.32 N6 ADP C1001 B 174 TYR A 70 TYR.? 48.30 N6 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -9.32 1.83 20.70 -11.98 2.20 22.31 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -7.30 -10.03 11.13 -6.31 -12.30 12.53 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG B 23 ARG.? 16.12 O1A ADP C1001 B 161 ASP B 9 ASP.? 24.63 N6 ADP C1001 B 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -35.24 15.53 3.08 -37.20 16.95 1.17 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG B 23 ARG.? 16.12 O1A ADP C1001 B 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -35.24 15.53 3.08 -37.20 16.95 1.17 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG B 94 ARG~? 24.19 N6 ADP C1001 B 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 7 3 # 7 B 14 ARG B 94 ARG~? 24.19 N6 ADP C1001 B 161 ASP B 110 ASP.? 12.77 N6 ADP C1001 B 174 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -30.45 31.51 3.79 -31.95 31.85 2.33 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 8 3 # 8 B 14 ARG C 23 ARG.? 19.01 O2' ADP C1001 B 161 ASP C 9 ASP.? 24.62 C2 ADP C1001 B 174 TYR C 26 TYR^? 24.03 C2 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -41.38 43.66 27.78 -43.67 44.44 29.75 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -34.52 40.90 40.15 -34.60 38.85 40.85 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -30.56 43.06 36.03 -31.04 45.27 37.68 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 9 3 # 9 B 14 ARG C 74 ARG~? 5.25 O1B ADP C1001 B 161 ASP B 110 ASP.? 12.77 N6 ADP C1001 B 174 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -39.58 36.65 12.40 -39.71 35.25 9.68 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -30.45 31.51 3.79 -31.95 31.85 2.33 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 10 3 # 10 B 14 ARG C 94 ARG~? 23.82 O3' ADP C1001 B 161 ASP C 110 ASP.? 10.54 O3' ADP C1001 B 174 TYR C 70 TYR.? 10.33 O3' ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -33.86 30.07 42.29 -36.45 31.77 42.05 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -42.40 26.72 28.14 -44.45 27.16 28.23 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -40.11 31.99 28.67 -42.64 30.90 28.52 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 11 3 # 11 B 14 ARG D 2 ARG^? 19.52 N6 ADP C1001 B 161 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 174 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -16.51 45.11 16.54 -19.16 44.24 15.23 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -29.67 41.42 14.91 -30.18 43.90 13.55 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 12 3 # 12 B 14 ARG D 94 ARG~? 36.27 N6 ADP C1001 B 161 ASP D 110 ASP.? 48.95 N6 ADP C1001 B 174 TYR D 70 TYR.? 43.17 N6 ADP C1001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -8.09 53.40 -0.40 -7.97 50.74 -1.98 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -3.52 66.57 9.69 -1.94 67.67 8.60 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -10.19 64.81 9.49 -8.66 67.08 8.77 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 12 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 2 ARG^? 31.43 N6 ADP C1001 C 161 ASP B 9 ASP.? 24.63 N6 ADP C1001 C 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 2.84 19.43 40.34 1.59 20.35 37.65 -10.05 8.79 1.44 -11.10 11.55 0.50 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 5.94 13.28 27.17 3.53 13.05 28.58 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 23 ARG.? 47.94 N6 ADP C1001 C 161 ASP A 9 ASP.? 35.63 N1 ADP C1001 C 174 TYR A 26 TYR^? 32.13 N6 ADP C1001 coo 2.84 19.43 40.34 1.59 20.35 37.65 -17.87 -12.22 3.83 -15.16 -13.38 2.91 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo 5.94 13.28 27.17 3.53 13.05 28.58 -20.23 -0.15 10.23 -22.87 -0.31 11.21 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG A 25 ARG.? 39.86 N6 ADP C1001 C 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 2.84 19.43 40.34 1.59 20.35 37.65 -23.17 -5.31 5.72 -21.44 -6.89 3.60 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 5.94 13.28 27.17 3.53 13.05 28.58 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG A 94 ARG~? 34.60 N1 ADP C1001 C 161 ASP A 110 ASP.? 52.32 N6 ADP C1001 C 174 TYR A 70 TYR.? 48.30 N6 ADP C1001 coo 2.84 19.43 40.34 1.59 20.35 37.65 -9.32 1.83 20.70 -11.98 2.20 22.31 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 5.94 13.28 27.17 3.53 13.05 28.58 -7.30 -10.03 11.13 -6.31 -12.30 12.53 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG B 94 ARG~? 24.19 N6 ADP C1001 C 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo 2.84 19.43 40.34 1.59 20.35 37.65 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 5.94 13.28 27.17 3.53 13.05 28.58 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG B 94 ARG~? 24.19 N6 ADP C1001 C 161 ASP B 110 ASP.? 12.77 N6 ADP C1001 C 174 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 2.84 19.43 40.34 1.59 20.35 37.65 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 5.94 13.28 27.17 3.53 13.05 28.58 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 7 3 # 7 C 14 ARG C 23 ARG.? 19.01 O2' ADP C1001 C 161 ASP C 9 ASP.? 24.62 C2 ADP C1001 C 174 TYR C 26 TYR^? 24.03 C2 ADP C1001 coo 2.84 19.43 40.34 1.59 20.35 37.65 -41.38 43.66 27.78 -43.67 44.44 29.75 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 5.94 13.28 27.17 3.53 13.05 28.58 -30.56 43.06 36.03 -31.04 45.27 37.68 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 8 3 # 8 C 14 ARG C 74 ARG~? 5.25 O1B ADP C1001 C 161 ASP B 110 ASP.? 12.77 N6 ADP C1001 C 174 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo 2.84 19.43 40.34 1.59 20.35 37.65 -39.58 36.65 12.40 -39.71 35.25 9.68 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 5.94 13.28 27.17 3.53 13.05 28.58 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 9 3 # 9 C 14 ARG C 94 ARG~? 23.82 O3' ADP C1001 C 161 ASP C 110 ASP.? 10.54 O3' ADP C1001 C 174 TYR C 70 TYR.? 10.33 O3' ADP C1001 coo 2.84 19.43 40.34 1.59 20.35 37.65 -33.86 30.07 42.29 -36.45 31.77 42.05 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 5.94 13.28 27.17 3.53 13.05 28.58 -40.11 31.99 28.67 -42.64 30.90 28.52 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 10 3 # 10 C 14 ARG D 2 ARG^? 19.52 N6 ADP C1001 C 161 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 174 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo 2.84 19.43 40.34 1.59 20.35 37.65 -16.51 45.11 16.54 -19.16 44.24 15.23 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 5.94 13.28 27.17 3.53 13.05 28.58 -29.67 41.42 14.91 -30.18 43.90 13.55 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 10 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 2 ARG^? 31.43 N6 ADP C1001 D 161 ASP B 9 ASP.? 24.63 N6 ADP C1001 D 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -10.05 8.79 1.44 -11.10 11.55 0.50 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 23 ARG.? 47.94 N6 ADP C1001 D 161 ASP A 9 ASP.? 35.63 N1 ADP C1001 D 174 TYR A 26 TYR^? 32.13 N6 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -17.87 -12.22 3.83 -15.16 -13.38 2.91 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -20.23 -0.15 10.23 -22.87 -0.31 11.21 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG A 25 ARG.? 39.86 N6 ADP C1001 D 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 D 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -23.17 -5.31 5.72 -21.44 -6.89 3.60 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG A 94 ARG~? 34.60 N1 ADP C1001 D 161 ASP A 110 ASP.? 52.32 N6 ADP C1001 D 174 TYR A 70 TYR.? 48.30 N6 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -9.32 1.83 20.70 -11.98 2.20 22.31 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -7.30 -10.03 11.13 -6.31 -12.30 12.53 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG B 23 ARG.? 16.12 O1A ADP C1001 D 161 ASP B 9 ASP.? 24.63 N6 ADP C1001 D 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -35.24 15.53 3.08 -37.20 16.95 1.17 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG B 23 ARG.? 16.12 O1A ADP C1001 D 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 D 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -35.24 15.53 3.08 -37.20 16.95 1.17 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 7 3 # 7 D 14 ARG B 94 ARG~? 24.19 N6 ADP C1001 D 161 ASP B 10 ASP.? 28.32 N6 ADP C1001 D 174 TYR B 26 TYR^? 24.12 N6 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -23.26 11.23 5.07 -23.26 9.04 3.31 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 8 3 # 8 D 14 ARG B 94 ARG~? 24.19 N6 ADP C1001 D 161 ASP B 110 ASP.? 12.77 N6 ADP C1001 D 174 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -30.45 31.51 3.79 -31.95 31.85 2.33 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 9 3 # 9 D 14 ARG C 23 ARG.? 19.01 O2' ADP C1001 D 161 ASP C 9 ASP.? 24.62 C2 ADP C1001 D 174 TYR C 26 TYR^? 24.03 C2 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -41.38 43.66 27.78 -43.67 44.44 29.75 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -34.52 40.90 40.15 -34.60 38.85 40.85 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -30.56 43.06 36.03 -31.04 45.27 37.68 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 10 3 # 10 D 14 ARG C 74 ARG~? 5.25 O1B ADP C1001 D 161 ASP B 110 ASP.? 12.77 N6 ADP C1001 D 174 TYR B 70 TYR.? 11.71 N6 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -39.58 36.65 12.40 -39.71 35.25 9.68 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -30.45 31.51 3.79 -31.95 31.85 2.33 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -30.56 25.72 4.57 -31.82 27.56 2.83 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 11 3 # 11 D 14 ARG C 94 ARG~? 23.82 O3' ADP C1001 D 161 ASP C 110 ASP.? 10.54 O3' ADP C1001 D 174 TYR C 70 TYR.? 10.33 O3' ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -33.86 30.07 42.29 -36.45 31.77 42.05 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -42.40 26.72 28.14 -44.45 27.16 28.23 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -40.11 31.99 28.67 -42.64 30.90 28.52 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 12 3 # 12 D 14 ARG D 2 ARG^? 19.52 N6 ADP C1001 D 161 ASP C 54 ASP~? 20.12 N1 ADP C1001 D 174 TYR C 79 TYR~? 13.12 N6 ADP C1001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -16.51 45.11 16.54 -19.16 44.24 15.23 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -29.67 41.42 14.91 -30.18 43.90 13.55 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 12 hits 2c7v_c11 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 36 ASP^? 33.81 N6 ADP C1001 A 233 GLU A 33 GLU^? 35.51 N6 ADP C1001 A 300 ASN A 39 ASN^? 26.27 N6 ADP C1001 coo 12.51 17.07 49.46 12.44 16.89 47.35 -1.45 15.76 11.21 -1.10 16.77 13.16 coo 6.52 19.14 48.16 7.77 18.42 46.61 -2.83 15.49 5.14 -2.18 15.03 3.15 coo 9.30 22.40 41.76 10.10 20.96 40.36 -10.50 14.02 7.34 -12.57 14.30 7.00 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 233 GLU A 41 GLU^? 26.55 N6 ADP C1001 A 300 ASN A 39 ASN^? 26.27 N6 ADP C1001 coo 12.51 17.07 49.46 12.44 16.89 47.35 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 6.52 19.14 48.16 7.77 18.42 46.61 -16.06 9.21 5.46 -17.05 10.76 4.34 coo 9.30 22.40 41.76 10.10 20.96 40.36 -10.50 14.02 7.34 -12.57 14.30 7.00 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 3 3 # 3 A 197 ASP B 36 ASP^? 26.54 N6 ADP C1001 A 233 GLU B 33 GLU^? 22.82 N1 ADP C1001 A 300 ASN B 39 ASN.? 27.14 N6 ADP C1001 coo 12.51 17.07 49.46 12.44 16.89 47.35 -7.49 25.66 16.69 -6.44 23.85 16.43 coo 6.52 19.14 48.16 7.77 18.42 46.61 -10.19 23.43 20.85 -11.43 22.93 22.49 coo 9.30 22.40 41.76 10.10 20.96 40.36 -11.13 15.65 16.64 -9.36 15.49 17.83 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 4 3 # 4 A 197 ASP C 36 ASP^? 27.15 C2 ADP C1001 A 233 GLU C 33 GLU^? 22.62 N1 ADP C1001 A 300 ASN C 39 ASN^? 25.44 C2 ADP C1001 coo 12.51 17.07 49.46 12.44 16.89 47.35 -16.89 23.06 36.75 -16.41 21.35 37.85 coo 6.52 19.14 48.16 7.77 18.42 46.61 -14.30 26.31 31.75 -13.99 26.91 29.72 coo 9.30 22.40 41.76 10.10 20.96 40.36 -16.77 32.66 36.54 -17.11 34.71 36.97 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 5 3 # 5 A 197 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 233 GLU C 48 GLU.? 22.51 O2' ADP C1001 A 300 ASN D 57 ASN~? 28.49 N1 ADP C1001 coo 12.51 17.07 49.46 12.44 16.89 47.35 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 6.52 19.14 48.16 7.77 18.42 46.61 -33.52 53.52 23.97 -33.48 52.09 22.33 coo 9.30 22.40 41.76 10.10 20.96 40.36 -26.50 55.76 21.71 -26.74 56.60 23.67 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 6 3 # 6 A 197 ASP D 36 ASP^? 31.16 N6 ADP C1001 A 233 GLU D 33 GLU^? 24.81 N6 ADP C1001 A 300 ASN D 39 ASN^? 19.52 N6 ADP C1001 coo 12.51 17.07 49.46 12.44 16.89 47.35 -4.58 39.61 12.64 -2.59 38.96 12.51 coo 6.52 19.14 48.16 7.77 18.42 46.61 -9.58 39.62 17.74 -10.11 39.83 19.83 coo 9.30 22.40 41.76 10.10 20.96 40.36 -14.81 40.52 11.20 -15.13 38.43 11.40 2cpu_c01 source 2cpu ALPHA-AMYLASE : 6 hits 2cpu_c01 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 5.98 42.76 7.73 10.19 38.62 9.02 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 2.77 37.17 4.99 6.33 34.76 8.06 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 A 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 5.98 42.76 7.73 10.19 38.62 9.02 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 2.77 37.17 4.99 6.33 34.76 8.06 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS B 100 LYS~? 23.96 N6 ADP C1001 A 184 LYS B 106 LYS.? 18.25 N6 ADP C1001 A 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 5.98 42.76 7.73 10.19 38.62 9.02 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 2.77 37.17 4.99 6.33 34.76 8.06 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 5.98 42.76 7.73 10.19 38.62 9.02 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 2.77 37.17 4.99 6.33 34.76 8.06 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 5 3 # 5 A 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 A 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 A 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 5.98 42.76 7.73 10.19 38.62 9.02 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 2.77 37.17 4.99 6.33 34.76 8.06 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 6 3 # 6 A 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 A 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 5.98 42.76 7.73 10.19 38.62 9.02 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 2.77 37.17 4.99 6.33 34.76 8.06 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 B 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 B 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 38.76 2.27 4.00 34.00 5.99 4.37 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 40.63 7.13 9.06 35.85 7.36 8.95 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 106 LYS.? 50.79 N6 ADP C1001 B 184 LYS A 100 LYS~? 39.84 N1 ADP C1001 B 345 ASP A 110 ASP.? 52.32 N6 ADP C1001 coo 38.76 2.27 4.00 34.00 5.99 4.37 5.53 0.28 13.93 10.17 1.85 15.47 coo 40.63 7.13 9.06 35.85 7.36 8.95 -1.03 5.78 15.30 1.15 8.50 19.55 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -2.05 -11.28 13.38 -2.43 -13.21 14.14 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS B 100 LYS~? 23.96 N6 ADP C1001 B 184 LYS B 106 LYS.? 18.25 N6 ADP C1001 B 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 38.76 2.27 4.00 34.00 5.99 4.37 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 40.63 7.13 9.06 35.85 7.36 8.95 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS B 106 LYS.? 18.25 N6 ADP C1001 B 184 LYS B 100 LYS~? 23.96 N6 ADP C1001 B 345 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 38.76 2.27 4.00 34.00 5.99 4.37 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 40.63 7.13 9.06 35.85 7.36 8.95 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS B 106 LYS.? 18.25 N6 ADP C1001 B 184 LYS B 100 LYS~? 23.96 N6 ADP C1001 B 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 38.76 2.27 4.00 34.00 5.99 4.37 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 40.63 7.13 9.06 35.85 7.36 8.95 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS C 106 LYS.? 22.18 C2 ADP C1001 B 184 LYS C 100 LYS~? 22.69 C2 ADP C1001 B 345 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 38.76 2.27 4.00 34.00 5.99 4.37 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 40.63 7.13 9.06 35.85 7.36 8.95 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -42.40 26.72 28.14 -44.45 27.16 28.23 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 C 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 C 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 0.95 12.72 73.51 1.58 12.72 68.31 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 C 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 C 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 0.95 12.72 73.51 1.58 12.72 68.31 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS B 100 LYS~? 23.96 N6 ADP C1001 C 184 LYS B 106 LYS.? 18.25 N6 ADP C1001 C 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 0.95 12.72 73.51 1.58 12.72 68.31 -19.68 36.01 11.35 -19.41 40.72 7.99 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 C 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 C 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 0.95 12.72 73.51 1.58 12.72 68.31 -21.73 32.18 22.71 -16.79 33.08 21.29 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 C 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 C 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 0.95 12.72 73.51 1.58 12.72 68.31 -21.36 39.39 22.00 -17.64 41.95 19.02 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 6 3 # 6 C 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 C 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 C 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 0.95 12.72 73.51 1.58 12.72 68.31 -21.35 51.92 21.59 -25.15 52.63 26.23 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 D 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 D 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 D 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 D 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS B 65 LYS.? 17.22 C2 ADP C1001 D 184 LYS B 60 LYS~? 21.40 C2 ADP C1001 D 345 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 D 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 D 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 D 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 D 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 6 3 # 6 D 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 D 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 D 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 E 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 E 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 E 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 E 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS B 65 LYS.? 17.22 C2 ADP C1001 E 184 LYS B 60 LYS~? 21.40 C2 ADP C1001 E 345 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -23.42 20.96 21.77 -22.73 18.61 26.55 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -26.04 13.89 21.83 -25.92 10.67 25.77 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 E 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 E 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -21.36 39.39 22.00 -17.64 41.95 19.02 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -21.73 32.18 22.71 -16.79 33.08 21.29 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 E 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 E 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -21.73 32.18 22.71 -16.79 33.08 21.29 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -21.36 39.39 22.00 -17.64 41.95 19.02 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 6 3 # 6 E 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 E 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 E 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -14.21 50.71 21.89 -14.80 46.21 24.73 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -21.35 51.92 21.59 -25.15 52.63 26.23 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 F 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 F 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 10.64 34.02 91.30 6.30 35.60 95.11 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 13.75 39.76 94.12 11.42 37.23 97.89 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 16.35 26.90 99.56 16.81 25.90 97.75 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 F 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 F 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 10.64 34.02 91.30 6.30 35.60 95.11 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 13.75 39.76 94.12 11.42 37.23 97.89 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 16.35 26.90 99.56 16.81 25.90 97.75 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS B 65 LYS.? 17.22 C2 ADP C1001 F 184 LYS B 60 LYS~? 21.40 C2 ADP C1001 F 345 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 10.64 34.02 91.30 6.30 35.60 95.11 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 13.75 39.76 94.12 11.42 37.23 97.89 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 16.35 26.90 99.56 16.81 25.90 97.75 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 F 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 F 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 10.64 34.02 91.30 6.30 35.60 95.11 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 13.75 39.76 94.12 11.42 37.23 97.89 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 16.35 26.90 99.56 16.81 25.90 97.75 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 F 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 F 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 10.64 34.02 91.30 6.30 35.60 95.11 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 13.75 39.76 94.12 11.42 37.23 97.89 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 16.35 26.90 99.56 16.81 25.90 97.75 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 6 3 # 6 F 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 F 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 F 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 10.64 34.02 91.30 6.30 35.60 95.11 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 13.75 39.76 94.12 11.42 37.23 97.89 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 16.35 26.90 99.56 16.81 25.90 97.75 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 G 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 G 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 39.68 42.04 76.11 43.42 46.43 74.96 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 36.69 47.69 78.93 39.38 50.40 75.35 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 33.43 44.37 65.47 33.10 42.30 65.37 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 G 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 G 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 39.68 42.04 76.11 43.42 46.43 74.96 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 36.69 47.69 78.93 39.38 50.40 75.35 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 33.43 44.37 65.47 33.10 42.30 65.37 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 G 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 G 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 39.68 42.04 76.11 43.42 46.43 74.96 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 36.69 47.69 78.93 39.38 50.40 75.35 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 33.43 44.37 65.47 33.10 42.30 65.37 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 G 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 G 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 39.68 42.04 76.11 43.42 46.43 74.96 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 36.69 47.69 78.93 39.38 50.40 75.35 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 33.43 44.37 65.47 33.10 42.30 65.37 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 G 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 G 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 39.68 42.04 76.11 43.42 46.43 74.96 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 36.69 47.69 78.93 39.38 50.40 75.35 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 33.43 44.37 65.47 33.10 42.30 65.37 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 H 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 H 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 71.58 83.18 80.51 66.88 79.77 79.84 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 73.65 78.64 75.66 68.14 79.07 75.04 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 67.43 90.73 71.39 68.27 92.30 72.52 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 H 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 H 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 71.58 83.18 80.51 66.88 79.77 79.84 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 73.65 78.64 75.66 68.14 79.07 75.04 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 67.43 90.73 71.39 68.27 92.30 72.52 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS B 65 LYS.? 17.22 C2 ADP C1001 H 184 LYS B 60 LYS~? 21.40 C2 ADP C1001 H 345 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 71.58 83.18 80.51 66.88 79.77 79.84 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 73.65 78.64 75.66 68.14 79.07 75.04 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 67.43 90.73 71.39 68.27 92.30 72.52 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 H 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 H 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 71.58 83.18 80.51 66.88 79.77 79.84 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 73.65 78.64 75.66 68.14 79.07 75.04 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 67.43 90.73 71.39 68.27 92.30 72.52 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 H 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 H 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 71.58 83.18 80.51 66.88 79.77 79.84 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 73.65 78.64 75.66 68.14 79.07 75.04 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 67.43 90.73 71.39 68.27 92.30 72.52 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 6 3 # 6 H 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 H 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 H 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 71.58 83.18 80.51 66.88 79.77 79.84 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 73.65 78.64 75.66 68.14 79.07 75.04 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 67.43 90.73 71.39 68.27 92.30 72.52 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 I 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 I 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 60.20 96.92 42.53 57.60 93.13 38.67 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 54.31 95.46 46.01 55.34 91.59 42.65 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 66.35 87.81 48.53 68.10 89.01 48.77 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 I 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 I 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 60.20 96.92 42.53 57.60 93.13 38.67 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 54.31 95.46 46.01 55.34 91.59 42.65 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 66.35 87.81 48.53 68.10 89.01 48.77 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS B 65 LYS.? 17.22 C2 ADP C1001 I 184 LYS B 60 LYS~? 21.40 C2 ADP C1001 I 345 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 60.20 96.92 42.53 57.60 93.13 38.67 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 54.31 95.46 46.01 55.34 91.59 42.65 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 66.35 87.81 48.53 68.10 89.01 48.77 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 I 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 I 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 60.20 96.92 42.53 57.60 93.13 38.67 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 54.31 95.46 46.01 55.34 91.59 42.65 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 66.35 87.81 48.53 68.10 89.01 48.77 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 I 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 I 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 60.20 96.92 42.53 57.60 93.13 38.67 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 54.31 95.46 46.01 55.34 91.59 42.65 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 66.35 87.81 48.53 68.10 89.01 48.77 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 6 3 # 6 I 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 I 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 I 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 60.20 96.92 42.53 57.60 93.13 38.67 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 54.31 95.46 46.01 55.34 91.59 42.65 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 66.35 87.81 48.53 68.10 89.01 48.77 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 J 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 J 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 25.22 70.55 14.03 27.64 73.07 18.65 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 31.73 69.87 11.50 32.73 70.19 16.40 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 25.87 58.42 18.79 23.95 58.54 17.90 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 J 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 J 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 25.22 70.55 14.03 27.64 73.07 18.65 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 31.73 69.87 11.50 32.73 70.19 16.40 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 25.87 58.42 18.79 23.95 58.54 17.90 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS B 100 LYS~? 23.96 N6 ADP C1001 J 184 LYS B 106 LYS.? 18.25 N6 ADP C1001 J 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 25.22 70.55 14.03 27.64 73.07 18.65 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 31.73 69.87 11.50 32.73 70.19 16.40 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 25.87 58.42 18.79 23.95 58.54 17.90 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 J 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 J 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 25.22 70.55 14.03 27.64 73.07 18.65 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 31.73 69.87 11.50 32.73 70.19 16.40 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 25.87 58.42 18.79 23.95 58.54 17.90 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 5 3 # 5 J 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 J 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 J 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 25.22 70.55 14.03 27.64 73.07 18.65 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 31.73 69.87 11.50 32.73 70.19 16.40 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 25.87 58.42 18.79 23.95 58.54 17.90 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 6 3 # 6 J 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 J 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 J 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 25.22 70.55 14.03 27.64 73.07 18.65 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 31.73 69.87 11.50 32.73 70.19 16.40 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 25.87 58.42 18.79 23.95 58.54 17.90 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 K 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 K 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 K 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 K 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS B 100 LYS~? 23.96 N6 ADP C1001 K 184 LYS B 106 LYS.? 18.25 N6 ADP C1001 K 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 K 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 K 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 K 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 K 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 6 3 # 6 K 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 K 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 K 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 L 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 L 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 106 LYS.? 50.79 N6 ADP C1001 L 184 LYS A 100 LYS~? 39.84 N1 ADP C1001 L 345 ASP A 110 ASP.? 52.32 N6 ADP C1001 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 5.53 0.28 13.93 10.17 1.85 15.47 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -1.03 5.78 15.30 1.15 8.50 19.55 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -2.05 -11.28 13.38 -2.43 -13.21 14.14 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS B 100 LYS~? 23.96 N6 ADP C1001 L 184 LYS B 106 LYS.? 18.25 N6 ADP C1001 L 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS B 106 LYS.? 18.25 N6 ADP C1001 L 184 LYS B 100 LYS~? 23.96 N6 ADP C1001 L 345 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS B 106 LYS.? 18.25 N6 ADP C1001 L 184 LYS B 100 LYS~? 23.96 N6 ADP C1001 L 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS C 106 LYS.? 22.18 C2 ADP C1001 L 184 LYS C 100 LYS~? 22.69 C2 ADP C1001 L 345 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS D 106 LYS.? 44.27 N6 ADP C1001 L 184 LYS D 100 LYS~? 39.55 N6 ADP C1001 L 345 ASP D 110 ASP.? 48.95 N6 ADP C1001 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 1.94 54.62 12.82 6.05 51.27 9.45 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -3.04 48.91 8.43 1.31 48.12 4.91 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -3.52 66.57 9.69 -1.94 67.67 8.60 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 7 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 M 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 M 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 106 LYS.? 50.79 N6 ADP C1001 M 184 LYS A 100 LYS~? 39.84 N1 ADP C1001 M 345 ASP A 110 ASP.? 52.32 N6 ADP C1001 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 5.53 0.28 13.93 10.17 1.85 15.47 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -1.03 5.78 15.30 1.15 8.50 19.55 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -2.05 -11.28 13.38 -2.43 -13.21 14.14 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS B 100 LYS~? 23.96 N6 ADP C1001 M 184 LYS B 106 LYS.? 18.25 N6 ADP C1001 M 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -14.49 29.22 9.50 -10.36 30.43 5.24 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -19.68 36.01 11.35 -19.41 40.72 7.99 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS B 106 LYS.? 18.25 N6 ADP C1001 M 184 LYS B 100 LYS~? 23.96 N6 ADP C1001 M 345 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -19.68 36.01 11.35 -19.41 40.72 7.99 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -14.49 29.22 9.50 -10.36 30.43 5.24 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS B 106 LYS.? 18.25 N6 ADP C1001 M 184 LYS B 100 LYS~? 23.96 N6 ADP C1001 M 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -19.68 36.01 11.35 -19.41 40.72 7.99 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -14.49 29.22 9.50 -10.36 30.43 5.24 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS C 106 LYS.? 22.18 C2 ADP C1001 M 184 LYS C 100 LYS~? 22.69 C2 ADP C1001 M 345 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -32.20 18.25 30.35 -29.71 15.02 34.83 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -28.01 22.62 36.30 -24.43 24.45 38.49 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS C 108 LYS.? 14.57 N3 ADP C1001 M 184 LYS C 106 LYS.? 22.18 C2 ADP C1001 M 345 ASP C 112 ASP.? 10.30 O3' ADP C1001 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -37.26 21.98 30.89 -34.43 24.41 31.94 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -32.20 18.25 30.35 -29.71 15.02 34.83 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -47.22 26.04 24.41 -47.86 24.10 23.79 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS D 106 LYS.? 44.27 N6 ADP C1001 M 184 LYS D 100 LYS~? 39.55 N6 ADP C1001 M 345 ASP D 110 ASP.? 48.95 N6 ADP C1001 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 1.94 54.62 12.82 6.05 51.27 9.45 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -3.04 48.91 8.43 1.31 48.12 4.91 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -3.52 66.57 9.69 -1.94 67.67 8.60 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 N 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 N 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 N 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 N 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS B 65 LYS.? 17.22 C2 ADP C1001 N 184 LYS B 60 LYS~? 21.40 C2 ADP C1001 N 345 ASP B 31 ASP^? 22.05 N1 ADP C1001 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -23.42 20.96 21.77 -22.73 18.61 26.55 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -13.40 19.33 18.81 -14.28 17.40 18.97 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 N 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 N 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 N 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 N 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 6 3 # 6 N 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 N 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 N 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 O 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 O 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 65 LYS.? 41.76 N6 ADP C1001 O 184 LYS A 60 LYS~? 43.57 N6 ADP C1001 O 345 ASP A 31 ASP^? 31.30 N6 ADP C1001 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -7.60 12.44 5.41 -8.89 12.13 3.85 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS C 60 LYS~? 19.47 N6 ADP C1001 O 184 LYS C 65 LYS.? 16.76 N1 ADP C1001 O 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -13.15 42.40 14.58 -15.11 42.76 15.19 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS C 65 LYS.? 16.76 N1 ADP C1001 O 184 LYS C 60 LYS~? 19.47 N6 ADP C1001 O 345 ASP C 31 ASP^? 21.62 C2 ADP C1001 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -21.36 39.39 22.00 -17.64 41.95 19.02 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -17.30 30.71 32.69 -16.98 32.62 31.85 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS D 65 LYS.? 25.59 N1 ADP C1001 O 184 LYS D 60 LYS~? 25.96 N1 ADP C1001 O 345 ASP D 31 ASP^? 21.52 N6 ADP C1001 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -14.21 50.71 21.89 -14.80 46.21 24.73 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -13.15 42.40 14.58 -15.11 42.76 15.19 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 60 LYS~? 43.57 N6 ADP C1001 P 184 LYS A 65 LYS.? 41.76 N6 ADP C1001 P 345 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -5.22 4.23 -1.84 -5.14 5.63 -5.71 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -19.64 10.11 1.49 -19.54 9.87 -0.69 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 106 LYS.? 50.79 N6 ADP C1001 P 184 LYS A 100 LYS~? 39.84 N1 ADP C1001 P 345 ASP A 110 ASP.? 52.32 N6 ADP C1001 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 5.53 0.28 13.93 10.17 1.85 15.47 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -1.03 5.78 15.30 1.15 8.50 19.55 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -2.05 -11.28 13.38 -2.43 -13.21 14.14 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS B 100 LYS~? 23.96 N6 ADP C1001 P 184 LYS B 106 LYS.? 18.25 N6 ADP C1001 P 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS B 106 LYS.? 18.25 N6 ADP C1001 P 184 LYS B 100 LYS~? 23.96 N6 ADP C1001 P 345 ASP B 110 ASP.? 12.77 N6 ADP C1001 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -30.45 31.51 3.79 -31.95 31.85 2.33 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS B 106 LYS.? 18.25 N6 ADP C1001 P 184 LYS B 100 LYS~? 23.96 N6 ADP C1001 P 345 ASP D 36 ASP^? 31.16 N6 ADP C1001 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -14.49 29.22 9.50 -10.36 30.43 5.24 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -4.58 39.61 12.64 -2.59 38.96 12.51 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS C 106 LYS.? 22.18 C2 ADP C1001 P 184 LYS C 100 LYS~? 22.69 C2 ADP C1001 P 345 ASP C 110 ASP.? 10.54 O3' ADP C1001 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -42.40 26.72 28.14 -44.45 27.16 28.23 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS D 106 LYS.? 44.27 N6 ADP C1001 P 184 LYS D 100 LYS~? 39.55 N6 ADP C1001 P 345 ASP D 110 ASP.? 48.95 N6 ADP C1001 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 1.94 54.62 12.82 6.05 51.27 9.45 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -3.04 48.91 8.43 1.31 48.12 4.91 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -3.52 66.57 9.69 -1.94 67.67 8.60 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 7 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 92 TYR.? 47.39 N1 ADP C1001 A 245 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 273 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -4.20 1.28 18.72 -4.75 1.76 20.72 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR B 92 TYR.? 14.20 N6 ADP C1001 A 245 ASP B 97 ASP~? 21.13 N6 ADP C1001 A 273 LYS B 106 LYS.? 18.25 N6 ADP C1001 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -17.01 28.05 3.64 -15.70 27.74 1.96 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -19.68 36.01 11.35 -19.41 40.72 7.99 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR C 92 TYR.? 13.82 O3' ADP C1001 A 245 ASP C 97 ASP~? 22.56 C2 ADP C1001 A 273 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.31 25.31 38.38 -33.83 25.06 40.38 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR D 79 TYR~? 36.26 N1 ADP C1001 A 245 ASP D 54 ASP~? 30.93 N6 ADP C1001 A 273 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -22.76 62.70 24.87 -24.61 64.61 25.82 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -28.33 59.98 17.64 -30.29 60.47 18.21 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR D 92 TYR.? 44.20 N6 ADP C1001 A 245 ASP D 97 ASP~? 39.15 N6 ADP C1001 A 273 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -4.34 53.74 3.65 -4.01 53.36 1.58 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 1.94 54.62 12.82 6.05 51.27 9.45 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 5 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 245 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 273 LYS A 100 LYS~? 39.84 N1 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -7.60 12.44 5.41 -8.89 12.13 3.85 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -1.03 5.78 15.30 1.15 8.50 19.55 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 245 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 273 LYS B 38 LYS.? 29.47 N6 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -7.60 12.44 5.41 -8.89 12.13 3.85 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -9.30 19.94 15.62 -4.67 19.41 15.25 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE A 47 PHE.? 38.97 O1A ADP C1001 A 245 ASP A 54 ASP~? 42.89 N6 ADP C1001 A 273 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -26.57 -5.13 -1.90 -27.64 -5.09 -4.56 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE A 58 PHE~? 34.92 N6 ADP C1001 A 245 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 273 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -17.56 0.82 -0.93 -18.36 2.22 1.34 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 245 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 273 LYS B 100 LYS~? 23.96 N6 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.40 19.33 18.81 -14.28 17.40 18.97 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -14.49 29.22 9.50 -10.36 30.43 5.24 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE B 47 PHE.? 28.85 O4' ADP C1001 A 245 ASP B 54 ASP~? 20.52 O4' ADP C1001 A 273 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -29.91 1.80 9.18 -28.86 -0.57 10.37 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -33.59 8.19 15.94 -35.17 6.84 16.43 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE B 58 PHE~? 21.02 N6 ADP C1001 A 245 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 273 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -26.58 9.98 15.28 -24.37 9.78 13.51 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -21.48 2.08 13.35 -22.87 1.76 14.94 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE C 29 PHE^? 17.94 C2 ADP C1001 A 245 ASP C 31 ASP^? 21.62 C2 ADP C1001 A 273 LYS C 100 LYS~? 22.69 C2 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -22.69 37.33 30.80 -23.71 39.19 28.97 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -17.30 30.71 32.69 -16.98 32.62 31.85 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -28.01 22.62 36.30 -24.43 24.45 38.49 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 245 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 273 LYS D 100 LYS~? 39.55 N6 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.15 42.40 14.58 -15.11 42.76 15.19 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -3.04 48.91 8.43 1.31 48.12 4.91 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 157 PHE D 47 PHE.? 27.02 N6 ADP C1001 A 245 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 273 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -29.38 57.47 13.70 -28.51 55.69 15.67 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 157 PHE D 58 PHE~? 24.52 N6 ADP C1001 A 245 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 273 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -24.99 53.85 15.24 -24.47 52.34 12.98 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -21.36 39.39 22.00 -17.64 41.95 19.02 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 11 hits 2gsa_c04 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 102 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 193 GLY B 12 GLY~? 22.61 N6 ADP C1001 coo 14.96 29.22 19.55 15.62 29.93 17.67 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 19.64 30.69 22.61 18.18 29.94 21.25 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 14.54 28.99 9.76 15.06 29.59 10.02 -17.91 15.52 4.82 -17.88 16.00 4.18 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 102 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 193 GLY A 12 GLY~? 30.18 N6 ADP C1001 coo 14.96 29.22 19.55 15.62 29.93 17.67 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 19.64 30.69 22.61 18.18 29.94 21.25 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 14.54 28.99 9.76 15.06 29.59 10.02 -15.34 4.79 13.98 -15.18 4.16 14.49 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS C 50 HIS.? 17.04 O2' ADP C1001 A 102 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 193 GLY C 73 GLY~? 7.38 O2' ADP C1001 coo 14.96 29.22 19.55 15.62 29.93 17.67 -36.38 48.00 21.35 -37.79 46.44 21.40 coo 19.64 30.69 22.61 18.18 29.94 21.25 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 14.54 28.99 9.76 15.06 29.59 10.02 -38.52 37.92 18.83 -37.81 37.51 18.99 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 3 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 21 PHE.? 42.86 N6 ADP C1001 A 263 ASP A 54 ASP~? 42.89 N6 ADP C1001 A 292 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 54.43 44.82 23.74 55.21 45.06 21.80 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 63.95 45.30 16.71 59.11 49.15 16.05 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 27 PHE^? 37.41 N6 ADP C1001 A 263 ASP A 10 ASP.? 29.48 N1 ADP C1001 A 292 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 54.43 44.82 23.74 55.21 45.06 21.80 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 63.95 45.30 16.71 59.11 49.15 16.05 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 27 PHE^? 37.41 N6 ADP C1001 A 263 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 292 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 54.43 44.82 23.74 55.21 45.06 21.80 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 63.95 45.30 16.71 59.11 49.15 16.05 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 263 ASP A 31 ASP^? 31.30 N6 ADP C1001 A 292 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 54.43 44.82 23.74 55.21 45.06 21.80 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 63.95 45.30 16.71 59.11 49.15 16.05 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE A 29 PHE^? 33.27 N6 ADP C1001 A 263 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 292 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 54.43 44.82 23.74 55.21 45.06 21.80 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 63.95 45.30 16.71 59.11 49.15 16.05 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE B 21 PHE.? 12.47 N7 ADP C1001 A 263 ASP B 54 ASP~? 20.52 O4' ADP C1001 A 292 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.61 18.24 11.10 -30.96 16.75 13.38 coo 54.43 44.82 23.74 55.21 45.06 21.80 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 63.95 45.30 16.71 59.11 49.15 16.05 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE B 27 PHE^? 16.30 N6 ADP C1001 A 263 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 292 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 54.43 44.82 23.74 55.21 45.06 21.80 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 63.95 45.30 16.71 59.11 49.15 16.05 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 263 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 292 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 54.43 44.82 23.74 55.21 45.06 21.80 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 63.95 45.30 16.71 59.11 49.15 16.05 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 177 PHE B 29 PHE^? 19.13 N6 ADP C1001 A 263 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 292 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 54.43 44.82 23.74 55.21 45.06 21.80 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 63.95 45.30 16.71 59.11 49.15 16.05 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 177 PHE C 21 PHE.? 11.41 C2 ADP C1001 A 263 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 292 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 54.43 44.82 23.74 55.21 45.06 21.80 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 63.95 45.30 16.71 59.11 49.15 16.05 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 177 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 263 ASP C 10 ASP.? 28.10 C2 ADP C1001 A 292 LYS C 14 LYS.? 27.01 C2 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 54.43 44.82 23.74 55.21 45.06 21.80 -29.82 42.88 40.75 -30.96 43.09 42.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -31.38 33.30 42.44 -27.73 35.10 43.96 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 A 177 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 263 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 292 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 54.43 44.82 23.74 55.21 45.06 21.80 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 63.95 45.30 16.71 59.11 49.15 16.05 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 A 177 PHE C 58 PHE~? 19.35 C2 ADP C1001 A 263 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 292 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 54.43 44.82 23.74 55.21 45.06 21.80 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 63.95 45.30 16.71 59.11 49.15 16.05 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 A 177 PHE D 21 PHE.? 33.63 N6 ADP C1001 A 263 ASP D 54 ASP~? 30.93 N6 ADP C1001 A 292 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 54.43 44.82 23.74 55.21 45.06 21.80 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 63.95 45.30 16.71 59.11 49.15 16.05 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 A 177 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 263 ASP D 31 ASP^? 21.52 N6 ADP C1001 A 292 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 54.43 44.82 23.74 55.21 45.06 21.80 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 63.95 45.30 16.71 59.11 49.15 16.05 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 A 177 PHE D 29 PHE^? 23.81 N6 ADP C1001 A 263 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 292 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 51.51 50.32 16.39 52.13 49.68 13.75 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 54.43 44.82 23.74 55.21 45.06 21.80 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 63.95 45.30 16.71 59.11 49.15 16.05 -21.36 39.39 22.00 -17.64 41.95 19.02 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 21 PHE.? 42.86 N6 ADP C1001 B 263 ASP A 54 ASP~? 42.89 N6 ADP C1001 B 292 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 60.53 31.67 0.97 57.79 27.51 3.63 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 27 PHE^? 37.41 N6 ADP C1001 B 263 ASP A 10 ASP.? 29.48 N1 ADP C1001 B 292 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 60.53 31.67 0.97 57.79 27.51 3.63 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 29 PHE^? 33.27 N6 ADP C1001 B 263 ASP A 31 ASP^? 31.30 N6 ADP C1001 B 292 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 60.53 31.67 0.97 57.79 27.51 3.63 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE A 29 PHE^? 33.27 N6 ADP C1001 B 263 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 292 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 60.53 31.67 0.97 57.79 27.51 3.63 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE B 21 PHE.? 12.47 N7 ADP C1001 B 263 ASP B 54 ASP~? 20.52 O4' ADP C1001 B 292 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.61 18.24 11.10 -30.96 16.75 13.38 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 60.53 31.67 0.97 57.79 27.51 3.63 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE B 29 PHE^? 19.13 N6 ADP C1001 B 263 ASP B 31 ASP^? 22.05 N1 ADP C1001 B 292 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 60.53 31.67 0.97 57.79 27.51 3.63 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE B 29 PHE^? 19.13 N6 ADP C1001 B 263 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 292 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 60.53 31.67 0.97 57.79 27.51 3.63 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE C 21 PHE.? 11.41 C2 ADP C1001 B 263 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 292 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 60.53 31.67 0.97 57.79 27.51 3.63 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE C 27 PHE^? 15.44 C2 ADP C1001 B 263 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 292 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 60.53 31.67 0.97 57.79 27.51 3.63 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE C 58 PHE~? 19.35 C2 ADP C1001 B 263 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 292 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 60.53 31.67 0.97 57.79 27.51 3.63 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 177 PHE D 21 PHE.? 33.63 N6 ADP C1001 B 263 ASP D 54 ASP~? 30.93 N6 ADP C1001 B 292 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 60.53 31.67 0.97 57.79 27.51 3.63 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 177 PHE D 29 PHE^? 23.81 N6 ADP C1001 B 263 ASP D 31 ASP^? 21.52 N6 ADP C1001 B 292 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 60.53 31.67 0.97 57.79 27.51 3.63 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 177 PHE D 29 PHE^? 23.81 N6 ADP C1001 B 263 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 292 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 49.99 26.05 6.28 51.46 26.87 8.49 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 60.53 31.67 0.97 57.79 27.51 3.63 -21.36 39.39 22.00 -17.64 41.95 19.02 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 13 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 21 PHE.? 42.86 N6 ADP C1001 C 263 ASP A 54 ASP~? 42.89 N6 ADP C1001 C 292 LYS A 60 LYS~? 43.57 N6 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 19.84 12.02 9.33 18.68 11.23 7.75 -19.38 -4.76 -4.80 -20.64 -5.74 -6.14 coo 12.82 3.49 4.98 17.80 5.59 1.90 -11.54 3.22 -4.84 -9.87 2.87 -11.02 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 27 PHE^? 37.41 N6 ADP C1001 C 263 ASP A 10 ASP.? 29.48 N1 ADP C1001 C 292 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 19.84 12.02 9.33 18.68 11.23 7.75 -21.48 2.08 13.35 -22.87 1.76 14.94 coo 12.82 3.49 4.98 17.80 5.59 1.90 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 27 PHE^? 37.41 N6 ADP C1001 C 263 ASP A 61 ASP~? 37.71 N6 ADP C1001 C 292 LYS A 65 LYS.? 41.76 N6 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo 19.84 12.02 9.33 18.68 11.23 7.75 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 12.82 3.49 4.98 17.80 5.59 1.90 -5.22 4.23 -1.84 -5.14 5.63 -5.71 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE A 29 PHE^? 33.27 N6 ADP C1001 C 263 ASP A 31 ASP^? 31.30 N6 ADP C1001 C 292 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 19.84 12.02 9.33 18.68 11.23 7.75 -7.60 12.44 5.41 -8.89 12.13 3.85 coo 12.82 3.49 4.98 17.80 5.59 1.90 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE A 29 PHE^? 33.27 N6 ADP C1001 C 263 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 292 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -12.99 5.90 3.87 -14.20 3.90 2.32 coo 19.84 12.02 9.33 18.68 11.23 7.75 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 12.82 3.49 4.98 17.80 5.59 1.90 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE B 21 PHE.? 12.47 N7 ADP C1001 C 263 ASP B 54 ASP~? 20.52 O4' ADP C1001 C 292 LYS B 60 LYS~? 21.40 C2 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.61 18.24 11.10 -30.96 16.75 13.38 coo 19.84 12.02 9.33 18.68 11.23 7.75 -33.59 8.19 15.94 -35.17 6.84 16.43 coo 12.82 3.49 4.98 17.80 5.59 1.90 -26.04 13.89 21.83 -25.92 10.67 25.77 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE B 27 PHE^? 16.30 N6 ADP C1001 C 263 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 292 LYS B 65 LYS.? 17.22 C2 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -25.23 14.62 11.31 -27.95 15.25 11.19 coo 19.84 12.02 9.33 18.68 11.23 7.75 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 12.82 3.49 4.98 17.80 5.59 1.90 -23.42 20.96 21.77 -22.73 18.61 26.55 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE B 29 PHE^? 19.13 N6 ADP C1001 C 263 ASP B 31 ASP^? 22.05 N1 ADP C1001 C 292 LYS A 38 LYS^? 31.29 N6 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 19.84 12.02 9.33 18.68 11.23 7.75 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 12.82 3.49 4.98 17.80 5.59 1.90 -6.79 15.32 9.19 -4.05 19.39 6.22 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 177 PHE B 29 PHE^? 19.13 N6 ADP C1001 C 263 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 292 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -19.97 14.78 14.91 -22.45 13.54 15.08 coo 19.84 12.02 9.33 18.68 11.23 7.75 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 12.82 3.49 4.98 17.80 5.59 1.90 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 177 PHE C 21 PHE.? 11.41 C2 ADP C1001 C 263 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 292 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 19.84 12.02 9.33 18.68 11.23 7.75 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 12.82 3.49 4.98 17.80 5.59 1.90 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 177 PHE C 27 PHE^? 15.44 C2 ADP C1001 C 263 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 292 LYS C 65 LYS.? 16.76 N1 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -28.49 39.61 29.74 -30.46 39.97 27.81 coo 19.84 12.02 9.33 18.68 11.23 7.75 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 12.82 3.49 4.98 17.80 5.59 1.90 -21.73 32.18 22.71 -16.79 33.08 21.29 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 177 PHE C 58 PHE~? 19.35 C2 ADP C1001 C 263 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 292 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -25.26 43.99 26.49 -25.09 43.67 29.27 coo 19.84 12.02 9.33 18.68 11.23 7.75 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 12.82 3.49 4.98 17.80 5.59 1.90 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 C 177 PHE D 21 PHE.? 33.63 N6 ADP C1001 C 263 ASP D 54 ASP~? 30.93 N6 ADP C1001 C 292 LYS D 60 LYS~? 25.96 N1 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 19.84 12.02 9.33 18.68 11.23 7.75 -28.33 59.98 17.64 -30.29 60.47 18.21 coo 12.82 3.49 4.98 17.80 5.59 1.90 -21.35 51.92 21.59 -25.15 52.63 26.23 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 C 177 PHE D 29 PHE^? 23.81 N6 ADP C1001 C 263 ASP D 31 ASP^? 21.52 N6 ADP C1001 C 292 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 19.84 12.02 9.33 18.68 11.23 7.75 -13.15 42.40 14.58 -15.11 42.76 15.19 coo 12.82 3.49 4.98 17.80 5.59 1.90 -21.36 39.39 22.00 -17.64 41.95 19.02 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 C 177 PHE D 29 PHE^? 23.81 N6 ADP C1001 C 263 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 292 LYS C 60 LYS~? 19.47 N6 ADP C1001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -18.44 48.91 13.36 -20.46 50.71 14.19 coo 19.84 12.02 9.33 18.68 11.23 7.75 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 12.82 3.49 4.98 17.80 5.59 1.90 -21.36 39.39 22.00 -17.64 41.95 19.02 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 15 hits 2oat_c05 naa= 3 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 178 TRP C 113 TRP.? -4.31 O3' ADP C1001s A 263 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 292 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 48.96 45.07 19.49 48.62 41.39 18.16 -41.02 28.74 23.55 -40.73 32.19 21.60 coo 54.43 44.82 23.74 55.21 45.06 21.80 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 178 TRP D 113 TRP.? 44.54 N6 ADP C1001 A 263 ASP D 110 ASP.? 48.95 N6 ADP C1001 A 292 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 48.96 45.07 19.49 48.62 41.39 18.16 -7.24 67.37 14.19 -10.84 68.18 15.49 coo 54.43 44.82 23.74 55.21 45.06 21.80 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 63.95 45.30 16.71 59.11 49.15 16.05 1.94 54.62 12.82 6.05 51.27 9.45 2oat_c06 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c06 naa= 3 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 178 TRP C 113 TRP.? -4.31 O3' ADP C1001s B 263 ASP C 110 ASP.? 10.54 O3' ADP C1001 B 292 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 45.83 31.15 4.65 45.88 34.74 6.24 -41.02 28.74 23.55 -40.73 32.19 21.60 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 178 TRP D 113 TRP.? 44.54 N6 ADP C1001 B 263 ASP D 110 ASP.? 48.95 N6 ADP C1001 B 292 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 45.83 31.15 4.65 45.88 34.74 6.24 -7.24 67.37 14.19 -10.84 68.18 15.49 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 60.53 31.67 0.97 57.79 27.51 3.63 1.94 54.62 12.82 6.05 51.27 9.45 2oat_c07 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c07 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP A 113 TRP.? 51.98 N6 ADP C1001 C 263 ASP A 110 ASP.? 52.32 N6 ADP C1001 C 292 LYS A 106 LYS.? 50.79 N6 ADP C1001 coo 20.52 16.65 4.15 17.32 18.91 4.39 -2.27 -12.30 8.14 -4.73 -13.16 5.16 coo 19.84 12.02 9.33 18.68 11.23 7.75 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 12.82 3.49 4.98 17.80 5.59 1.90 5.53 0.28 13.93 10.17 1.85 15.47 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 178 TRP C 113 TRP.? -4.31 O3' ADP C1001s C 263 ASP C 110 ASP.? 10.54 O3' ADP C1001 C 292 LYS C 106 LYS.? 22.18 C2 ADP C1001 coo 20.52 16.65 4.15 17.32 18.91 4.39 -41.02 28.74 23.55 -40.73 32.19 21.60 coo 19.84 12.02 9.33 18.68 11.23 7.75 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 -32.20 18.25 30.35 -29.71 15.02 34.83 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 178 TRP D 113 TRP.? 44.54 N6 ADP C1001 C 263 ASP D 110 ASP.? 48.95 N6 ADP C1001 C 292 LYS D 106 LYS.? 44.27 N6 ADP C1001 coo 20.52 16.65 4.15 17.32 18.91 4.39 -7.24 67.37 14.19 -10.84 68.18 15.49 coo 19.84 12.02 9.33 18.68 11.23 7.75 -3.52 66.57 9.69 -1.94 67.67 8.60 coo 12.82 3.49 4.98 17.80 5.59 1.90 1.94 54.62 12.82 6.05 51.27 9.45 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c08 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 110 ASP.? 52.32 N6 ADP C1001 A 151 LYS A 114 LYS.? 56.27 N6 ADP C1001 A 186 THR A 89 THR.? 50.21 N6 ADP C1001 coo 41.42 17.90 44.98 43.39 18.36 45.61 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 45.75 16.58 39.61 47.43 18.26 45.54 -4.38 -17.33 7.81 -3.33 -16.78 2.19 coo 45.88 23.02 44.72 46.99 21.16 44.68 -3.01 -7.90 5.97 -2.57 -9.33 4.41 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 151 LYS B 114 LYS.? -3.14 O1A ADP C1001s A 186 THR B 89 THR.? -3.20 N6 ADP C1001s coo 41.42 17.90 44.98 43.39 18.36 45.61 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 45.75 16.58 39.61 47.43 18.26 45.54 -38.05 28.30 5.66 -42.50 28.99 10.13 coo 45.88 23.02 44.72 46.99 21.16 44.68 -30.78 27.78 11.26 -32.72 28.03 12.28 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 151 LYS C 114 LYS.? -2.76 O3B ADP C1001s A 186 THR C 89 THR.? 3.96 N3 ADP C1001 coo 41.42 17.90 44.98 43.39 18.36 45.61 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 45.75 16.58 39.61 47.43 18.26 45.54 -44.82 31.28 21.50 -43.38 31.47 16.20 coo 45.88 23.02 44.72 46.99 21.16 44.68 -36.03 29.56 23.55 -36.59 29.86 21.42 2phk_c02 source 2phk MC-PEPTIDE : 3 hits 2phk_c02 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP B 31 ASP^? 22.05 N1 ADP C1001 A 151 LYS B 38 LYS.? 29.47 N6 ADP C1001 A 154 ASN B 39 ASN.? 27.14 N6 ADP C1001 coo 41.42 17.90 44.98 43.39 18.36 45.61 -13.40 19.33 18.81 -14.28 17.40 18.97 coo 45.75 16.58 39.61 47.43 18.26 45.54 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 44.77 13.10 43.25 45.01 14.21 45.03 -11.13 15.65 16.64 -9.36 15.49 17.83 2phk_c03 source 2phk MC-PEPTIDE : 1 hits 2phk_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 9 ASP.? 35.63 N1 ADP C1001 166 GLY A 90 GLY.? 49.17 N6 ADP C1001 169 GLU A 115 GLU.? 59.12 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -18.49 -1.48 16.12 -18.32 -3.14 17.40 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -2.63 -9.10 9.59 -2.95 -8.41 9.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -2.13 -20.10 11.70 -1.63 -20.78 13.69 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 36 ASP^? 33.81 N6 ADP C1001 166 GLY A 12 GLY~? 30.18 N6 ADP C1001 169 GLU A 8 GLU.? 40.05 N1 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.45 15.76 11.21 -1.10 16.77 13.16 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -15.34 4.79 13.98 -15.18 4.16 14.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -16.47 -6.15 15.18 -15.55 -6.74 17.02 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 36 ASP^? 33.81 N6 ADP C1001 166 GLY A 12 GLY~? 30.18 N6 ADP C1001 169 GLU A 44 GLU^? 29.72 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.45 15.76 11.21 -1.10 16.77 13.16 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -15.34 4.79 13.98 -15.18 4.16 14.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -23.95 2.54 6.45 -25.82 1.78 7.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 36 ASP^? 33.81 N6 ADP C1001 166 GLY A 12 GLY~? 30.18 N6 ADP C1001 169 GLU B 44 GLU^? 27.54 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.45 15.76 11.21 -1.10 16.77 13.16 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -15.34 4.79 13.98 -15.18 4.16 14.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -24.18 6.66 6.64 -23.83 5.58 4.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 36 ASP^? 33.81 N6 ADP C1001 166 GLY B 12 GLY~? 22.61 N6 ADP C1001 169 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.45 15.76 11.21 -1.10 16.77 13.16 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -17.91 15.52 4.82 -17.88 16.00 4.18 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -24.54 18.07 0.49 -24.62 18.94 -1.46 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 36 ASP^? 33.81 N6 ADP C1001 166 GLY B 12 GLY~? 22.61 N6 ADP C1001 169 GLU B 44 GLU^? 27.54 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.45 15.76 11.21 -1.10 16.77 13.16 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -17.91 15.52 4.82 -17.88 16.00 4.18 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -24.18 6.66 6.64 -23.83 5.58 4.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 36 ASP^? 33.81 N6 ADP C1001 166 GLY B 34 GLY.? 22.44 N6 ADP C1001 169 GLU D 33 GLU^? 24.81 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.45 15.76 11.21 -1.10 16.77 13.16 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.23 29.41 19.16 -10.67 28.78 18.72 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.58 39.62 17.74 -10.11 39.83 19.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP A 61 ASP~? 37.71 N6 ADP C1001 166 GLY A 12 GLY~? 30.18 N6 ADP C1001 169 GLU A 8 GLU.? 40.05 N1 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -15.34 4.79 13.98 -15.18 4.16 14.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -16.47 -6.15 15.18 -15.55 -6.74 17.02 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP A 110 ASP.? 52.32 N6 ADP C1001 166 GLY A 105 GLY.? 47.26 N6 ADP C1001 169 GLU A 35 GLU.? 41.16 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo -8.58 13.22 3.21 -8.90 13.15 4.05 6.33 2.76 11.10 5.97 2.70 11.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 4.51 12.95 12.26 5.81 14.21 13.42 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP B 9 ASP.? 24.63 N6 ADP C1001 166 GLY A 12 GLY~? 30.18 N6 ADP C1001 169 GLU A 8 GLU.? 40.05 N1 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -15.34 4.79 13.98 -15.18 4.16 14.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -16.47 -6.15 15.18 -15.55 -6.74 17.02 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP B 9 ASP.? 24.63 N6 ADP C1001 166 GLY B 71 GLY.? 8.94 N7 ADP C1001 169 GLU B 115 GLU.? 12.48 O1B ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -33.60 23.98 7.54 -33.01 23.50 7.82 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.49 31.51 1.54 -40.33 32.66 0.02 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP B 9 ASP.? 24.63 N6 ADP C1001 166 GLY B 90 GLY.? 7.42 N6 ADP C1001 169 GLU B 115 GLU.? 12.48 O1B ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -30.30 29.32 7.79 -29.71 28.87 8.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -39.49 31.51 1.54 -40.33 32.66 0.02 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP B 31 ASP^? 22.05 N1 ADP C1001 166 GLY C 63 GLY.? 18.10 N1 ADP C1001 169 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.40 19.33 18.81 -14.28 17.40 18.97 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.24 37.08 25.10 -19.00 37.10 25.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP B 36 ASP^? 26.54 N6 ADP C1001 166 GLY B 12 GLY~? 22.61 N6 ADP C1001 169 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.49 25.66 16.69 -6.44 23.85 16.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -17.91 15.52 4.82 -17.88 16.00 4.18 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -24.54 18.07 0.49 -24.62 18.94 -1.46 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP B 36 ASP^? 26.54 N6 ADP C1001 166 GLY C 63 GLY.? 18.10 N1 ADP C1001 169 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -7.49 25.66 16.69 -6.44 23.85 16.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.24 37.08 25.10 -19.00 37.10 25.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP B 54 ASP~? 20.52 O4' ADP C1001 166 GLY C 105 GLY.? 16.33 C2 ADP C1001 169 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -33.59 8.19 15.94 -35.17 6.84 16.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -28.59 18.07 29.12 -28.98 18.05 29.83 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP B 110 ASP.? 12.77 N6 ADP C1001 166 GLY B 104 GLY~? 17.92 N6 ADP C1001 169 GLU D 33 GLU^? 24.81 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -30.45 31.51 3.79 -31.95 31.85 2.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -14.96 34.23 13.50 -15.73 33.92 13.69 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.58 39.62 17.74 -10.11 39.83 19.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP B 110 ASP.? 12.77 N6 ADP C1001 166 GLY B 105 GLY.? 14.83 N6 ADP C1001 169 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -30.45 31.51 3.79 -31.95 31.85 2.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.36 34.95 14.87 -18.15 34.98 14.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP B 110 ASP.? 12.77 N6 ADP C1001 166 GLY B 105 GLY.? 14.83 N6 ADP C1001 169 GLU D 33 GLU^? 24.81 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -30.45 31.51 3.79 -31.95 31.85 2.33 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.36 34.95 14.87 -18.15 34.98 14.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.58 39.62 17.74 -10.11 39.83 19.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP C 9 ASP.? 24.62 C2 ADP C1001 166 GLY C 71 GLY.? 8.01 O2' ADP C1001 169 GLU C 115 GLU.? 11.76 O3B ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.52 40.90 40.15 -34.60 38.85 40.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -39.43 34.32 24.82 -38.66 34.55 25.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -50.58 33.44 21.57 -49.74 35.49 21.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP C 31 ASP^? 21.62 C2 ADP C1001 166 GLY B 105 GLY.? 14.83 N6 ADP C1001 169 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -17.30 30.71 32.69 -16.98 32.62 31.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.36 34.95 14.87 -18.15 34.98 14.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP C 36 ASP^? 27.15 C2 ADP C1001 166 GLY B 34 GLY.? 22.44 N6 ADP C1001 169 GLU D 33 GLU^? 24.81 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.89 23.06 36.75 -16.41 21.35 37.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.23 29.41 19.16 -10.67 28.78 18.72 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.58 39.62 17.74 -10.11 39.83 19.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP C 36 ASP^? 27.15 C2 ADP C1001 166 GLY B 63 GLY.? 19.32 N1 ADP C1001 169 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.89 23.06 36.75 -16.41 21.35 37.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -21.09 14.83 22.17 -21.52 14.99 21.54 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 24 3 # 24 141 ASP C 36 ASP^? 27.15 C2 ADP C1001 166 GLY C 63 GLY.? 18.10 N1 ADP C1001 169 GLU D 33 GLU^? 24.81 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.89 23.06 36.75 -16.41 21.35 37.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.24 37.08 25.10 -19.00 37.10 25.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.58 39.62 17.74 -10.11 39.83 19.83 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 25 3 # 25 141 ASP C 54 ASP~? 20.12 N1 ADP C1001 166 GLY B 105 GLY.? 14.83 N6 ADP C1001 169 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.36 34.95 14.87 -18.15 34.98 14.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 26 3 # 26 141 ASP C 54 ASP~? 20.12 N1 ADP C1001 166 GLY C 71 GLY.? 8.01 O2' ADP C1001 169 GLU C 115 GLU.? 11.76 O3B ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -39.43 34.32 24.82 -38.66 34.55 25.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -50.58 33.44 21.57 -49.74 35.49 21.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 27 3 # 27 141 ASP C 61 ASP~? 22.05 N1 ADP C1001 166 GLY D 53 GLY~? 32.56 N1 ADP C1001 169 GLU D 78 GLU~? 42.25 N1 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -26.31 61.10 21.77 -26.62 61.15 20.99 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -17.63 66.44 26.22 -18.72 68.28 26.46 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 28 3 # 28 141 ASP C 97 ASP~? 22.56 C2 ADP C1001 166 GLY C 71 GLY.? 8.01 O2' ADP C1001 169 GLU C 115 GLU.? 11.76 O3B ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -33.31 25.31 38.38 -33.83 25.06 40.38 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -39.43 34.32 24.82 -38.66 34.55 25.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -50.58 33.44 21.57 -49.74 35.49 21.49 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 29 3 # 29 141 ASP C 110 ASP.? 10.54 O3' ADP C1001 166 GLY C 22 GLY.? 14.12 O2' ADP C1001 169 GLU C 49 GLU.? 21.81 N1 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -42.40 26.72 28.14 -44.45 27.16 28.23 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -35.88 42.47 25.00 -35.89 42.36 25.87 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -30.22 47.91 25.82 -28.66 49.28 25.41 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 30 3 # 30 141 ASP C 110 ASP.? 10.54 O3' ADP C1001 166 GLY C 105 GLY.? 16.33 C2 ADP C1001 169 GLU C 35 GLU.? 24.58 C2 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -42.40 26.72 28.14 -44.45 27.16 28.23 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -28.59 18.07 29.12 -28.98 18.05 29.83 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -21.26 18.31 34.64 -21.49 16.34 35.41 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 31 3 # 31 141 ASP D 31 ASP^? 21.52 N6 ADP C1001 166 GLY C 53 GLY~? 15.49 N6 ADP C1001 169 GLU C 48 GLU.? 22.51 O2' ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.15 42.40 14.58 -15.11 42.76 15.19 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -29.67 44.87 17.26 -30.14 45.11 17.88 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -33.52 53.52 23.97 -33.48 52.09 22.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 32 3 # 32 141 ASP D 36 ASP^? 31.16 N6 ADP C1001 166 GLY D 12 GLY~? 28.94 N6 ADP C1001 169 GLU D 8 GLU.? 38.64 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.58 39.61 12.64 -2.59 38.96 12.51 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -16.72 51.02 2.91 -16.29 51.55 2.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -15.71 59.79 2.00 -14.33 61.02 0.98 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 33 3 # 33 141 ASP D 61 ASP~? 23.08 N1 ADP C1001 166 GLY B 105 GLY.? 14.83 N6 ADP C1001 169 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.36 34.95 14.87 -18.15 34.98 14.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 34 3 # 34 141 ASP D 61 ASP~? 23.08 N1 ADP C1001 166 GLY D 12 GLY~? 28.94 N6 ADP C1001 169 GLU D 8 GLU.? 38.64 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -16.72 51.02 2.91 -16.29 51.55 2.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -15.71 59.79 2.00 -14.33 61.02 0.98 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 35 3 # 35 141 ASP D 97 ASP~? 39.15 N6 ADP C1001 166 GLY D 34 GLY.? 30.79 N6 ADP C1001 169 GLU B 35 GLU.? 24.64 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.34 53.74 3.65 -4.01 53.36 1.58 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.44 40.17 17.98 -3.83 40.71 17.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -8.42 31.70 14.79 -7.88 32.87 13.09 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 36 3 # 36 141 ASP D 110 ASP.? 48.95 N6 ADP C1001 166 GLY D 105 GLY.? 39.91 N6 ADP C1001 169 GLU D 35 GLU.? 34.89 N6 ADP C1001 coo 8.28 6.87 1.62 10.08 5.77 1.34 -3.52 66.57 9.69 -1.94 67.67 8.60 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.03 51.79 15.18 0.84 51.88 14.37 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -1.41 44.17 17.18 -1.59 46.26 17.19 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 36 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR C 79 TYR~? 13.12 N6 ADP C1001 A 214 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 256 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -29.67 41.42 14.91 -30.18 43.90 13.55 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -14.21 50.71 21.89 -14.80 46.21 24.73 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 1 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR C 79 TYR~? 13.12 N6 ADP C1001 B 214 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 256 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -29.67 41.42 14.91 -30.18 43.90 13.55 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -14.21 50.71 21.89 -14.80 46.21 24.73 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR C 79 TYR~? 13.12 N6 ADP C1001 B 214 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 256 LYS D 65 LYS.? 25.59 N1 ADP C1001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -29.67 41.42 14.91 -30.18 43.90 13.55 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -14.21 50.71 21.89 -14.80 46.21 24.73 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 11 ARG~? 32.97 N1 ADP C1001 A 130 SER A 18 SER.? 40.87 N6 ADP C1001 A 159 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 18.35 45.84 20.99 16.20 47.83 21.89 -18.24 1.32 19.87 -15.89 1.49 21.96 coo 15.14 43.67 10.77 15.61 44.43 13.04 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo 11.57 48.49 22.18 13.51 49.99 17.21 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG B 11 ARG~? 27.94 N6 ADP C1001 A 130 SER B 18 SER.? 16.80 N6 ADP C1001 A 159 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 18.35 45.84 20.99 16.20 47.83 21.89 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 15.14 43.67 10.77 15.61 44.43 13.04 -27.97 19.58 3.98 -27.31 17.40 4.71 coo 11.57 48.49 22.18 13.51 49.99 17.21 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG D 11 ARG~? 37.61 N6 ADP C1001 A 130 SER D 18 SER.? 35.50 N6 ADP C1001 A 159 LYS D 14 LYS~? 32.56 N6 ADP C1001 coo 18.35 45.84 20.99 16.20 47.83 21.89 -15.91 54.83 -3.29 -13.93 57.19 -3.15 coo 15.14 43.67 10.77 15.61 44.43 13.04 -15.27 61.31 6.78 -16.76 61.07 8.60 coo 11.57 48.49 22.18 13.51 49.99 17.21 -12.53 51.88 -0.15 -12.30 47.61 -3.60 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 3 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 11 ARG~? 32.97 N1 ADP C1001 B 130 SER A 18 SER.? 40.87 N6 ADP C1001 B 159 LYS A 14 LYS~? 28.69 N1 ADP C1001 coo 58.72 31.58 20.45 60.80 29.39 20.94 -18.24 1.32 19.87 -15.89 1.49 21.96 coo 61.66 35.17 10.39 61.29 34.14 12.56 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo 65.38 28.77 21.17 63.49 28.03 16.12 -12.97 3.35 18.51 -15.05 7.51 22.75 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG B 11 ARG~? 27.94 N6 ADP C1001 B 130 SER B 18 SER.? 16.80 N6 ADP C1001 B 159 LYS B 14 LYS~? 27.17 N6 ADP C1001 coo 58.72 31.58 20.45 60.80 29.39 20.94 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 61.66 35.17 10.39 61.29 34.14 12.56 -27.97 19.58 3.98 -27.31 17.40 4.71 coo 65.38 28.77 21.17 63.49 28.03 16.12 -15.99 19.51 1.82 -10.82 19.61 1.70 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG D 11 ARG~? 37.61 N6 ADP C1001 B 130 SER D 18 SER.? 35.50 N6 ADP C1001 B 159 LYS D 14 LYS~? 32.56 N6 ADP C1001 coo 58.72 31.58 20.45 60.80 29.39 20.94 -15.91 54.83 -3.29 -13.93 57.19 -3.15 coo 61.66 35.17 10.39 61.29 34.14 12.56 -15.27 61.31 6.78 -16.76 61.07 8.60 coo 65.38 28.77 21.17 63.49 28.03 16.12 -12.53 51.88 -0.15 -12.30 47.61 -3.60 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 3 hits 2tps_c01 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG B 11 ARG~? 27.94 N6 ADP C1001 195 HIS A 62 HIS~? 32.10 N6 ADP C1001 199 ASP B 10 ASP.? 28.32 N6 ADP C1001 coo 21.96 2.03 15.24 19.33 1.86 13.55 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -19.64 10.11 1.49 -19.54 9.87 -0.69 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 1 hits 3cla_c00 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 161 ARG B 11 ARG~? 27.94 N6 ADP C1001 B 186 HIS A 62 HIS~? 32.10 N6 ADP C1001 coo 44.53 16.44 28.54 44.89 18.45 28.77 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 39.64 19.27 28.15 40.19 21.74 29.94 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 48.32 20.00 31.44 46.45 20.91 31.50 -15.84 6.06 -0.29 -17.94 5.95 -0.14 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 1 hits 4mdh_c03 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 97 ASP~? 39.49 N1 ADP C1001 A 99 GLY A 93 GLY.? 42.20 N1 ADP C1001 A 125 ASN A 16 ASN.? 39.53 N1 ADP C1001 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -4.20 1.28 18.72 -4.75 1.76 20.72 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -7.00 -4.03 17.29 -7.39 -3.85 16.59 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -11.80 -4.14 16.79 -11.72 -4.01 18.95 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP C 97 ASP~? 22.56 C2 ADP C1001 A 99 GLY C 93 GLY.? 17.53 O3' ADP C1001 A 125 ASN C 16 ASN.? 20.87 O3' ADP C1001 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -33.31 25.31 38.38 -33.83 25.06 40.38 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -37.56 29.10 36.07 -37.16 29.70 35.68 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -37.30 33.94 37.34 -37.96 32.85 39.06 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 3 3 # 3 A 81 ASP D 97 ASP~? 39.15 N6 ADP C1001 A 99 GLY D 93 GLY.? 40.08 N6 ADP C1001 A 125 ASN D 16 ASN.? 38.61 N6 ADP C1001 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -4.34 53.74 3.65 -4.01 53.36 1.58 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -7.15 59.04 4.03 -7.87 58.92 4.42 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -11.62 59.03 2.34 -10.83 58.47 0.52 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 3 hits 1hkd_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 16 ASN.? 39.53 N1 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.80 -4.14 16.79 -11.72 -4.01 18.95 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 39 ASN^? 26.27 N6 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -10.50 14.02 7.34 -12.57 14.30 7.00 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 57 ASN~? 43.07 N6 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -15.73 -0.75 -7.31 -14.92 -1.39 -9.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 81 ASN~? 50.50 N6 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -3.09 -5.47 -6.59 -2.17 -5.74 -4.66 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN B 16 ASN.? 20.20 N6 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -23.35 21.88 0.52 -22.21 22.66 -1.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 39 ASN.? 27.14 N6 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.13 15.65 16.64 -9.36 15.49 17.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 57 ASN~? 18.41 O4' ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -30.78 10.03 20.77 -32.50 10.37 22.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 81 ASN~? 5.38 N3 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -34.12 23.31 22.91 -33.74 24.78 21.37 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN C 16 ASN.? 20.87 O3' ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.30 33.94 37.34 -37.96 32.85 39.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN C 39 ASN^? 25.44 C2 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.77 32.66 36.54 -17.11 34.71 36.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN C 57 ASN~? 16.68 N6 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -24.16 44.44 19.70 -24.30 44.19 17.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN C 81 ASN~? -3.50 N6 ADP C1001s coo 5.80 63.03 55.85 5.52 65.03 56.45 -28.27 33.11 13.90 -29.33 31.68 15.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN D 16 ASN.? 38.61 N6 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.62 59.03 2.34 -10.83 58.47 0.52 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN D 39 ASN^? 19.52 N6 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -14.81 40.52 11.20 -15.13 38.43 11.40 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN D 57 ASN~? 28.49 N1 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -26.50 55.76 21.71 -26.74 56.60 23.67 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN D 81 ASN~? 37.73 N1 ADP C1001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -15.08 60.44 27.09 -13.56 60.92 25.66 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 16 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR C 79 TYR~? 13.12 N6 ADP C1001 A 112 PHE C 80 PHE~? 9.30 N1 ADP C1001 A 140 ASN C 81 ASN~? -3.50 N6 ADP C1001s coo -6.29 44.15 17.65 -9.00 44.92 17.68 -29.67 41.42 14.91 -30.18 43.90 13.55 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -28.50 36.34 19.61 -28.58 37.64 22.04 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -28.27 33.11 13.90 -29.33 31.68 15.09 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR D 79 TYR~? 36.26 N1 ADP C1001 A 112 PHE D 80 PHE~? 32.28 N6 ADP C1001 A 140 ASN D 81 ASN~? 37.73 N1 ADP C1001 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -22.76 62.70 24.87 -24.61 64.61 25.82 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -17.84 58.74 21.22 -19.00 58.24 18.75 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -15.08 60.44 27.09 -13.56 60.92 25.66 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 2 hits 1o8s_p00 naa= 3 ULMN 4 2cl8_p00 DECTIN-1 user 1 4 # 1 A 145 ARG B 23 ARG.? 16.12 O1A ADP C1001 A 148 SER B 24 SER.? 17.25 N6 ADP C1001 A 152 ALA B 7 ALA^? 19.02 N6 ADP C1001 A 194 GLU B 44 GLU^? 27.54 N6 ADP C1001 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -35.24 15.53 3.08 -37.20 16.95 1.17 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -29.56 14.13 6.20 -27.58 15.07 7.20 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -23.95 17.01 5.35 -22.53 16.46 5.45 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -24.18 6.66 6.64 -23.83 5.58 4.84 ULMN 4 2cl8_p00 DECTIN-1 user 2 4 # 2 A 145 ARG C 23 ARG.? 19.01 O2' ADP C1001 A 148 SER C 24 SER.? 15.73 O2' ADP C1001 A 152 ALA C 7 ALA^? 19.38 C2 ADP C1001 A 194 GLU C 44 GLU^? 27.03 C2 ADP C1001 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -41.38 43.66 27.78 -43.67 44.44 29.75 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -34.60 42.57 30.36 -34.63 40.35 29.52 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -32.65 37.85 34.38 -31.51 37.98 35.41 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -28.75 47.24 35.01 -29.12 48.55 36.63 ULMN 4 2cl8_p00 DECTIN-1 user 3 4 # 3 A 145 ARG D 23 ARG.? 42.28 N6 ADP C1001 A 148 SER D 24 SER.? 31.80 N6 ADP C1001 A 152 ALA D 7 ALA^? 31.06 N6 ADP C1001 A 194 GLU D 44 GLU^? 25.61 N6 ADP C1001 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -21.76 67.41 8.31 -21.73 70.32 9.28 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -21.41 60.30 8.38 -19.94 58.41 8.67 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -16.88 56.61 6.05 -17.27 55.26 5.42 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -26.92 53.16 5.77 -28.08 52.58 4.08 2cl8_p00 source 2cl8 DECTIN-1 : 3 hits 2cl8_p00 naa= 4 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG B 23 ARG.? 16.12 O1A ADP C1001 A 188 TYR B 70 TYR.? 11.71 N6 ADP C1001 A 190 SER B 18 SER.? 16.80 N6 ADP C1001 coo 37.69 7.64 13.51 38.82 8.84 16.11 -35.24 15.53 3.08 -37.20 16.95 1.17 coo 47.14 12.10 13.73 48.75 12.33 16.01 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 43.77 6.93 15.46 45.49 7.21 17.11 -27.97 19.58 3.98 -27.31 17.40 4.71 2p3i_p00 source 2p3i VP4 : 1 hits 2p3i_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 57 ASN~? 43.07 N6 ADP C1001 A 384 ASN B 16 ASN.? 20.20 N6 ADP C1001 A 385 GLU B 8 GLU.? 21.08 N6 ADP C1001 coo 22.28 63.17 110.61 22.47 65.06 111.53 -15.73 -0.75 -7.31 -14.92 -1.39 -9.21 coo 7.06 50.07 96.17 8.50 48.54 96.31 -23.35 21.88 0.52 -22.21 22.66 -1.09 coo 11.59 49.83 99.41 10.92 47.97 100.16 -24.54 18.07 0.49 -24.62 18.94 -1.46 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN B 57 ASN~? 18.41 O4' ADP C1001 A 384 ASN A 16 ASN.? 39.53 N1 ADP C1001 A 385 GLU A 8 GLU.? 40.05 N1 ADP C1001 coo 22.28 63.17 110.61 22.47 65.06 111.53 -30.78 10.03 20.77 -32.50 10.37 22.02 coo 7.06 50.07 96.17 8.50 48.54 96.31 -11.80 -4.14 16.79 -11.72 -4.01 18.95 coo 11.59 49.83 99.41 10.92 47.97 100.16 -16.47 -6.15 15.18 -15.55 -6.74 17.02 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN B 57 ASN~? 18.41 O4' ADP C1001 A 384 ASN A 39 ASN^? 26.27 N6 ADP C1001 A 385 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 22.28 63.17 110.61 22.47 65.06 111.53 -30.78 10.03 20.77 -32.50 10.37 22.02 coo 7.06 50.07 96.17 8.50 48.54 96.31 -10.50 14.02 7.34 -12.57 14.30 7.00 coo 11.59 49.83 99.41 10.92 47.97 100.16 -16.06 9.21 5.46 -17.05 10.76 4.34 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 3 hits 2v3r_p00 naa= 3 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 1 4 # 1 A 15 TYR A 26 TYR^? 32.13 N6 ADP C1001 A 19 VAL A 45 VAL.? 35.40 N6 ADP C1001 A 37 PHE A 21 PHE.? 42.86 N6 ADP C1001 A 41 SER A 24 SER.? 39.01 N6 ADP C1001 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 -21.27 -0.65 3.11 -19.62 -2.13 2.86 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 -17.71 -6.23 7.18 -16.21 -4.71 6.28 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 2 4 # 2 A 15 TYR A 92 TYR.? 47.39 N1 ADP C1001 A 19 VAL A 91 VAL.? 45.15 N6 ADP C1001 A 37 PHE A 21 PHE.? 42.86 N6 ADP C1001 A 41 SER A 18 SER.? 40.87 N6 ADP C1001 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 -3.68 -5.79 11.19 -3.32 -3.78 10.35 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 -13.14 -6.41 11.44 -13.61 -6.13 9.12 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 3 4 # 3 A 15 TYR B 92 TYR.? 14.20 N6 ADP C1001 A 19 VAL B 91 VAL.? 9.34 N6 ADP C1001 A 37 PHE B 21 PHE.? 12.47 N7 ADP C1001 A 41 SER B 18 SER.? 16.80 N6 ADP C1001 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 -26.65 28.26 7.42 -25.23 27.90 9.10 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 -31.61 18.24 11.10 -30.96 16.75 13.38 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 -27.97 19.58 3.98 -27.31 17.40 4.71 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 4 4 # 4 A 15 TYR C 92 TYR.? 13.82 O3' ADP C1001 A 19 VAL C 91 VAL.? 10.93 N3 ADP C1001 A 37 PHE C 21 PHE.? 11.41 C2 ADP C1001 A 41 SER C 18 SER.? 15.10 O2' ADP C1001 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 -39.98 27.63 32.25 -40.82 24.99 32.44 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 -36.49 28.15 29.02 -34.25 27.86 28.89 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 -33.74 38.44 24.72 -31.32 39.34 23.74 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 -36.98 36.98 32.18 -36.06 38.40 30.49 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 5 4 # 5 A 15 TYR D 26 TYR^? 28.03 N6 ADP C1001 A 19 VAL D 45 VAL.? 26.95 N6 ADP C1001 A 37 PHE D 21 PHE.? 33.63 N6 ADP C1001 A 41 SER D 24 SER.? 31.80 N6 ADP C1001 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 -22.48 54.16 4.72 -24.58 53.78 2.92 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 -26.52 54.77 10.29 -25.43 56.49 11.10 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 -21.41 60.30 8.38 -19.94 58.41 8.67 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 6 4 # 6 A 15 TYR D 92 TYR.? 44.20 N6 ADP C1001 A 19 VAL D 91 VAL.? 39.23 N6 ADP C1001 A 37 PHE D 21 PHE.? 33.63 N6 ADP C1001 A 41 SER D 18 SER.? 35.50 N6 ADP C1001 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 -7.01 60.72 10.97 -7.36 58.77 12.00 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 -18.15 61.60 14.21 -19.50 59.60 15.67 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 -15.27 61.31 6.78 -16.76 61.07 8.60 1ckt_d00 source 1ckt GENE REGULATION/DNA : 6 hits 1ckt_d00 naa= 4 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 26 TYR^? 32.13 N6 ADP C1001 I 306 VAL A 42 VAL^? 28.28 N6 ADP C1001 I 308 VAL B 42 VAL^? 23.32 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.22 6.50 9.05 -17.23 6.12 11.14 coo 16.43 30.18 9.35 15.05 30.67 11.01 -17.95 12.57 9.46 -17.80 12.68 7.30 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 26 TYR^? 32.13 N6 ADP C1001 I 306 VAL A 43 VAL^? 29.07 N6 ADP C1001 I 308 VAL B 42 VAL^? 23.32 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 -19.60 5.09 6.39 -18.76 6.07 4.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 -17.95 12.57 9.46 -17.80 12.68 7.30 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 26 TYR^? 32.13 N6 ADP C1001 I 306 VAL A 43 VAL^? 29.07 N6 ADP C1001 I 308 VAL B 43 VAL^? 23.70 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 -19.60 5.09 6.39 -18.76 6.07 4.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 -20.38 9.81 10.42 -20.34 9.32 12.56 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 26 TYR^? 32.13 N6 ADP C1001 I 306 VAL A 43 VAL^? 29.07 N6 ADP C1001 I 308 VAL B 45 VAL.? 22.45 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -20.23 -0.15 10.23 -22.87 -0.31 11.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 -19.60 5.09 6.39 -18.76 6.07 4.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 -26.29 7.76 10.45 -27.74 9.22 9.62 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 70 TYR.? 48.30 N6 ADP C1001 I 306 VAL A 17 VAL.? 40.72 N6 ADP C1001 I 308 VAL A 98 VAL~? 40.75 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 23.55 29.53 9.81 23.15 27.39 10.24 -10.52 -3.92 12.63 -8.53 -3.88 11.57 coo 16.43 30.18 9.35 15.05 30.67 11.01 -3.64 1.06 14.31 -4.63 -0.44 13.12 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 70 TYR.? 48.30 N6 ADP C1001 I 306 VAL A 91 VAL.? 45.15 N6 ADP C1001 I 308 VAL A 88 VAL^? 46.85 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 23.55 29.53 9.81 23.15 27.39 10.24 -3.68 -5.79 11.19 -3.32 -3.78 10.35 coo 16.43 30.18 9.35 15.05 30.67 11.01 -1.93 -4.57 4.36 -0.59 -3.24 5.54 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 70 TYR.? 48.30 N6 ADP C1001 I 306 VAL A 91 VAL.? 45.15 N6 ADP C1001 I 308 VAL A 98 VAL~? 40.75 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -7.30 -10.03 11.13 -6.31 -12.30 12.53 coo 23.55 29.53 9.81 23.15 27.39 10.24 -3.68 -5.79 11.19 -3.32 -3.78 10.35 coo 16.43 30.18 9.35 15.05 30.67 11.01 -3.64 1.06 14.31 -4.63 -0.44 13.12 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR A 92 TYR.? 47.39 N1 ADP C1001 I 306 VAL A 91 VAL.? 45.15 N6 ADP C1001 I 308 VAL A 88 VAL^? 46.85 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -4.46 -7.57 15.71 -2.05 -7.82 17.04 coo 23.55 29.53 9.81 23.15 27.39 10.24 -3.68 -5.79 11.19 -3.32 -3.78 10.35 coo 16.43 30.18 9.35 15.05 30.67 11.01 -1.93 -4.57 4.36 -0.59 -3.24 5.54 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 26 TYR^? 24.12 N6 ADP C1001 I 306 VAL A 42 VAL^? 28.28 N6 ADP C1001 I 308 VAL A 40 VAL^? 28.74 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.22 6.50 9.05 -17.23 6.12 11.14 coo 16.43 30.18 9.35 15.05 30.67 11.01 -12.04 10.51 9.85 -11.74 9.36 11.65 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR B 26 TYR^? 24.12 N6 ADP C1001 I 306 VAL A 43 VAL^? 29.07 N6 ADP C1001 I 308 VAL A 28 VAL^? 32.57 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 -19.60 5.09 6.39 -18.76 6.07 4.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 -13.34 3.93 8.27 -12.88 4.12 10.43 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR B 26 TYR^? 24.12 N6 ADP C1001 I 306 VAL A 43 VAL^? 29.07 N6 ADP C1001 I 308 VAL A 45 VAL.? 35.40 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 -19.60 5.09 6.39 -18.76 6.07 4.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 -21.27 -0.65 3.11 -19.62 -2.13 2.86 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR B 26 TYR^? 24.12 N6 ADP C1001 I 306 VAL B 42 VAL^? 23.32 N6 ADP C1001 I 308 VAL A 40 VAL^? 28.74 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.95 12.57 9.46 -17.80 12.68 7.30 coo 16.43 30.18 9.35 15.05 30.67 11.01 -12.04 10.51 9.85 -11.74 9.36 11.65 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR B 26 TYR^? 24.12 N6 ADP C1001 I 306 VAL B 43 VAL^? 23.70 N6 ADP C1001 I 308 VAL A 40 VAL^? 28.74 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 -20.38 9.81 10.42 -20.34 9.32 12.56 coo 16.43 30.18 9.35 15.05 30.67 11.01 -12.04 10.51 9.85 -11.74 9.36 11.65 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR B 70 TYR.? 11.71 N6 ADP C1001 I 306 VAL B 17 VAL.? 14.01 N6 ADP C1001 I 308 VAL B 98 VAL~? 14.35 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 -24.96 21.86 4.55 -25.07 23.45 6.01 coo 16.43 30.18 9.35 15.05 30.67 11.01 -19.28 27.54 7.41 -21.33 26.65 7.49 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR B 70 TYR.? 11.71 N6 ADP C1001 I 306 VAL B 91 VAL.? 9.34 N6 ADP C1001 I 308 VAL B 88 VAL^? 4.85 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 -26.65 28.26 7.42 -25.23 27.90 9.10 coo 16.43 30.18 9.35 15.05 30.67 11.01 -28.56 27.62 14.44 -26.80 28.90 14.42 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR B 70 TYR.? 11.71 N6 ADP C1001 I 306 VAL B 91 VAL.? 9.34 N6 ADP C1001 I 308 VAL B 98 VAL~? 14.35 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 -26.65 28.26 7.42 -25.23 27.90 9.10 coo 16.43 30.18 9.35 15.05 30.67 11.01 -19.28 27.54 7.41 -21.33 26.65 7.49 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR B 92 TYR.? 14.20 N6 ADP C1001 I 306 VAL B 91 VAL.? 9.34 N6 ADP C1001 I 308 VAL B 88 VAL^? 4.85 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -26.28 29.17 2.52 -25.72 31.84 1.90 coo 23.55 29.53 9.81 23.15 27.39 10.24 -26.65 28.26 7.42 -25.23 27.90 9.10 coo 16.43 30.18 9.35 15.05 30.67 11.01 -28.56 27.62 14.44 -26.80 28.90 14.42 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR C 70 TYR.? 10.33 O3' ADP C1001 I 306 VAL C 17 VAL.? 15.05 C2 ADP C1001 I 308 VAL C 98 VAL~? 15.88 C2 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -40.11 31.99 28.67 -42.64 30.90 28.52 coo 23.55 29.53 9.81 23.15 27.39 10.24 -35.30 33.77 33.44 -35.04 32.26 31.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 -31.65 26.19 34.49 -32.56 27.76 33.27 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR C 70 TYR.? 10.33 O3' ADP C1001 I 306 VAL C 91 VAL.? 10.93 N3 ADP C1001 I 308 VAL C 88 VAL^? 5.84 C2 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -40.11 31.99 28.67 -42.64 30.90 28.52 coo 23.55 29.53 9.81 23.15 27.39 10.24 -36.49 28.15 29.02 -34.25 27.86 28.89 coo 16.43 30.18 9.35 15.05 30.67 11.01 -32.41 28.41 23.16 -31.73 26.52 24.08 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR C 70 TYR.? 10.33 O3' ADP C1001 I 306 VAL C 91 VAL.? 10.93 N3 ADP C1001 I 308 VAL C 98 VAL~? 15.88 C2 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -40.11 31.99 28.67 -42.64 30.90 28.52 coo 23.55 29.53 9.81 23.15 27.39 10.24 -36.49 28.15 29.02 -34.25 27.86 28.89 coo 16.43 30.18 9.35 15.05 30.67 11.01 -31.65 26.19 34.49 -32.56 27.76 33.27 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR D 70 TYR.? 43.17 N6 ADP C1001 I 306 VAL D 17 VAL.? 36.25 N6 ADP C1001 I 308 VAL D 98 VAL~? 36.45 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -10.19 64.81 9.49 -8.66 67.08 8.77 coo 23.55 29.53 9.81 23.15 27.39 10.24 -12.38 58.83 6.66 -11.07 58.60 8.38 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.69 53.69 7.95 -6.96 55.30 8.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR D 70 TYR.? 43.17 N6 ADP C1001 I 306 VAL D 91 VAL.? 39.23 N6 ADP C1001 I 308 VAL D 88 VAL^? 38.01 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -10.19 64.81 9.49 -8.66 67.08 8.77 coo 23.55 29.53 9.81 23.15 27.39 10.24 -7.01 60.72 10.97 -7.36 58.77 12.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 -8.68 59.59 17.79 -7.12 58.08 17.33 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 23 3 # 23 I 303 TYR D 70 TYR.? 43.17 N6 ADP C1001 I 306 VAL D 91 VAL.? 39.23 N6 ADP C1001 I 308 VAL D 98 VAL~? 36.45 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -10.19 64.81 9.49 -8.66 67.08 8.77 coo 23.55 29.53 9.81 23.15 27.39 10.24 -7.01 60.72 10.97 -7.36 58.77 12.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.69 53.69 7.95 -6.96 55.30 8.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 24 3 # 24 I 303 TYR D 92 TYR.? 44.20 N6 ADP C1001 I 306 VAL D 91 VAL.? 39.23 N6 ADP C1001 I 308 VAL D 88 VAL^? 38.01 N6 ADP C1001 coo 26.18 35.24 6.87 24.33 35.18 8.97 -5.36 62.57 6.57 -2.60 62.73 6.26 coo 23.55 29.53 9.81 23.15 27.39 10.24 -7.01 60.72 10.97 -7.36 58.77 12.00 coo 16.43 30.18 9.35 15.05 30.67 11.01 -8.68 59.59 17.79 -7.12 58.08 17.33 1cqt_d00 source 1cqt GENE REGULATION/DNA : 24 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 56 PRO~? 43.38 N6 ADP C1001 A 272 LEU A 55 LEU~? 40.94 N6 ADP C1001 A 276 ARG A 23 ARG.? 47.94 N6 ADP C1001 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -12.45 -5.07 -4.36 -13.43 -3.13 -3.80 coo 10.97 0.43 16.73 11.31 2.11 18.06 -15.73 -4.74 -1.28 -16.63 -4.61 0.71 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -17.87 -12.22 3.83 -15.16 -13.38 2.91 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO C 56 PRO~? 12.62 N1 ADP C1001 A 272 LEU C 83 LEU~? 12.70 N6 ADP C1001 A 276 ARG D 2 ARG^? 19.52 N6 ADP C1001 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -29.27 40.71 19.48 -27.80 41.34 20.99 coo 10.97 0.43 16.73 11.31 2.11 18.06 -23.31 37.75 16.31 -23.61 39.91 16.28 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -16.51 45.11 16.54 -19.16 44.24 15.23 1emh_d00 source 1emh HYDROLASE/DNA : 2 hits 1emh_d00 naa= 3 ULMN 4 1hbx_d00 GENE REGULATION user 1 4 # 1 D 140 THR B 89 THR.? -3.20 N6 ADP C1001s D 143 ARG C 74 ARG~? 5.25 O1B ADP C1001 D 158 TYR C 70 TYR.? 10.33 O3' ADP C1001 D 163 LYS C 114 LYS.? -2.76 O3B ADP C1001s coo 59.11 133.43 75.29 57.02 133.64 74.76 -30.78 27.78 11.26 -32.72 28.03 12.28 coo 52.93 123.10 78.03 50.59 121.17 78.38 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 39.29 134.52 82.26 37.39 135.28 80.34 -40.11 31.99 28.67 -42.64 30.90 28.52 coo 42.67 127.66 76.73 46.82 129.80 74.10 -44.82 31.28 21.50 -43.38 31.47 16.20 ULMN 4 1hbx_d00 GENE REGULATION user 2 4 # 2 D 140 THR C 89 THR.? 3.96 N3 ADP C1001 D 143 ARG B 74 ARG~? -6.26 O2A ADP C1001s D 158 TYR B 70 TYR.? 11.71 N6 ADP C1001 D 163 LYS B 114 LYS.? -3.14 O1A ADP C1001s coo 59.11 133.43 75.29 57.02 133.64 74.76 -36.03 29.56 23.55 -36.59 29.86 21.42 coo 52.93 123.10 78.03 50.59 121.17 78.38 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 39.29 134.52 82.26 37.39 135.28 80.34 -30.56 25.72 4.57 -31.82 27.56 2.83 coo 42.67 127.66 76.73 46.82 129.80 74.10 -38.05 28.30 5.66 -42.50 28.99 10.13 1hbx_d00 source 1hbx GENE REGULATION : 2 hits 1hbx_d00 naa= 4 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 75 ARG~? 52.31 N6 ADP C1001 E 41 TYR A 79 TYR~? 47.68 N6 ADP C1001 E 83 ARG B 75 ARG~? 7.41 O2A ADP C1001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -9.93 -13.21 -7.89 -9.68 -10.57 -9.55 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -11.04 -6.77 -8.02 -12.97 -5.68 -9.76 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -43.83 18.61 16.41 -46.11 20.56 15.85 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG B 25 ARG.? 26.72 N7 ADP C1001 E 41 TYR B 26 TYR^? 24.12 N6 ADP C1001 E 83 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG B 25 ARG.? 26.72 N7 ADP C1001 E 41 TYR B 26 TYR^? 24.12 N6 ADP C1001 E 83 ARG D 25 ARG.? 35.20 N6 ADP C1001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -29.04 7.60 4.48 -27.73 5.04 5.73 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -23.26 11.23 5.07 -23.26 9.04 3.31 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -26.42 60.33 5.19 -27.57 62.82 3.77 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG B 75 ARG~? 7.41 O2A ADP C1001 E 41 TYR B 79 TYR~? 13.34 O4' ADP C1001 E 83 ARG A 75 ARG~? 52.31 N6 ADP C1001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -9.93 -13.21 -7.89 -9.68 -10.57 -9.55 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG B 75 ARG~? 7.41 O2A ADP C1001 E 41 TYR B 79 TYR~? 13.34 O4' ADP C1001 E 83 ARG D 11 ARG~? 37.61 N6 ADP C1001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -15.91 54.83 -3.29 -13.93 57.19 -3.15 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 6 3 # 6 E 40 ARG B 75 ARG~? 7.41 O2A ADP C1001 E 41 TYR B 79 TYR~? 13.34 O4' ADP C1001 E 83 ARG D 94 ARG~? 36.27 N6 ADP C1001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -8.09 53.40 -0.40 -7.97 50.74 -1.98 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 7 3 # 7 E 40 ARG B 75 ARG~? 7.41 O2A ADP C1001 E 41 TYR C 111 TYR.? 9.78 O3' ADP C1001 E 83 ARG D 11 ARG~? 37.61 N6 ADP C1001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -42.34 21.68 23.98 -40.45 19.79 24.70 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -15.91 54.83 -3.29 -13.93 57.19 -3.15 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 8 3 # 8 E 40 ARG C 25 ARG.? 26.50 C2 ADP C1001 E 41 TYR C 26 TYR^? 24.03 C2 ADP C1001 E 83 ARG B 11 ARG~? 27.94 N6 ADP C1001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -32.85 47.91 34.77 -31.37 50.53 33.86 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -30.56 43.06 36.03 -31.04 45.27 37.68 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -18.01 15.98 -2.43 -14.90 16.29 -2.31 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 8 hits 1id3_d00 naa= 3 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 1 4 # 1 G 5 LYS A 14 LYS~? 28.69 N1 ADP C1001 G 13 LYS B 60 LYS~? 21.40 C2 ADP C1001 G 42 ARG B 94 ARG~? 24.19 N6 ADP C1001 G 77 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -12.97 3.35 18.51 -15.05 7.51 22.75 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 39.46 58.80 1.48 39.21 55.92 0.43 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -32.85 47.91 34.77 -31.37 50.53 33.86 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 2 4 # 2 G 5 LYS A 60 LYS~? 43.57 N6 ADP C1001 G 13 LYS B 14 LYS~? 27.17 N6 ADP C1001 G 42 ARG A 11 ARG~? 32.97 N1 ADP C1001 G 77 ARG C 75 ARG~? 8.05 O3B ADP C1001 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -15.99 19.51 1.82 -10.82 19.61 1.70 coo 39.46 58.80 1.48 39.21 55.92 0.43 -18.24 1.32 19.87 -15.89 1.49 21.96 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -38.47 40.65 15.33 -40.88 39.19 16.61 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 3 4 # 3 G 5 LYS C 100 LYS~? 22.69 C2 ADP C1001 G 13 LYS C 65 LYS.? 16.76 N1 ADP C1001 G 42 ARG B 74 ARG~? -6.26 O2A ADP C1001s G 77 ARG D 11 ARG~? 37.61 N6 ADP C1001 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 39.46 58.80 1.48 39.21 55.92 0.43 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -15.91 54.83 -3.29 -13.93 57.19 -3.15 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 4 4 # 4 G 5 LYS C 100 LYS~? 22.69 C2 ADP C1001 G 13 LYS C 65 LYS.? 16.76 N1 ADP C1001 G 42 ARG B 75 ARG~? 7.41 O2A ADP C1001 G 77 ARG D 25 ARG.? 35.20 N6 ADP C1001 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -28.01 22.62 36.30 -24.43 24.45 38.49 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 39.46 58.80 1.48 39.21 55.92 0.43 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -26.42 60.33 5.19 -27.57 62.82 3.77 1kx5_d03 source 1kx5 STRUCTURAL PROTEIN/DNA : 4 hits 1kx5_d03 naa= 4 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 19 ARG A 94 ARG~? 34.60 N1 ADP C1001 A 30 THR A 69 THR.? 44.69 N6 ADP C1001 A 34 VAL A 91 VAL.? 45.15 N6 ADP C1001 A 38 LYS A 108 LYS.? 49.24 N1 ADP C1001 coo 30.09 31.19 5.41 30.53 28.24 4.72 -9.32 1.83 20.70 -11.98 2.20 22.31 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -7.10 -5.38 7.02 -7.46 -6.06 5.00 coo 18.16 36.88 2.14 19.60 35.97 0.73 -3.68 -5.79 11.19 -3.32 -3.78 10.35 coo 16.75 32.35 6.21 21.42 30.93 2.22 1.67 -4.82 14.87 3.65 -3.69 19.86 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 19 ARG B 94 ARG~? 24.19 N6 ADP C1001 A 30 THR B 69 THR.? 8.02 N6 ADP C1001 A 34 VAL B 91 VAL.? 9.34 N6 ADP C1001 A 38 LYS B 108 LYS.? 17.61 N6 ADP C1001 coo 30.09 31.19 5.41 30.53 28.24 4.72 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -28.27 23.67 9.92 -29.81 23.02 11.35 coo 18.16 36.88 2.14 19.60 35.97 0.73 -26.65 28.26 7.42 -25.23 27.90 9.10 coo 16.75 32.35 6.21 21.42 30.93 2.22 -23.61 33.84 6.26 -20.57 37.69 4.41 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 3 4 # 3 A 19 ARG C 94 ARG~? 23.82 O3' ADP C1001 A 30 THR C 69 THR.? 8.25 C2 ADP C1001 A 34 VAL C 91 VAL.? 10.93 N3 ADP C1001 A 38 LYS C 108 LYS.? 14.57 N3 ADP C1001 coo 30.09 31.19 5.41 30.53 28.24 4.72 -33.86 30.07 42.29 -36.45 31.77 42.05 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -34.19 32.67 26.93 -33.84 33.77 25.09 coo 18.16 36.88 2.14 19.60 35.97 0.73 -36.49 28.15 29.02 -34.25 27.86 28.89 coo 16.75 32.35 6.21 21.42 30.93 2.22 -37.26 21.98 30.89 -34.43 24.41 31.94 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 4 4 # 4 A 19 ARG D 94 ARG~? 36.27 N6 ADP C1001 A 30 THR D 69 THR.? 36.92 N6 ADP C1001 A 34 VAL D 91 VAL.? 39.23 N6 ADP C1001 A 38 LYS D 108 LYS.? 47.30 N6 ADP C1001 coo 30.09 31.19 5.41 30.53 28.24 4.72 -8.09 53.40 -0.40 -7.97 50.74 -1.98 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -11.97 60.08 12.90 -13.39 61.48 13.64 coo 18.16 36.88 2.14 19.60 35.97 0.73 -7.01 60.72 10.97 -7.36 58.77 12.00 coo 16.75 32.35 6.21 21.42 30.93 2.22 -0.82 59.67 9.89 3.99 59.45 8.43 1mnm_d00 source 1mnm TRANSCRIPTION/DNA : 4 hits 1mnm_d00 naa= 4 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 14 LYS~? 28.69 N1 ADP C1001 A1294 ASN A 16 ASN.? 39.53 N1 ADP C1001 A1297 GLU A 8 GLU.? 40.05 N1 ADP C1001 coo 39.24 18.84-161.99 36.62 21.47-165.99 -12.97 3.35 18.51 -15.05 7.51 22.75 coo 33.53 17.37-161.81 34.31 17.81-163.76 -11.80 -4.14 16.79 -11.72 -4.01 18.95 coo 29.78 23.31-161.30 31.23 23.66-162.84 -16.47 -6.15 15.18 -15.55 -6.74 17.02 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS A 38 LYS^? 31.29 N6 ADP C1001 A1294 ASN A 39 ASN^? 26.27 N6 ADP C1001 A1297 GLU A 41 GLU^? 26.55 N6 ADP C1001 coo 39.24 18.84-161.99 36.62 21.47-165.99 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 33.53 17.37-161.81 34.31 17.81-163.76 -10.50 14.02 7.34 -12.57 14.30 7.00 coo 29.78 23.31-161.30 31.23 23.66-162.84 -16.06 9.21 5.46 -17.05 10.76 4.34 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS A 38 LYS^? 31.29 N6 ADP C1001 A1294 ASN A 39 ASN^? 26.27 N6 ADP C1001 A1297 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 39.24 18.84-161.99 36.62 21.47-165.99 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 33.53 17.37-161.81 34.31 17.81-163.76 -10.50 14.02 7.34 -12.57 14.30 7.00 coo 29.78 23.31-161.30 31.23 23.66-162.84 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS B 38 LYS.? 29.47 N6 ADP C1001 A1294 ASN B 39 ASN.? 27.14 N6 ADP C1001 A1297 GLU B 41 GLU^? 24.52 N6 ADP C1001 coo 39.24 18.84-161.99 36.62 21.47-165.99 -9.30 19.94 15.62 -4.67 19.41 15.25 coo 33.53 17.37-161.81 34.31 17.81-163.76 -11.13 15.65 16.64 -9.36 15.49 17.83 coo 29.78 23.31-161.30 31.23 23.66-162.84 -15.90 11.43 13.39 -16.60 10.91 15.33 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 5 3 # 5 A1290 LYS B 106 LYS.? 18.25 N6 ADP C1001 A1294 ASN D 39 ASN^? 19.52 N6 ADP C1001 A1297 GLU D 33 GLU^? 24.81 N6 ADP C1001 coo 39.24 18.84-161.99 36.62 21.47-165.99 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 33.53 17.37-161.81 34.31 17.81-163.76 -14.81 40.52 11.20 -15.13 38.43 11.40 coo 29.78 23.31-161.30 31.23 23.66-162.84 -9.58 39.62 17.74 -10.11 39.83 19.83 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 6 3 # 6 A1290 LYS B 106 LYS.? 18.25 N6 ADP C1001 A1294 ASN D 39 ASN^? 19.52 N6 ADP C1001 A1297 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 39.24 18.84-161.99 36.62 21.47-165.99 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 33.53 17.37-161.81 34.31 17.81-163.76 -14.81 40.52 11.20 -15.13 38.43 11.40 coo 29.78 23.31-161.30 31.23 23.66-162.84 -19.13 44.82 10.40 -20.77 44.03 11.36 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 7 3 # 7 A1290 LYS C 14 LYS.? 27.01 C2 ADP C1001 A1294 ASN C 16 ASN.? 20.87 O3' ADP C1001 A1297 GLU C 8 GLU.? 21.29 O3' ADP C1001 coo 39.24 18.84-161.99 36.62 21.47-165.99 -31.38 33.30 42.44 -27.73 35.10 43.96 coo 33.53 17.37-161.81 34.31 17.81-163.76 -37.30 33.94 37.34 -37.96 32.85 39.06 coo 29.78 23.31-161.30 31.23 23.66-162.84 -38.22 39.03 36.55 -39.65 38.08 37.81 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 8 3 # 8 A1290 LYS C 38 LYS^? 29.32 C2 ADP C1001 A1294 ASN C 39 ASN^? 25.44 C2 ADP C1001 A1297 GLU C 41 GLU^? 24.05 C2 ADP C1001 coo 39.24 18.84-161.99 36.62 21.47-165.99 -16.18 28.34 36.63 -11.47 27.59 37.59 coo 33.53 17.37-161.81 34.31 17.81-163.76 -16.77 32.66 36.54 -17.11 34.71 36.97 coo 29.78 23.31-161.30 31.23 23.66-162.84 -20.29 38.32 35.00 -18.64 39.42 34.23 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 9 3 # 9 A1290 LYS D 38 LYS^? 26.03 N6 ADP C1001 A1294 ASN D 39 ASN^? 19.52 N6 ADP C1001 A1297 GLU D 41 GLU^? 18.65 N6 ADP C1001 coo 39.24 18.84-161.99 36.62 21.47-165.99 -10.44 39.35 12.00 -7.01 36.04 14.36 coo 33.53 17.37-161.81 34.31 17.81-163.76 -14.81 40.52 11.20 -15.13 38.43 11.40 coo 29.78 23.31-161.30 31.23 23.66-162.84 -19.13 44.82 10.40 -20.77 44.03 11.36 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 9 hits 1xpx_d00 naa= 3 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 1 4 # 1 D 41 HIS B 62 HIS~? 22.43 N1 ADP C1001 D 67 LYS C 106 LYS.? 22.18 C2 ADP C1001 D 69 ILE C 109 ILE.? 9.05 O3' ADP C1001 D 70 VAL C 91 VAL.? 10.93 N3 ADP C1001 coo 33.21 28.24 12.68 34.93 27.24 13.36 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 -38.02 23.33 26.43 -37.19 24.19 25.39 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 -36.49 28.15 29.02 -34.25 27.86 28.89 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 2 4 # 2 D 41 HIS C 62 HIS~? 21.13 N1 ADP C1001 D 67 LYS B 106 LYS.? 18.25 N6 ADP C1001 D 69 ILE B 109 ILE.? 8.16 N6 ADP C1001 D 70 VAL B 91 VAL.? 9.34 N6 ADP C1001 coo 33.21 28.24 12.68 34.93 27.24 13.36 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 -27.70 33.33 8.38 -27.98 33.04 9.59 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 -26.65 28.26 7.42 -25.23 27.90 9.10 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 3 4 # 3 D 41 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 67 LYS C 65 LYS.? 16.76 N1 ADP C1001 D 69 ILE B 66 ILE^? 10.33 N1 ADP C1001 D 70 VAL B 3 VAL^? 14.14 N6 ADP C1001 coo 33.21 28.24 12.68 34.93 27.24 13.36 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 -23.49 24.37 18.65 -23.33 25.84 18.84 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 -20.36 21.33 16.68 -20.22 23.45 16.09 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 4 4 # 4 D 41 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 67 LYS C 65 LYS.? 16.76 N1 ADP C1001 D 69 ILE B 66 ILE^? 10.33 N1 ADP C1001 D 70 VAL B 87 VAL^? -5.85 N1 ADP C1001s coo 33.21 28.24 12.68 34.93 27.24 13.36 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 -21.73 32.18 22.71 -16.79 33.08 21.29 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 -23.49 24.37 18.65 -23.33 25.84 18.84 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 -29.44 24.98 17.08 -30.82 23.47 16.25 1zme_d00 source 1zme TRANSCRIPTION/DNA : 4 hits 1zme_d00 naa= 4 ULMN 4 2bgw_d00 HYDROLASE user 1 4 # 1 A 86 ALA B 76 ALA~? 9.09 O4' ADP C1001 A 87 GLU B 78 GLU~? 5.47 O3' ADP C1001 A 123 TYR B 79 TYR~? 13.34 O4' ADP C1001 A 182 ARG B 74 ARG~? -6.26 O2A ADP C1001s coo 33.66 63.14 16.62 34.95 63.46 15.91 -36.72 18.92 16.14 -36.15 18.54 14.79 coo 28.97 64.99 12.92 27.92 64.06 11.28 -39.37 23.43 20.35 -41.49 23.57 20.23 coo 38.40 63.73 13.00 38.79 62.53 10.47 -36.09 15.89 20.59 -36.23 13.43 21.88 coo 29.35 67.59 19.60 30.93 68.47 17.09 -43.21 24.74 16.58 -45.29 23.99 18.72 2bgw_d00 source 2bgw HYDROLASE : 1 hits 2bgw_d00 naa= 4 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG A 75 ARG~? 52.31 N6 ADP C1001 A 50 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 51 ASN A 57 ASN~? 43.07 N6 ADP C1001 coo 28.68 23.77 42.74 27.76 26.72 42.93 -9.93 -13.21 -7.89 -9.68 -10.57 -9.55 coo 14.40 30.33 40.28 14.25 28.31 45.36 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 19.09 30.55 41.51 19.09 28.89 42.82 -15.73 -0.75 -7.31 -14.92 -1.39 -9.21 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 5 ARG B 11 ARG~? 27.94 N6 ADP C1001 A 50 LYS A 38 LYS^? 31.29 N6 ADP C1001 A 51 ASN A 39 ASN^? 26.27 N6 ADP C1001 coo 28.68 23.77 42.74 27.76 26.72 42.93 -18.01 15.98 -2.43 -14.90 16.29 -2.31 coo 14.40 30.33 40.28 14.25 28.31 45.36 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 19.09 30.55 41.51 19.09 28.89 42.82 -10.50 14.02 7.34 -12.57 14.30 7.00 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 5 ARG B 94 ARG~? 24.19 N6 ADP C1001 A 50 LYS A 38 LYS^? 31.29 N6 ADP C1001 A 51 ASN A 39 ASN^? 26.27 N6 ADP C1001 coo 28.68 23.77 42.74 27.76 26.72 42.93 -16.51 23.41 0.38 -17.12 22.32 -2.40 coo 14.40 30.33 40.28 14.25 28.31 45.36 -6.79 15.32 9.19 -4.05 19.39 6.22 coo 19.09 30.55 41.51 19.09 28.89 42.82 -10.50 14.02 7.34 -12.57 14.30 7.00 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 5 ARG D 75 ARG~? 42.87 N1 ADP C1001 A 50 LYS D 60 LYS~? 25.96 N1 ADP C1001 A 51 ASN D 57 ASN~? 28.49 N1 ADP C1001 coo 28.68 23.77 42.74 27.76 26.72 42.93 -22.47 67.51 24.43 -22.92 70.53 24.84 coo 14.40 30.33 40.28 14.25 28.31 45.36 -21.35 51.92 21.59 -25.15 52.63 26.23 coo 19.09 30.55 41.51 19.09 28.89 42.82 -26.50 55.76 21.71 -26.74 56.60 23.67 2hos_d00 source 2hos TRANSCRIPTION/DNA : 4 hits 2hos_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 15 SER~? 35.42 N1 ADP C1001 B 37 ASN A 16 ASN.? 39.53 N1 ADP C1001 B 45 THR A 89 THR.? 50.21 N6 ADP C1001 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -11.80 -4.14 16.79 -11.72 -4.01 18.95 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -3.01 -7.90 5.97 -2.57 -9.33 4.41 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 82 SER~? 49.36 N6 ADP C1001 B 37 ASN A 81 ASN~? 50.50 N6 ADP C1001 B 45 THR A 69 THR.? 44.69 N6 ADP C1001 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -5.39 -4.03 -10.23 -7.69 -4.72 -10.44 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -3.09 -5.47 -6.59 -2.17 -5.74 -4.66 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -7.10 -5.38 7.02 -7.46 -6.06 5.00 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER A 82 SER~? 49.36 N6 ADP C1001 B 37 ASN A 81 ASN~? 50.50 N6 ADP C1001 B 45 THR A 89 THR.? 50.21 N6 ADP C1001 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -5.39 -4.03 -10.23 -7.69 -4.72 -10.44 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -3.09 -5.47 -6.59 -2.17 -5.74 -4.66 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -3.01 -7.90 5.97 -2.57 -9.33 4.41 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 15 SER~? 20.97 N6 ADP C1001 B 37 ASN B 16 ASN.? 20.20 N6 ADP C1001 B 45 THR B 89 THR.? -3.20 N6 ADP C1001s coo -19.49 41.97 71.08 -17.37 40.80 71.17 -19.71 18.90 1.41 -21.68 17.51 1.61 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -23.35 21.88 0.52 -22.21 22.66 -1.09 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -30.78 27.78 11.26 -32.72 28.03 12.28 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER B 82 SER~? 11.53 O4' ADP C1001 B 37 ASN B 81 ASN~? 5.38 N3 ADP C1001 B 45 THR B 69 THR.? 8.02 N6 ADP C1001 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -34.46 19.85 25.71 -36.11 18.63 24.45 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -34.12 23.31 22.91 -33.74 24.78 21.37 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -28.27 23.67 9.92 -29.81 23.02 11.35 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER B 82 SER~? 11.53 O4' ADP C1001 B 37 ASN B 81 ASN~? 5.38 N3 ADP C1001 B 45 THR B 89 THR.? -3.20 N6 ADP C1001s coo -19.49 41.97 71.08 -17.37 40.80 71.17 -34.46 19.85 25.71 -36.11 18.63 24.45 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -34.12 23.31 22.91 -33.74 24.78 21.37 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -30.78 27.78 11.26 -32.72 28.03 12.28 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 B 34 SER C 15 SER.? 21.32 C2 ADP C1001 B 37 ASN C 16 ASN.? 20.87 O3' ADP C1001 B 45 THR C 89 THR.? 3.96 N3 ADP C1001 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -33.57 35.15 39.94 -32.12 36.31 38.28 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -37.30 33.94 37.34 -37.96 32.85 39.06 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -36.03 29.56 23.55 -36.59 29.86 21.42 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 B 34 SER C 82 SER~? 10.86 N6 ADP C1001 B 37 ASN C 81 ASN~? -3.50 N6 ADP C1001s B 45 THR C 69 THR.? 8.25 C2 ADP C1001 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -25.49 36.24 12.26 -26.11 38.47 12.83 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -28.27 33.11 13.90 -29.33 31.68 15.09 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -34.19 32.67 26.93 -33.84 33.77 25.09 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 B 34 SER C 82 SER~? 10.86 N6 ADP C1001 B 37 ASN C 81 ASN~? -3.50 N6 ADP C1001s B 45 THR C 89 THR.? 3.96 N3 ADP C1001 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -25.49 36.24 12.26 -26.11 38.47 12.83 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -28.27 33.11 13.90 -29.33 31.68 15.09 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -36.03 29.56 23.55 -36.59 29.86 21.42 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 B 34 SER D 15 SER~? 33.93 N6 ADP C1001 B 37 ASN D 16 ASN.? 38.61 N6 ADP C1001 B 45 THR D 89 THR.? 41.56 N6 ADP C1001 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -14.05 55.07 1.32 -15.85 56.53 2.06 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -11.62 59.03 2.34 -10.83 58.47 0.52 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -8.88 62.80 15.73 -9.19 64.25 17.31 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 B 34 SER D 82 SER~? 36.34 N1 ADP C1001 B 37 ASN D 81 ASN~? 37.73 N1 ADP C1001 B 45 THR D 69 THR.? 36.92 N6 ADP C1001 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -18.91 58.91 29.15 -19.67 61.09 29.56 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -15.08 60.44 27.09 -13.56 60.92 25.66 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -11.97 60.08 12.90 -13.39 61.48 13.64 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 B 34 SER D 82 SER~? 36.34 N1 ADP C1001 B 37 ASN D 81 ASN~? 37.73 N1 ADP C1001 B 45 THR D 89 THR.? 41.56 N6 ADP C1001 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -18.91 58.91 29.15 -19.67 61.09 29.56 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -15.08 60.44 27.09 -13.56 60.92 25.66 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -8.88 62.80 15.73 -9.19 64.25 17.31 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 12 hits 2z3x_d00 naa= 3 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 B 122 ARG B 74 ARG~? -6.26 O2A ADP C1001s B 148 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 151 LEU B 83 LEU~? 14.46 C2 ADP C1001 B 154 ILE B 85 ILE.? 11.41 C2 ADP C1001 coo 13.00 32.05 60.31 16.02 31.73 59.80 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 11.05 44.13 44.68 12.77 44.45 49.56 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 11.72 38.91 44.77 13.11 39.67 46.23 -30.91 17.01 24.26 -31.89 15.25 23.69 coo 7.03 36.97 46.99 7.83 37.90 47.52 -28.32 20.11 21.52 -27.91 19.02 20.80 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 2 4 # 2 B 122 ARG B 74 ARG~? -6.26 O2A ADP C1001s B 148 LYS C 106 LYS.? 22.18 C2 ADP C1001 B 151 LEU B 83 LEU~? 14.46 C2 ADP C1001 B 154 ILE B 85 ILE.? 11.41 C2 ADP C1001 coo 13.00 32.05 60.31 16.02 31.73 59.80 -43.21 24.74 16.58 -45.29 23.99 18.72 coo 11.05 44.13 44.68 12.77 44.45 49.56 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 11.72 38.91 44.77 13.11 39.67 46.23 -30.91 17.01 24.26 -31.89 15.25 23.69 coo 7.03 36.97 46.99 7.83 37.90 47.52 -28.32 20.11 21.52 -27.91 19.02 20.80 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 3 4 # 3 B 122 ARG B 75 ARG~? 7.41 O2A ADP C1001 B 148 LYS B 60 LYS~? 21.40 C2 ADP C1001 B 151 LEU B 83 LEU~? 14.46 C2 ADP C1001 B 154 ILE B 85 ILE.? 11.41 C2 ADP C1001 coo 13.00 32.05 60.31 16.02 31.73 59.80 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 11.05 44.13 44.68 12.77 44.45 49.56 -26.04 13.89 21.83 -25.92 10.67 25.77 coo 11.72 38.91 44.77 13.11 39.67 46.23 -30.91 17.01 24.26 -31.89 15.25 23.69 coo 7.03 36.97 46.99 7.83 37.90 47.52 -28.32 20.11 21.52 -27.91 19.02 20.80 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 4 4 # 4 B 122 ARG B 75 ARG~? 7.41 O2A ADP C1001 B 148 LYS C 106 LYS.? 22.18 C2 ADP C1001 B 151 LEU B 83 LEU~? 14.46 C2 ADP C1001 B 154 ILE B 85 ILE.? 11.41 C2 ADP C1001 coo 13.00 32.05 60.31 16.02 31.73 59.80 -43.83 18.61 16.41 -46.11 20.56 15.85 coo 11.05 44.13 44.68 12.77 44.45 49.56 -32.20 18.25 30.35 -29.71 15.02 34.83 coo 11.72 38.91 44.77 13.11 39.67 46.23 -30.91 17.01 24.26 -31.89 15.25 23.69 coo 7.03 36.97 46.99 7.83 37.90 47.52 -28.32 20.11 21.52 -27.91 19.02 20.80 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 5 4 # 5 B 122 ARG C 74 ARG~? 5.25 O1B ADP C1001 B 148 LYS B 106 LYS.? 18.25 N6 ADP C1001 B 151 LEU C 83 LEU~? 12.70 N6 ADP C1001 B 154 ILE C 85 ILE.? 10.18 N1 ADP C1001 coo 13.00 32.05 60.31 16.02 31.73 59.80 -39.58 36.65 12.40 -39.71 35.25 9.68 coo 11.05 44.13 44.68 12.77 44.45 49.56 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 11.72 38.91 44.77 13.11 39.67 46.23 -23.31 37.75 16.31 -23.61 39.91 16.28 coo 7.03 36.97 46.99 7.83 37.90 47.52 -24.56 34.31 19.55 -24.20 35.15 20.44 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 6 4 # 6 B 122 ARG C 75 ARG~? 8.05 O3B ADP C1001 B 148 LYS B 106 LYS.? 18.25 N6 ADP C1001 B 151 LEU B 107 LEU.? 10.48 N6 ADP C1001 B 154 ILE B 109 ILE.? 8.16 N6 ADP C1001 coo 13.00 32.05 60.31 16.02 31.73 59.80 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 11.05 44.13 44.68 12.77 44.45 49.56 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 11.72 38.91 44.77 13.11 39.67 46.23 -23.07 32.49 10.53 -22.44 30.58 11.22 coo 7.03 36.97 46.99 7.83 37.90 47.52 -27.70 33.33 8.38 -27.98 33.04 9.59 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 7 4 # 7 B 122 ARG C 75 ARG~? 8.05 O3B ADP C1001 B 148 LYS B 106 LYS.? 18.25 N6 ADP C1001 B 151 LEU C 83 LEU~? 12.70 N6 ADP C1001 B 154 ILE C 85 ILE.? 10.18 N1 ADP C1001 coo 13.00 32.05 60.31 16.02 31.73 59.80 -38.47 40.65 15.33 -40.88 39.19 16.61 coo 11.05 44.13 44.68 12.77 44.45 49.56 -19.68 36.01 11.35 -19.41 40.72 7.99 coo 11.72 38.91 44.77 13.11 39.67 46.23 -23.31 37.75 16.31 -23.61 39.91 16.28 coo 7.03 36.97 46.99 7.83 37.90 47.52 -24.56 34.31 19.55 -24.20 35.15 20.44 3odc_d00 source 3odc DNA BINDING PROTEIN/DNA : 7 hits 3odc_d00 naa= 4 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG A 2 ARG^? 31.43 N6 ADP C1001 A 82 LYS A 60 LYS~? 43.57 N6 ADP C1001 A 97 ARG B 11 ARG~? 27.94 N6 ADP C1001 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -10.05 8.79 1.44 -11.10 11.55 0.50 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -11.54 3.22 -4.84 -9.87 2.87 -11.02 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -18.01 15.98 -2.43 -14.90 16.29 -2.31 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 78 ARG B 23 ARG.? 16.12 O1A ADP C1001 A 82 LYS B 19 LYS.? 15.59 N6 ADP C1001 A 97 ARG B 25 ARG.? 26.72 N7 ADP C1001 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -35.24 15.53 3.08 -37.20 16.95 1.17 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -31.10 21.58 3.18 -29.68 25.32 0.22 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -29.04 7.60 4.48 -27.73 5.04 5.73 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 78 ARG C 23 ARG.? 19.01 O2' ADP C1001 A 82 LYS C 19 LYS.? 18.77 O3' ADP C1001 A 97 ARG C 25 ARG.? 26.50 C2 ADP C1001 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -41.38 43.66 27.78 -43.67 44.44 29.75 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -40.14 36.21 30.10 -44.63 37.95 34.40 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -32.85 47.91 34.77 -31.37 50.53 33.86 4er8_d00 source 4er8 DNA BINDING PROTEIN/DNA : 3 hits 4er8_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 20 HIS.? 47.81 N6 ADP C1001 A 208 ASP A 110 ASP.? 52.32 N6 ADP C1001 A 296 SER A 82 SER~? 49.36 N6 ADP C1001 coo 12.72 17.48 24.71 12.80 19.37 23.81 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo 18.47 29.19 29.68 19.30 29.17 27.75 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo 6.89 17.22 46.63 5.08 16.21 47.91 -5.39 -4.03 -10.23 -7.69 -4.72 -10.44 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 208 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 296 SER C 82 SER~? 10.86 N6 ADP C1001 coo 12.72 17.48 24.71 12.80 19.37 23.81 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 18.47 29.19 29.68 19.30 29.17 27.75 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 6.89 17.22 46.63 5.08 16.21 47.91 -25.49 36.24 12.26 -26.11 38.47 12.83 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 208 ASP B 9 ASP.? 24.63 N6 ADP C1001 A 296 SER C 86 SER^? 7.39 N1 ADP C1001 coo 12.72 17.48 24.71 12.80 19.37 23.81 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 18.47 29.19 29.68 19.30 29.17 27.75 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo 6.89 17.22 46.63 5.08 16.21 47.91 -26.83 30.24 19.36 -25.45 28.48 18.57 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS B 20 HIS.? 13.19 O1A ADP C1001 A 208 ASP B 110 ASP.? 12.77 N6 ADP C1001 A 296 SER B 82 SER~? 11.53 O4' ADP C1001 coo 12.72 17.48 24.71 12.80 19.37 23.81 -35.44 19.24 3.79 -36.86 20.32 2.70 coo 18.47 29.19 29.68 19.30 29.17 27.75 -30.45 31.51 3.79 -31.95 31.85 2.33 coo 6.89 17.22 46.63 5.08 16.21 47.91 -34.46 19.85 25.71 -36.11 18.63 24.45 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 208 ASP C 9 ASP.? 24.62 C2 ADP C1001 A 296 SER B 82 SER~? 11.53 O4' ADP C1001 coo 12.72 17.48 24.71 12.80 19.37 23.81 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 18.47 29.19 29.68 19.30 29.17 27.75 -34.52 40.90 40.15 -34.60 38.85 40.85 coo 6.89 17.22 46.63 5.08 16.21 47.91 -34.46 19.85 25.71 -36.11 18.63 24.45 ULMN 3 2odj_o00 PORIN D user 6 3 # 6 A 156 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 208 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 296 SER B 86 SER^? 6.21 N1 ADP C1001 coo 12.72 17.48 24.71 12.80 19.37 23.81 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 18.47 29.19 29.68 19.30 29.17 27.75 -29.26 47.42 21.46 -29.58 49.13 20.24 coo 6.89 17.22 46.63 5.08 16.21 47.91 -28.54 24.76 20.78 -28.08 27.14 20.69 ULMN 3 2odj_o00 PORIN D user 7 3 # 7 A 156 HIS C 20 HIS.? 13.76 O2' ADP C1001 A 208 ASP C 110 ASP.? 10.54 O3' ADP C1001 A 296 SER C 82 SER~? 10.86 N6 ADP C1001 coo 12.72 17.48 24.71 12.80 19.37 23.81 -41.73 39.63 27.45 -43.78 39.16 27.51 coo 18.47 29.19 29.68 19.30 29.17 27.75 -42.40 26.72 28.14 -44.45 27.16 28.23 coo 6.89 17.22 46.63 5.08 16.21 47.91 -25.49 36.24 12.26 -26.11 38.47 12.83 2odj_o00 source 2ODJ PORIN D : 7 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 20 HIS.? 47.81 N6 ADP C1001 B 208 ASP A 110 ASP.? 52.32 N6 ADP C1001 B 296 SER A 82 SER~? 49.36 N6 ADP C1001 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -13.99 -12.93 8.41 -13.37 -14.79 9.16 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -2.05 -11.28 13.38 -2.43 -13.21 14.14 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -5.39 -4.03 -10.23 -7.69 -4.72 -10.44 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS B 20 HIS.? 13.19 O1A ADP C1001 B 208 ASP B 9 ASP.? 24.63 N6 ADP C1001 B 296 SER C 82 SER~? 10.86 N6 ADP C1001 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -35.44 19.24 3.79 -36.86 20.32 2.70 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -21.79 14.69 -0.26 -22.78 14.66 -2.05 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -25.49 36.24 12.26 -26.11 38.47 12.83 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS B 20 HIS.? 13.19 O1A ADP C1001 B 208 ASP B 110 ASP.? 12.77 N6 ADP C1001 B 296 SER B 82 SER~? 11.53 O4' ADP C1001 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -35.44 19.24 3.79 -36.86 20.32 2.70 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -30.45 31.51 3.79 -31.95 31.85 2.33 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -34.46 19.85 25.71 -36.11 18.63 24.45 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS C 20 HIS.? 13.76 O2' ADP C1001 B 208 ASP C 110 ASP.? 10.54 O3' ADP C1001 B 296 SER C 82 SER~? 10.86 N6 ADP C1001 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -41.73 39.63 27.45 -43.78 39.16 27.51 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -42.40 26.72 28.14 -44.45 27.16 28.23 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -25.49 36.24 12.26 -26.11 38.47 12.83 2odj_o01 source 2ODJ PORIN D : 4 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 15 SER~? 35.42 N1 ADP C1001 A 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 A 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 18 SER.? 40.87 N6 ADP C1001 A 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 A 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 18 SER.? 40.87 N6 ADP C1001 A 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 A 182 PHE A 58 PHE~? 34.92 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -17.56 0.82 -0.93 -18.36 2.22 1.34 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER A 24 SER.? 39.01 N6 ADP C1001 A 166 PHE A 58 PHE~? 34.92 N6 ADP C1001 A 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -17.71 -6.23 7.18 -16.21 -4.71 6.28 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -17.56 0.82 -0.93 -18.36 2.22 1.34 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER A 86 SER^? 47.04 N6 ADP C1001 A 166 PHE A 21 PHE.? 42.86 N6 ADP C1001 A 182 PHE A 27 PHE^? 37.41 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -2.30 -1.54 -1.75 -0.44 -0.25 -2.37 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -14.93 -0.17 4.77 -14.26 -2.70 3.79 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER B 15 SER~? 20.97 N6 ADP C1001 A 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 A 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -19.71 18.90 1.41 -21.68 17.51 1.61 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER B 18 SER.? 16.80 N6 ADP C1001 A 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 A 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -27.97 19.58 3.98 -27.31 17.40 4.71 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER B 18 SER.? 16.80 N6 ADP C1001 A 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 A 182 PHE B 58 PHE~? 21.02 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -27.97 19.58 3.98 -27.31 17.40 4.71 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -26.58 9.98 15.28 -24.37 9.78 13.51 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 9 3 # 9 A 130 SER B 24 SER.? 17.25 N6 ADP C1001 A 166 PHE B 58 PHE~? 21.02 N6 ADP C1001 A 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -29.56 14.13 6.20 -27.58 15.07 7.20 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -26.58 9.98 15.28 -24.37 9.78 13.51 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 10 3 # 10 A 130 SER B 86 SER^? 6.21 N1 ADP C1001 A 166 PHE B 21 PHE.? 12.47 N7 ADP C1001 A 182 PHE B 27 PHE^? 16.30 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -28.54 24.76 20.78 -28.08 27.14 20.69 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -31.61 18.24 11.10 -30.96 16.75 13.38 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -25.23 14.62 11.31 -27.95 15.25 11.19 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 11 3 # 11 A 130 SER B 86 SER^? 6.21 N1 ADP C1001 A 166 PHE C 80 PHE~? 9.30 N1 ADP C1001 A 182 PHE C 21 PHE.? 11.41 C2 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -28.54 24.76 20.78 -28.08 27.14 20.69 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -28.50 36.34 19.61 -28.58 37.64 22.04 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -33.74 38.44 24.72 -31.32 39.34 23.74 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 12 3 # 12 A 130 SER C 15 SER.? 21.32 C2 ADP C1001 A 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -33.57 35.15 39.94 -32.12 36.31 38.28 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 13 3 # 13 A 130 SER C 18 SER.? 15.10 O2' ADP C1001 A 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -36.98 36.98 32.18 -36.06 38.40 30.49 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 14 3 # 14 A 130 SER C 18 SER.? 15.10 O2' ADP C1001 A 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 A 182 PHE C 58 PHE~? 19.35 C2 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -36.98 36.98 32.18 -36.06 38.40 30.49 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -25.26 43.99 26.49 -25.09 43.67 29.27 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 15 3 # 15 A 130 SER C 24 SER.? 15.73 O2' ADP C1001 A 166 PHE C 58 PHE~? 19.35 C2 ADP C1001 A 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -34.60 42.57 30.36 -34.63 40.35 29.52 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 16 3 # 16 A 130 SER C 86 SER^? 7.39 N1 ADP C1001 A 166 PHE C 21 PHE.? 11.41 C2 ADP C1001 A 182 PHE C 27 PHE^? 15.44 C2 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -26.83 30.24 19.36 -25.45 28.48 18.57 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -33.74 38.44 24.72 -31.32 39.34 23.74 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -28.49 39.61 29.74 -30.46 39.97 27.81 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 17 3 # 17 A 130 SER D 15 SER~? 33.93 N6 ADP C1001 A 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 A 182 PHE D 21 PHE.? 33.63 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -14.05 55.07 1.32 -15.85 56.53 2.06 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -18.15 61.60 14.21 -19.50 59.60 15.67 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 18 3 # 18 A 130 SER D 15 SER~? 33.93 N6 ADP C1001 A 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 A 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -14.05 55.07 1.32 -15.85 56.53 2.06 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 19 3 # 19 A 130 SER D 18 SER.? 35.50 N6 ADP C1001 A 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 A 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -15.27 61.31 6.78 -16.76 61.07 8.60 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 20 3 # 20 A 130 SER D 18 SER.? 35.50 N6 ADP C1001 A 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 A 182 PHE D 58 PHE~? 24.52 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -15.27 61.31 6.78 -16.76 61.07 8.60 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -24.99 53.85 15.24 -24.47 52.34 12.98 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 21 3 # 21 A 130 SER D 24 SER.? 31.80 N6 ADP C1001 A 166 PHE D 58 PHE~? 24.52 N6 ADP C1001 A 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -21.41 60.30 8.38 -19.94 58.41 8.67 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -24.99 53.85 15.24 -24.47 52.34 12.98 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 22 3 # 22 A 130 SER D 86 SER^? 34.36 N1 ADP C1001 A 166 PHE D 21 PHE.? 33.63 N6 ADP C1001 A 182 PHE D 27 PHE^? 29.27 N6 ADP C1001 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -12.04 56.90 23.17 -10.44 55.07 22.97 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -18.15 61.60 14.21 -19.50 59.60 15.67 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -19.87 54.80 11.53 -19.94 57.47 12.38 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 22 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 15 SER~? 35.42 N1 ADP C1001 B 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 B 182 PHE A 21 PHE.? 42.86 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.01 -6.76 3.07 -12.69 -5.08 0.95 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 15 SER~? 35.42 N1 ADP C1001 B 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 B 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 18 SER.? 40.87 N6 ADP C1001 B 166 PHE A 21 PHE.? 42.86 N6 ADP C1001 B 182 PHE A 80 PHE~? 43.84 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -8.29 -3.88 -2.77 -10.49 -3.33 -1.12 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 18 SER.? 40.87 N6 ADP C1001 B 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 B 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER A 18 SER.? 40.87 N6 ADP C1001 B 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 B 182 PHE A 58 PHE~? 34.92 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -17.56 0.82 -0.93 -18.36 2.22 1.34 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER A 24 SER.? 39.01 N6 ADP C1001 B 166 PHE A 58 PHE~? 34.92 N6 ADP C1001 B 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -17.71 -6.23 7.18 -16.21 -4.71 6.28 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -17.56 0.82 -0.93 -18.36 2.22 1.34 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER A 86 SER^? 47.04 N6 ADP C1001 B 166 PHE A 21 PHE.? 42.86 N6 ADP C1001 B 182 PHE A 27 PHE^? 37.41 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -2.30 -1.54 -1.75 -0.44 -0.25 -2.37 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -14.93 -0.17 4.77 -14.26 -2.70 3.79 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER B 15 SER~? 20.97 N6 ADP C1001 B 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 B 182 PHE B 21 PHE.? 12.47 N7 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -19.71 18.90 1.41 -21.68 17.51 1.61 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -31.61 18.24 11.10 -30.96 16.75 13.38 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 9 3 # 9 B 130 SER B 15 SER~? 20.97 N6 ADP C1001 B 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 B 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -19.71 18.90 1.41 -21.68 17.51 1.61 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 10 3 # 10 B 130 SER B 18 SER.? 16.80 N6 ADP C1001 B 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 B 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -27.97 19.58 3.98 -27.31 17.40 4.71 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 11 3 # 11 B 130 SER B 18 SER.? 16.80 N6 ADP C1001 B 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 B 182 PHE B 58 PHE~? 21.02 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -27.97 19.58 3.98 -27.31 17.40 4.71 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -26.58 9.98 15.28 -24.37 9.78 13.51 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 12 3 # 12 B 130 SER B 24 SER.? 17.25 N6 ADP C1001 B 166 PHE B 58 PHE~? 21.02 N6 ADP C1001 B 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -29.56 14.13 6.20 -27.58 15.07 7.20 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -26.58 9.98 15.28 -24.37 9.78 13.51 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 13 3 # 13 B 130 SER B 86 SER^? 6.21 N1 ADP C1001 B 166 PHE B 21 PHE.? 12.47 N7 ADP C1001 B 182 PHE B 27 PHE^? 16.30 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -28.54 24.76 20.78 -28.08 27.14 20.69 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -31.61 18.24 11.10 -30.96 16.75 13.38 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -25.23 14.62 11.31 -27.95 15.25 11.19 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 14 3 # 14 B 130 SER B 86 SER^? 6.21 N1 ADP C1001 B 166 PHE C 80 PHE~? 9.30 N1 ADP C1001 B 182 PHE C 21 PHE.? 11.41 C2 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -28.54 24.76 20.78 -28.08 27.14 20.69 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -28.50 36.34 19.61 -28.58 37.64 22.04 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -33.74 38.44 24.72 -31.32 39.34 23.74 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 15 3 # 15 B 130 SER C 15 SER.? 21.32 C2 ADP C1001 B 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 B 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -33.57 35.15 39.94 -32.12 36.31 38.28 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 16 3 # 16 B 130 SER C 18 SER.? 15.10 O2' ADP C1001 B 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 B 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -36.98 36.98 32.18 -36.06 38.40 30.49 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 17 3 # 17 B 130 SER C 18 SER.? 15.10 O2' ADP C1001 B 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 B 182 PHE C 58 PHE~? 19.35 C2 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -36.98 36.98 32.18 -36.06 38.40 30.49 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -25.26 43.99 26.49 -25.09 43.67 29.27 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 18 3 # 18 B 130 SER C 24 SER.? 15.73 O2' ADP C1001 B 166 PHE C 58 PHE~? 19.35 C2 ADP C1001 B 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -34.60 42.57 30.36 -34.63 40.35 29.52 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 19 3 # 19 B 130 SER C 86 SER^? 7.39 N1 ADP C1001 B 166 PHE B 80 PHE~? 11.23 C2 ADP C1001 B 182 PHE B 21 PHE.? 12.47 N7 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -26.83 30.24 19.36 -25.45 28.48 18.57 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -31.32 19.21 18.41 -30.35 17.46 16.44 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -31.61 18.24 11.10 -30.96 16.75 13.38 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 20 3 # 20 B 130 SER C 86 SER^? 7.39 N1 ADP C1001 B 166 PHE C 21 PHE.? 11.41 C2 ADP C1001 B 182 PHE C 27 PHE^? 15.44 C2 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -26.83 30.24 19.36 -25.45 28.48 18.57 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -33.74 38.44 24.72 -31.32 39.34 23.74 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -28.49 39.61 29.74 -30.46 39.97 27.81 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 21 3 # 21 B 130 SER D 15 SER~? 33.93 N6 ADP C1001 B 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 B 182 PHE D 21 PHE.? 33.63 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -14.05 55.07 1.32 -15.85 56.53 2.06 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -18.15 61.60 14.21 -19.50 59.60 15.67 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 22 3 # 22 B 130 SER D 15 SER~? 33.93 N6 ADP C1001 B 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 B 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -14.05 55.07 1.32 -15.85 56.53 2.06 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 23 3 # 23 B 130 SER D 18 SER.? 35.50 N6 ADP C1001 B 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 B 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -15.27 61.31 6.78 -16.76 61.07 8.60 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 24 3 # 24 B 130 SER D 18 SER.? 35.50 N6 ADP C1001 B 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 B 182 PHE D 58 PHE~? 24.52 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -15.27 61.31 6.78 -16.76 61.07 8.60 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -24.99 53.85 15.24 -24.47 52.34 12.98 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 25 3 # 25 B 130 SER D 24 SER.? 31.80 N6 ADP C1001 B 166 PHE D 58 PHE~? 24.52 N6 ADP C1001 B 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -21.41 60.30 8.38 -19.94 58.41 8.67 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -24.99 53.85 15.24 -24.47 52.34 12.98 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 26 3 # 26 B 130 SER D 86 SER^? 34.36 N1 ADP C1001 B 166 PHE D 21 PHE.? 33.63 N6 ADP C1001 B 182 PHE D 27 PHE^? 29.27 N6 ADP C1001 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -12.04 56.90 23.17 -10.44 55.07 22.97 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -18.15 61.60 14.21 -19.50 59.60 15.67 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -19.87 54.80 11.53 -19.94 57.47 12.38 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 26 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 15 SER~? 35.42 N1 ADP C1001 C 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 C 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 18 SER.? 40.87 N6 ADP C1001 C 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 C 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 18 SER.? 40.87 N6 ADP C1001 C 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 C 182 PHE A 58 PHE~? 34.92 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -17.56 0.82 -0.93 -18.36 2.22 1.34 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER A 24 SER.? 39.01 N6 ADP C1001 C 166 PHE A 58 PHE~? 34.92 N6 ADP C1001 C 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -17.71 -6.23 7.18 -16.21 -4.71 6.28 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -17.56 0.82 -0.93 -18.36 2.22 1.34 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER A 86 SER^? 47.04 N6 ADP C1001 C 166 PHE A 21 PHE.? 42.86 N6 ADP C1001 C 182 PHE A 27 PHE^? 37.41 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -2.30 -1.54 -1.75 -0.44 -0.25 -2.37 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -14.93 -0.17 4.77 -14.26 -2.70 3.79 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER B 15 SER~? 20.97 N6 ADP C1001 C 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 C 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -19.71 18.90 1.41 -21.68 17.51 1.61 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER B 18 SER.? 16.80 N6 ADP C1001 C 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 C 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -27.97 19.58 3.98 -27.31 17.40 4.71 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER B 18 SER.? 16.80 N6 ADP C1001 C 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 C 182 PHE B 58 PHE~? 21.02 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -27.97 19.58 3.98 -27.31 17.40 4.71 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -26.58 9.98 15.28 -24.37 9.78 13.51 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 9 3 # 9 C 130 SER B 24 SER.? 17.25 N6 ADP C1001 C 166 PHE B 58 PHE~? 21.02 N6 ADP C1001 C 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -29.56 14.13 6.20 -27.58 15.07 7.20 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -26.58 9.98 15.28 -24.37 9.78 13.51 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 10 3 # 10 C 130 SER B 86 SER^? 6.21 N1 ADP C1001 C 166 PHE B 21 PHE.? 12.47 N7 ADP C1001 C 182 PHE B 27 PHE^? 16.30 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -28.54 24.76 20.78 -28.08 27.14 20.69 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -31.61 18.24 11.10 -30.96 16.75 13.38 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -25.23 14.62 11.31 -27.95 15.25 11.19 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 11 3 # 11 C 130 SER C 18 SER.? 15.10 O2' ADP C1001 C 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 C 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -36.98 36.98 32.18 -36.06 38.40 30.49 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 12 3 # 12 C 130 SER C 18 SER.? 15.10 O2' ADP C1001 C 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 C 182 PHE C 58 PHE~? 19.35 C2 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -36.98 36.98 32.18 -36.06 38.40 30.49 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -25.26 43.99 26.49 -25.09 43.67 29.27 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 13 3 # 13 C 130 SER C 24 SER.? 15.73 O2' ADP C1001 C 166 PHE C 58 PHE~? 19.35 C2 ADP C1001 C 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -34.60 42.57 30.36 -34.63 40.35 29.52 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 14 3 # 14 C 130 SER C 86 SER^? 7.39 N1 ADP C1001 C 166 PHE C 21 PHE.? 11.41 C2 ADP C1001 C 182 PHE C 27 PHE^? 15.44 C2 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -26.83 30.24 19.36 -25.45 28.48 18.57 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -33.74 38.44 24.72 -31.32 39.34 23.74 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -28.49 39.61 29.74 -30.46 39.97 27.81 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 15 3 # 15 C 130 SER D 15 SER~? 33.93 N6 ADP C1001 C 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 C 182 PHE D 21 PHE.? 33.63 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -14.05 55.07 1.32 -15.85 56.53 2.06 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -18.15 61.60 14.21 -19.50 59.60 15.67 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 16 3 # 16 C 130 SER D 15 SER~? 33.93 N6 ADP C1001 C 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 C 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -14.05 55.07 1.32 -15.85 56.53 2.06 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 17 3 # 17 C 130 SER D 18 SER.? 35.50 N6 ADP C1001 C 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 C 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -15.27 61.31 6.78 -16.76 61.07 8.60 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 18 3 # 18 C 130 SER D 18 SER.? 35.50 N6 ADP C1001 C 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 C 182 PHE D 58 PHE~? 24.52 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -15.27 61.31 6.78 -16.76 61.07 8.60 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -24.99 53.85 15.24 -24.47 52.34 12.98 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 19 3 # 19 C 130 SER D 24 SER.? 31.80 N6 ADP C1001 C 166 PHE D 58 PHE~? 24.52 N6 ADP C1001 C 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -21.41 60.30 8.38 -19.94 58.41 8.67 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -24.99 53.85 15.24 -24.47 52.34 12.98 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 20 3 # 20 C 130 SER D 86 SER^? 34.36 N1 ADP C1001 C 166 PHE D 21 PHE.? 33.63 N6 ADP C1001 C 182 PHE D 27 PHE^? 29.27 N6 ADP C1001 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -12.04 56.90 23.17 -10.44 55.07 22.97 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -18.15 61.60 14.21 -19.50 59.60 15.67 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -19.87 54.80 11.53 -19.94 57.47 12.38 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 20 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 15 SER~? 35.42 N1 ADP C1001 D 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 D 182 PHE A 21 PHE.? 42.86 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.01 -6.76 3.07 -12.69 -5.08 0.95 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 15 SER~? 35.42 N1 ADP C1001 D 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 D 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.03 0.17 16.67 -15.21 -1.29 15.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 18 SER.? 40.87 N6 ADP C1001 D 166 PHE A 21 PHE.? 42.86 N6 ADP C1001 D 182 PHE A 80 PHE~? 43.84 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -8.29 -3.88 -2.77 -10.49 -3.33 -1.12 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 18 SER.? 40.87 N6 ADP C1001 D 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 D 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER A 18 SER.? 40.87 N6 ADP C1001 D 166 PHE A 27 PHE^? 37.41 N6 ADP C1001 D 182 PHE A 58 PHE~? 34.92 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -13.14 -6.41 11.44 -13.61 -6.13 9.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.93 -0.17 4.77 -14.26 -2.70 3.79 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -17.56 0.82 -0.93 -18.36 2.22 1.34 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER A 24 SER.? 39.01 N6 ADP C1001 D 166 PHE A 58 PHE~? 34.92 N6 ADP C1001 D 182 PHE A 29 PHE^? 33.27 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -17.71 -6.23 7.18 -16.21 -4.71 6.28 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -17.56 0.82 -0.93 -18.36 2.22 1.34 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.99 5.90 3.87 -14.20 3.90 2.32 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER A 86 SER^? 47.04 N6 ADP C1001 D 166 PHE A 21 PHE.? 42.86 N6 ADP C1001 D 182 PHE A 27 PHE^? 37.41 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -2.30 -1.54 -1.75 -0.44 -0.25 -2.37 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -12.01 -6.76 3.07 -12.69 -5.08 0.95 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -14.93 -0.17 4.77 -14.26 -2.70 3.79 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER B 15 SER~? 20.97 N6 ADP C1001 D 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 D 182 PHE B 21 PHE.? 12.47 N7 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -19.71 18.90 1.41 -21.68 17.51 1.61 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -31.61 18.24 11.10 -30.96 16.75 13.38 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 9 3 # 9 D 130 SER B 15 SER~? 20.97 N6 ADP C1001 D 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 D 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -19.71 18.90 1.41 -21.68 17.51 1.61 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 10 3 # 10 D 130 SER B 18 SER.? 16.80 N6 ADP C1001 D 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 D 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -27.97 19.58 3.98 -27.31 17.40 4.71 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 11 3 # 11 D 130 SER B 18 SER.? 16.80 N6 ADP C1001 D 166 PHE B 27 PHE^? 16.30 N6 ADP C1001 D 182 PHE B 58 PHE~? 21.02 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -27.97 19.58 3.98 -27.31 17.40 4.71 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -25.23 14.62 11.31 -27.95 15.25 11.19 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -26.58 9.98 15.28 -24.37 9.78 13.51 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 12 3 # 12 D 130 SER B 24 SER.? 17.25 N6 ADP C1001 D 166 PHE B 58 PHE~? 21.02 N6 ADP C1001 D 182 PHE B 29 PHE^? 19.13 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -29.56 14.13 6.20 -27.58 15.07 7.20 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -26.58 9.98 15.28 -24.37 9.78 13.51 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -19.97 14.78 14.91 -22.45 13.54 15.08 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 13 3 # 13 D 130 SER B 86 SER^? 6.21 N1 ADP C1001 D 166 PHE B 21 PHE.? 12.47 N7 ADP C1001 D 182 PHE B 27 PHE^? 16.30 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -28.54 24.76 20.78 -28.08 27.14 20.69 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -31.61 18.24 11.10 -30.96 16.75 13.38 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -25.23 14.62 11.31 -27.95 15.25 11.19 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 14 3 # 14 D 130 SER B 86 SER^? 6.21 N1 ADP C1001 D 166 PHE C 80 PHE~? 9.30 N1 ADP C1001 D 182 PHE C 21 PHE.? 11.41 C2 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -28.54 24.76 20.78 -28.08 27.14 20.69 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -28.50 36.34 19.61 -28.58 37.64 22.04 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -33.74 38.44 24.72 -31.32 39.34 23.74 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 15 3 # 15 D 130 SER C 15 SER.? 21.32 C2 ADP C1001 D 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 D 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -33.57 35.15 39.94 -32.12 36.31 38.28 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 16 3 # 16 D 130 SER C 18 SER.? 15.10 O2' ADP C1001 D 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 D 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -36.98 36.98 32.18 -36.06 38.40 30.49 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 17 3 # 17 D 130 SER C 18 SER.? 15.10 O2' ADP C1001 D 166 PHE C 27 PHE^? 15.44 C2 ADP C1001 D 182 PHE C 58 PHE~? 19.35 C2 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -36.98 36.98 32.18 -36.06 38.40 30.49 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -28.49 39.61 29.74 -30.46 39.97 27.81 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -25.26 43.99 26.49 -25.09 43.67 29.27 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 18 3 # 18 D 130 SER C 24 SER.? 15.73 O2' ADP C1001 D 166 PHE C 58 PHE~? 19.35 C2 ADP C1001 D 182 PHE C 29 PHE^? 17.94 C2 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -34.60 42.57 30.36 -34.63 40.35 29.52 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -25.26 43.99 26.49 -25.09 43.67 29.27 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -22.69 37.33 30.80 -23.71 39.19 28.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 19 3 # 19 D 130 SER C 86 SER^? 7.39 N1 ADP C1001 D 166 PHE B 80 PHE~? 11.23 C2 ADP C1001 D 182 PHE B 21 PHE.? 12.47 N7 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -26.83 30.24 19.36 -25.45 28.48 18.57 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -31.32 19.21 18.41 -30.35 17.46 16.44 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -31.61 18.24 11.10 -30.96 16.75 13.38 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 20 3 # 20 D 130 SER C 86 SER^? 7.39 N1 ADP C1001 D 166 PHE C 21 PHE.? 11.41 C2 ADP C1001 D 182 PHE C 27 PHE^? 15.44 C2 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -26.83 30.24 19.36 -25.45 28.48 18.57 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -33.74 38.44 24.72 -31.32 39.34 23.74 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -28.49 39.61 29.74 -30.46 39.97 27.81 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 21 3 # 21 D 130 SER D 15 SER~? 33.93 N6 ADP C1001 D 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 D 182 PHE D 21 PHE.? 33.63 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.05 55.07 1.32 -15.85 56.53 2.06 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -18.15 61.60 14.21 -19.50 59.60 15.67 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 22 3 # 22 D 130 SER D 15 SER~? 33.93 N6 ADP C1001 D 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 D 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.05 55.07 1.32 -15.85 56.53 2.06 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 23 3 # 23 D 130 SER D 18 SER.? 35.50 N6 ADP C1001 D 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 D 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -15.27 61.31 6.78 -16.76 61.07 8.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 24 3 # 24 D 130 SER D 18 SER.? 35.50 N6 ADP C1001 D 166 PHE D 27 PHE^? 29.27 N6 ADP C1001 D 182 PHE D 58 PHE~? 24.52 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -15.27 61.31 6.78 -16.76 61.07 8.60 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -19.87 54.80 11.53 -19.94 57.47 12.38 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -24.99 53.85 15.24 -24.47 52.34 12.98 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 25 3 # 25 D 130 SER D 24 SER.? 31.80 N6 ADP C1001 D 166 PHE D 58 PHE~? 24.52 N6 ADP C1001 D 182 PHE D 29 PHE^? 23.81 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -21.41 60.30 8.38 -19.94 58.41 8.67 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -24.99 53.85 15.24 -24.47 52.34 12.98 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -18.44 48.91 13.36 -20.46 50.71 14.19 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 26 3 # 26 D 130 SER D 86 SER^? 34.36 N1 ADP C1001 D 166 PHE D 21 PHE.? 33.63 N6 ADP C1001 D 182 PHE D 27 PHE^? 29.27 N6 ADP C1001 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -12.04 56.90 23.17 -10.44 55.07 22.97 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -18.15 61.60 14.21 -19.50 59.60 15.67 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -19.87 54.80 11.53 -19.94 57.47 12.38 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 26 hits 2r11_o03 naa= 3 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 250 ALA A 4 ALA^? 37.50 N6 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -9.47 2.58 4.42 -9.97 2.04 3.08 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 A 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP B 10 ASP.? 28.32 N6 ADP C1001 A 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 A 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 A 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 A 250 ALA B 64 ALA.? 15.41 N1 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -22.22 17.81 20.01 -22.67 17.81 18.54 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 250 ALA C 4 ALA^? 13.75 C2 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -25.90 34.40 28.80 -25.82 35.52 27.80 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 A 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 A 250 ALA C 64 ALA.? 14.62 N1 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -21.29 34.81 25.43 -22.58 35.15 26.14 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP D 61 ASP~? 23.08 N1 ADP C1001 A 86 HIS D 62 HIS.? 20.37 N6 ADP C1001 A 250 ALA D 64 ALA.? 26.15 N6 ADP C1001 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -16.76 49.68 19.26 -17.00 50.74 18.25 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 7 hits 2wwt_o00 naa= 3 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 B 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 250 ALA A 4 ALA^? 37.50 N6 ADP C1001 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -9.47 2.58 4.42 -9.97 2.04 3.08 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 B 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 B 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 B 49 ASP B 10 ASP.? 28.32 N6 ADP C1001 B 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 B 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 B 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 250 ALA B 4 ALA^? 14.54 N6 ADP C1001 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -22.49 19.03 14.42 -23.52 18.15 15.03 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 B 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 B 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 B 250 ALA B 64 ALA.? 15.41 N1 ADP C1001 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -22.22 17.81 20.01 -22.67 17.81 18.54 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 B 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 B 250 ALA C 4 ALA^? 13.75 C2 ADP C1001 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -25.90 34.40 28.80 -25.82 35.52 27.80 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 B 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 B 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 B 250 ALA C 64 ALA.? 14.62 N1 ADP C1001 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -21.29 34.81 25.43 -22.58 35.15 26.14 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 B 49 ASP D 61 ASP~? 23.08 N1 ADP C1001 B 86 HIS D 62 HIS.? 20.37 N6 ADP C1001 B 250 ALA D 64 ALA.? 26.15 N6 ADP C1001 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -16.76 49.68 19.26 -17.00 50.74 18.25 2wwt_o01 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o01 naa= 3 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 C 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 C 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 C 250 ALA A 4 ALA^? 37.50 N6 ADP C1001 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -9.47 2.58 4.42 -9.97 2.04 3.08 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 C 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 C 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 C 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 C 49 ASP B 10 ASP.? 28.32 N6 ADP C1001 C 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 C 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 C 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 C 250 ALA B 4 ALA^? 14.54 N6 ADP C1001 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -22.49 19.03 14.42 -23.52 18.15 15.03 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 C 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 C 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 C 250 ALA B 64 ALA.? 15.41 N1 ADP C1001 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -22.22 17.81 20.01 -22.67 17.81 18.54 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 C 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 C 250 ALA C 4 ALA^? 13.75 C2 ADP C1001 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -25.90 34.40 28.80 -25.82 35.52 27.80 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 C 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 C 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 C 250 ALA C 64 ALA.? 14.62 N1 ADP C1001 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -21.29 34.81 25.43 -22.58 35.15 26.14 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 C 49 ASP D 61 ASP~? 23.08 N1 ADP C1001 C 86 HIS D 62 HIS.? 20.37 N6 ADP C1001 C 250 ALA D 64 ALA.? 26.15 N6 ADP C1001 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -16.76 49.68 19.26 -17.00 50.74 18.25 2wwt_o02 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o02 naa= 3 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 D 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 D 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 D 250 ALA A 4 ALA^? 37.50 N6 ADP C1001 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -9.47 2.58 4.42 -9.97 2.04 3.08 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 D 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 D 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 D 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 D 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 D 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 D 250 ALA B 64 ALA.? 15.41 N1 ADP C1001 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -24.91 9.18 21.46 -26.77 8.69 22.33 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -21.68 10.95 17.44 -21.09 9.22 16.39 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -22.22 17.81 20.01 -22.67 17.81 18.54 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 D 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 D 250 ALA C 4 ALA^? 13.75 C2 ADP C1001 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -25.90 34.40 28.80 -25.82 35.52 27.80 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 D 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 D 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 D 250 ALA C 64 ALA.? 14.62 N1 ADP C1001 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -20.25 43.54 24.10 -19.06 45.03 24.94 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -20.79 41.45 28.58 -20.89 43.35 29.47 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -21.29 34.81 25.43 -22.58 35.15 26.14 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 D 49 ASP D 61 ASP~? 23.08 N1 ADP C1001 D 86 HIS D 62 HIS.? 20.37 N6 ADP C1001 D 250 ALA D 64 ALA.? 26.15 N6 ADP C1001 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -25.68 50.03 20.54 -26.38 51.13 22.17 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -23.21 48.47 15.79 -25.03 48.41 14.73 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -16.76 49.68 19.26 -17.00 50.74 18.25 2wwt_o03 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 6 hits 2wwt_o03 naa= 3 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 E 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 E 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 E 250 ALA A 4 ALA^? 37.50 N6 ADP C1001 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -9.47 2.58 4.42 -9.97 2.04 3.08 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 E 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 E 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 E 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 E 49 ASP B 10 ASP.? 28.32 N6 ADP C1001 E 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 E 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 E 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 E 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 E 250 ALA B 4 ALA^? 14.54 N6 ADP C1001 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -22.49 19.03 14.42 -23.52 18.15 15.03 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 E 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 E 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 E 250 ALA B 64 ALA.? 15.41 N1 ADP C1001 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -22.22 17.81 20.01 -22.67 17.81 18.54 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 E 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 E 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 E 250 ALA C 4 ALA^? 13.75 C2 ADP C1001 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -25.90 34.40 28.80 -25.82 35.52 27.80 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 E 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 E 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 E 250 ALA C 64 ALA.? 14.62 N1 ADP C1001 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -21.29 34.81 25.43 -22.58 35.15 26.14 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 E 49 ASP D 61 ASP~? 23.08 N1 ADP C1001 E 86 HIS D 62 HIS.? 20.37 N6 ADP C1001 E 250 ALA D 4 ALA^? 27.82 N6 ADP C1001 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -15.17 52.28 14.24 -16.54 52.72 14.92 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 E 49 ASP D 61 ASP~? 23.08 N1 ADP C1001 E 86 HIS D 62 HIS.? 20.37 N6 ADP C1001 E 250 ALA D 64 ALA.? 26.15 N6 ADP C1001 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -16.76 49.68 19.26 -17.00 50.74 18.25 2wwt_o04 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 9 hits 2wwt_o04 naa= 3 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 F 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 F 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 F 250 ALA A 4 ALA^? 37.50 N6 ADP C1001 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -9.47 2.58 4.42 -9.97 2.04 3.08 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 F 49 ASP A 61 ASP~? 37.71 N6 ADP C1001 F 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 F 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -16.08 4.88 -5.43 -16.33 3.76 -7.24 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 F 49 ASP B 10 ASP.? 28.32 N6 ADP C1001 F 86 HIS A 62 HIS~? 32.10 N6 ADP C1001 F 250 ALA A 64 ALA.? 37.27 N6 ADP C1001 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -19.64 10.11 1.49 -19.54 9.87 -0.69 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -15.84 6.06 -0.29 -17.94 5.95 -0.14 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -8.60 5.30 -0.48 -9.23 4.31 0.41 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 F 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 F 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 F 250 ALA B 4 ALA^? 14.54 N6 ADP C1001 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -22.49 19.03 14.42 -23.52 18.15 15.03 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 F 49 ASP B 61 ASP~? 21.98 C2 ADP C1001 F 86 HIS B 62 HIS~? 22.43 N1 ADP C1001 F 250 ALA B 64 ALA.? 15.41 N1 ADP C1001 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -24.91 9.18 21.46 -26.77 8.69 22.33 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -21.68 10.95 17.44 -21.09 9.22 16.39 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -22.22 17.81 20.01 -22.67 17.81 18.54 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 F 49 ASP C 61 ASP~? 22.05 N1 ADP C1001 F 86 HIS C 62 HIS~? 21.13 N1 ADP C1001 F 250 ALA C 4 ALA^? 13.75 C2 ADP C1001 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -20.25 43.54 24.10 -19.06 45.03 24.94 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -20.79 41.45 28.58 -20.89 43.35 29.47 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -25.90 34.40 28.80 -25.82 35.52 27.80 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 F 49 ASP D 61 ASP~? 23.08 N1 ADP C1001 F 86 HIS D 62 HIS.? 20.37 N6 ADP C1001 F 250 ALA D 4 ALA^? 27.82 N6 ADP C1001 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -15.17 52.28 14.24 -16.54 52.72 14.92 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 F 49 ASP D 61 ASP~? 23.08 N1 ADP C1001 F 86 HIS D 62 HIS.? 20.37 N6 ADP C1001 F 250 ALA D 64 ALA.? 26.15 N6 ADP C1001 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -25.68 50.03 20.54 -26.38 51.13 22.17 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -23.21 48.47 15.79 -25.03 48.41 14.73 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -16.76 49.68 19.26 -17.00 50.74 18.25 2wwt_o05 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o05 naa= 3 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 1 3 # 1 A 220 HIS C 50 HIS.? 17.04 O2' ADP C1001 A 250 ASP C 54 ASP~? 20.12 N1 ADP C1001 A 328 SER C 24 SER.? 15.73 O2' ADP C1001 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -36.38 48.00 21.35 -37.79 46.44 21.40 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -34.60 42.57 30.36 -34.63 40.35 29.52 3nwu_o00 source 3NWU SERINE PROTEASE HTRA1 : 1 hits 3nwu_o00 naa= 3 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 1 3 # 1 B 220 HIS C 50 HIS.? 17.04 O2' ADP C1001 B 250 ASP C 54 ASP~? 20.12 N1 ADP C1001 B 328 SER C 24 SER.? 15.73 O2' ADP C1001 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -36.38 48.00 21.35 -37.79 46.44 21.40 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -34.60 42.57 30.36 -34.63 40.35 29.52 3nwu_o01 source 3NWU SERINE PROTEASE HTRA1 : 1 hits 3nwu_o01 naa= 3 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 1 3 # 1 C 220 HIS C 50 HIS.? 17.04 O2' ADP C1001 C 250 ASP C 54 ASP~? 20.12 N1 ADP C1001 C 328 SER C 24 SER.? 15.73 O2' ADP C1001 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -36.38 48.00 21.35 -37.79 46.44 21.40 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -29.26 47.42 21.46 -29.58 49.13 20.24 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -34.60 42.57 30.36 -34.63 40.35 29.52 3nwu_o02 source 3NWU SERINE PROTEASE HTRA1 : 1 hits 3nwu_o02 naa= 3